data_2akk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2akk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.474 ' HB3' HD21 ' A' ' 12' ' ' LEU . 32.6 mt-10 . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.374 0.607 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.758 HG13 HG21 ' A' ' 52' ' ' ILE . 19.2 t -85.96 121.26 37.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.602 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -124.93 153.19 43.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -174.17 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 111.085 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.594 ' SG ' HG21 ' A' ' 22' ' ' ILE . 13.7 p -56.05 -30.68 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.607 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -83.85 -56.7 3.55 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.29 19.2 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.245 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.624 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . . . -83.05 135.6 34.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.047 0.423 . . . . 0.0 110.039 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 4' ' ' GLU . 15.8 mt -77.29 135.7 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.288 0.566 . . . . 0.0 112.445 -174.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.417 ' HB3' HD12 ' A' ' 43' ' ' ILE . 63.9 mt -112.0 166.72 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.711 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.9 179.49 9.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.26 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -64.69 118.37 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.16 8.56 50.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.217 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.84 174.19 8.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.838 -0.213 . . . . 0.0 110.467 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 3.2 p30 -133.7 139.63 46.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.526 0.679 . . . . 0.0 111.585 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.48 HG21 HD11 ' A' ' 69' ' ' LEU . 34.6 m -131.88 174.7 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.213 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 m -151.89 148.88 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.807 0.337 . . . . 0.0 110.781 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.598 HD12 HD21 ' A' ' 25' ' ' LEU . 4.5 mm? -60.74 130.04 44.5 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.236 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.64 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -91.15 -11.33 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.56 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.64 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.55 178.34 10.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.296 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -91.44 121.9 33.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.598 HD21 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.463 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.5 mmmt . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.529 0.68 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -61.61 138.78 58.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.984 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.04 -13.07 63.75 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.634 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.521 ' HB ' HD23 ' A' ' 21' ' ' LEU . 77.9 m -58.78 119.41 7.09 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 7.4 ttt -87.98 124.65 33.93 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.282 0.563 . . . . 0.0 110.751 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.6 mt -114.53 91.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.664 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -108.61 149.53 28.77 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.708 -176.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.58 6.54 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.221 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.537 HG23 ' HA3' ' A' ' 54' ' ' GLY . 2.0 pp -91.65 160.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 8.2 ptt180 -141.06 161.01 38.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.748 0.309 . . . . 0.0 110.579 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.512 HD23 ' CG2' ' A' ' 5' ' ' VAL . 25.9 mt -79.86 154.06 28.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.238 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -121.46 -159.33 0.8 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.23 -14.2 62.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.686 0.755 . . . . 0.0 109.261 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 65.6 m -101.03 148.35 25.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.669 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.572 ' HA ' HG22 ' A' ' 5' ' ' VAL . 23.8 mt-10 -92.5 -16.43 25.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.36 -14.94 23.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.382 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 8.2 mp0 -125.66 148.73 48.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.548 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.758 HG21 HG13 ' A' ' 5' ' ' VAL . 2.5 pp -132.45 160.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.253 171.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -115.58 122.68 46.37 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.537 ' HA3' HG23 ' A' ' 43' ' ' ILE . . . -133.33 -156.1 7.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.716 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.7 ptp180 . . . . . 0 C--N 1.32 -0.712 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HD2' ' C ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.797 0.332 . . . . 0.0 110.485 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.61 50.57 42.05 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.64 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -115.23 135.39 54.22 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.083 0.468 . . . . 0.0 110.033 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -92.66 122.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.722 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 25.7 mt -134.02 147.0 50.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.37 0.605 . . . . 0.0 112.191 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.578 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.8 ptp180 -66.34 130.51 43.47 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.947 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.493 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.2 t -86.23 26.29 1.06 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.251 0.548 . . . . 0.0 110.856 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.573 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.0 mt-10 -84.17 -22.58 30.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.714 0.769 . . . . 0.0 109.652 -175.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HZ ' HD21 ' A' ' 64' ' ' LEU . 24.2 p90 -117.32 19.44 14.09 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.749 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 66' ' ' THR . 60.6 mt -116.68 145.48 43.41 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.014 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HB2' HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -114.4 133.27 55.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.247 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.624 ' HD2' ' HB2' ' A' ' 11' ' ' ALA . 52.1 tttt -58.43 122.32 13.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -175.155 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.539 HG21 ' HA ' ' A' ' 49' ' ' GLU . 3.6 t -91.63 129.84 41.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.779 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.527 ' HG3' HD22 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -133.98 171.09 14.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.19 -169.72 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 22' ' ' ILE . 7.7 p -66.39 -27.77 68.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.295 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -82.46 -51.03 8.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.09 27.1 0.26 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.772 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.65 123.78 40.43 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.527 HD22 ' HG3' ' A' ' 6' ' ' ARG . 27.4 mt -60.35 143.78 52.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.457 0.646 . . . . 0.0 112.642 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 43' ' ' ILE . 95.7 mt -111.36 170.85 7.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.14 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.47 178.17 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.86 122.0 14.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.012 0.434 . . . . 0.0 110.946 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.19 64.33 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.374 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.578 ' C ' HD21 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -78.54 173.06 12.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.697 0.284 . . . . 0.0 110.703 -175.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.578 HD21 ' C ' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -124.46 146.35 48.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.255 0.55 . . . . 0.0 110.523 -177.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.419 HG22 HD11 ' A' ' 69' ' ' LEU . 27.7 m -142.55 170.82 11.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.532 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -153.18 158.66 42.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.76 0.314 . . . . 0.0 110.713 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD23 ' HB ' ' A' ' 38' ' ' THR . 3.4 mm? -67.66 135.16 52.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.537 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.566 HG13 ' HG2' ' A' ' 23' ' ' LYS . 37.2 pt -96.59 -11.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 110.838 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.566 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -155.86 174.79 14.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.134 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.54 107.61 18.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.514 HD22 HD11 ' A' ' 21' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.278 0.561 . . . . 0.0 111.199 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.6 mmmt . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.471 0.653 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.47 139.56 58.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.249 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.71 68.54 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.943 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.525 ' HB ' HD23 ' A' ' 21' ' ' LEU . 85.3 m -58.17 121.39 10.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.783 0.291 . . . . 0.0 110.256 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.24 117.01 29.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.363 0.601 . . . . 0.0 111.516 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.408 ' HB ' HG23 ' A' ' 19' ' ' VAL . 51.5 mt -104.05 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.586 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.33 135.74 47.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.394 -174.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.68 48.85 2.06 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.335 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 pp -94.25 160.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -138.95 159.88 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.106 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.433 HD22 HG22 ' A' ' 5' ' ' VAL . 47.6 mt -85.87 138.26 32.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 -175.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.4 p -98.33 -156.8 0.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.779 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -90.29 -2.08 57.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 109.668 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 58.1 m -98.29 149.08 22.98 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.539 ' HA ' HG21 ' A' ' 5' ' ' VAL . 27.3 mt-10 -94.85 -14.88 24.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.623 0.725 . . . . 0.0 109.376 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.4 ' O ' HG21 ' A' ' 66' ' ' THR . 1.0 OUTLIER -108.32 -2.94 18.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.538 -176.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -130.01 147.57 51.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.156 0.503 . . . . 0.0 111.044 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.489 ' CG2' HG13 ' A' ' 5' ' ' VAL . 15.7 pt -135.18 175.76 10.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.642 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HG3' HG23 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -130.74 135.31 47.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -139.65 -177.6 15.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.281 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 55' ' ' ARG . 10.1 ptt180 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 121.234 0.54 . . . . 0.0 110.179 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 60' ' ' LYS . 20.0 ptmt . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.28 5.86 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.651 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -110.99 134.57 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 53' ' ' GLU . 39.4 t -91.72 125.09 44.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.908 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.531 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 33.4 mt -137.31 145.77 43.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.666 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.654 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -62.99 130.48 44.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.759 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.411 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -83.83 23.96 0.94 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.745 0.783 . . . . 0.0 110.204 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -89.58 -15.1 33.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.537 0.684 . . . . 0.0 110.101 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.654 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 53.4 p90 -121.84 17.0 11.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.303 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.419 HD11 HG22 ' A' ' 19' ' ' VAL . 73.6 mt -113.53 147.11 38.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.512 0.672 . . . . 0.0 110.087 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HB2' HG21 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -117.36 124.81 49.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.106 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -59.95 118.83 6.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 0.0 110.042 -177.722 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.505 ' HB3' HD21 ' A' ' 12' ' ' LEU . 46.1 mt-10 . . . . . 0 CA--C 1.517 -0.297 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.506 ' HB ' HD23 ' A' ' 45' ' ' LEU . 3.5 t -113.24 119.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.959 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.505 ' HG3' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -122.32 175.17 6.56 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.837 -177.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.453 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 3.1 p-10 -86.05 -164.29 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.065 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 25.8 p -63.57 -20.37 65.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.547 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.445 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -95.78 -49.36 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.63 10.89 0.77 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.526 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.86 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.505 HD21 ' HB3' ' A' ' 4' ' ' GLU . 25.3 mt -72.51 143.74 48.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.379 0.609 . . . . 0.0 112.28 -173.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.59 166.06 11.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.387 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.79 174.31 15.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.911 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -63.96 121.5 14.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.514 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.49 1.67 53.4 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.006 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -81.73 174.05 11.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 110.404 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.9 p30 -132.69 142.91 49.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.617 0.722 . . . . 0.0 111.652 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 71' ' ' LYS . 29.5 m -137.57 174.88 10.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.927 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.1 m -152.19 150.87 30.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.715 0.293 . . . . 0.0 110.714 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.587 HD11 HD23 ' A' ' 25' ' ' LEU . 4.3 mm? -62.0 128.26 35.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.679 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.633 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -89.6 -10.03 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.814 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.633 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -159.79 174.27 14.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -85.01 118.75 24.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.587 HD23 HD11 ' A' ' 21' ' ' LEU . 4.2 mm? . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 110.407 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 26.8 mmmt . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.273 0.559 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.76 145.58 44.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.438 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.92 -8.13 78.4 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.608 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.525 ' HB ' HD22 ' A' ' 21' ' ' LEU . 89.6 m -65.16 112.8 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 0.0 110.313 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.0 ttm -81.5 117.49 21.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.421 0.629 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mt -108.9 99.81 9.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.961 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -111.03 156.58 21.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.924 0.392 . . . . 0.0 111.128 -176.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.51 28.52 35.65 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.542 HG23 ' HA3' ' A' ' 54' ' ' GLY . 2.3 pp -78.94 161.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.678 0.275 . . . . 0.0 110.423 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.6 ptp180 -140.91 166.2 25.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.506 HD23 ' HB ' ' A' ' 5' ' ' VAL . 39.3 mt -88.47 137.96 31.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.973 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -95.16 -159.77 0.74 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -81.94 -4.76 57.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.385 0.612 . . . . 0.0 109.454 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 73.9 m -99.35 146.75 25.94 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.501 ' HA ' HG22 ' A' ' 5' ' ' VAL . 22.3 mt-10 -90.51 -15.26 31.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.381 0.61 . . . . 0.0 109.904 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.4 -5.44 20.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.078 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -126.67 145.18 50.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 111.81 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -131.04 173.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.2 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.621 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 11.7 tm-20 -127.98 131.19 49.27 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' HA3' HG23 ' A' ' 43' ' ' ILE . . . -145.04 -166.32 11.61 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.69 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.466 HH11 ' HB3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 121.361 0.601 . . . . 0.0 111.258 -175.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 60' ' ' LYS . 7.3 ptpp? . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.124 0.487 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.621 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 103.98 43.14 1.83 Allowed Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.405 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 54' ' ' GLY . 2.3 pt? -115.39 132.67 56.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.237 0.541 . . . . 0.0 110.032 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -90.89 124.57 43.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.691 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.678 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -134.05 146.3 50.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.294 0.569 . . . . 0.0 112.189 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.583 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.5 ptp180 -64.7 130.82 45.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.814 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 t -86.24 33.09 0.61 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.986 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -85.96 -29.63 23.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.435 0.636 . . . . 0.0 110.161 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.678 ' HZ ' HD23 ' A' ' 64' ' ' LEU . 38.3 p90 -113.62 18.97 17.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.982 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 19' ' ' VAL . 59.4 mt -113.31 144.71 42.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.972 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HB2' HG21 ' A' ' 22' ' ' ILE . 3.0 tmtt? -114.17 122.38 46.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.641 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HA ' HG13 ' A' ' 19' ' ' VAL . 48.7 tttp -57.77 120.59 8.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.109 0.48 . . . . 0.0 110.602 -174.816 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 32.6 mt-10 . . . . . 0 CA--C 1.516 -0.35 0 CA-C-O 121.587 0.708 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.737 HG11 HG21 ' A' ' 52' ' ' ILE . 10.3 t -94.8 132.0 40.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.815 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.46 ' HG3' HD22 ' A' ' 12' ' ' LEU . 2.4 mpt_? -132.43 150.06 52.23 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.566 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 3.8 p-10 -77.59 -163.5 0.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.725 0.297 . . . . 0.0 110.634 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.6 t -70.98 -15.6 62.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.309 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.436 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 2.3 t-20 -85.83 -54.78 4.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.716 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 10.89 1.91 Allowed Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.609 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.43 133.07 35.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.46 HD22 ' HG3' ' A' ' 6' ' ' ARG . 15.2 mt -72.7 135.07 45.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.168 0.508 . . . . 0.0 111.621 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -102.4 163.72 12.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.401 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HA ' HD13 ' A' ' 45' ' ' LEU . . . -149.23 177.55 9.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.16 118.24 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 29.01 12.46 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.647 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.7 t0 -98.72 175.13 6.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -132.73 141.15 48.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.664 0.745 . . . . 0.0 111.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 40' ' ' ILE . 30.6 m -136.86 174.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.097 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.8 m -153.08 150.94 29.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.77 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.555 HD11 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -64.61 129.42 39.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.739 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.652 HG13 ' HG2' ' A' ' 23' ' ' LYS . 32.1 pt -90.94 -4.61 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 110.639 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.652 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -165.09 -179.15 5.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.886 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.83 116.56 29.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.555 HD23 HD11 ' A' ' 21' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.173 0.511 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -63.67 140.13 58.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.474 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.27 84.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.838 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.511 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -64.32 114.43 4.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.95 0.375 . . . . 0.0 110.077 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 29.8 ttm -81.24 119.32 23.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.491 0.662 . . . . 0.0 111.121 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 19' ' ' VAL . 43.0 mt -106.64 90.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.469 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' C ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -101.07 162.68 12.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.268 -176.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.82 57.72 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.988 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -92.96 163.91 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.991 0.424 . . . . 0.0 109.953 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -136.09 159.05 42.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.821 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 14' ' ' ALA . 55.2 mt -82.04 130.19 35.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.631 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.4 p -87.98 -158.69 0.48 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.244 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -85.58 -8.37 58.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 75.4 m -96.94 150.54 20.65 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.665 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 5' ' ' VAL . 2.9 mt-10 -90.28 -22.89 21.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 109.927 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -101.77 1.06 36.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.521 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.6 OUTLIER -133.18 144.4 49.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.53 0.681 . . . . 0.0 111.305 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.737 HG21 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -131.37 157.08 43.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.605 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -113.81 125.84 54.53 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.574 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.49 -160.89 8.72 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.751 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 . . . . . 0 C--N 1.317 -0.845 0 CA-C-O 121.362 0.601 . . . . 0.0 109.971 -178.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.78 0.324 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.08 47.35 5.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.818 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -111.53 133.19 53.98 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.99 114.89 30.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.765 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 47.6 mt -128.99 135.79 49.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.78 0.8 . . . . 0.0 112.312 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.567 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 1.4 ptp180 -56.92 130.3 45.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.009 167.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.528 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 10.1 t -88.31 27.79 1.19 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.758 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 14.6 mt-10 -86.17 -16.19 38.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.981 0.896 . . . . 0.0 109.458 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.765 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 34.5 p90 -120.36 19.05 12.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.097 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 66' ' ' THR . 86.2 mt -116.65 148.28 41.15 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -115.71 126.59 54.28 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.581 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.0 122.31 16.22 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -174.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.48 ' HB3' HD21 ' A' ' 12' ' ' LEU . 48.4 mt-10 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.433 0.635 . . . . 0.0 111.528 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.489 ' HB ' HD23 ' A' ' 45' ' ' LEU . 5.1 t -108.88 130.46 61.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.983 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.518 ' HG3' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -131.89 165.14 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.469 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.31 -166.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.668 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 21.9 p -61.59 -34.36 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.372 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.28 -40.45 26.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.96 0.41 . . . . 0.0 110.767 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 20.09 2.06 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.238 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.06 132.27 36.12 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.518 HD22 ' HG3' ' A' ' 6' ' ' ARG . 24.7 mt -70.55 142.84 51.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.293 0.568 . . . . 0.0 111.894 -172.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 43' ' ' ILE . 83.7 mt -108.96 173.77 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.63 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.78 175.89 9.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.873 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.7 t70 -62.26 125.43 23.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.493 . . . . 0.0 110.574 175.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.69 59.38 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.935 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.563 ' C ' HD21 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -89.91 171.75 9.37 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.563 HD21 ' C ' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -123.91 145.83 48.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.674 -176.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 27.7 m -145.07 172.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.5 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.9 m -155.09 156.26 35.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.605 0.24 . . . . 0.0 110.73 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.572 HD11 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -70.53 128.16 35.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.651 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.626 HG13 ' HG2' ' A' ' 23' ' ' LYS . 40.2 pt -91.45 -10.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.111 0.481 . . . . 0.0 110.823 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.626 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -158.04 176.51 12.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.37 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.33 118.94 25.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.572 HD23 HD11 ' A' ' 21' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.796 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 121.589 0.709 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -59.78 136.35 57.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.43 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.97 64.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.893 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.514 ' HB ' HD22 ' A' ' 21' ' ' LEU . 87.6 m -59.83 115.81 3.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 110.365 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ttm -87.23 123.54 32.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.455 0.645 . . . . 0.0 111.306 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.5 mt -114.6 95.92 4.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.145 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.64 135.96 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.733 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.09 40.33 3.79 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.641 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.473 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 2.2 pp -85.09 167.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 6.7 ptp85 -143.2 158.97 43.15 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.072 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.489 HD23 ' HB ' ' A' ' 5' ' ' VAL . 33.2 mt -84.01 162.74 20.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.635 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -126.92 -167.62 1.76 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.52 -6.45 55.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.277 0.561 . . . . 0.0 109.542 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 55.1 m -96.81 145.89 25.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.422 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' O ' HG11 ' A' ' 5' ' ' VAL . 23.2 mt-10 -89.47 -23.94 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.189 0.519 . . . . 0.0 110.616 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.436 ' O ' HG21 ' A' ' 66' ' ' THR . 16.4 m-20 -105.98 -3.37 21.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.972 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 14.9 mp0 -122.64 146.15 47.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.224 0.535 . . . . 0.0 110.836 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.431 ' CG2' HG13 ' A' ' 5' ' ' VAL . 24.7 pt -133.78 178.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.801 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -132.23 127.88 36.71 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.506 ' O ' HD21 ' A' ' 62' ' ' LEU . . . -138.67 178.57 19.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.082 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.397 0.617 . . . . 0.0 110.851 179.777 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.065 0.46 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.539 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 92.58 51.14 2.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.506 HD21 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -115.28 135.03 54.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 46.4 t -90.16 119.65 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.147 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.639 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 22.3 mt -133.12 142.89 48.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.648 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.581 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 15.8 ptt180 -64.3 131.65 47.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.736 171.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' HD13 ' A' ' 69' ' ' LEU . 10.6 t -88.35 27.97 1.16 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.972 -174.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.3 mt-10 -79.87 -27.57 40.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.845 0.831 . . . . 0.0 109.24 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.639 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 31.8 p90 -113.92 17.88 17.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.765 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 66' ' ' THR . 72.5 mt -112.48 141.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.393 0.616 . . . . 0.0 110.161 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -110.94 122.05 46.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.486 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -59.13 121.35 11.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 121.512 0.672 . . . . 0.0 110.962 -175.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 121.316 0.579 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.62 HG11 HG22 ' A' ' 52' ' ' ILE . 3.0 t -95.81 133.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.629 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.534 ' HG3' HD22 ' A' ' 12' ' ' LEU . 2.0 mpt_? -131.02 166.09 21.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.16 -174.8 5.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 110.21 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 p -57.44 -34.47 69.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.659 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -79.23 -43.19 24.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.836 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.79 18.37 1.4 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.563 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.54 128.26 34.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.534 HD22 ' HG3' ' A' ' 6' ' ' ARG . 17.4 mt -65.53 142.49 58.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -110.39 171.8 7.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.623 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.51 178.99 9.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.6 t70 -75.45 111.04 10.33 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.14 22.75 9.63 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 176.61 6.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -135.04 140.45 45.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.467 0.651 . . . . 0.0 111.66 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.67 176.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.213 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -149.71 157.32 43.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.769 0.319 . . . . 0.0 111.015 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.552 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -69.79 127.24 32.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.813 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.932 HG13 ' HG3' ' A' ' 23' ' ' LYS . 39.2 pt -92.27 -9.24 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.225 0.536 . . . . 0.0 110.368 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.932 ' HG3' HG13 ' A' ' 22' ' ' ILE . 24.1 mtpp -143.02 -179.74 6.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.671 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 35' ' ' LYS . 10.3 m-20 -98.27 94.89 7.03 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 3.7 mm? . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 26.1 mmmt . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.454 0.645 . . . . 0.0 112.177 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -57.17 134.02 55.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.374 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.18 -9.26 61.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.908 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.502 ' HB ' HD22 ' A' ' 21' ' ' LEU . 97.2 m -60.56 119.78 8.73 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.964 0.382 . . . . 0.0 110.212 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.0 ttm -88.22 122.24 31.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.434 0.635 . . . . 0.0 111.179 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.2 mt -113.22 91.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.906 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.96 135.69 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.284 0.564 . . . . 0.0 110.676 -176.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.67 43.76 1.77 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -171.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.578 HG21 ' HA3' ' A' ' 54' ' ' GLY . 1.9 pp -98.5 158.05 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 177.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.54 HD22 ' HB ' ' A' ' 5' ' ' VAL . 26.9 mt -75.82 149.03 37.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.163 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.3 p -118.8 -167.96 1.47 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.3 -3.49 33.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 0.0 110.065 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 47.3 m -100.64 138.23 37.96 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.826 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -92.53 -15.04 27.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.146 0.498 . . . . 0.0 110.213 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -106.24 -5.23 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.949 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.5 mp0 -125.9 146.56 49.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.002 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.62 HG22 HG11 ' A' ' 5' ' ' VAL . 9.3 pt -131.4 172.4 16.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.528 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -126.09 129.73 49.69 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -137.26 -167.07 10.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.966 -1.112 . . . . 0.0 112.623 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 -179.167 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.93 51.44 9.1 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.32 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -113.33 135.46 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.0 t -96.3 119.96 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.116 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.717 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 33.3 mt -133.34 138.91 46.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.585 0.707 . . . . 0.0 112.37 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.5 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.2 ptp180 -56.69 134.06 54.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.283 168.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -89.29 31.9 0.87 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.622 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 23.4 mt-10 -81.88 -32.93 30.78 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.851 0.834 . . . . 0.0 109.887 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.717 ' HZ ' HD21 ' A' ' 64' ' ' LEU . 30.3 p90 -115.16 20.63 14.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.921 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 72.1 mt -116.03 143.75 45.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.049 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HZ1' ' HB3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -119.98 128.94 54.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.945 -176.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -59.61 126.39 27.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -172.769 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 CA--C 1.516 -0.354 0 CA-C-O 121.393 0.616 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.537 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.4 t -93.01 123.76 45.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.042 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.528 ' HG3' HD23 ' A' ' 12' ' ' LEU . 1.4 mpt_? -126.49 170.24 12.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.561 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 39.4 p-10 -84.17 -162.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.637 ' SG ' HG23 ' A' ' 22' ' ' ILE . 20.2 p -78.52 12.16 2.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 110.591 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 7' ' ' ASP . 2.1 t-20 -118.35 -48.03 2.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.494 0.664 . . . . 0.0 110.254 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.04 5.51 3.44 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.108 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.1 125.83 29.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.528 HD23 ' HG3' ' A' ' 6' ' ' ARG . 17.3 mt -72.32 135.05 45.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.698 -175.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.01 162.42 13.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.48 8.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.977 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.0 t70 -64.62 125.72 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.82 17.07 53.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.264 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.02 175.48 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 13.3 p30 -131.06 139.08 49.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.698 0.761 . . . . 0.0 112.078 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.28 173.39 14.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.806 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -152.91 152.25 31.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.769 0.318 . . . . 0.0 110.619 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.543 HD11 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -64.63 128.58 36.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.641 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.964 HG13 ' HG3' ' A' ' 23' ' ' LYS . 35.0 pt -92.69 -9.68 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.174 0.511 . . . . 0.0 110.361 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.964 ' HG3' HG13 ' A' ' 22' ' ' ILE . 23.2 mtpp -145.47 -175.94 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.411 ' CG ' ' HZ2' ' A' ' 35' ' ' LYS . 4.6 m-20 -98.9 109.22 22.01 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.543 HD23 HD11 ' A' ' 21' ' ' LEU . 3.8 mm? . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.955 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 23.4 mmmt . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.24 0.543 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -59.99 131.71 51.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.459 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.13 -3.46 62.03 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.107 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.503 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -65.09 113.42 3.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.201 0.501 . . . . 0.0 110.371 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -82.97 122.44 28.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.556 0.693 . . . . 0.0 111.499 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.49 93.51 2.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.935 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.38 149.65 24.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.93 43.01 5.51 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.533 HG23 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -91.29 166.96 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.297 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -147.22 156.92 43.37 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.609 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.4 mt -84.69 158.49 20.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.559 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -118.21 -162.75 0.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.72 -16.65 60.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.748 0.785 . . . . 0.0 109.235 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 19.9 m -87.22 144.86 26.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.874 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.537 ' HA ' HG22 ' A' ' 5' ' ' VAL . 24.5 mt-10 -91.6 -13.55 31.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.551 0.691 . . . . 0.0 109.749 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -110.46 -5.85 15.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.748 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 14.0 mp0 -123.72 145.44 48.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.346 0.593 . . . . 0.0 110.943 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CG2' HG12 ' A' ' 5' ' ' VAL . 11.6 pt -135.69 175.26 11.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.436 174.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.71 137.46 49.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.533 ' HA3' HG23 ' A' ' 43' ' ' ILE . . . -140.73 -167.88 11.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.772 -1.204 . . . . 0.0 112.67 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 . . . . . 0 C--N 1.323 -0.566 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.203 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.254 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.05 48.98 70.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.933 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -105.32 134.21 48.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.82 120.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.108 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.763 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 26.2 mt -132.57 144.24 50.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.741 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.593 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 1.1 ptp180 -64.78 133.45 52.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.793 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 t -85.34 26.16 0.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.503 0.668 . . . . 0.0 110.773 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -87.79 -20.89 25.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.636 0.731 . . . . 0.0 110.164 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.763 ' HZ ' HD21 ' A' ' 64' ' ' LEU . 53.5 p90 -120.78 21.16 11.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.53 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.8 mt -117.07 148.93 41.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.269 0.556 . . . . 0.0 110.028 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.6 tmtt? -120.38 131.7 54.94 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.778 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -64.58 122.38 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.269 -172.313 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.504 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 44.4 mt-10 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.413 0.625 . . . . 0.0 111.306 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.734 HG11 HG22 ' A' ' 52' ' ' ILE . 8.5 t -88.08 131.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.673 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -122.24 167.04 13.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.629 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 36.4 p-10 -90.07 -162.02 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' A' ' 22' ' ' ILE . 20.2 p -76.32 3.62 10.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.287 0.565 . . . . 0.0 110.752 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.58 -48.29 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.73 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.07 7.67 4.91 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.951 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.95 136.64 36.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.504 ' CD2' ' HB3' ' A' ' 4' ' ' GLU . 34.5 mt -80.75 135.71 36.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 112.083 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -101.47 166.9 10.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.36 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.75 174.45 13.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 14.7 t70 -63.53 118.18 7.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.775 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.02 -0.78 38.39 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.068 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.468 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -83.12 175.15 10.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 110.691 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -135.55 137.67 42.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.172 -177.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 69' ' ' LEU . 34.5 m -128.82 167.31 24.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.613 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.44 152.5 47.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.613 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 25' ' ' LEU . 3.4 mm? -72.7 122.92 22.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.5 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.537 HG13 ' HG2' ' A' ' 23' ' ' LYS . 39.4 pt -88.33 -7.34 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 111.102 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -160.05 -176.79 5.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.177 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.5 117.57 30.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' A' ' 23' ' ' LYS . 4.0 mm? . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.032 0.444 . . . . 0.0 110.253 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.141 0.496 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -60.53 135.88 57.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.41 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.41 -0.63 59.98 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.859 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.464 ' HB ' ' HG ' ' A' ' 21' ' ' LEU . 91.8 m -63.48 120.21 11.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.842 0.353 . . . . 0.0 110.049 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.449 ' HE1' ' CB ' ' A' ' 72' ' ' ALA . 13.9 tpt -93.52 114.58 26.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.624 -174.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.9 mt -111.21 90.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.472 0.653 . . . . 0.0 109.434 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.45 136.98 45.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.65 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.48 46.24 2.19 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.554 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -93.48 168.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 0.0 110.325 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 4.6 ptp180 -151.71 156.68 40.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.472 HD22 ' CG2' ' A' ' 5' ' ' VAL . 20.2 mt -78.6 127.7 32.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 p -82.81 -68.91 0.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.204 1.002 . . . . 0.0 111.878 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -176.79 -34.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.763 -173.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.1 m -75.08 146.49 41.43 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.356 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.509 ' HA ' HG21 ' A' ' 5' ' ' VAL . 2.1 mp0 -91.46 -19.25 23.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.513 0.673 . . . . 0.0 110.163 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -103.54 -3.59 25.07 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.728 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -132.65 145.56 51.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.584 0.707 . . . . 0.0 111.347 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.734 HG22 HG11 ' A' ' 5' ' ' VAL . 9.4 pt -132.09 173.8 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.451 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -125.01 137.01 54.25 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -142.54 -161.18 8.67 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.232 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 9.0 ptp180 . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 120.918 0.39 . . . . 0.0 110.633 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 17.7 ptpt . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.82 0.343 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.94 47.98 5.63 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.076 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -112.51 136.63 51.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.1 t -94.41 119.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.616 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 25.8 mt -128.16 146.11 50.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.706 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.545 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 14.1 ptt180 -65.36 135.32 55.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.23 172.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 t -89.27 33.01 0.81 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.502 0.668 . . . . 0.0 110.656 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.7 mt-10 -81.69 -30.97 32.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.005 0.907 . . . . 0.0 109.444 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.616 ' HZ ' HD21 ' A' ' 64' ' ' LEU . 39.9 p90 -115.79 19.11 15.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.506 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 19' ' ' VAL . 68.6 mt -113.2 147.65 37.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.224 0.535 . . . . 0.0 110.349 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.629 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -117.8 130.89 56.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.752 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.2 tmtt? -67.04 121.14 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.303 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HB3' HD23 ' A' ' 12' ' ' LEU . 82.3 mt-10 . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.122 0.487 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -95.48 121.28 45.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.516 ' HG3' HD21 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -125.92 153.41 44.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.577 ' HA ' ' HG1' ' A' ' 66' ' ' THR . 8.5 p-10 -79.57 -170.52 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' HG22 ' A' ' 22' ' ' ILE . 28.0 p -63.49 -26.37 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -76.03 -39.37 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.096 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.68 12.27 8.04 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.529 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.71 132.18 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.516 HD21 ' HG3' ' A' ' 6' ' ' ARG . 20.0 mt -69.24 131.18 44.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.1 177.33 5.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.803 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' A' ' 45' ' ' LEU . . . -154.61 178.47 10.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -80.14 111.61 16.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.689 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.78 27.36 8.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.656 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.08 176.5 5.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.366 0.266 . . . . 0.0 110.361 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -129.2 136.09 49.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 111.102 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 69' ' ' LEU . 35.4 m -125.05 179.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.992 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -154.82 151.15 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.692 0.282 . . . . 0.0 111.239 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD11 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -66.25 130.49 43.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.604 HG22 ' SG ' ' A' ' 8' ' ' CYS . 41.4 pt -91.99 -9.15 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 110.856 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.588 ' HG3' HD22 ' A' ' 25' ' ' LEU . 4.9 ptpt -156.88 -178.86 7.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.93 108.18 19.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.588 HD22 ' HG3' ' A' ' 23' ' ' LYS . 3.3 mm? . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.645 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 21.3 mmmt . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.491 0.662 . . . . 0.0 112.356 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -59.69 136.56 58.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.711 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.69 -3.05 81.09 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.989 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.532 ' HB ' HD22 ' A' ' 21' ' ' LEU . 93.0 m -63.86 112.56 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.486 ' HE2' ' HB1' ' A' ' 72' ' ' ALA . 39.7 ttm -83.35 116.29 22.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.321 0.582 . . . . 0.0 111.144 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.418 ' HB ' HG23 ' A' ' 19' ' ' VAL . 39.7 mt -99.66 89.97 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.901 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 3.3 ppt_? -100.15 135.72 41.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 46.98 1.8 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.595 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 1.9 pp -97.18 148.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.55 142.6 51.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.246 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 14' ' ' ALA . 61.3 mt -71.93 132.69 44.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -97.43 -169.17 1.8 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.07 7.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.434 0.635 . . . . 0.0 109.564 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -109.89 149.38 29.97 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.671 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.537 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -103.39 -14.8 16.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -102.18 -7.74 21.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.897 0.379 . . . . 0.0 110.333 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -123.31 149.3 45.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.507 0.67 . . . . 0.0 111.125 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.482 HD12 ' HB ' ' A' ' 43' ' ' ILE . 17.9 pt -136.29 172.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.161 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.2 tt0 -125.53 122.01 35.33 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -128.43 -169.47 12.62 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.846 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 . . . . . 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 110.203 179.779 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 60' ' ' LYS . 17.1 ptmt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.775 0.321 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.16 43.71 31.66 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.785 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -107.18 131.31 54.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.9 t -89.73 120.53 38.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.625 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 28.8 mt -134.35 140.93 46.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.563 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 1.5 ptp180 -58.88 130.39 46.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 168.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.577 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 10.9 t -87.68 25.64 1.45 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.454 0.645 . . . . 0.0 110.204 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.5 mt-10 -89.31 -10.0 48.41 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.762 0.791 . . . . 0.0 109.769 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.625 ' HZ ' HD23 ' A' ' 64' ' ' LEU . 42.8 p90 -125.22 15.59 8.39 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.114 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 19' ' ' VAL . 68.8 mt -112.06 149.06 32.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.832 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -61.15 120.9 11.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.486 ' HB1' ' HE2' ' A' ' 39' ' ' MET . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.733 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' HB3' HD23 ' A' ' 12' ' ' LEU . 33.3 mt-10 . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 121.467 0.651 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.713 HG13 HG21 ' A' ' 52' ' ' ILE . 6.7 t -80.84 118.29 28.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.526 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -124.75 155.07 39.91 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.512 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 38.2 p-10 -79.48 -161.93 0.37 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.815 0.34 . . . . 0.0 110.343 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 22' ' ' ILE . 24.8 p -74.62 -1.14 20.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.188 0.518 . . . . 0.0 110.85 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.13 -44.96 4.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.37 11.05 4.31 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.033 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.5 134.52 35.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 4' ' ' GLU . 20.9 mt -78.3 134.34 37.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.338 0.589 . . . . 0.0 112.01 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -100.63 162.73 12.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.229 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.98 176.53 12.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.295 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.56 123.27 16.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 16.82 46.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.596 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.432 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t70 -93.93 175.64 6.64 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.725 -0.279 . . . . 0.0 110.716 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -130.22 135.98 48.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.199 0.523 . . . . 0.0 110.938 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.563 HG23 HD11 ' A' ' 69' ' ' LEU . 27.6 m -124.05 175.95 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.787 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -150.59 151.79 33.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.858 0.361 . . . . 0.0 111.366 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.525 HD11 HD21 ' A' ' 25' ' ' LEU . 4.1 mm? -64.68 127.4 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.45 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.837 HG13 ' HG3' ' A' ' 23' ' ' LYS . 38.5 pt -95.53 -8.36 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.762 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.837 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.4 mttt -141.87 179.8 6.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.56 100.64 12.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 3.8 mm? . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mmmt . . . . . 0 CA--C 1.516 -0.339 0 CA-C-O 121.17 0.509 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -62.42 137.55 58.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.488 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.73 8.03 70.57 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.916 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.521 ' HB ' HD21 ' A' ' 21' ' ' LEU . 90.9 m -73.47 116.28 13.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.2 ttm -87.75 111.71 21.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.449 0.642 . . . . 0.0 111.448 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.431 ' HB ' HG21 ' A' ' 19' ' ' VAL . 48.8 mt -95.12 91.51 3.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 135.1 43.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.33 1.43 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.6 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -102.89 162.66 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.366 . . . . 0.0 110.231 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -143.24 164.66 29.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.345 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.522 HD22 HG23 ' A' ' 5' ' ' VAL . 43.3 mt -82.16 142.28 32.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.204 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.1 p -104.35 -154.48 0.51 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.176 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.31 -2.95 56.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.519 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 33.5 t -108.16 157.92 17.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.014 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.55 ' HA ' HG22 ' A' ' 5' ' ' VAL . 31.9 mt-10 -95.89 -13.43 23.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.909 172.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -108.98 -9.6 15.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.356 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -121.68 146.28 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 111.427 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.713 HG21 HG13 ' A' ' 5' ' ' VAL . 2.4 pp -134.76 166.86 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.505 172.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -120.36 130.0 54.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.6 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.01 -175.4 13.99 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.964 -175.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 55' ' ' ARG . 17.0 ptt180 . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.459 0.647 . . . . 0.0 110.765 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.66 54.09 6.88 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.677 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.6 pt? -115.09 138.34 50.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.5 116.29 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.516 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -129.48 146.13 51.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.558 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 2.3 ptp180 -65.25 139.07 58.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.055 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.523 ' HA ' HD12 ' A' ' 69' ' ' LEU . 8.9 t -93.74 23.82 4.51 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.593 -174.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.626 ' HG2' HH11 ' A' ' 65' ' ' ARG . 0.6 OUTLIER -92.81 -8.46 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.275 -176.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 54.0 p90 -122.41 19.58 10.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.563 HD11 HG23 ' A' ' 19' ' ' VAL . 65.7 mt -120.46 145.66 47.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.081 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.512 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -113.35 130.68 56.22 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.698 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.432 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.4 tmtt? -64.21 123.14 18.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.45 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . . . . . . . . 0 C--N 1.322 -0.597 0 CA-C-O 121.137 0.494 . . . . 0.0 111.319 -174.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.503 ' HB3' HD22 ' A' ' 12' ' ' LEU . 37.7 mt-10 . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 111.457 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 49' ' ' GLU . 14.9 t -90.19 117.83 34.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.079 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -128.19 148.58 50.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -80.63 -169.78 2.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.456 -177.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.63 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.9 p -65.05 -22.82 67.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 110.961 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -76.14 -31.76 58.76 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.536 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.89 14.29 27.24 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.53 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.94 31.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 120.799 0.333 . . . . 0.0 110.143 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' A' ' 4' ' ' GLU . 19.9 mt -71.57 141.0 50.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.872 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.57 176.85 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.602 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.96 10.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.849 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 17.3 t70 -65.3 121.33 14.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.798 0.332 . . . . 0.0 110.164 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.91 11.13 50.89 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.036 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.93 174.81 8.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 1.1 p30 -139.11 136.15 34.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.399 0.619 . . . . 0.0 111.565 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.579 HG21 HD13 ' A' ' 69' ' ' LEU . 27.3 m -128.63 176.81 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.968 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -150.67 149.24 29.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.733 0.301 . . . . 0.0 111.048 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.615 HD12 HD23 ' A' ' 25' ' ' LEU . 4.5 mm? -61.17 133.36 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.329 0.651 . . . . 0.0 112.259 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.649 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -94.71 -11.56 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.2 0.524 . . . . 0.0 110.559 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.649 ' HG2' HG13 ' A' ' 22' ' ' ILE . 18.4 ptmt -158.43 176.1 12.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.232 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.13 127.63 33.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.615 HD23 HD12 ' A' ' 21' ' ' LEU . 4.1 mm? . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 121.297 0.57 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.22 132.74 51.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.82 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.16 -11.39 55.29 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.729 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.517 ' HB ' HD21 ' A' ' 21' ' ' LEU . 60.6 m -59.33 125.7 24.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.981 0.39 . . . . 0.0 110.037 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -90.71 122.58 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.082 0.468 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 90.53 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.11 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -101.51 154.29 18.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.2 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.99 45.94 6.9 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.301 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.533 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.39 160.45 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 19.6 ptt180 -139.46 159.09 42.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.305 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' HB ' ' A' ' 5' ' ' VAL . 52.0 mt -78.85 134.58 36.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.141 -176.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -94.44 -157.95 0.6 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.807 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.94 -6.99 59.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.504 0.669 . . . . 0.0 109.205 174.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 66.1 m -102.88 150.47 23.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.913 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HA ' HG23 ' A' ' 5' ' ' VAL . 16.3 mt-10 -87.76 -26.57 22.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.477 0.656 . . . . 0.0 109.939 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -98.01 -6.67 31.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.695 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 10.8 mp0 -124.42 145.16 49.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 111.499 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.461 ' CG2' HG13 ' A' ' 5' ' ' VAL . 2.6 pp -133.32 167.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.521 173.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -119.93 128.36 53.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.533 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.42 -159.32 7.95 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.333 -177.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.5 ptp180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 120.821 0.343 . . . . 0.0 110.243 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.01 52.08 4.78 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.388 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -114.31 137.05 52.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.65 121.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.926 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.614 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 27.4 mt -135.42 143.58 46.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.226 0.536 . . . . 0.0 111.941 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.618 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 9.4 ptp180 -60.71 130.13 44.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.694 171.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.519 ' HA ' HD11 ' A' ' 69' ' ' LEU . 10.9 t -88.48 22.27 2.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.219 0.533 . . . . 0.0 110.739 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 2.4 pt-20 -90.92 -9.74 45.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.318 0.58 . . . . 0.0 110.222 -176.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.614 ' HZ ' HD23 ' A' ' 64' ' ' LEU . 28.7 p90 -117.06 16.99 14.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.329 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.579 HD13 HG21 ' A' ' 19' ' ' VAL . 68.8 mt -117.29 146.38 43.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.296 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.471 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -118.45 125.0 49.01 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.008 -178.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HA ' HG11 ' A' ' 19' ' ' VAL . 46.5 tttp -62.06 121.01 11.97 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.313 0.383 . . . . 0.0 110.235 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . . . . . . 0 C--N 1.321 -0.666 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 121.282 0.563 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 49' ' ' GLU . 10.9 t -92.28 122.65 43.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.983 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.515 ' HG3' HD21 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -130.26 162.19 29.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.644 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 4.1 p-10 -82.51 -165.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.509 ' SG ' HG23 ' A' ' 22' ' ' ILE . 28.6 p -64.24 -25.62 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.772 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -74.5 -51.97 13.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.236 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.41 12.73 3.34 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.974 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.47 132.72 33.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.515 HD21 ' HG3' ' A' ' 6' ' ' ARG . 21.5 mt -69.15 145.18 53.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.509 0.671 . . . . 0.0 112.223 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.96 169.36 9.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.427 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.32 13.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.038 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 31.3 t70 -68.09 117.6 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.22 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.88 30.77 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.796 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.71 174.22 7.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -133.4 145.03 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.297 0.57 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 71' ' ' LYS . 28.3 m -140.54 175.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.275 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -152.31 156.89 40.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.555 HD13 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -69.23 131.51 45.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.721 -178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.645 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -91.94 -11.01 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.405 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.645 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -154.6 -179.09 7.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.96 113.56 25.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.555 HD23 HD13 ' A' ' 21' ' ' LEU . 3.5 mm? . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.522 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 121.295 0.569 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -58.39 129.86 44.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.256 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.43 66.36 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.322 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.518 ' HB ' HD22 ' A' ' 21' ' ' LEU . 98.6 m -63.32 118.49 8.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.497 0.649 . . . . 0.0 110.23 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.407 ' HG2' ' HG3' ' A' ' 41' ' ' ARG . 35.7 ttm -87.62 119.88 28.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.628 0.728 . . . . 0.0 111.445 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -108.34 95.03 3.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.026 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.407 ' HG3' ' HG2' ' A' ' 39' ' ' MET . 0.0 OUTLIER -104.95 136.17 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.231 -176.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.94 50.69 1.59 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.572 HG21 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -99.32 164.0 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 7.0 ptp85 -141.62 167.49 22.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.464 HD21 ' HB ' ' A' ' 5' ' ' VAL . 36.5 mt -89.27 147.79 23.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.155 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -104.14 -159.77 0.73 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -85.05 2.4 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 m -113.51 156.68 23.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.541 ' HA ' HG22 ' A' ' 5' ' ' VAL . 21.9 mt-10 -93.54 -27.9 16.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.605 0.717 . . . . 0.0 109.65 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 66' ' ' THR . 6.6 m-20 -90.21 -12.01 39.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.321 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.7 mp0 -121.17 148.84 43.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.359 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.481 ' CG2' HG13 ' A' ' 5' ' ' VAL . 26.8 pt -133.91 175.78 10.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.716 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -130.14 123.78 31.13 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -136.38 -177.01 14.68 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.89 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.56 . . . . 0.0 110.401 179.707 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.526 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 58.5 46.59 92.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.444 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.552 HD21 ' O ' ' A' ' 54' ' ' GLY . 2.5 pt? -103.38 135.01 45.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.225 0.513 . . . . 0.0 109.754 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.5 t -88.68 116.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.002 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.54 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 30.7 mt -129.56 143.45 50.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.452 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.637 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 14.6 ptt180 -62.14 129.95 43.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.43 ' HA ' HD13 ' A' ' 69' ' ' LEU . 11.9 t -88.19 27.06 1.27 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.238 0.542 . . . . 0.0 110.525 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.5 mt-10 -81.85 -26.27 34.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 109.159 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.637 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 21.4 p90 -114.56 17.91 17.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.998 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 66' ' ' THR . 58.3 mt -113.74 144.84 42.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.3 0.572 . . . . 0.0 110.205 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.644 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtp? -113.82 129.67 56.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.107 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.413 ' HA ' HG12 ' A' ' 19' ' ' VAL . 53.1 tttp -60.44 129.76 43.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.596 0 CA-C-O 121.11 0.481 . . . . 0.0 111.331 -174.471 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.321 0.582 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 49' ' ' GLU . 7.0 t -97.8 121.36 48.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.709 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.523 ' HG3' HD21 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.67 157.35 42.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.027 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.52 ' HA ' ' HG1' ' A' ' 66' ' ' THR . 7.7 p-10 -83.25 -168.7 2.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 p -68.2 -13.09 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.46 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 50.4 t30 -87.65 -38.23 16.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 9.56 10.49 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.179 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.86 124.25 30.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.523 HD21 ' HG3' ' A' ' 6' ' ' ARG . 23.9 mt -66.76 129.54 40.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.907 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.96 166.71 10.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.579 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.49 178.42 10.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.139 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 13.2 t70 -65.12 129.66 40.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.452 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.61 60.67 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.523 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t0 -88.11 173.81 8.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.594 0.235 . . . . 0.0 110.453 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -132.7 128.84 37.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 -177.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.55 HG22 HD13 ' A' ' 69' ' ' LEU . 26.9 m -125.78 176.94 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.29 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -153.53 149.25 27.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.52 HD21 ' HB ' ' A' ' 38' ' ' THR . 4.4 mm? -65.25 125.18 24.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.743 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.89 HG13 ' HG3' ' A' ' 23' ' ' LYS . 33.5 pt -93.56 -7.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.162 0.506 . . . . 0.0 110.283 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.89 ' HG3' HG13 ' A' ' 22' ' ' ILE . 4.2 mtpm? -144.58 177.91 8.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.856 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.888 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 5.8 m-20 -93.73 102.22 14.36 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.672 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 4.3 mm? . . . . . 0 CA--C 1.511 -0.539 0 CA-C-O 121.632 0.73 . . . . 0.0 111.647 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.888 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 3.3 mmpt? . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 121.248 0.547 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -68.76 144.77 54.25 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.281 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.59 15.3 73.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.722 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.52 ' HB ' HD21 ' A' ' 21' ' ' LEU . 60.2 m -84.84 117.75 24.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 ttm -86.13 123.18 31.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.397 0.617 . . . . 0.0 110.975 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.0 mt -112.23 95.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.504 175.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.483 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -108.16 142.45 38.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.067 0.461 . . . . 0.0 111.009 -178.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.97 42.14 4.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.4 pp -92.5 165.72 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 110.234 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.547 ' HD2' ' OE1' ' A' ' 53' ' ' GLU . 3.8 ptp180 -139.76 164.19 30.62 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.321 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.5 162.18 14.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -130.48 -166.56 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -75.86 -8.98 58.2 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.249 0.547 . . . . 0.0 109.644 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 53.7 m -92.33 145.7 24.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.195 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HA ' HG23 ' A' ' 5' ' ' VAL . 16.3 mt-10 -95.81 -20.6 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.806 -178.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.33 -5.94 22.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.145 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 17.7 mp0 -124.0 147.71 47.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.9 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -137.1 173.12 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.214 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.547 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 41.1 tt0 -125.62 135.02 51.72 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.574 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.92 -177.98 21.04 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.138 -177.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 121.009 0.433 . . . . 0.0 110.127 179.922 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.55 53.41 3.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.514 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -115.29 138.71 50.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 48.5 t -93.11 116.72 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.001 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.544 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 26.6 mt -129.33 142.93 50.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.663 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.626 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.9 ptp85 -60.68 130.61 47.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.563 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.52 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 10.4 t -88.59 24.24 2.03 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.294 0.569 . . . . 0.0 110.379 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.554 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.7 mt-10 -82.42 -20.3 37.32 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.926 0.87 . . . . 0.0 109.525 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 33.1 p90 -117.27 17.53 14.69 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.61 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.55 HD13 HG22 ' A' ' 19' ' ' VAL . 63.8 mt -113.42 144.02 43.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.058 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -113.93 126.98 55.77 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.358 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.523 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 11.1 tmtt? -59.83 124.87 21.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.468 ' N ' ' HD3' ' A' ' 71' ' ' LYS . . . . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.247 -170.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 121.302 0.572 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.79 HG13 HG21 ' A' ' 52' ' ' ILE . 2.7 t -87.58 128.91 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.257 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.534 ' HG3' HD22 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -132.28 158.93 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -178.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.51 -171.8 2.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 110.589 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.542 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.6 p -58.49 -29.73 66.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -84.02 -42.85 15.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.072 0.463 . . . . 0.0 110.516 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.21 16.91 1.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.47 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.02 126.26 30.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.534 HD22 ' HG3' ' A' ' 6' ' ' ARG . 27.1 mt -64.96 131.58 46.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.331 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.61 164.15 12.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.88 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.78 178.52 10.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 16.1 t70 -67.02 115.36 6.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 0.0 110.564 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.36 25.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.479 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -91.7 174.1 7.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -134.27 137.13 44.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.497 0.665 . . . . 0.0 111.49 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.519 HG22 HD11 ' A' ' 69' ' ' LEU . 27.2 m -126.4 176.01 7.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.236 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -153.24 156.69 38.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.72 0.295 . . . . 0.0 110.75 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' A' ' 38' ' ' THR . 4.0 mm? -66.96 127.53 32.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.351 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.866 HG13 ' HG3' ' A' ' 23' ' ' LYS . 34.9 pt -92.91 -10.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.866 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.7 mtpt -141.71 -174.01 3.94 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.9 94.31 6.5 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 3.4 mm? . . . . . 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.586 -175.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.3 mmmt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.284 0.564 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -59.88 129.86 43.94 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.685 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.95 -6.66 54.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.849 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.508 ' HB ' HD23 ' A' ' 21' ' ' LEU . 89.3 m -59.98 112.11 1.75 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.152 0.476 . . . . 0.0 110.241 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.4 ttm -89.29 117.6 28.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.303 0.573 . . . . 0.0 111.254 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -106.27 92.85 2.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.89 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.75 140.27 37.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 -175.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 49.68 2.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.644 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.546 HG21 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.71 169.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 21.6 ptt180 -148.56 156.21 42.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.133 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.514 HD21 HG23 ' A' ' 5' ' ' VAL . 37.6 mt -76.82 135.42 38.91 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 p -87.33 -70.96 0.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.801 0.81 . . . . 0.0 111.164 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.4 t70 179.07 -31.05 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.283 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -73.6 145.51 45.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.833 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.566 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -89.32 -18.23 27.34 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.44 -20.29 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.506 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' OE2' ' HB3' ' A' ' 65' ' ' ARG . 7.2 mp0 -127.26 154.56 44.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.533 -174.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.79 HG21 HG13 ' A' ' 5' ' ' VAL . 10.7 pt -134.35 176.71 8.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.254 171.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 7.8 tt0 -125.39 140.02 53.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -145.7 -166.33 11.85 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.053 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 . . . . . 0 C--N 1.316 -0.881 0 CA-C-O 121.195 0.521 . . . . 0.0 110.473 -177.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.7 48.25 29.43 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.337 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 54' ' ' GLY . 2.6 pt? -114.39 135.99 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 109.831 177.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 32.0 t -92.77 123.84 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.906 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.425 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -135.5 143.17 45.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.899 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.741 ' HG3' ' HE1' ' A' ' 68' ' ' PHE . 3.2 ptp85 -60.05 134.29 56.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.482 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.8 t -87.98 26.21 1.41 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.546 0.688 . . . . 0.0 110.456 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 28.8 mt-10 -84.59 -30.98 24.56 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.835 0.826 . . . . 0.0 109.96 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.741 ' HE1' ' HG3' ' A' ' 65' ' ' ARG . 53.7 p90 -114.15 19.72 16.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.106 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.519 HD11 HG22 ' A' ' 19' ' ' VAL . 74.4 mt -114.22 145.48 41.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.405 0.621 . . . . 0.0 110.62 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 1.5 tmtt? -113.27 126.0 54.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.583 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -64.71 121.94 15.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.053 -174.617 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB2' HD21 ' A' ' 12' ' ' LEU . 5.2 pt-20 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 121.381 0.61 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.674 HG11 HG21 ' A' ' 52' ' ' ILE . 3.0 t -92.45 119.42 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.41 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -123.73 161.32 25.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.868 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.633 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 21.0 p-10 -82.64 -166.23 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 22' ' ' ILE . 24.9 p -72.1 -7.62 50.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.994 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -97.94 -37.51 9.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.444 0.64 . . . . 0.0 109.712 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.92 9.37 7.51 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.269 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 128.84 34.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 4' ' ' GLU . 24.7 mt -70.77 139.75 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.744 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -103.64 173.31 6.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.032 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -160.92 -179.73 7.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.307 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.31 122.18 17.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 0.0 110.288 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.03 27.56 20.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.758 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -98.35 173.62 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -135.17 140.57 45.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.707 0.765 . . . . 0.0 111.69 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 71' ' ' LYS . 19.4 m -139.44 178.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.245 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -153.38 155.1 35.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 0.0 111.197 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -68.9 127.53 33.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.704 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 68' ' ' PHE . 27.3 pt -93.09 -7.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.982 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 25' ' ' LEU . 18.6 ptpt -160.1 178.55 9.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.4 122.58 30.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.647 0.261 . . . . 0.0 110.33 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt . . . . . 0 N--CA 1.448 -0.532 0 CA-C-O 121.029 0.443 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -61.87 141.14 58.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.022 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.82 -6.28 54.43 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.433 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.5 ' HB ' HD23 ' A' ' 21' ' ' LEU . 31.6 m -71.77 121.47 18.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.44 129.07 36.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.328 0.585 . . . . 0.0 110.763 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.485 ' HB ' HG21 ' A' ' 19' ' ' VAL . 33.1 mt -113.7 94.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.189 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.07 142.91 42.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.005 0.431 . . . . 0.0 110.915 -176.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.15 47.34 4.44 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.592 HG21 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -94.71 164.29 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.783 0.325 . . . . 0.0 110.192 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -137.72 148.91 46.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.205 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.464 HD21 HG22 ' A' ' 5' ' ' VAL . 44.3 mt -71.88 149.76 44.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.912 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.4 p -116.86 -160.9 0.78 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.791 0.329 . . . . 0.0 110.43 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.47 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.42 0.629 . . . . 0.0 109.601 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.5 m -107.47 142.45 37.31 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.028 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.525 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -87.9 -18.49 29.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.503 177.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -94.98 -13.77 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.138 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 4.0 mt-10 -126.63 146.32 50.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.959 0.885 . . . . 0.0 112.48 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.674 HG21 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -135.33 162.75 37.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.303 173.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.91 132.9 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.592 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -148.93 -163.98 11.26 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.83 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 . . . . . 0 C--N 1.317 -0.821 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 -179.176 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.755 0.312 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.98 47.33 89.66 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.58 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -109.93 135.55 50.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.65 120.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.672 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.717 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 38.6 mt -132.01 141.11 49.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.539 0.685 . . . . 0.0 112.785 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.618 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.7 ptm180 -53.61 129.05 31.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.095 164.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.497 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.0 t -91.78 21.07 5.04 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.26 0.552 . . . . 0.0 110.843 -173.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CD ' HH21 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.69 -8.49 37.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.192 0.52 . . . . 0.0 110.675 -174.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.717 ' HZ ' HD23 ' A' ' 64' ' ' LEU . 5.1 p90 -114.4 16.07 17.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.435 0.636 . . . . 0.0 109.938 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.525 HD11 HG23 ' A' ' 19' ' ' VAL . 82.4 mt -112.24 149.1 32.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.386 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.633 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtt? -119.58 124.76 47.16 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.675 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.526 ' HA ' HG11 ' A' ' 19' ' ' VAL . 62.1 tttp -62.39 125.29 23.39 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.977 0.418 . . . . 0.0 111.015 -174.049 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.514 -0.429 0 CA-C-O 121.469 0.652 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 49' ' ' GLU . 2.6 t -81.95 127.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.091 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.41 ' HG3' HD21 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.48 160.52 32.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.881 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -172.84 1.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.509 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 p -54.88 -33.37 61.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.66 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -81.33 -59.64 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.322 0.582 . . . . 0.0 110.647 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.23 25.21 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.722 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 128.23 35.56 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.41 HD21 ' HG3' ' A' ' 6' ' ' ARG . 18.6 mt -71.05 137.58 49.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.543 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HB3' HD12 ' A' ' 43' ' ' ILE . 87.3 mt -107.49 172.26 6.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.736 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.25 175.38 11.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.188 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 21.7 t70 -65.87 117.04 7.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.989 0.423 . . . . 0.0 110.796 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.6 10.15 38.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.983 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.551 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -90.08 174.87 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.58 143.89 47.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.643 0.735 . . . . 0.0 112.215 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.436 HG22 HD12 ' A' ' 69' ' ' LEU . 34.7 m -135.09 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.096 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 39' ' ' MET . 73.9 m -153.2 157.82 40.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.483 HD13 HD22 ' A' ' 25' ' ' LEU . 3.9 mm? -70.15 129.13 38.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.889 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.736 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.2 pt -93.04 -4.76 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.736 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -164.22 179.34 6.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.272 -178.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.09 110.1 19.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.191 0.307 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.548 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 4.0 mm? . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 21.9 mmmt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.361 0.601 . . . . 0.0 111.977 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -59.61 132.53 54.25 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.171 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.72 -15.92 40.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.726 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.476 ' HB ' HD22 ' A' ' 21' ' ' LEU . 59.9 m -56.2 121.93 10.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.485 ' HG3' ' OG ' ' A' ' 20' ' ' SER . 11.0 ttt -100.31 120.47 39.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.179 0.514 . . . . 0.0 111.039 -173.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HB ' HG23 ' A' ' 19' ' ' VAL . 47.9 mt -109.84 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.669 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.18 135.81 43.11 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.874 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 51.13 1.3 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.414 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.557 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -100.51 165.29 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.703 0.287 . . . . 0.0 110.322 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.5 ptp180 -142.19 158.47 43.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.394 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.477 HD23 ' CG2' ' A' ' 5' ' ' VAL . 34.8 mt -78.15 138.47 38.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -107.48 -172.4 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.658 -171.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.34 -35.75 78.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.684 0.754 . . . . 0.0 109.217 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 71.3 m -88.02 147.12 25.14 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.208 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.585 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.76 -1.4 26.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.842 0.83 . . . . 0.0 109.593 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 66' ' ' THR . 36.1 t70 -95.94 -5.69 40.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.81 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 7.6 mt-10 -133.3 157.9 44.3 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.559 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.553 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 7.3 pt -139.01 168.12 19.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.625 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.459 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -122.67 127.84 49.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -138.98 -170.98 11.99 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.274 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 . . . . . 0 C--N 1.317 -0.805 0 CA-C-O 121.173 0.511 . . . . 0.0 109.952 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.26 47.69 69.87 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.016 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD21 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -107.53 133.35 52.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.6 t -92.49 117.46 35.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.814 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.57 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 23.7 mt -127.34 143.97 51.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.135 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.588 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.8 ptp180 -59.66 133.35 56.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.377 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 50' ' ' ASP . 13.1 t -89.37 31.83 0.89 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.487 0.661 . . . . 0.0 110.732 -175.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 16.3 mt-10 -85.3 -32.4 22.52 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.58 0.705 . . . . 0.0 109.795 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 38.2 p90 -112.92 15.95 19.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.366 -172.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.436 HD12 HG22 ' A' ' 19' ' ' VAL . 61.3 mt -112.64 142.31 45.39 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.337 0.589 . . . . 0.0 110.294 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -115.32 132.82 56.49 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.767 -177.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.551 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.0 tmtt? -66.07 120.54 13.34 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.618 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -167.616 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.503 ' HB3' HD22 ' A' ' 12' ' ' LEU . 41.4 mt-10 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.278 0.561 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 49' ' ' GLU . 5.8 t -105.24 123.92 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.05 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -131.14 158.79 39.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.791 ' HA ' ' HG1' ' A' ' 66' ' ' THR . 30.0 p-10 -80.27 -169.75 2.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' HG23 ' A' ' 22' ' ' ILE . 26.7 p -67.34 -19.24 65.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.665 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -80.29 -48.67 12.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.844 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 17.18 2.85 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.612 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.53 133.22 35.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' A' ' 4' ' ' GLU . 19.8 mt -72.7 135.91 45.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.102 0.477 . . . . 0.0 111.354 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.04 168.74 8.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.749 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.48 172.98 14.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.669 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.0 t70 -63.95 120.73 12.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.968 0.414 . . . . 0.0 110.134 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.12 3.79 44.83 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.975 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -84.28 174.85 9.82 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -139.9 132.85 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.328 0.585 . . . . 0.0 111.094 -178.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.559 HG23 HD11 ' A' ' 69' ' ' LEU . 29.7 m -124.77 173.62 10.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.004 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 m -150.49 151.95 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.962 0.411 . . . . 0.0 111.146 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.579 ' CD1' HD22 ' A' ' 25' ' ' LEU . 4.1 mm? -65.03 127.12 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.78 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.582 HG23 ' SG ' ' A' ' 8' ' ' CYS . 35.0 pt -90.31 -11.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.26 0.553 . . . . 0.0 110.765 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HG3' ' CD2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -154.47 -178.81 7.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.473 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . 1.6 m-20 -96.79 110.22 22.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' A' ' 21' ' ' LEU . 3.6 mm? . . . . . 0 C--N 1.323 -0.545 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HD2' ' HB3' ' A' ' 24' ' ' ASP . 29.0 mmmt . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 36' ' ' ARG . 39.0 ttt-85 -56.43 133.57 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.563 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.79 -10.2 64.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.184 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.403 ' HB ' HD21 ' A' ' 21' ' ' LEU . 87.3 m -57.23 124.0 17.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.142 0.471 . . . . 0.0 110.291 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -93.96 122.4 36.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.255 0.55 . . . . 0.0 111.281 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.408 ' HB ' HG21 ' A' ' 19' ' ' VAL . 41.1 mt -110.8 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.069 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 13.3 ptt180 -108.76 159.28 16.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.719 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.2 39.63 15.44 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.603 HG21 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -91.05 161.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.874 0.368 . . . . 0.0 110.368 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 2.9 ptp180 -141.99 158.25 43.99 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.258 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.507 HD22 ' HB ' ' A' ' 5' ' ' VAL . 30.9 mt -80.33 154.75 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.808 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 p -127.8 -167.13 1.71 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.232 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.42 -21.95 66.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.201 0.525 . . . . 0.0 110.324 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 70.8 m -85.09 142.87 29.23 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -90.03 -7.6 53.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.8 0.809 . . . . 0.0 108.969 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -116.39 -5.5 11.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.185 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.7 mp0 -125.25 144.4 50.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 0.0 111.217 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.429 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -134.32 156.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.146 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HB2' HG23 ' A' ' 63' ' ' VAL . 37.9 tt0 -115.32 130.56 56.94 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.603 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -148.92 -161.14 9.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.299 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.646 -178.311 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.915 0.388 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.0 47.04 5.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.756 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -115.09 136.08 53.51 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.184 0.516 . . . . 0.0 110.465 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 53' ' ' GLU . 45.7 t -89.48 119.34 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.791 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.541 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 25.0 mt -129.9 147.36 51.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.917 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.564 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.4 ptp85 -65.18 130.25 42.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.954 172.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.791 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 9.8 t -85.58 30.69 0.62 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 0.0 110.592 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -88.03 -21.32 24.84 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.825 0.822 . . . . 0.0 109.706 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.564 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 33.8 p90 -117.97 18.41 13.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.563 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.559 HD11 HG23 ' A' ' 19' ' ' VAL . 68.0 mt -115.54 148.34 39.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.104 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -125.07 128.64 48.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.75 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.06 119.21 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.325 -172.74 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.519 ' HB3' HD22 ' A' ' 12' ' ' LEU . 30.5 mt-10 . . . . . 0 CA--C 1.516 -0.332 0 CA-C-O 121.178 0.513 . . . . 0.0 111.699 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -104.52 126.12 59.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.51 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.599 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 32.4 p-10 -80.07 -165.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.696 ' SG ' HG23 ' A' ' 22' ' ' ILE . 24.3 p -74.86 -8.59 56.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.25 0.548 . . . . 0.0 110.646 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -91.83 -44.66 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.686 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.22 13.25 3.61 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.301 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.7 130.76 38.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 4' ' ' GLU . 19.8 mt -66.7 143.57 56.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 112.241 -176.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -109.93 169.13 8.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.21 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -160.37 177.93 10.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.2 t70 -66.84 122.84 18.59 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 14.74 41.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.747 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.447 ' C ' HD21 ' A' ' 18' ' ' ASN . 0.7 OUTLIER -91.14 165.01 13.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.531 ' N ' HD21 ' A' ' 18' ' ' ASN . 0.6 OUTLIER -117.96 147.86 42.76 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.543 HG22 HD13 ' A' ' 69' ' ' LEU . 28.0 m -143.82 171.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.119 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -152.11 157.56 41.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.747 0.308 . . . . 0.0 111.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.593 HD11 HD21 ' A' ' 25' ' ' LEU . 4.0 mm? -69.6 124.19 23.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.632 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.696 HG23 ' SG ' ' A' ' 8' ' ' CYS . 40.5 pt -91.93 -12.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.269 0.557 . . . . 0.0 110.572 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.609 ' HG2' HG13 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -150.95 173.6 14.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.25 -177.016 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.17 122.76 32.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 21' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 120.931 0.396 . . . . 0.0 110.71 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 27.4 mmmt . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 121.49 0.662 . . . . 0.0 111.379 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -60.86 149.29 36.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.719 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.21 -3.04 79.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.898 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.437 ' HB ' HD21 ' A' ' 21' ' ' LEU . 84.5 m -68.08 121.84 16.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.509 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttm -87.86 129.38 35.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.603 . . . . 0.0 111.192 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.492 ' HB ' HG23 ' A' ' 19' ' ' VAL . 52.0 mt -122.14 92.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.973 172.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -106.87 136.26 47.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 111.012 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.82 52.09 1.22 Allowed Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.55 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -104.41 164.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 10.2 ptp85 -143.91 165.4 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.239 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.419 HD21 ' HB ' ' A' ' 5' ' ' VAL . 30.7 mt -80.67 150.88 29.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.052 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -111.99 -155.97 0.58 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.62 -8.53 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.094 0.473 . . . . 0.0 109.736 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 44.4 t -94.99 161.81 13.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.702 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.523 ' HA ' HG21 ' A' ' 5' ' ' VAL . 33.8 mt-10 -101.02 -5.29 26.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.774 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.464 ' O ' HG21 ' A' ' 66' ' ' THR . 5.1 m-20 -131.5 0.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.297 -176.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 3.6 mp0 -120.43 143.41 48.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.104 0.478 . . . . 0.0 110.185 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.11 165.33 32.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.873 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.445 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 4.0 tm-20 -125.04 125.56 44.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -151.94 -166.78 14.38 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.676 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -178.082 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 60' ' ' LYS . 1.6 ptmm? . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.819 0.342 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 89.6 52.48 2.65 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.703 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.416 HD21 ' O ' ' A' ' 54' ' ' GLY . 2.5 pt? -116.13 140.71 49.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.035 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.69 116.57 35.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.082 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.551 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 31.7 mt -130.17 152.66 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.245 0.545 . . . . 0.0 111.988 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.575 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 ptt180 -72.93 131.04 41.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.48 173.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' HD11 ' A' ' 69' ' ' LEU . 10.2 t -85.6 25.86 1.01 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.659 -175.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 1.3 pt-20 -83.33 -19.9 35.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.626 0.727 . . . . 0.0 109.667 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.575 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 26.8 p90 -118.31 17.51 13.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.055 -178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.543 HD13 HG22 ' A' ' 19' ' ' VAL . 76.1 mt -114.21 149.07 36.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.444 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.599 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.6 tmtt? -119.54 129.06 54.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.666 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HZ3' ' CG ' ' A' ' 17' ' ' ASP . 39.9 tttp -62.05 116.49 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.419 . . . . 0.0 111.406 -174.531 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HB3' HD23 ' A' ' 12' ' ' LEU . 42.4 mt-10 . . . . . 0 CA--C 1.511 -0.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.731 HG11 HG23 ' A' ' 52' ' ' ILE . 2.7 t -78.58 121.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.226 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -126.29 151.59 47.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.969 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.6 ' HA ' ' HG1' ' A' ' 66' ' ' THR . 3.0 p-10 -77.37 -172.05 2.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.637 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.573 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.7 p -65.11 -23.64 67.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.602 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.17 -28.62 31.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.563 177.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.14 15.73 12.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.229 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.7 136.05 33.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 4' ' ' GLU . 17.7 mt -70.51 138.75 51.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.559 . . . . 0.0 111.658 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.63 173.53 6.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.06 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.2 173.36 14.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.128 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 29.2 t70 -64.84 121.34 14.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.344 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.27 31.55 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.024 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.91 173.93 6.83 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.826 -0.22 . . . . 0.0 111.147 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.3 p30 -131.22 139.45 49.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.619 0.723 . . . . 0.0 112.092 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 71' ' ' LYS . 29.3 m -140.45 172.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.036 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -152.55 157.03 40.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 0.0 111.625 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.579 HD11 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -66.9 135.73 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.381 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.722 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.3 pt -97.1 -8.32 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.092 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.722 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -159.63 175.71 12.88 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -176.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.36 110.3 21.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.579 HD23 HD11 ' A' ' 21' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.578 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.428 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.9 mmmt . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.407 0.623 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -61.61 134.92 57.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.267 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.49 -9.36 64.63 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.053 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.444 ' HB ' HD22 ' A' ' 21' ' ' LEU . 97.6 m -59.5 124.56 20.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.815 0.308 . . . . 0.0 110.316 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.8 ttm -96.55 124.92 40.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.516 0.674 . . . . 0.0 111.038 -176.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.0 mt -115.14 94.47 3.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.002 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -111.23 147.13 35.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -177.352 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.23 39.03 5.51 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.561 HG21 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -89.99 166.7 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.906 0.384 . . . . 0.0 110.278 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 5.7 ptp85 -140.29 158.07 44.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.936 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD23 ' HB ' ' A' ' 5' ' ' VAL . 39.7 mt -84.12 130.51 34.85 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.9 p -93.43 -171.62 2.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.55 6.96 15.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.497 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -103.64 143.66 32.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.48 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' HG12 ' A' ' 5' ' ' VAL . 17.3 mt-10 -87.58 -25.14 23.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.359 0.6 . . . . 0.0 109.936 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.94 -7.31 33.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.136 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -126.87 147.74 50.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 111.5 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.731 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -131.6 168.45 23.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.339 173.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.25 129.31 53.99 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.561 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -141.21 -165.86 10.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.074 -175.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 18.3 ptt85 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.177 0.513 . . . . 0.0 110.046 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 11.5 ptmm? . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.768 0.318 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.65 30.66 39.07 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.411 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -101.81 139.9 36.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.32 116.88 36.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.761 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -128.37 144.51 51.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.579 0.704 . . . . 0.0 111.996 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.556 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 13.8 ptt180 -66.16 135.83 55.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.43 173.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.6 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 9.0 t -89.23 30.51 0.97 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.568 0.699 . . . . 0.0 110.561 -176.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.556 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 31.0 mt-10 -80.1 -31.8 39.21 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.944 0.878 . . . . 0.0 109.501 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 48.8 p90 -116.77 16.57 15.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.441 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.58 145.61 36.09 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.163 0.506 . . . . 0.0 109.871 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -119.74 128.47 53.8 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.588 -178.268 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HA ' HG12 ' A' ' 19' ' ' VAL . 58.5 tttp -63.36 127.81 33.0 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.806 -169.073 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 34.7 mt-10 . . . . . 0 CA--C 1.516 -0.342 0 CA-C-O 121.567 0.698 . . . . 0.0 111.886 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.616 HG13 HG23 ' A' ' 52' ' ' ILE . 4.6 t -96.99 127.61 49.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.077 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.526 ' HG3' HD21 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -128.03 148.68 50.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.553 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.594 ' HA ' ' HG1' ' A' ' 66' ' ' THR . 3.4 p-10 -73.98 -171.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.627 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 22' ' ' ILE . 26.5 p -63.82 -29.12 70.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -25.89 56.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.38 18.93 13.23 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.962 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.23 136.25 36.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.137 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.526 HD21 ' HG3' ' A' ' 6' ' ' ARG . 25.6 mt -67.93 138.3 55.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.759 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -108.13 170.29 8.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.155 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.42 174.16 15.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.455 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 19.9 t70 -67.68 114.16 6.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.845 0.355 . . . . 0.0 110.357 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.49 2.27 29.25 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.65 173.05 11.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -136.12 141.68 44.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 111.411 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 71' ' ' LYS . 31.3 m -134.88 177.03 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.342 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 m -151.07 153.24 34.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.0 111.321 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.517 HD11 HD21 ' A' ' 25' ' ' LEU . 4.2 mm? -64.21 128.52 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.7 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.689 HG13 ' HG2' ' A' ' 23' ' ' LYS . 42.2 pt -90.53 -11.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.773 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.689 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.99 -178.28 7.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.174 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.55 117.18 26.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 21' ' ' LEU . 3.9 mm? . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.174 0.512 . . . . 0.0 110.631 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 22.4 mmmt . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 121.321 0.582 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -61.25 137.83 58.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.142 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.03 -14.88 59.77 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.52 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.454 ' HB ' HD22 ' A' ' 21' ' ' LEU . 88.2 m -56.61 119.93 6.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 110.039 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.1 ttt -94.05 122.91 37.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.363 0.601 . . . . 0.0 110.753 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.3 mt -110.54 90.51 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.797 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -104.67 137.6 42.25 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.371 -175.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.02 50.45 2.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.379 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.54 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -97.18 164.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.7 ptp180 -142.83 157.79 44.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.532 HD22 ' HB ' ' A' ' 5' ' ' VAL . 32.9 mt -75.64 155.1 36.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.665 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -121.69 -167.87 1.6 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.79 -20.08 65.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.6 m -85.75 147.74 26.19 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.954 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HA ' HG23 ' A' ' 5' ' ' VAL . 28.1 mt-10 -96.14 -13.8 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.503 0.668 . . . . 0.0 109.517 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -106.85 -5.92 18.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.862 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 2.0 mp0 -127.96 146.56 50.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.335 0.588 . . . . 0.0 111.44 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.616 HG23 HG13 ' A' ' 5' ' ' VAL . 2.7 pp -131.09 166.62 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.304 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -117.92 124.84 49.23 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.54 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.04 -166.16 10.69 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.085 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 15.5 ptp180 . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 12.6 ptmm? . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.69 39.8 13.55 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.209 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -110.54 138.64 46.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.907 0.384 . . . . 0.0 109.983 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.23 116.77 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.48 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -128.69 145.6 51.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 111.796 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.608 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -64.11 130.88 45.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.235 173.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.594 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 9.5 t -86.41 26.47 1.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.647 -175.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 32.5 mt-10 -84.0 -25.51 29.91 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.938 0.875 . . . . 0.0 109.392 -175.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.608 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 32.1 p90 -113.98 16.95 18.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.61 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 66' ' ' THR . 65.1 mt -114.17 145.84 41.14 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.953 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -118.7 125.59 50.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.124 -178.021 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.555 ' HA ' HG11 ' A' ' 19' ' ' VAL . 54.3 tttp -62.65 122.37 15.68 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.392 0.432 . . . . 0.0 110.125 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.653 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -177.234 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.849 0.357 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 m -136.8 93.59 2.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.624 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -113.85 53.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.484 0.659 . . . . 0.0 109.467 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' HB3' HD21 ' A' ' 12' ' ' LEU . 32.6 mt-10 -63.55 100.09 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.559 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.758 HG13 HG21 ' A' ' 52' ' ' ILE . 19.2 t -85.96 121.26 37.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.602 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -124.93 153.19 43.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -174.17 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 111.085 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.594 ' SG ' HG21 ' A' ' 22' ' ' ILE . 13.7 p -56.05 -30.68 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.607 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -83.85 -56.7 3.55 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.29 19.2 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.245 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.624 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . . . -83.05 135.6 34.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.047 0.423 . . . . 0.0 110.039 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 4' ' ' GLU . 15.8 mt -77.29 135.7 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.288 0.566 . . . . 0.0 112.445 -174.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.417 ' HB3' HD12 ' A' ' 43' ' ' ILE . 63.9 mt -112.0 166.72 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.711 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.9 179.49 9.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.26 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -64.69 118.37 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.16 8.56 50.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.217 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.84 174.19 8.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.838 -0.213 . . . . 0.0 110.467 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 3.2 p30 -133.7 139.63 46.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.526 0.679 . . . . 0.0 111.585 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG21 HD11 ' A' ' 69' ' ' LEU . 34.6 m -131.88 174.7 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.213 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 m -151.89 148.88 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.807 0.337 . . . . 0.0 110.781 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.598 HD12 HD21 ' A' ' 25' ' ' LEU . 4.5 mm? -60.74 130.04 44.5 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.236 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.64 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -91.15 -11.33 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.56 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.64 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.55 178.34 10.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.296 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -91.44 121.9 33.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.598 HD21 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? -117.33 125.23 50.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.735 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.6 tmmt? -101.04 138.01 38.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.576 0.703 . . . . 0.0 111.167 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.417 HD22 HD12 ' A' ' 34' ' ' LEU . 4.4 mm? -109.31 149.64 29.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.543 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 49.5 mtpt -72.48 -33.7 67.16 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.796 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.25 105.81 0.54 Allowed Glycine 0 C--N 1.329 0.172 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.976 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 m 59.42 20.78 9.13 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 122.837 0.455 . . . . 0.0 111.315 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 t 55.89 73.53 0.43 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.261 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.1 m -101.51 103.14 14.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.828 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.735 HG22 ' HG3' ' A' ' 26' ' ' LYS . 30.0 t -96.88 101.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.013 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.417 HD12 HD22 ' A' ' 27' ' ' LEU . 6.1 mp -77.86 147.53 35.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.463 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.5 mmmt -109.96 160.85 16.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.529 0.68 . . . . 0.0 111.668 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -61.61 138.78 58.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.984 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.04 -13.07 63.75 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.634 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.521 ' HB ' HD23 ' A' ' 21' ' ' LEU . 77.9 m -58.78 119.41 7.09 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 7.4 ttt -87.98 124.65 33.93 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.282 0.563 . . . . 0.0 110.751 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.735 HG12 HG22 ' A' ' 56' ' ' THR . 43.6 mt -114.53 91.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.664 173.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -108.61 149.53 28.77 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.708 -176.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.58 6.54 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.221 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.537 HG23 ' HA3' ' A' ' 54' ' ' GLY . 2.0 pp -91.65 160.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 8.2 ptt180 -141.06 161.01 38.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.748 0.309 . . . . 0.0 110.579 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.512 HD23 ' CG2' ' A' ' 5' ' ' VAL . 25.9 mt -79.86 154.06 28.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.238 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -121.46 -159.33 0.8 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.23 -14.2 62.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.686 0.755 . . . . 0.0 109.261 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 65.6 m -101.03 148.35 25.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.669 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.572 ' HA ' HG22 ' A' ' 5' ' ' VAL . 23.8 mt-10 -92.5 -16.43 25.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.36 -14.94 23.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.382 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 8.2 mp0 -125.66 148.73 48.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.548 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.758 HG21 HG13 ' A' ' 5' ' ' VAL . 2.5 pp -132.45 160.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.253 171.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -115.58 122.68 46.37 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.537 ' HA3' HG23 ' A' ' 43' ' ' ILE . . . -133.33 -156.1 7.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.716 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.7 ptp180 -149.45 148.17 29.11 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.735 HG22 HG12 ' A' ' 40' ' ' ILE . 68.4 p -122.41 -176.06 3.28 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.58 -38.03 89.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.963 0.411 . . . . 0.0 110.677 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -101.98 -39.9 7.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mm -114.63 104.2 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HD2' ' C ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -100.16 149.16 23.82 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.485 176.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.61 50.57 42.05 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.64 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -115.23 135.39 54.22 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.083 0.468 . . . . 0.0 110.033 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.3 t -92.66 122.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.722 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 25.7 mt -134.02 147.0 50.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.37 0.605 . . . . 0.0 112.191 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.578 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.8 ptp180 -66.34 130.51 43.47 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.947 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.493 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.2 t -86.23 26.29 1.06 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.251 0.548 . . . . 0.0 110.856 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.573 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.0 mt-10 -84.17 -22.58 30.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.714 0.769 . . . . 0.0 109.652 -175.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HZ ' HD21 ' A' ' 64' ' ' LEU . 24.2 p90 -117.32 19.44 14.09 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.749 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 66' ' ' THR . 60.6 mt -116.68 145.48 43.41 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.014 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HB2' HG23 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -114.4 133.27 55.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.247 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.624 ' HD2' ' HB2' ' A' ' 11' ' ' ALA . 52.1 tttt -58.43 122.32 13.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.64 173.1 8.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.35 -89.37 1.3 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.585 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.57 -0.728 . . . . 0.0 109.955 178.804 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -129.1 110.16 11.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.248 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.57 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 23.7 pt -138.91 68.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.567 0.698 . . . . 0.0 110.181 172.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.83 102.91 7.45 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG21 ' HA ' ' A' ' 49' ' ' GLU . 3.6 t -91.63 129.84 41.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.779 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.527 ' HG3' HD22 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -133.98 171.09 14.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.19 -169.72 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 22' ' ' ILE . 7.7 p -66.39 -27.77 68.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.295 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -82.46 -51.03 8.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.09 27.1 0.26 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.772 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.65 123.78 40.43 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.527 HD22 ' HG3' ' A' ' 6' ' ' ARG . 27.4 mt -60.35 143.78 52.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.457 0.646 . . . . 0.0 112.642 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 43' ' ' ILE . 95.7 mt -111.36 170.85 7.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.14 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.47 178.17 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.86 122.0 14.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.012 0.434 . . . . 0.0 110.946 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.19 64.33 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.374 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.578 ' C ' HD21 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -78.54 173.06 12.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.697 0.284 . . . . 0.0 110.703 -175.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.578 HD21 ' C ' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -124.46 146.35 48.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.255 0.55 . . . . 0.0 110.523 -177.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.419 HG22 HD11 ' A' ' 69' ' ' LEU . 27.7 m -142.55 170.82 11.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.532 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -153.18 158.66 42.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.76 0.314 . . . . 0.0 110.713 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD23 ' HB ' ' A' ' 38' ' ' THR . 3.4 mm? -67.66 135.16 52.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.537 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.566 HG13 ' HG2' ' A' ' 23' ' ' LYS . 37.2 pt -96.59 -11.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 110.838 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.566 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -155.86 174.79 14.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.134 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.54 107.61 18.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.514 HD22 HD11 ' A' ' 21' ' ' LEU . 4.3 mm? -101.1 115.66 31.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.278 0.561 . . . . 0.0 111.199 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.697 ' HG3' HG21 ' A' ' 33' ' ' VAL . 4.3 tmmt? -98.88 132.68 44.03 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.448 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.6 mt -104.36 157.34 17.21 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.078 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.36 148.32 35.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.655 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.15 -119.91 2.48 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 p -86.54 23.25 1.68 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.722 0.296 . . . . 0.0 110.548 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.6 m 63.91 79.52 0.26 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.574 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 m -101.07 104.03 15.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.942 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 26' ' ' LYS . 31.4 t -99.57 116.69 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.464 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.46 146.82 26.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.6 mmmt -106.76 161.38 14.72 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.471 0.653 . . . . 0.0 111.812 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.47 139.56 58.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.249 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.71 68.54 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.943 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.525 ' HB ' HD23 ' A' ' 21' ' ' LEU . 85.3 m -58.17 121.39 10.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.783 0.291 . . . . 0.0 110.256 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.24 117.01 29.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.363 0.601 . . . . 0.0 111.516 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.408 ' HB ' HG23 ' A' ' 19' ' ' VAL . 51.5 mt -104.05 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.586 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.33 135.74 47.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.394 -174.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.68 48.85 2.06 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.335 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 pp -94.25 160.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -138.95 159.88 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.106 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.433 HD22 HG22 ' A' ' 5' ' ' VAL . 47.6 mt -85.87 138.26 32.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 -175.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.4 p -98.33 -156.8 0.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.779 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -90.29 -2.08 57.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 109.668 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 58.1 m -98.29 149.08 22.98 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 27.3 mt-10 -94.85 -14.88 24.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.623 0.725 . . . . 0.0 109.376 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' O ' HG21 ' A' ' 66' ' ' THR . 1.0 OUTLIER -108.32 -2.94 18.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.538 -176.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -130.01 147.57 51.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.156 0.503 . . . . 0.0 111.044 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.489 ' CG2' HG13 ' A' ' 5' ' ' VAL . 15.7 pt -135.18 175.76 10.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.642 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HG3' HG23 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -130.74 135.31 47.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -139.65 -177.6 15.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.281 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 55' ' ' ARG . 10.1 ptt180 -130.0 137.07 50.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.234 0.54 . . . . 0.0 110.179 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.6 p -104.55 -171.52 1.94 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.244 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.01 -23.64 62.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.994 0.426 . . . . 0.0 110.265 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -108.48 -73.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.166 0.507 . . . . 0.0 110.556 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.8 mm -82.25 117.22 27.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.415 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 60' ' ' LYS . 20.0 ptmt -107.17 135.03 49.39 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.28 5.86 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.651 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -110.99 134.57 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 53' ' ' GLU . 39.4 t -91.72 125.09 44.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.908 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.531 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 33.4 mt -137.31 145.77 43.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.666 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.654 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -62.99 130.48 44.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.759 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.411 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -83.83 23.96 0.94 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.745 0.783 . . . . 0.0 110.204 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -89.58 -15.1 33.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.537 0.684 . . . . 0.0 110.101 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.654 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 53.4 p90 -121.84 17.0 11.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.303 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.419 HD11 HG22 ' A' ' 19' ' ' VAL . 73.6 mt -113.53 147.11 38.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.512 0.672 . . . . 0.0 110.087 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HB2' HG21 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -117.36 124.81 49.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.106 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -59.95 118.83 6.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.61 -46.59 78.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 0.0 110.042 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.41 -129.63 3.29 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.267 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.175 178.085 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.835 0.35 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -135.93 97.98 3.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.808 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.439 ' HB ' ' HG2' ' A' ' 49' ' ' GLU . 20.9 pt -115.12 53.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.505 ' HB3' HD21 ' A' ' 12' ' ' LEU . 46.1 mt-10 -54.69 123.97 14.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.496 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.506 ' HB ' HD23 ' A' ' 45' ' ' LEU . 3.5 t -113.24 119.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.959 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.505 ' HG3' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -122.32 175.17 6.56 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.837 -177.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.453 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 3.1 p-10 -86.05 -164.29 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.065 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 25.8 p -63.57 -20.37 65.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.547 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.445 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -95.78 -49.36 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.63 10.89 0.77 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.526 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.86 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.505 HD21 ' HB3' ' A' ' 4' ' ' GLU . 25.3 mt -72.51 143.74 48.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.379 0.609 . . . . 0.0 112.28 -173.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.59 166.06 11.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.387 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.79 174.31 15.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.911 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -63.96 121.5 14.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.514 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.49 1.67 53.4 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.006 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -81.73 174.05 11.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 110.404 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.9 p30 -132.69 142.91 49.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.617 0.722 . . . . 0.0 111.652 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 71' ' ' LYS . 29.5 m -137.57 174.88 10.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.927 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.1 m -152.19 150.87 30.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.715 0.293 . . . . 0.0 110.714 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.587 HD11 HD23 ' A' ' 25' ' ' LEU . 4.3 mm? -62.0 128.26 35.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.679 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.633 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -89.6 -10.03 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.814 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.633 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -159.79 174.27 14.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -85.01 118.75 24.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.587 HD23 HD11 ' A' ' 21' ' ' LEU . 4.2 mm? -112.18 108.71 18.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 110.407 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' CG ' HG22 ' A' ' 33' ' ' VAL . 5.2 tmmm? -95.07 130.63 41.68 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.414 HD11 ' HB ' ' A' ' 32' ' ' THR . 56.2 mt -78.08 151.08 33.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.491 -173.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -86.77 -47.65 8.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.086 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.78 11.52 10.42 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.266 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 58.0 m -159.76 -174.24 4.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.5 m -103.93 20.82 17.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.801 0.81 . . . . 0.0 109.124 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.414 ' HB ' HD11 ' A' ' 27' ' ' LEU . 27.7 m -71.44 104.53 3.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG22 ' CG ' ' A' ' 26' ' ' LYS . 6.5 t -100.92 102.75 13.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.06 141.1 32.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 26.8 mmmt -111.79 157.84 20.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.273 0.559 . . . . 0.0 111.579 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.76 145.58 44.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.438 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.92 -8.13 78.4 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.608 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.525 ' HB ' HD22 ' A' ' 21' ' ' LEU . 89.6 m -65.16 112.8 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 0.0 110.313 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.0 ttm -81.5 117.49 21.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.421 0.629 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.573 HG12 HG23 ' A' ' 56' ' ' THR . 48.1 mt -108.9 99.81 9.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.961 174.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -111.03 156.58 21.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.924 0.392 . . . . 0.0 111.128 -176.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.51 28.52 35.65 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.542 HG23 ' HA3' ' A' ' 54' ' ' GLY . 2.3 pp -78.94 161.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.678 0.275 . . . . 0.0 110.423 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.6 ptp180 -140.91 166.2 25.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.506 HD23 ' HB ' ' A' ' 5' ' ' VAL . 39.3 mt -88.47 137.96 31.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.973 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -95.16 -159.77 0.74 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -81.94 -4.76 57.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.385 0.612 . . . . 0.0 109.454 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 73.9 m -99.35 146.75 25.94 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.501 ' HA ' HG22 ' A' ' 5' ' ' VAL . 22.3 mt-10 -90.51 -15.26 31.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.381 0.61 . . . . 0.0 109.904 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.4 -5.44 20.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.078 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -126.67 145.18 50.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 111.81 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -131.04 173.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.2 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.621 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 11.7 tm-20 -127.98 131.19 49.27 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' HA3' HG23 ' A' ' 43' ' ' ILE . . . -145.04 -166.32 11.61 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.69 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.466 HH11 ' HB3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -151.16 147.87 27.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.361 0.601 . . . . 0.0 111.258 -175.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.573 HG23 HG12 ' A' ' 40' ' ' ILE . 44.2 p -122.17 -170.97 2.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.142 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -59.53 -47.08 86.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.887 0.375 . . . . 0.0 110.304 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -96.92 -70.37 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.215 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mm -75.02 102.27 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.775 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 60' ' ' LYS . 7.3 ptpp? -119.18 118.37 31.16 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.124 0.487 . . . . 0.0 109.835 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.621 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 103.98 43.14 1.83 Allowed Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.405 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 54' ' ' GLY . 2.3 pt? -115.39 132.67 56.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.237 0.541 . . . . 0.0 110.032 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -90.89 124.57 43.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.691 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.678 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -134.05 146.3 50.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.294 0.569 . . . . 0.0 112.189 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.583 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.5 ptp180 -64.7 130.82 45.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.814 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 t -86.24 33.09 0.61 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.986 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -85.96 -29.63 23.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.435 0.636 . . . . 0.0 110.161 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.678 ' HZ ' HD23 ' A' ' 64' ' ' LEU . 38.3 p90 -113.62 18.97 17.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.982 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 19' ' ' VAL . 59.4 mt -113.31 144.71 42.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.972 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HB2' HG21 ' A' ' 22' ' ' ILE . 3.0 tmtt? -114.17 122.38 46.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.641 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HA ' HG13 ' A' ' 19' ' ' VAL . 48.7 tttp -57.77 120.59 8.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.3 99.15 6.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.109 0.48 . . . . 0.0 110.602 -174.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.93 24.52 3.62 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.836 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.567 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.628 0.251 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -108.85 151.54 26.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.61 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 45.6 pt -119.93 42.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.889 0.376 . . . . 0.0 110.553 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 32.6 mt-10 -61.71 111.74 1.98 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.587 0.708 . . . . 0.0 110.535 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.737 HG11 HG21 ' A' ' 52' ' ' ILE . 10.3 t -94.8 132.0 40.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.815 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.46 ' HG3' HD22 ' A' ' 12' ' ' LEU . 2.4 mpt_? -132.43 150.06 52.23 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.566 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 3.8 p-10 -77.59 -163.5 0.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.725 0.297 . . . . 0.0 110.634 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.6 t -70.98 -15.6 62.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.309 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.436 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 2.3 t-20 -85.83 -54.78 4.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.716 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 10.89 1.91 Allowed Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.609 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.43 133.07 35.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.46 HD22 ' HG3' ' A' ' 6' ' ' ARG . 15.2 mt -72.7 135.07 45.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.168 0.508 . . . . 0.0 111.621 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -102.4 163.72 12.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.401 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HA ' HD13 ' A' ' 45' ' ' LEU . . . -149.23 177.55 9.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.16 118.24 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 29.01 12.46 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.647 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.7 t0 -98.72 175.13 6.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -132.73 141.15 48.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.664 0.745 . . . . 0.0 111.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 40' ' ' ILE . 30.6 m -136.86 174.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.097 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.8 m -153.08 150.94 29.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.77 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.555 HD11 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -64.61 129.42 39.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.739 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.652 HG13 ' HG2' ' A' ' 23' ' ' LYS . 32.1 pt -90.94 -4.61 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 110.639 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.652 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -165.09 -179.15 5.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.886 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.83 116.56 29.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.555 HD23 HD11 ' A' ' 21' ' ' LEU . 4.3 mm? -110.18 117.43 33.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.673 ' HG3' HG23 ' A' ' 33' ' ' VAL . 2.6 tmmt? -99.44 130.38 45.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 66.3 mt -103.3 153.9 19.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.776 -171.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -82.8 144.39 30.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.684 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.01 -61.83 0.53 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.8 m -128.26 -76.67 0.56 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -176.18 43.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.3 m -75.19 103.76 5.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.699 -174.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG23 ' HG3' ' A' ' 26' ' ' LYS . 20.1 t -105.2 100.47 10.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp -80.61 147.7 30.61 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -111.42 159.2 18.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.173 0.511 . . . . 0.0 111.764 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -63.67 140.13 58.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.474 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.27 84.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.838 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.511 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -64.32 114.43 4.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.95 0.375 . . . . 0.0 110.077 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 29.8 ttm -81.24 119.32 23.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.491 0.662 . . . . 0.0 111.121 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.63 HG12 HG23 ' A' ' 56' ' ' THR . 43.0 mt -106.64 90.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.469 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' C ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -101.07 162.68 12.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.268 -176.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.82 57.72 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.988 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -92.96 163.91 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.991 0.424 . . . . 0.0 109.953 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -136.09 159.05 42.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.821 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 14' ' ' ALA . 55.2 mt -82.04 130.19 35.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.631 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.4 p -87.98 -158.69 0.48 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.244 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -85.58 -8.37 58.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 75.4 m -96.94 150.54 20.65 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.665 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 2.9 mt-10 -90.28 -22.89 21.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 109.927 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -101.77 1.06 36.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.521 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.6 OUTLIER -133.18 144.4 49.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.53 0.681 . . . . 0.0 111.305 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.737 HG21 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -131.37 157.08 43.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.605 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -113.81 125.84 54.53 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.574 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.49 -160.89 8.72 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.751 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -148.96 144.7 26.97 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.362 0.601 . . . . 0.0 109.971 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.63 HG23 HG12 ' A' ' 40' ' ' ILE . 80.9 p -111.32 -170.09 1.58 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.003 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.5 11.42 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.534 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -147.39 -56.14 0.24 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.409 176.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.64 104.11 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.611 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.76 129.45 45.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.597 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.08 47.35 5.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.818 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -111.53 133.19 53.98 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.99 114.89 30.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.765 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 47.6 mt -128.99 135.79 49.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.78 0.8 . . . . 0.0 112.312 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.567 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 1.4 ptp180 -56.92 130.3 45.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.009 167.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.528 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 10.1 t -88.31 27.79 1.19 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.758 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 14.6 mt-10 -86.17 -16.19 38.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.981 0.896 . . . . 0.0 109.458 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.765 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 34.5 p90 -120.36 19.05 12.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.097 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 66' ' ' THR . 86.2 mt -116.65 148.28 41.15 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -115.71 126.59 54.28 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.581 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.0 122.31 16.22 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.99 121.13 21.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.82 -37.93 3.11 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.147 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.132 -178.755 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 tpp . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.987 0.422 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 m -130.79 84.04 2.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.406 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -107.26 50.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.46 0.648 . . . . 0.0 109.821 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.48 ' HB3' HD21 ' A' ' 12' ' ' LEU . 48.4 mt-10 -54.89 127.19 27.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.528 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' HB ' HD23 ' A' ' 45' ' ' LEU . 5.1 t -108.88 130.46 61.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.983 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.518 ' HG3' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -131.89 165.14 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.469 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.31 -166.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.668 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 21.9 p -61.59 -34.36 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.372 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.28 -40.45 26.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.96 0.41 . . . . 0.0 110.767 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 20.09 2.06 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.238 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.06 132.27 36.12 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.518 HD22 ' HG3' ' A' ' 6' ' ' ARG . 24.7 mt -70.55 142.84 51.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.293 0.568 . . . . 0.0 111.894 -172.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 43' ' ' ILE . 83.7 mt -108.96 173.77 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.63 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.78 175.89 9.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.873 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.7 t70 -62.26 125.43 23.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.493 . . . . 0.0 110.574 175.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.69 59.38 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.935 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.563 ' C ' HD21 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -89.91 171.75 9.37 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.563 HD21 ' C ' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -123.91 145.83 48.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.674 -176.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 27.7 m -145.07 172.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.5 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.9 m -155.09 156.26 35.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.605 0.24 . . . . 0.0 110.73 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.572 HD11 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -70.53 128.16 35.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.651 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.626 HG13 ' HG2' ' A' ' 23' ' ' LYS . 40.2 pt -91.45 -10.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.111 0.481 . . . . 0.0 110.823 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.626 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -158.04 176.51 12.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.37 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.33 118.94 25.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.572 HD23 HD11 ' A' ' 21' ' ' LEU . 4.0 mm? -114.39 109.72 18.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.796 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.727 ' HG3' HG21 ' A' ' 33' ' ' VAL . 4.4 tmmm? -90.9 144.71 25.41 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.036 0.446 . . . . 0.0 110.212 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.7 mt -97.94 141.77 30.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.514 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.88 161.38 23.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.799 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.44 -49.44 1.12 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.942 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.1 p -136.6 178.78 6.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 p -83.93 40.96 0.78 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.8 m -90.0 104.86 17.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.006 0.432 . . . . 0.0 110.586 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.727 HG21 ' HG3' ' A' ' 26' ' ' LYS . 17.3 t -112.91 104.15 16.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.108 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 5.7 mp -76.8 141.79 40.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -111.39 159.78 17.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.589 0.709 . . . . 0.0 112.127 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -59.78 136.35 57.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.43 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.97 64.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.893 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.514 ' HB ' HD22 ' A' ' 21' ' ' LEU . 87.6 m -59.83 115.81 3.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 110.365 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ttm -87.23 123.54 32.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.455 0.645 . . . . 0.0 111.306 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 56' ' ' THR . 45.5 mt -114.6 95.92 4.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.145 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.64 135.96 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.733 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.09 40.33 3.79 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.641 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.473 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 2.2 pp -85.09 167.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 6.7 ptp85 -143.2 158.97 43.15 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.072 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.489 HD23 ' HB ' ' A' ' 5' ' ' VAL . 33.2 mt -84.01 162.74 20.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.635 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -126.92 -167.62 1.76 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.52 -6.45 55.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.277 0.561 . . . . 0.0 109.542 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 55.1 m -96.81 145.89 25.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.422 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' O ' HG11 ' A' ' 5' ' ' VAL . 23.2 mt-10 -89.47 -23.94 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.189 0.519 . . . . 0.0 110.616 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.436 ' O ' HG21 ' A' ' 66' ' ' THR . 16.4 m-20 -105.98 -3.37 21.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.972 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 14.9 mp0 -122.64 146.15 47.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.224 0.535 . . . . 0.0 110.836 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.431 ' CG2' HG13 ' A' ' 5' ' ' VAL . 24.7 pt -133.78 178.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.801 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -132.23 127.88 36.71 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.506 ' O ' HD21 ' A' ' 62' ' ' LEU . . . -138.67 178.57 19.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.082 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -136.5 141.09 43.44 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.397 0.617 . . . . 0.0 110.851 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.521 HG22 HG12 ' A' ' 40' ' ' ILE . 30.1 p -107.6 -170.19 1.65 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.618 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.89 -16.7 60.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.162 0.506 . . . . 0.0 109.992 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -114.6 -74.13 0.63 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.733 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.428 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -78.81 108.9 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -112.85 122.29 47.21 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.496 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.539 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 92.58 51.14 2.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.506 HD21 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -115.28 135.03 54.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 46.4 t -90.16 119.65 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.147 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.639 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 22.3 mt -133.12 142.89 48.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.648 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.581 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 15.8 ptt180 -64.3 131.65 47.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.736 171.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' HD13 ' A' ' 69' ' ' LEU . 10.6 t -88.35 27.97 1.16 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.972 -174.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.3 mt-10 -79.87 -27.57 40.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.845 0.831 . . . . 0.0 109.24 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.639 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 31.8 p90 -113.92 17.88 17.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.765 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 66' ' ' THR . 72.5 mt -112.48 141.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.393 0.616 . . . . 0.0 110.161 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -110.94 122.05 46.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.486 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -59.13 121.35 11.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.69 67.71 3.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.512 0.672 . . . . 0.0 110.962 -175.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.3 126.73 2.15 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.093 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.266 -178.564 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.677 0.275 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -149.6 96.48 2.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.162 0.506 . . . . 0.0 110.182 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.3 pt -135.91 28.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.222 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -49.23 112.63 0.66 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.316 0.579 . . . . 0.0 111.447 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.62 HG11 HG22 ' A' ' 52' ' ' ILE . 3.0 t -95.81 133.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.629 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.534 ' HG3' HD22 ' A' ' 12' ' ' LEU . 2.0 mpt_? -131.02 166.09 21.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.16 -174.8 5.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 110.21 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 p -57.44 -34.47 69.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.659 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -79.23 -43.19 24.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.836 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.79 18.37 1.4 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.563 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.54 128.26 34.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.534 HD22 ' HG3' ' A' ' 6' ' ' ARG . 17.4 mt -65.53 142.49 58.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -110.39 171.8 7.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.623 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.51 178.99 9.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.6 t70 -75.45 111.04 10.33 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.14 22.75 9.63 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 176.61 6.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -135.04 140.45 45.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.467 0.651 . . . . 0.0 111.66 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.67 176.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.213 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -149.71 157.32 43.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.769 0.319 . . . . 0.0 111.015 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.552 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -69.79 127.24 32.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.813 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.932 HG13 ' HG3' ' A' ' 23' ' ' LYS . 39.2 pt -92.27 -9.24 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.225 0.536 . . . . 0.0 110.368 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.932 ' HG3' HG13 ' A' ' 22' ' ' ILE . 24.1 mtpp -143.02 -179.74 6.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.671 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 35' ' ' LYS . 10.3 m-20 -98.27 94.89 7.03 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 3.7 mm? -96.28 108.65 21.18 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.57 ' HG2' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -89.89 128.53 36.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.609 HD22 ' HB2' ' A' ' 30' ' ' SER . 6.4 tt -63.6 136.33 57.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.602 -175.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' N ' HD21 ' A' ' 27' ' ' LEU . 21.9 pttp -82.98 114.23 21.11 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.794 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.26 7.13 55.0 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.135 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.609 ' HB2' HD22 ' A' ' 27' ' ' LEU . 61.1 m -150.59 154.52 37.68 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.4 p -83.44 16.77 2.41 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 m -80.71 104.44 11.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.077 0.465 . . . . 0.0 110.32 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG23 ' HG2' ' A' ' 26' ' ' LYS . 4.9 t -94.1 104.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 8.7 mt -80.44 90.69 5.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.55 0.69 . . . . 0.0 109.464 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 26.1 mmmt -71.18 160.86 32.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.177 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -57.17 134.02 55.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.374 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.18 -9.26 61.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.908 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.502 ' HB ' HD22 ' A' ' 21' ' ' LEU . 97.2 m -60.56 119.78 8.73 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.964 0.382 . . . . 0.0 110.212 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.0 ttm -88.22 122.24 31.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.434 0.635 . . . . 0.0 111.179 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.641 HG12 HG22 ' A' ' 56' ' ' THR . 50.2 mt -113.22 91.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.906 173.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.96 135.69 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.284 0.564 . . . . 0.0 110.676 -176.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.67 43.76 1.77 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -171.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.578 HG21 ' HA3' ' A' ' 54' ' ' GLY . 1.9 pp -98.5 158.05 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 177.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.54 HD22 ' HB ' ' A' ' 5' ' ' VAL . 26.9 mt -75.82 149.03 37.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.163 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.3 p -118.8 -167.96 1.47 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.3 -3.49 33.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 0.0 110.065 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 47.3 m -100.64 138.23 37.96 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.826 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -92.53 -15.04 27.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.146 0.498 . . . . 0.0 110.213 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -106.24 -5.23 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.949 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.5 mp0 -125.9 146.56 49.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.002 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.62 HG22 HG11 ' A' ' 5' ' ' VAL . 9.3 pt -131.4 172.4 16.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.528 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -126.09 129.73 49.69 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -137.26 -167.07 10.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.966 -1.112 . . . . 0.0 112.623 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -148.19 144.5 27.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.641 HG22 HG12 ' A' ' 40' ' ' ILE . 50.5 p -115.88 -171.35 1.96 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.691 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.34 -25.92 68.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.233 0.54 . . . . 0.0 110.282 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -119.99 -71.18 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.892 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 mm -74.26 109.05 6.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.171 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -108.8 138.88 44.43 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.93 51.44 9.1 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.32 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -113.33 135.46 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.0 t -96.3 119.96 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.116 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.717 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 33.3 mt -133.34 138.91 46.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.585 0.707 . . . . 0.0 112.37 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.5 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.2 ptp180 -56.69 134.06 54.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.283 168.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -89.29 31.9 0.87 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.622 -174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 23.4 mt-10 -81.88 -32.93 30.78 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.851 0.834 . . . . 0.0 109.887 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.717 ' HZ ' HD21 ' A' ' 64' ' ' LEU . 30.3 p90 -115.16 20.63 14.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.921 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 72.1 mt -116.03 143.75 45.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.049 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HZ1' ' HB3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -119.98 128.94 54.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.945 -176.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -59.61 126.39 27.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.64 -146.41 0.35 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -172.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.68 145.19 14.37 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.252 1.213 0 C-N-CA 123.877 0.871 . . . . 0.0 112.797 177.583 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.689 0.281 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.2 m -78.61 86.71 4.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.068 0.461 . . . . 0.0 110.61 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.0 pt -129.63 44.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.062 173.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -61.02 106.83 0.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.451 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.537 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.4 t -93.01 123.76 45.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.042 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.528 ' HG3' HD23 ' A' ' 12' ' ' LEU . 1.4 mpt_? -126.49 170.24 12.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.561 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 39.4 p-10 -84.17 -162.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.637 ' SG ' HG23 ' A' ' 22' ' ' ILE . 20.2 p -78.52 12.16 2.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 110.591 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 7' ' ' ASP . 2.1 t-20 -118.35 -48.03 2.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.494 0.664 . . . . 0.0 110.254 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.04 5.51 3.44 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.108 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.1 125.83 29.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.528 HD23 ' HG3' ' A' ' 6' ' ' ARG . 17.3 mt -72.32 135.05 45.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.698 -175.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.01 162.42 13.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.48 8.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.977 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.0 t70 -64.62 125.72 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.82 17.07 53.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.264 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.02 175.48 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 13.3 p30 -131.06 139.08 49.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.698 0.761 . . . . 0.0 112.078 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.28 173.39 14.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.806 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -152.91 152.25 31.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.769 0.318 . . . . 0.0 110.619 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.543 HD11 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -64.63 128.58 36.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.641 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.964 HG13 ' HG3' ' A' ' 23' ' ' LYS . 35.0 pt -92.69 -9.68 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.174 0.511 . . . . 0.0 110.361 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.964 ' HG3' HG13 ' A' ' 22' ' ' ILE . 23.2 mtpp -145.47 -175.94 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.411 ' CG ' ' HZ2' ' A' ' 35' ' ' LYS . 4.6 m-20 -98.9 109.22 22.01 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.543 HD23 HD11 ' A' ' 21' ' ' LEU . 3.8 mm? -109.91 111.83 23.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.955 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.627 ' HG3' HG22 ' A' ' 33' ' ' VAL . 5.6 tmmm? -94.51 143.24 26.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.326 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.79 138.46 31.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.403 0.62 . . . . 0.0 110.57 -175.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -87.11 128.7 35.11 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.267 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.3 13.62 47.88 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.935 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 t -164.02 173.25 12.78 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.9 p -94.08 8.33 41.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.833 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -69.04 104.63 2.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.765 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.627 HG22 ' HG3' ' A' ' 26' ' ' LYS . 17.5 t -111.31 100.31 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp -76.32 140.31 41.41 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 23.4 mmmt -110.37 160.15 16.82 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.24 0.543 . . . . 0.0 111.269 -175.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -59.99 131.71 51.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.459 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.13 -3.46 62.03 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.107 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.503 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -65.09 113.42 3.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.201 0.501 . . . . 0.0 110.371 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -82.97 122.44 28.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.556 0.693 . . . . 0.0 111.499 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 56' ' ' THR . 56.2 mt -112.49 93.51 2.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.935 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.38 149.65 24.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.93 43.01 5.51 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.533 HG23 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -91.29 166.96 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.297 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -147.22 156.92 43.37 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.609 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.4 mt -84.69 158.49 20.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.559 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -118.21 -162.75 0.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.72 -16.65 60.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.748 0.785 . . . . 0.0 109.235 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 19.9 m -87.22 144.86 26.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.874 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.537 ' HA ' HG22 ' A' ' 5' ' ' VAL . 24.5 mt-10 -91.6 -13.55 31.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.551 0.691 . . . . 0.0 109.749 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -110.46 -5.85 15.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.748 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 14.0 mp0 -123.72 145.44 48.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.346 0.593 . . . . 0.0 110.943 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.485 ' CG2' HG12 ' A' ' 5' ' ' VAL . 11.6 pt -135.69 175.26 11.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.436 174.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.71 137.46 49.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' HA3' HG23 ' A' ' 43' ' ' ILE . . . -140.73 -167.88 11.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.772 -1.204 . . . . 0.0 112.67 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -144.72 141.74 29.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.515 HG22 HG12 ' A' ' 40' ' ' ILE . 40.9 p -114.81 -170.39 1.73 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.718 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -56.66 -32.85 65.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.045 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -123.22 -65.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.482 -175.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.473 ' H ' HD13 ' A' ' 59' ' ' ILE . 2.3 mp -68.98 107.43 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.313 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -107.18 144.42 33.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.869 0.366 . . . . 0.0 110.254 176.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.05 48.98 70.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.933 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -105.32 134.21 48.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.82 120.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.108 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.763 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 26.2 mt -132.57 144.24 50.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.741 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.593 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 1.1 ptp180 -64.78 133.45 52.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.793 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 t -85.34 26.16 0.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.503 0.668 . . . . 0.0 110.773 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -87.79 -20.89 25.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.636 0.731 . . . . 0.0 110.164 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.763 ' HZ ' HD21 ' A' ' 64' ' ' LEU . 53.5 p90 -120.78 21.16 11.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.53 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.8 mt -117.07 148.93 41.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.269 0.556 . . . . 0.0 110.028 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.6 tmtt? -120.38 131.7 54.94 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.778 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -64.58 122.38 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.67 -59.96 2.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.269 -172.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.63 133.09 2.42 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.923 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.247 0.962 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.101 178.806 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mmt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 111.036 0.013 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.9 m 56.84 43.14 25.45 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.169 0.509 . . . . 0.0 110.328 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -91.46 54.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.684 0.754 . . . . 0.0 109.967 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.504 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 44.4 mt-10 -64.84 95.84 0.17 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.306 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.734 HG11 HG22 ' A' ' 52' ' ' ILE . 8.5 t -88.08 131.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.673 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -122.24 167.04 13.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.629 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 36.4 p-10 -90.07 -162.02 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' A' ' 22' ' ' ILE . 20.2 p -76.32 3.62 10.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.287 0.565 . . . . 0.0 110.752 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.58 -48.29 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.73 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.07 7.67 4.91 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.951 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.95 136.64 36.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.504 ' CD2' ' HB3' ' A' ' 4' ' ' GLU . 34.5 mt -80.75 135.71 36.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 112.083 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -101.47 166.9 10.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.36 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.75 174.45 13.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 14.7 t70 -63.53 118.18 7.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.775 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.02 -0.78 38.39 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.068 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.468 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -83.12 175.15 10.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 110.691 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -135.55 137.67 42.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.172 -177.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 69' ' ' LEU . 34.5 m -128.82 167.31 24.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.613 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.44 152.5 47.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.613 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.509 HD12 HD23 ' A' ' 25' ' ' LEU . 3.4 mm? -72.7 122.92 22.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.5 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.537 HG13 ' HG2' ' A' ' 23' ' ' LYS . 39.4 pt -88.33 -7.34 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 111.102 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -160.05 -176.79 5.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.177 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.5 117.57 30.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' A' ' 23' ' ' LYS . 4.0 mm? -114.11 118.27 33.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.032 0.444 . . . . 0.0 110.253 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.552 ' HB2' HG11 ' A' ' 33' ' ' VAL . 5.3 tmmm? -96.82 144.29 26.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.314 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.56 157.94 25.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.729 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.594 ' HD3' ' HB2' ' A' ' 31' ' ' SER . 53.5 mtpt 72.03 -62.03 0.47 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.706 0.802 . . . . 0.0 111.654 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.66 -57.74 0.39 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.776 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 p -144.25 55.48 1.29 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.275 0.559 . . . . 0.0 110.661 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.594 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 26.2 m -143.5 -74.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.858 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -99.55 104.47 16.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 110.842 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 26' ' ' LYS . 16.3 t -108.58 109.86 29.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.446 HD22 HG23 ' A' ' 38' ' ' THR . 5.9 mp -87.52 146.44 25.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.916 0.389 . . . . 0.0 109.998 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -111.1 163.18 14.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.512 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -60.53 135.88 57.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.41 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.41 -0.63 59.98 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.859 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.464 ' HB ' ' HG ' ' A' ' 21' ' ' LEU . 91.8 m -63.48 120.21 11.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.842 0.353 . . . . 0.0 110.049 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.449 ' HE1' ' CB ' ' A' ' 72' ' ' ALA . 13.9 tpt -93.52 114.58 26.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.624 -174.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 56' ' ' THR . 51.9 mt -111.21 90.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.472 0.653 . . . . 0.0 109.434 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.45 136.98 45.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.65 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.48 46.24 2.19 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.554 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -93.48 168.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 0.0 110.325 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 4.6 ptp180 -151.71 156.68 40.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.472 HD22 ' CG2' ' A' ' 5' ' ' VAL . 20.2 mt -78.6 127.7 32.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 p -82.81 -68.91 0.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.204 1.002 . . . . 0.0 111.878 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -176.79 -34.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.763 -173.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.1 m -75.08 146.49 41.43 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.356 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.509 ' HA ' HG21 ' A' ' 5' ' ' VAL . 2.1 mp0 -91.46 -19.25 23.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.513 0.673 . . . . 0.0 110.163 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -103.54 -3.59 25.07 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.728 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -132.65 145.56 51.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.584 0.707 . . . . 0.0 111.347 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.734 HG22 HG11 ' A' ' 5' ' ' VAL . 9.4 pt -132.09 173.8 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.451 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -125.01 137.01 54.25 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -142.54 -161.18 8.67 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.232 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 9.0 ptp180 -150.16 148.87 29.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.918 0.39 . . . . 0.0 110.633 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.483 HG22 HG12 ' A' ' 40' ' ' ILE . 39.2 p -122.44 -171.95 2.37 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.96 -30.99 69.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.165 0.507 . . . . 0.0 110.881 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.04 -69.95 0.83 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.068 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 59' ' ' ILE . 1.2 mp -74.57 103.73 2.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.033 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 17.7 ptpt -111.18 131.31 55.21 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.82 0.343 . . . . 0.0 110.159 176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.94 47.98 5.63 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.076 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -112.51 136.63 51.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.1 t -94.41 119.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.616 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 25.8 mt -128.16 146.11 50.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.706 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.545 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 14.1 ptt180 -65.36 135.32 55.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.23 172.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 t -89.27 33.01 0.81 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.502 0.668 . . . . 0.0 110.656 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.7 mt-10 -81.69 -30.97 32.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.005 0.907 . . . . 0.0 109.444 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.616 ' HZ ' HD21 ' A' ' 64' ' ' LEU . 39.9 p90 -115.79 19.11 15.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.506 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 19' ' ' VAL . 68.6 mt -113.2 147.65 37.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.224 0.535 . . . . 0.0 110.349 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.629 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -117.8 130.89 56.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.752 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 13.2 tmtt? -67.04 121.14 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . -83.43 135.25 34.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.303 -172.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.26 19.6 56.78 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.035 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.576 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . 46.6 m . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.549 -0.738 . . . . 0.0 110.239 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.602 0.239 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -74.86 84.08 2.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.628 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.7 pt -127.21 43.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.219 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HB3' HD23 ' A' ' 12' ' ' LEU . 82.3 mt-10 -54.4 116.96 2.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.067 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -95.48 121.28 45.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.516 ' HG3' HD21 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -125.92 153.41 44.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.577 ' HA ' ' HG1' ' A' ' 66' ' ' THR . 8.5 p-10 -79.57 -170.52 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' HG22 ' A' ' 22' ' ' ILE . 28.0 p -63.49 -26.37 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -76.03 -39.37 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.096 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.68 12.27 8.04 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.529 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.71 132.18 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.516 HD21 ' HG3' ' A' ' 6' ' ' ARG . 20.0 mt -69.24 131.18 44.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.1 177.33 5.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.803 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' A' ' 45' ' ' LEU . . . -154.61 178.47 10.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -80.14 111.61 16.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.689 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.78 27.36 8.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.656 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.08 176.5 5.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.366 0.266 . . . . 0.0 110.361 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -129.2 136.09 49.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 111.102 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 69' ' ' LEU . 35.4 m -125.05 179.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.992 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -154.82 151.15 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.692 0.282 . . . . 0.0 111.239 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.56 HD11 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -66.25 130.49 43.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.604 HG22 ' SG ' ' A' ' 8' ' ' CYS . 41.4 pt -91.99 -9.15 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 110.856 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.588 ' HG3' HD22 ' A' ' 25' ' ' LEU . 4.9 ptpt -156.88 -178.86 7.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.93 108.18 19.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.588 HD22 ' HG3' ' A' ' 23' ' ' LYS . 3.3 mm? -113.13 110.72 20.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.645 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.725 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 19.8 ttmm -68.29 142.13 55.64 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 167.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.575 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 8.9 tt -45.97 -72.48 0.05 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.661 0.601 . . . . 0.0 110.92 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 86.7 mttt -163.21 -96.38 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.97 57.8 0.9 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 25.8 t -138.97 156.82 46.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.563 -0.318 . . . . 0.0 110.403 -171.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.9 m -86.41 12.1 10.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.067 0.46 . . . . 0.0 110.632 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.6 m -96.67 106.36 18.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.594 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.725 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 25.6 t -102.07 110.64 29.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mt -85.91 98.91 11.06 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.48 0.657 . . . . 0.0 110.297 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 21.3 mmmt -67.73 161.89 25.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.356 -174.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -59.69 136.56 58.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.711 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.69 -3.05 81.09 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.989 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.532 ' HB ' HD22 ' A' ' 21' ' ' LEU . 93.0 m -63.86 112.56 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.486 ' HE2' ' HB1' ' A' ' 72' ' ' ALA . 39.7 ttm -83.35 116.29 22.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.321 0.582 . . . . 0.0 111.144 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.555 HG12 HG21 ' A' ' 56' ' ' THR . 39.7 mt -99.66 89.97 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.901 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 3.3 ppt_? -100.15 135.72 41.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 46.98 1.8 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.595 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 1.9 pp -97.18 148.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.55 142.6 51.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.246 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 14' ' ' ALA . 61.3 mt -71.93 132.69 44.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -97.43 -169.17 1.8 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.07 7.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.434 0.635 . . . . 0.0 109.564 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -109.89 149.38 29.97 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.671 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.537 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -103.39 -14.8 16.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -102.18 -7.74 21.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.897 0.379 . . . . 0.0 110.333 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -123.31 149.3 45.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.507 0.67 . . . . 0.0 111.125 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.482 HD12 ' HB ' ' A' ' 43' ' ' ILE . 17.9 pt -136.29 172.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.161 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.2 tt0 -125.53 122.01 35.33 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -128.43 -169.47 12.62 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.846 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -147.29 145.19 29.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 110.203 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.555 HG21 HG12 ' A' ' 40' ' ' ILE . 69.4 p -119.34 -171.13 2.06 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.611 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.59 -27.08 68.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.179 0.514 . . . . 0.0 110.338 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.24 -64.05 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.951 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 mm -85.41 108.36 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.477 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 60' ' ' LYS . 17.1 ptmt -105.64 140.47 38.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.775 0.321 . . . . 0.0 110.144 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.16 43.71 31.66 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.785 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -107.18 131.31 54.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.9 t -89.73 120.53 38.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.625 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 28.8 mt -134.35 140.93 46.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.563 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 1.5 ptp180 -58.88 130.39 46.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 168.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.577 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 10.9 t -87.68 25.64 1.45 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.454 0.645 . . . . 0.0 110.204 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.5 mt-10 -89.31 -10.0 48.41 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.762 0.791 . . . . 0.0 109.769 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.625 ' HZ ' HD23 ' A' ' 64' ' ' LEU . 42.8 p90 -125.22 15.59 8.39 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.114 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 19' ' ' VAL . 68.8 mt -112.06 149.06 32.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.832 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -61.15 120.9 11.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.486 ' HB1' ' HE2' ' A' ' 39' ' ' MET . . . -93.3 -176.07 4.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.733 -171.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.13 -84.71 1.48 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.202 176.275 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.857 0.36 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -86.89 -163.88 0.98 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.661 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 18.9 pt -127.04 64.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.997 0.903 . . . . 0.0 109.92 174.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' HB3' HD23 ' A' ' 12' ' ' LEU . 33.3 mt-10 -75.86 87.25 2.84 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.939 -178.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.713 HG13 HG21 ' A' ' 52' ' ' ILE . 6.7 t -80.84 118.29 28.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.526 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -124.75 155.07 39.91 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.512 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 38.2 p-10 -79.48 -161.93 0.37 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.815 0.34 . . . . 0.0 110.343 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 22' ' ' ILE . 24.8 p -74.62 -1.14 20.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.188 0.518 . . . . 0.0 110.85 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.13 -44.96 4.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.37 11.05 4.31 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.033 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.5 134.52 35.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 4' ' ' GLU . 20.9 mt -78.3 134.34 37.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.338 0.589 . . . . 0.0 112.01 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -100.63 162.73 12.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.229 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.98 176.53 12.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.295 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.56 123.27 16.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 16.82 46.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.596 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.432 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t70 -93.93 175.64 6.64 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.725 -0.279 . . . . 0.0 110.716 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -130.22 135.98 48.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.199 0.523 . . . . 0.0 110.938 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.563 HG23 HD11 ' A' ' 69' ' ' LEU . 27.6 m -124.05 175.95 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.787 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -150.59 151.79 33.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.858 0.361 . . . . 0.0 111.366 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.525 HD11 HD21 ' A' ' 25' ' ' LEU . 4.1 mm? -64.68 127.4 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.45 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.837 HG13 ' HG3' ' A' ' 23' ' ' LYS . 38.5 pt -95.53 -8.36 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.762 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.837 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.4 mttt -141.87 179.8 6.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.56 100.64 12.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 3.8 mm? -102.99 115.19 30.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.474 ' CG ' HG23 ' A' ' 33' ' ' VAL . 1.4 tmmt? -91.0 133.26 35.43 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 34.4 mt -71.97 165.09 24.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.716 0.769 . . . . 0.0 112.8 -171.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -82.67 123.41 29.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.039 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.56 -59.64 4.59 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.439 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.9 m -79.57 150.81 30.96 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.0 t -84.33 33.65 0.51 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.629 0.728 . . . . 0.0 110.129 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.5 m -83.6 104.7 13.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.254 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 HG23 ' CG ' ' A' ' 26' ' ' LYS . 3.6 t -99.82 111.83 30.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.1 mp -90.73 145.31 24.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mmmt -110.55 161.41 15.73 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.17 0.509 . . . . 0.0 111.211 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -62.42 137.55 58.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.488 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.73 8.03 70.57 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.916 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.521 ' HB ' HD21 ' A' ' 21' ' ' LEU . 90.9 m -73.47 116.28 13.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.2 ttm -87.75 111.71 21.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.449 0.642 . . . . 0.0 111.448 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.615 HG12 HG23 ' A' ' 56' ' ' THR . 48.8 mt -95.12 91.51 3.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 135.1 43.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.33 1.43 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.6 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -102.89 162.66 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.366 . . . . 0.0 110.231 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -143.24 164.66 29.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.345 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.522 HD22 HG23 ' A' ' 5' ' ' VAL . 43.3 mt -82.16 142.28 32.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.204 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.1 p -104.35 -154.48 0.51 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.176 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.31 -2.95 56.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.519 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 33.5 t -108.16 157.92 17.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.014 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.661 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 31.9 mt-10 -95.89 -13.43 23.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.909 172.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -108.98 -9.6 15.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.356 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -121.68 146.28 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 111.427 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.713 HG21 HG13 ' A' ' 5' ' ' VAL . 2.4 pp -134.76 166.86 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.505 172.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -120.36 130.0 54.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.6 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.01 -175.4 13.99 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.964 -175.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 55' ' ' ARG . 17.0 ptt180 -134.91 139.71 45.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.459 0.647 . . . . 0.0 110.765 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.615 HG23 HG12 ' A' ' 40' ' ' ILE . 31.1 p -106.54 -170.47 1.73 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.514 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.33 -16.51 59.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.106 0.479 . . . . 0.0 110.094 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -113.23 -73.4 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.371 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.404 ' H ' HD12 ' A' ' 59' ' ' ILE . 1.3 mp -77.56 115.93 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.855 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -109.69 134.05 52.43 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.66 54.09 6.88 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.677 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.6 pt? -115.09 138.34 50.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.5 116.29 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.516 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -129.48 146.13 51.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.558 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 2.3 ptp180 -65.25 139.07 58.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.055 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.523 ' HA ' HD12 ' A' ' 69' ' ' LEU . 8.9 t -93.74 23.82 4.51 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.593 -174.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.626 ' HG2' HH11 ' A' ' 65' ' ' ARG . 0.6 OUTLIER -92.81 -8.46 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.275 -176.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.651 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 54.0 p90 -122.41 19.58 10.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.563 HD11 HG23 ' A' ' 19' ' ' VAL . 65.7 mt -120.46 145.66 47.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.081 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.512 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -113.35 130.68 56.22 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.698 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.432 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.4 tmtt? -64.21 123.14 18.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.45 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . . . -83.38 136.14 34.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.137 0.494 . . . . 0.0 111.319 -174.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.83 -169.83 55.01 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.94 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.0 p . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.24 179.66 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m -93.54 120.06 33.35 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.391 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 pt -128.11 64.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.826 0.822 . . . . 0.0 109.706 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.503 ' HB3' HD22 ' A' ' 12' ' ' LEU . 37.7 mt-10 -67.67 107.64 2.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.457 -178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 49' ' ' GLU . 14.9 t -90.19 117.83 34.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.079 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -128.19 148.58 50.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -80.63 -169.78 2.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.456 -177.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.63 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.9 p -65.05 -22.82 67.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 110.961 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -76.14 -31.76 58.76 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.536 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.89 14.29 27.24 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.53 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.94 31.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 120.799 0.333 . . . . 0.0 110.143 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' A' ' 4' ' ' GLU . 19.9 mt -71.57 141.0 50.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.872 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.57 176.85 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.602 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.96 10.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.849 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 17.3 t70 -65.3 121.33 14.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.798 0.332 . . . . 0.0 110.164 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.91 11.13 50.89 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.036 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.93 174.81 8.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 1.1 p30 -139.11 136.15 34.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.399 0.619 . . . . 0.0 111.565 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.579 HG21 HD13 ' A' ' 69' ' ' LEU . 27.3 m -128.63 176.81 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.968 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -150.67 149.24 29.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.733 0.301 . . . . 0.0 111.048 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.615 HD12 HD23 ' A' ' 25' ' ' LEU . 4.5 mm? -61.17 133.36 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.329 0.651 . . . . 0.0 112.259 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.649 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -94.71 -11.56 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.2 0.524 . . . . 0.0 110.559 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.649 ' HG2' HG13 ' A' ' 22' ' ' ILE . 18.4 ptmt -158.43 176.1 12.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.232 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.13 127.63 33.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.615 HD23 HD12 ' A' ' 21' ' ' LEU . 4.1 mm? -123.78 150.99 43.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.489 ' HG3' HG11 ' A' ' 33' ' ' VAL . 6.7 mptt -121.39 150.53 41.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.439 0.638 . . . . 0.0 111.673 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 4.3 mm? -119.22 149.38 41.85 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.832 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 91.2 mttt 66.67 2.7 2.65 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.669 0.605 . . . . 0.0 111.475 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.67 -80.91 0.3 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 p -140.58 10.7 2.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.849 0.357 . . . . 0.0 110.8 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 23.4 m -72.37 -70.37 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.562 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 27.3 m -90.45 104.37 16.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG11 ' HG3' ' A' ' 26' ' ' LYS . 51.3 t -105.26 120.66 56.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.162 0.506 . . . . 0.0 110.738 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.517 HD21 HG22 ' A' ' 38' ' ' THR . 6.3 mp -102.47 145.56 29.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.779 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -109.63 160.27 16.41 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.816 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.22 132.74 51.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.82 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.16 -11.39 55.29 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.729 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.517 ' HB ' HD21 ' A' ' 21' ' ' LEU . 60.6 m -59.33 125.7 24.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.981 0.39 . . . . 0.0 110.037 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -90.71 122.58 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.082 0.468 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 90.53 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.11 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -101.51 154.29 18.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.2 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.99 45.94 6.9 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.301 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.533 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.39 160.45 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 19.6 ptt180 -139.46 159.09 42.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.305 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' HB ' ' A' ' 5' ' ' VAL . 52.0 mt -78.85 134.58 36.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.141 -176.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -94.44 -157.95 0.6 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.807 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.94 -6.99 59.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.504 0.669 . . . . 0.0 109.205 174.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 66.1 m -102.88 150.47 23.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.913 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HA ' HG23 ' A' ' 5' ' ' VAL . 16.3 mt-10 -87.76 -26.57 22.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.477 0.656 . . . . 0.0 109.939 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -98.01 -6.67 31.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.695 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 10.8 mp0 -124.42 145.16 49.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 111.499 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.461 ' CG2' HG13 ' A' ' 5' ' ' VAL . 2.6 pp -133.32 167.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.521 173.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -119.93 128.36 53.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.42 -159.32 7.95 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.333 -177.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.5 ptp180 -142.7 149.91 39.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.821 0.343 . . . . 0.0 110.243 -176.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.8 p -115.31 -171.41 1.95 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -70.87 -24.59 62.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.953 0.406 . . . . 0.0 110.408 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -112.52 -68.05 0.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.427 ' H ' HD13 ' A' ' 59' ' ' ILE . 2.1 mp -77.3 107.34 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.94 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -107.06 134.47 50.14 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.01 52.08 4.78 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.388 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -114.31 137.05 52.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.65 121.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.926 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.614 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 27.4 mt -135.42 143.58 46.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.226 0.536 . . . . 0.0 111.941 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.618 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 9.4 ptp180 -60.71 130.13 44.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.694 171.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.519 ' HA ' HD11 ' A' ' 69' ' ' LEU . 10.9 t -88.48 22.27 2.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.219 0.533 . . . . 0.0 110.739 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 2.4 pt-20 -90.92 -9.74 45.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.318 0.58 . . . . 0.0 110.222 -176.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.614 ' HZ ' HD23 ' A' ' 64' ' ' LEU . 28.7 p90 -117.06 16.99 14.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.329 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.579 HD13 HG21 ' A' ' 19' ' ' VAL . 68.8 mt -117.29 146.38 43.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.296 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.471 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -118.45 125.0 49.01 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.008 -178.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HA ' HG11 ' A' ' 19' ' ' VAL . 46.5 tttp -62.06 121.01 11.97 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.313 0.383 . . . . 0.0 110.235 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . -78.27 139.04 38.9 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.02 32.51 4.04 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.377 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.045 179.071 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.972 0.415 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 m -83.6 93.76 7.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.197 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.59 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 14.0 pt -146.05 75.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.724 0.773 . . . . 0.0 110.064 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -81.51 99.05 8.57 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.307 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 49' ' ' GLU . 10.9 t -92.28 122.65 43.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.983 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.515 ' HG3' HD21 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -130.26 162.19 29.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.644 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 4.1 p-10 -82.51 -165.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.509 ' SG ' HG23 ' A' ' 22' ' ' ILE . 28.6 p -64.24 -25.62 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.772 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -74.5 -51.97 13.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.236 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.41 12.73 3.34 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.974 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.47 132.72 33.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.515 HD21 ' HG3' ' A' ' 6' ' ' ARG . 21.5 mt -69.15 145.18 53.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.509 0.671 . . . . 0.0 112.223 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.96 169.36 9.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.427 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.32 13.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.038 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 31.3 t70 -68.09 117.6 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.22 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.88 30.77 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.796 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.71 174.22 7.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -133.4 145.03 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.297 0.57 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 71' ' ' LYS . 28.3 m -140.54 175.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.275 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -152.31 156.89 40.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.555 HD13 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -69.23 131.51 45.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.721 -178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.645 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -91.94 -11.01 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.405 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.645 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -154.6 -179.09 7.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.96 113.56 25.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.555 HD23 HD13 ' A' ' 21' ' ' LEU . 3.5 mm? -117.57 123.41 46.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.522 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.667 ' HG3' HG23 ' A' ' 33' ' ' VAL . 4.0 tmmm? -92.28 140.5 29.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.507 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 43.4 mt -73.07 151.04 41.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.644 -176.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -76.85 3.22 12.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.875 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.59 117.83 3.04 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.1 t 67.17 -171.37 0.19 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.013 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 t -100.0 36.32 1.86 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.159 0.504 . . . . 0.0 110.086 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 m -76.22 105.21 7.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.361 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.667 HG23 ' HG3' ' A' ' 26' ' ' LYS . 3.0 t -104.92 112.01 36.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.371 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mp -81.55 147.47 29.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -111.65 161.72 15.94 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.295 0.569 . . . . 0.0 111.423 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -58.39 129.86 44.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.256 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.43 66.36 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.322 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.518 ' HB ' HD22 ' A' ' 21' ' ' LEU . 98.6 m -63.32 118.49 8.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.497 0.649 . . . . 0.0 110.23 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.407 ' HG2' ' HG3' ' A' ' 41' ' ' ARG . 35.7 ttm -87.62 119.88 28.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.628 0.728 . . . . 0.0 111.445 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -108.34 95.03 3.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.026 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.407 ' HG3' ' HG2' ' A' ' 39' ' ' MET . 0.0 OUTLIER -104.95 136.17 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.231 -176.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.94 50.69 1.59 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.572 HG21 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -99.32 164.0 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 7.0 ptp85 -141.62 167.49 22.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.464 HD21 ' HB ' ' A' ' 5' ' ' VAL . 36.5 mt -89.27 147.79 23.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.155 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -104.14 -159.77 0.73 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -85.05 2.4 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 m -113.51 156.68 23.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 21.9 mt-10 -93.54 -27.9 16.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.605 0.717 . . . . 0.0 109.65 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 66' ' ' THR . 6.6 m-20 -90.21 -12.01 39.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.321 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.7 mp0 -121.17 148.84 43.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.359 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.481 ' CG2' HG13 ' A' ' 5' ' ' VAL . 26.8 pt -133.91 175.78 10.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.716 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -130.14 123.78 31.13 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -136.38 -177.01 14.68 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.89 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -139.51 143.47 37.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.56 . . . . 0.0 110.401 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -128.09 -171.5 2.46 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.545 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.22 5.08 3.79 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -174.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -134.79 -69.8 0.51 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.097 0.475 . . . . 0.0 110.111 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.9 mm -92.43 123.66 44.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.053 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -103.33 148.31 26.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.526 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 58.5 46.59 92.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.444 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.552 HD21 ' O ' ' A' ' 54' ' ' GLY . 2.5 pt? -103.38 135.01 45.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.225 0.513 . . . . 0.0 109.754 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.5 t -88.68 116.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.002 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.54 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 30.7 mt -129.56 143.45 50.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.452 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.637 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 14.6 ptt180 -62.14 129.95 43.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.43 ' HA ' HD13 ' A' ' 69' ' ' LEU . 11.9 t -88.19 27.06 1.27 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.238 0.542 . . . . 0.0 110.525 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.5 mt-10 -81.85 -26.27 34.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 109.159 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.637 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 21.4 p90 -114.56 17.91 17.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.998 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 66' ' ' THR . 58.3 mt -113.74 144.84 42.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.3 0.572 . . . . 0.0 110.205 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.644 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtp? -113.82 129.67 56.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.107 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.413 ' HA ' HG12 ' A' ' 19' ' ' VAL . 53.1 tttp -60.44 129.76 43.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.07 -157.94 0.47 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.11 0.481 . . . . 0.0 111.331 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.5 -31.78 6.01 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.263 177.267 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.917 0.389 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -107.25 84.83 2.03 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.669 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.596 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 38.8 pt -137.35 60.75 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.432 0.634 . . . . 0.0 110.692 175.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.21 111.45 9.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.321 0.582 . . . . 0.0 110.334 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 49' ' ' GLU . 7.0 t -97.8 121.36 48.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.709 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.523 ' HG3' HD21 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.67 157.35 42.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.027 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.52 ' HA ' ' HG1' ' A' ' 66' ' ' THR . 7.7 p-10 -83.25 -168.7 2.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 p -68.2 -13.09 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.46 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 50.4 t30 -87.65 -38.23 16.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 9.56 10.49 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.179 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.86 124.25 30.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.523 HD21 ' HG3' ' A' ' 6' ' ' ARG . 23.9 mt -66.76 129.54 40.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.907 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.96 166.71 10.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.579 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.49 178.42 10.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.139 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 13.2 t70 -65.12 129.66 40.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.452 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.61 60.67 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.523 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t0 -88.11 173.81 8.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.594 0.235 . . . . 0.0 110.453 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -132.7 128.84 37.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 -177.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.55 HG22 HD13 ' A' ' 69' ' ' LEU . 26.9 m -125.78 176.94 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.29 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -153.53 149.25 27.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.52 HD21 ' HB ' ' A' ' 38' ' ' THR . 4.4 mm? -65.25 125.18 24.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.743 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.89 HG13 ' HG3' ' A' ' 23' ' ' LYS . 33.5 pt -93.56 -7.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.162 0.506 . . . . 0.0 110.283 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.89 ' HG3' HG13 ' A' ' 22' ' ' ILE . 4.2 mtpm? -144.58 177.91 8.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.856 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.888 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 5.8 m-20 -93.73 102.22 14.36 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.672 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 4.3 mm? -102.62 108.95 20.41 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.632 0.73 . . . . 0.0 111.647 -171.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.6 tmmt? -90.58 137.76 32.1 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.895 173.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.422 HD21 ' HA ' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -78.23 -74.85 0.25 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.716 -172.03 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -143.54 142.9 31.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.952 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' O ' ' HD3' ' A' ' 26' ' ' LYS . . . 55.08 -117.26 7.95 Favored Glycine 0 N--CA 1.45 -0.411 0 O-C-N 123.642 0.589 . . . . 0.0 112.065 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.5 m -138.06 18.09 2.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.0 m -75.37 -64.0 1.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.357 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -104.14 108.42 19.79 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.391 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 31.3 t -117.89 110.73 31.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp -92.36 150.41 20.85 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.888 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 3.3 mmpt? -110.61 162.74 14.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.248 0.547 . . . . 0.0 111.523 -176.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -68.76 144.77 54.25 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.281 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.59 15.3 73.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.722 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.52 ' HB ' HD21 ' A' ' 21' ' ' LEU . 60.2 m -84.84 117.75 24.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 ttm -86.13 123.18 31.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.397 0.617 . . . . 0.0 110.975 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.737 HG12 HG23 ' A' ' 56' ' ' THR . 35.0 mt -112.23 95.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.504 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -108.16 142.45 38.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.067 0.461 . . . . 0.0 111.009 -178.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.97 42.14 4.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.4 pp -92.5 165.72 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 110.234 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.547 ' HD2' ' OE1' ' A' ' 53' ' ' GLU . 3.8 ptp180 -139.76 164.19 30.62 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.321 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.5 162.18 14.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -130.48 -166.56 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -75.86 -8.98 58.2 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.249 0.547 . . . . 0.0 109.644 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 53.7 m -92.33 145.7 24.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.195 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.596 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 16.3 mt-10 -95.81 -20.6 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.806 -178.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.33 -5.94 22.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.145 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 17.7 mp0 -124.0 147.71 47.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.9 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -137.1 173.12 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.214 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.547 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 41.1 tt0 -125.62 135.02 51.72 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.574 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.92 -177.98 21.04 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.138 -177.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -132.1 142.47 49.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.009 0.433 . . . . 0.0 110.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.737 HG23 HG12 ' A' ' 40' ' ' ILE . 27.3 p -122.56 -171.84 2.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.565 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.17 -15.55 59.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.808 0.337 . . . . 0.0 110.658 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -114.2 -59.23 2.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.413 0.625 . . . . 0.0 110.597 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -100.69 112.88 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.205 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -105.06 121.24 43.38 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.928 0.394 . . . . 0.0 110.848 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.55 53.41 3.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.514 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -115.29 138.71 50.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 48.5 t -93.11 116.72 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.001 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.544 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 26.6 mt -129.33 142.93 50.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.663 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.626 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.9 ptp85 -60.68 130.61 47.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.563 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.52 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 10.4 t -88.59 24.24 2.03 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.294 0.569 . . . . 0.0 110.379 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.554 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.7 mt-10 -82.42 -20.3 37.32 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.926 0.87 . . . . 0.0 109.525 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.626 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 33.1 p90 -117.27 17.53 14.69 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.61 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD13 HG22 ' A' ' 19' ' ' VAL . 63.8 mt -113.42 144.02 43.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.058 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -113.93 126.98 55.77 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.358 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.523 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 11.1 tmtt? -59.83 124.87 21.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' N ' ' HD3' ' A' ' 71' ' ' LYS . . . -69.99 125.24 26.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.247 -170.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.11 -122.5 25.79 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.558 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.468 ' C ' ' HZ1' ' A' ' 71' ' ' LYS . 30.9 m . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.425 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 p -81.81 117.81 22.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.167 -172.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.562 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 33.8 pt -138.72 68.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 122.345 1.069 . . . . 0.0 108.901 171.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -81.05 92.7 6.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.27 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.79 HG13 HG21 ' A' ' 52' ' ' ILE . 2.7 t -87.58 128.91 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.257 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.534 ' HG3' HD22 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -132.28 158.93 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -178.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.51 -171.8 2.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 110.589 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.542 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.6 p -58.49 -29.73 66.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -84.02 -42.85 15.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.072 0.463 . . . . 0.0 110.516 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.21 16.91 1.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.47 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.02 126.26 30.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.534 HD22 ' HG3' ' A' ' 6' ' ' ARG . 27.1 mt -64.96 131.58 46.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.331 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.61 164.15 12.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.88 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.78 178.52 10.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 16.1 t70 -67.02 115.36 6.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 0.0 110.564 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.36 25.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.479 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -91.7 174.1 7.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -134.27 137.13 44.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.497 0.665 . . . . 0.0 111.49 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.519 HG22 HD11 ' A' ' 69' ' ' LEU . 27.2 m -126.4 176.01 7.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.236 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -153.24 156.69 38.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.72 0.295 . . . . 0.0 110.75 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' A' ' 38' ' ' THR . 4.0 mm? -66.96 127.53 32.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.351 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.866 HG13 ' HG3' ' A' ' 23' ' ' LYS . 34.9 pt -92.91 -10.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.866 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.7 mtpt -141.71 -174.01 3.94 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.9 94.31 6.5 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 3.4 mm? -103.02 111.12 23.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.586 -175.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.1 tmmt? -88.01 134.9 33.63 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.559 0.695 . . . . 0.0 110.535 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 67.3 mt -103.71 143.06 33.29 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.378 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -72.89 -32.98 65.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.943 0.401 . . . . 0.0 110.158 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.11 114.08 6.26 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.016 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.6 t 65.81 13.92 9.26 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.788 0.435 . . . . 0.0 110.927 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.5 m 54.85 35.86 25.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.217 0.532 . . . . 0.0 110.486 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 50.0 m -71.04 103.53 2.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.193 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 16.7 t -91.61 102.78 13.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.439 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 28.6 mt -85.06 91.99 8.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.438 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.3 mmmt -64.73 158.96 23.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.533 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -59.88 129.86 43.94 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.685 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.95 -6.66 54.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.849 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.508 ' HB ' HD23 ' A' ' 21' ' ' LEU . 89.3 m -59.98 112.11 1.75 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.152 0.476 . . . . 0.0 110.241 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.4 ttm -89.29 117.6 28.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.303 0.573 . . . . 0.0 111.254 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.434 HG12 ' HB ' ' A' ' 56' ' ' THR . 65.1 mt -106.27 92.85 2.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.89 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.75 140.27 37.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 -175.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 49.68 2.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.644 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.546 HG21 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.71 169.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 21.6 ptt180 -148.56 156.21 42.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.133 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.514 HD21 HG23 ' A' ' 5' ' ' VAL . 37.6 mt -76.82 135.42 38.91 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 p -87.33 -70.96 0.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.801 0.81 . . . . 0.0 111.164 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.4 t70 179.07 -31.05 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.283 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -73.6 145.51 45.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.833 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.566 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -89.32 -18.23 27.34 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.44 -20.29 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.506 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' OE2' ' HB3' ' A' ' 65' ' ' ARG . 7.2 mp0 -127.26 154.56 44.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.533 -174.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.79 HG21 HG13 ' A' ' 5' ' ' VAL . 10.7 pt -134.35 176.71 8.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.254 171.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 7.8 tt0 -125.39 140.02 53.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -145.7 -166.33 11.85 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.053 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -147.25 139.11 24.25 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.195 0.521 . . . . 0.0 110.473 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.434 ' HB ' HG12 ' A' ' 40' ' ' ILE . 12.1 t -131.17 -176.15 3.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.214 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -67.41 -33.98 76.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 -173.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HG2' HG13 ' A' ' 59' ' ' ILE . 86.0 tttt -83.54 -50.37 8.32 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.001 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.416 HG13 ' HG2' ' A' ' 58' ' ' LYS . 5.3 mt -130.02 129.11 65.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.047 -171.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -109.68 146.28 35.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.7 48.25 29.43 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.337 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 54' ' ' GLY . 2.6 pt? -114.39 135.99 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 109.831 177.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 32.0 t -92.77 123.84 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.906 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.425 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -135.5 143.17 45.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.899 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.741 ' HG3' ' HE1' ' A' ' 68' ' ' PHE . 3.2 ptp85 -60.05 134.29 56.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.482 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.8 t -87.98 26.21 1.41 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.546 0.688 . . . . 0.0 110.456 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 28.8 mt-10 -84.59 -30.98 24.56 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.835 0.826 . . . . 0.0 109.96 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.741 ' HE1' ' HG3' ' A' ' 65' ' ' ARG . 53.7 p90 -114.15 19.72 16.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.106 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.519 HD11 HG22 ' A' ' 19' ' ' VAL . 74.4 mt -114.22 145.48 41.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.405 0.621 . . . . 0.0 110.62 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 1.5 tmtt? -113.27 126.0 54.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.583 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -64.71 121.94 15.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.82 139.12 31.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.053 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.34 -176.32 35.44 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.046 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.087 -179.945 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.546 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 60.2 m -162.79 121.35 2.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.021 -176.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.524 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 37.4 pt -116.37 25.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 169.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.546 ' HG2' ' HB3' ' A' ' 2' ' ' SER . 5.2 pt-20 -51.39 107.71 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.908 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.674 HG11 HG21 ' A' ' 52' ' ' ILE . 3.0 t -92.45 119.42 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.41 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -123.73 161.32 25.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.868 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.633 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 21.0 p-10 -82.64 -166.23 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 22' ' ' ILE . 24.9 p -72.1 -7.62 50.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.994 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -97.94 -37.51 9.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.444 0.64 . . . . 0.0 109.712 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.92 9.37 7.51 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.269 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 128.84 34.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 4' ' ' GLU . 24.7 mt -70.77 139.75 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.744 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -103.64 173.31 6.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.032 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -160.92 -179.73 7.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.307 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.31 122.18 17.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 0.0 110.288 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.03 27.56 20.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.758 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -98.35 173.62 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -135.17 140.57 45.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.707 0.765 . . . . 0.0 111.69 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 71' ' ' LYS . 19.4 m -139.44 178.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.245 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -153.38 155.1 35.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 0.0 111.197 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -68.9 127.53 33.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.704 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 68' ' ' PHE . 27.3 pt -93.09 -7.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.982 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.416 ' HG3' ' CD2' ' A' ' 25' ' ' LEU . 18.6 ptpt -160.1 178.55 9.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.4 122.58 30.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? -117.99 123.42 45.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.647 0.261 . . . . 0.0 110.33 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.742 ' HG3' HG21 ' A' ' 33' ' ' VAL . 3.2 tmmt? -100.49 139.5 36.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.17 0.51 . . . . 0.0 110.315 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.0 155.48 19.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.77 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG3' ' H ' ' A' ' 29' ' ' GLY . 25.9 tptt 65.16 -165.36 0.24 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.828 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' A' ' 28' ' ' LYS . . . -68.94 -58.58 6.66 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.998 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 m -157.13 84.95 0.93 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.2 t -144.51 -79.9 0.18 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.111 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 m -91.4 104.34 16.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.974 0.416 . . . . 0.0 110.784 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.742 HG21 ' HG3' ' A' ' 26' ' ' LYS . 24.7 t -101.92 105.89 18.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.18 146.11 27.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.895 0.378 . . . . 0.0 110.119 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -111.39 160.76 16.77 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.018 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -61.87 141.14 58.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.022 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.82 -6.28 54.43 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.433 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.5 ' HB ' HD23 ' A' ' 21' ' ' LEU . 31.6 m -71.77 121.47 18.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.44 129.07 36.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.328 0.585 . . . . 0.0 110.763 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.88 HG12 HG23 ' A' ' 56' ' ' THR . 33.1 mt -113.7 94.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.189 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.07 142.91 42.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.005 0.431 . . . . 0.0 110.915 -176.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.15 47.34 4.44 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.592 HG21 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -94.71 164.29 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.783 0.325 . . . . 0.0 110.192 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -137.72 148.91 46.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.205 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.464 HD21 HG22 ' A' ' 5' ' ' VAL . 44.3 mt -71.88 149.76 44.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.912 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.4 p -116.86 -160.9 0.78 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.791 0.329 . . . . 0.0 110.43 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.47 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.42 0.629 . . . . 0.0 109.601 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.5 m -107.47 142.45 37.31 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.028 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.525 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -87.9 -18.49 29.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.503 177.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -94.98 -13.77 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.138 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 4.0 mt-10 -126.63 146.32 50.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.959 0.885 . . . . 0.0 112.48 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.674 HG21 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -135.33 162.75 37.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.303 173.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.91 132.9 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.592 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -148.93 -163.98 11.26 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.83 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -141.68 146.37 36.03 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.88 HG23 HG12 ' A' ' 40' ' ' ILE . 24.5 p -114.04 -170.61 1.75 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.215 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.31 -27.24 66.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.909 0.385 . . . . 0.0 110.42 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -113.64 -70.86 0.78 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.193 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.3 mp -71.05 143.78 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -133.05 144.76 50.24 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.397 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.98 47.33 89.66 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.58 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -109.93 135.55 50.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.65 120.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.672 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.717 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 38.6 mt -132.01 141.11 49.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.539 0.685 . . . . 0.0 112.785 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.618 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.7 ptm180 -53.61 129.05 31.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.095 164.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.497 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.0 t -91.78 21.07 5.04 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.26 0.552 . . . . 0.0 110.843 -173.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CD ' HH21 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.69 -8.49 37.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.192 0.52 . . . . 0.0 110.675 -174.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.717 ' HZ ' HD23 ' A' ' 64' ' ' LEU . 5.1 p90 -114.4 16.07 17.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.435 0.636 . . . . 0.0 109.938 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.525 HD11 HG23 ' A' ' 19' ' ' VAL . 82.4 mt -112.24 149.1 32.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.386 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.633 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtt? -119.58 124.76 47.16 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.675 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' HA ' HG11 ' A' ' 19' ' ' VAL . 62.1 tttp -62.39 125.29 23.39 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.41 152.06 34.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.977 0.418 . . . . 0.0 111.015 -174.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.48 -40.52 2.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.774 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.335 178.803 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 m -142.66 147.58 35.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.971 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.628 ' HB ' ' HB3' ' A' ' 49' ' ' GLU . 48.6 pt -107.99 50.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.497 0.665 . . . . 0.0 110.103 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.68 99.43 0.79 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.119 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 49' ' ' GLU . 2.6 t -81.95 127.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.091 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' HG3' HD21 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.48 160.52 32.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.881 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -172.84 1.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.509 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.2 p -54.88 -33.37 61.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.66 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -81.33 -59.64 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.322 0.582 . . . . 0.0 110.647 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.23 25.21 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.722 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 128.23 35.56 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.41 HD21 ' HG3' ' A' ' 6' ' ' ARG . 18.6 mt -71.05 137.58 49.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.543 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HB3' HD12 ' A' ' 43' ' ' ILE . 87.3 mt -107.49 172.26 6.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.736 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.25 175.38 11.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.188 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 21.7 t70 -65.87 117.04 7.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.989 0.423 . . . . 0.0 110.796 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.6 10.15 38.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.983 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.551 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -90.08 174.87 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.58 143.89 47.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.643 0.735 . . . . 0.0 112.215 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.436 HG22 HD12 ' A' ' 69' ' ' LEU . 34.7 m -135.09 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.096 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 39' ' ' MET . 73.9 m -153.2 157.82 40.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.483 HD13 HD22 ' A' ' 25' ' ' LEU . 3.9 mm? -70.15 129.13 38.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.889 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.736 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.2 pt -93.04 -4.76 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.736 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -164.22 179.34 6.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.272 -178.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.09 110.1 19.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.191 0.307 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.548 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 4.0 mm? -109.74 118.83 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.655 ' HG3' HG21 ' A' ' 33' ' ' VAL . 2.9 tmmm? -99.96 136.86 39.23 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.59 145.18 34.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.105 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -84.88 -51.06 7.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -170.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.46 -49.83 50.3 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.465 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.6 m -131.49 145.23 51.66 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 p -70.04 74.52 0.47 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.367 0.603 . . . . 0.0 112.159 -174.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.1 m -105.62 106.97 17.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.538 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.655 HG21 ' HG3' ' A' ' 26' ' ' LYS . 4.2 t -91.65 106.96 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.896 0.379 . . . . 0.0 110.705 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.13 98.56 11.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.206 0.526 . . . . 0.0 109.934 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 21.9 mmmt -68.65 162.85 25.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.977 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -59.61 132.53 54.25 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.171 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.72 -15.92 40.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.726 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.476 ' HB ' HD22 ' A' ' 21' ' ' LEU . 59.9 m -56.2 121.93 10.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.485 ' HG3' ' OG ' ' A' ' 20' ' ' SER . 11.0 ttt -100.31 120.47 39.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.179 0.514 . . . . 0.0 111.039 -173.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.62 HG12 HG22 ' A' ' 56' ' ' THR . 47.9 mt -109.84 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.669 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.18 135.81 43.11 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.874 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 51.13 1.3 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.414 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.557 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -100.51 165.29 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.703 0.287 . . . . 0.0 110.322 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.5 ptp180 -142.19 158.47 43.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.394 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.477 HD23 ' CG2' ' A' ' 5' ' ' VAL . 34.8 mt -78.15 138.47 38.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.553 ' OG1' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -107.48 -172.4 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.658 -171.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.34 -35.75 78.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.684 0.754 . . . . 0.0 109.217 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 71.3 m -88.02 147.12 25.14 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.208 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -104.76 -1.4 26.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.842 0.83 . . . . 0.0 109.593 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 66' ' ' THR . 36.1 t70 -95.94 -5.69 40.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.81 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 7.6 mt-10 -133.3 157.9 44.3 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.559 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 7.3 pt -139.01 168.12 19.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.625 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.459 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -122.67 127.84 49.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -138.98 -170.98 11.99 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.274 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -135.86 143.01 44.84 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.173 0.511 . . . . 0.0 109.952 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.62 HG22 HG12 ' A' ' 40' ' ' ILE . 71.2 p -111.95 -171.17 1.79 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.454 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.74 -25.29 67.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.955 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -117.19 -63.04 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 111.019 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mm -85.23 113.58 23.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.46 -174.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -101.41 146.69 27.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.26 47.69 69.87 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.016 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD21 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -107.53 133.35 52.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.6 t -92.49 117.46 35.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.814 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.57 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 23.7 mt -127.34 143.97 51.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.135 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.588 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.8 ptp180 -59.66 133.35 56.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.377 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 50' ' ' ASP . 13.1 t -89.37 31.83 0.89 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.487 0.661 . . . . 0.0 110.732 -175.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 16.3 mt-10 -85.3 -32.4 22.52 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.58 0.705 . . . . 0.0 109.795 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 38.2 p90 -112.92 15.95 19.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.366 -172.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.436 HD12 HG22 ' A' ' 19' ' ' VAL . 61.3 mt -112.64 142.31 45.39 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.337 0.589 . . . . 0.0 110.294 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -115.32 132.82 56.49 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.767 -177.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.551 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.0 tmtt? -66.07 120.54 13.34 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.83 -72.99 0.2 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -167.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.64 -123.21 1.03 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.97 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.858 -0.592 . . . . 0.0 110.632 -179.289 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.922 0.392 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.3 m -99.78 126.66 45.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.113 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -110.83 56.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.402 0.62 . . . . 0.0 110.891 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.503 ' HB3' HD22 ' A' ' 12' ' ' LEU . 41.4 mt-10 -54.67 121.85 9.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.423 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 49' ' ' GLU . 5.8 t -105.24 123.92 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.05 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -131.14 158.79 39.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.791 ' HA ' ' HG1' ' A' ' 66' ' ' THR . 30.0 p-10 -80.27 -169.75 2.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' HG23 ' A' ' 22' ' ' ILE . 26.7 p -67.34 -19.24 65.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.665 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -80.29 -48.67 12.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.844 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 17.18 2.85 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.612 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.53 133.22 35.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' A' ' 4' ' ' GLU . 19.8 mt -72.7 135.91 45.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.102 0.477 . . . . 0.0 111.354 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.04 168.74 8.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.749 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.48 172.98 14.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.669 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.0 t70 -63.95 120.73 12.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.968 0.414 . . . . 0.0 110.134 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.12 3.79 44.83 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.975 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -84.28 174.85 9.82 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -139.9 132.85 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.328 0.585 . . . . 0.0 111.094 -178.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.559 HG23 HD11 ' A' ' 69' ' ' LEU . 29.7 m -124.77 173.62 10.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.004 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 m -150.49 151.95 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.962 0.411 . . . . 0.0 111.146 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.579 ' CD1' HD22 ' A' ' 25' ' ' LEU . 4.1 mm? -65.03 127.12 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.78 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.582 HG23 ' SG ' ' A' ' 8' ' ' CYS . 35.0 pt -90.31 -11.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.26 0.553 . . . . 0.0 110.765 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HG3' ' CD2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -154.47 -178.81 7.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.473 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . 1.6 m-20 -96.79 110.22 22.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' A' ' 21' ' ' LEU . 3.6 mm? -103.8 146.63 28.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HG2' HG12 ' A' ' 33' ' ' VAL . 55.5 mtmt -126.76 123.27 37.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.207 0.527 . . . . 0.0 110.446 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.3 mm? -110.71 173.52 6.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.174 -169.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -85.06 -173.09 4.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.321 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.08 -108.42 3.58 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -95.05 26.36 3.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.7 m 58.17 73.61 0.46 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.871 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 19.7 m -83.3 103.12 12.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.184 -175.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG12 ' HG2' ' A' ' 26' ' ' LYS . 51.6 t -93.59 108.47 20.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.237 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 30.6 mt -100.16 91.76 4.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.308 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HD2' ' HB3' ' A' ' 24' ' ' ASP . 29.0 mmmt -70.51 164.61 24.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.363 -175.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 36' ' ' ARG . 39.0 ttt-85 -56.43 133.57 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.563 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.79 -10.2 64.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.184 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.403 ' HB ' HD21 ' A' ' 21' ' ' LEU . 87.3 m -57.23 124.0 17.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.142 0.471 . . . . 0.0 110.291 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -93.96 122.4 36.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.255 0.55 . . . . 0.0 111.281 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.835 HG12 HG21 ' A' ' 56' ' ' THR . 41.1 mt -110.8 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.069 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 13.3 ptt180 -108.76 159.28 16.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.719 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.2 39.63 15.44 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.603 HG21 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -91.05 161.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.874 0.368 . . . . 0.0 110.368 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 2.9 ptp180 -141.99 158.25 43.99 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.258 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.507 HD22 ' HB ' ' A' ' 5' ' ' VAL . 30.9 mt -80.33 154.75 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.808 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 p -127.8 -167.13 1.71 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.232 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.42 -21.95 66.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.201 0.525 . . . . 0.0 110.324 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 70.8 m -85.09 142.87 29.23 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -90.03 -7.6 53.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.8 0.809 . . . . 0.0 108.969 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -116.39 -5.5 11.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.185 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.7 mp0 -125.25 144.4 50.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 0.0 111.217 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.429 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -134.32 156.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.146 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HB2' HG23 ' A' ' 63' ' ' VAL . 37.9 tt0 -115.32 130.56 56.94 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.603 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -148.92 -161.14 9.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.299 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -137.36 142.64 41.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.646 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.835 HG21 HG12 ' A' ' 40' ' ' ILE . 21.1 p -114.51 -172.21 2.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -73.74 -26.1 60.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.18 0.514 . . . . 0.0 109.768 174.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.48 -75.87 0.53 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.301 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mm -89.08 125.17 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.502 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -113.66 130.52 56.39 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.915 0.388 . . . . 0.0 110.289 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.0 47.04 5.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.756 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -115.09 136.08 53.51 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.184 0.516 . . . . 0.0 110.465 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 53' ' ' GLU . 45.7 t -89.48 119.34 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.791 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.541 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 25.0 mt -129.9 147.36 51.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.917 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.564 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.4 ptp85 -65.18 130.25 42.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.954 172.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.791 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 9.8 t -85.58 30.69 0.62 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 0.0 110.592 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -88.03 -21.32 24.84 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.825 0.822 . . . . 0.0 109.706 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.564 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 33.8 p90 -117.97 18.41 13.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.563 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.559 HD11 HG23 ' A' ' 19' ' ' VAL . 68.0 mt -115.54 148.34 39.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.104 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -125.07 128.64 48.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.75 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.06 119.21 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.06 -64.8 0.84 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.325 -172.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.8 75.19 0.59 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.841 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.433 178.217 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mtp . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -64.79 112.38 3.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.189 0.518 . . . . 0.0 110.506 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -118.63 63.43 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.748 0.785 . . . . 0.0 109.227 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.519 ' HB3' HD22 ' A' ' 12' ' ' LEU . 30.5 mt-10 -56.13 112.52 1.23 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.699 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.523 HG21 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -104.52 126.12 59.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.51 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.599 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 32.4 p-10 -80.07 -165.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.696 ' SG ' HG23 ' A' ' 22' ' ' ILE . 24.3 p -74.86 -8.59 56.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.25 0.548 . . . . 0.0 110.646 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -91.83 -44.66 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.686 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.22 13.25 3.61 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.301 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.7 130.76 38.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 4' ' ' GLU . 19.8 mt -66.7 143.57 56.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 112.241 -176.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -109.93 169.13 8.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.21 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -160.37 177.93 10.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.2 t70 -66.84 122.84 18.59 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 14.74 41.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.747 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.447 ' C ' HD21 ' A' ' 18' ' ' ASN . 0.7 OUTLIER -91.14 165.01 13.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.531 ' N ' HD21 ' A' ' 18' ' ' ASN . 0.6 OUTLIER -117.96 147.86 42.76 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.543 HG22 HD13 ' A' ' 69' ' ' LEU . 28.0 m -143.82 171.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.119 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -152.11 157.56 41.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.747 0.308 . . . . 0.0 111.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.593 HD11 HD21 ' A' ' 25' ' ' LEU . 4.0 mm? -69.6 124.19 23.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.632 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.696 HG23 ' SG ' ' A' ' 8' ' ' CYS . 40.5 pt -91.93 -12.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.269 0.557 . . . . 0.0 110.572 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.609 ' HG2' HG13 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -150.95 173.6 14.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.25 -177.016 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.17 122.76 32.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 21' ' ' LEU . 3.7 mm? -117.48 116.1 26.47 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.931 0.396 . . . . 0.0 110.71 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.701 ' HG3' HG21 ' A' ' 33' ' ' VAL . 2.4 tmmt? -97.18 129.4 44.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.281 0.562 . . . . 0.0 109.497 176.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 34' ' ' LEU . 4.0 mm? -99.94 155.39 17.71 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.529 -173.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -76.23 176.56 7.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.797 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.33 -87.19 0.81 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.567 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -80.16 -0.91 38.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.434 0.159 . . . . 0.0 111.394 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m 60.17 32.96 21.08 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.316 0.579 . . . . 0.0 110.122 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.0 m -66.67 108.99 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.391 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.701 HG21 ' HG3' ' A' ' 26' ' ' LYS . 21.0 t -95.9 99.33 9.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.48 HD13 HD21 ' A' ' 27' ' ' LEU . 5.8 mp -85.87 145.68 27.07 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 27.4 mmmt -110.5 163.62 13.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.49 0.662 . . . . 0.0 111.379 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -60.86 149.29 36.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.719 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.21 -3.04 79.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.898 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.437 ' HB ' HD21 ' A' ' 21' ' ' LEU . 84.5 m -68.08 121.84 16.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.509 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttm -87.86 129.38 35.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.603 . . . . 0.0 111.192 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.656 HG12 ' HB ' ' A' ' 56' ' ' THR . 52.0 mt -122.14 92.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.973 172.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -106.87 136.26 47.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 111.012 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.82 52.09 1.22 Allowed Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.55 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -104.41 164.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 10.2 ptp85 -143.91 165.4 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.239 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.419 HD21 ' HB ' ' A' ' 5' ' ' VAL . 30.7 mt -80.67 150.88 29.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.052 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -111.99 -155.97 0.58 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.62 -8.53 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.094 0.473 . . . . 0.0 109.736 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 44.4 t -94.99 161.81 13.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.702 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.523 ' HA ' HG21 ' A' ' 5' ' ' VAL . 33.8 mt-10 -101.02 -5.29 26.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.774 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.464 ' O ' HG21 ' A' ' 66' ' ' THR . 5.1 m-20 -131.5 0.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.297 -176.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 3.6 mp0 -120.43 143.41 48.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.104 0.478 . . . . 0.0 110.185 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.11 165.33 32.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.873 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.445 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 4.0 tm-20 -125.04 125.56 44.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -151.94 -166.78 14.38 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.676 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -134.16 145.08 48.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.656 ' HB ' HG12 ' A' ' 40' ' ' ILE . 9.3 t -122.73 -177.95 3.79 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -65.06 -18.73 65.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.724 0.297 . . . . 0.0 111.458 -177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -100.69 -73.38 0.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.134 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mp -94.85 122.63 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.988 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 60' ' ' LYS . 1.6 ptmm? -104.26 121.41 43.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.819 0.342 . . . . 0.0 110.518 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 89.6 52.48 2.65 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.703 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.416 HD21 ' O ' ' A' ' 54' ' ' GLY . 2.5 pt? -116.13 140.71 49.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.035 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.69 116.57 35.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.082 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.551 HD23 ' HZ ' ' A' ' 68' ' ' PHE . 31.7 mt -130.17 152.66 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.245 0.545 . . . . 0.0 111.988 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.575 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 ptt180 -72.93 131.04 41.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.48 173.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' HD11 ' A' ' 69' ' ' LEU . 10.2 t -85.6 25.86 1.01 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.659 -175.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 1.3 pt-20 -83.33 -19.9 35.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.626 0.727 . . . . 0.0 109.667 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.575 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 26.8 p90 -118.31 17.51 13.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.055 -178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.543 HD13 HG22 ' A' ' 19' ' ' VAL . 76.1 mt -114.21 149.07 36.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.444 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.599 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.6 tmtt? -119.54 129.06 54.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.666 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HZ3' ' CG ' ' A' ' 17' ' ' ASP . 39.9 tttp -62.05 116.49 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.73 31.93 0.75 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.419 . . . . 0.0 111.406 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.15 -15.45 74.52 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.601 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.595 177.652 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.256 0.074 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m 69.76 136.75 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.724 0.64 . . . . 0.0 111.644 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.604 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 21.0 pt 38.83 54.24 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.621 1.168 . . . . 0.0 113.421 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HB3' HD23 ' A' ' 12' ' ' LEU . 42.4 mt-10 -78.82 85.38 4.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.388 170.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.731 HG11 HG23 ' A' ' 52' ' ' ILE . 2.7 t -78.58 121.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.226 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -126.29 151.59 47.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.969 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.6 ' HA ' ' HG1' ' A' ' 66' ' ' THR . 3.0 p-10 -77.37 -172.05 2.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.637 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.573 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.7 p -65.11 -23.64 67.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.602 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.17 -28.62 31.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.563 177.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.14 15.73 12.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.229 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.7 136.05 33.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 4' ' ' GLU . 17.7 mt -70.51 138.75 51.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.559 . . . . 0.0 111.658 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.63 173.53 6.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.06 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.2 173.36 14.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.128 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 29.2 t70 -64.84 121.34 14.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.344 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.27 31.55 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.024 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.91 173.93 6.83 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.826 -0.22 . . . . 0.0 111.147 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.3 p30 -131.22 139.45 49.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.619 0.723 . . . . 0.0 112.092 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 71' ' ' LYS . 29.3 m -140.45 172.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.036 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -152.55 157.03 40.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 0.0 111.625 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.579 HD11 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -66.9 135.73 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.381 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.722 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.3 pt -97.1 -8.32 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.092 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.722 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -159.63 175.71 12.88 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -176.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.36 110.3 21.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.579 HD23 HD11 ' A' ' 21' ' ' LEU . 4.3 mm? -100.18 125.65 46.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.578 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HG3' HG13 ' A' ' 33' ' ' VAL . 10.7 mptt -93.84 148.01 22.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.233 0.54 . . . . 0.0 110.514 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -126.81 154.53 44.17 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.954 -174.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -99.27 147.07 25.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.801 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.9 -74.38 0.44 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.8 m -111.04 17.09 20.77 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.5 m 58.64 38.97 25.05 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.379 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 m -75.57 121.44 22.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.808 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG13 ' HG3' ' A' ' 26' ' ' LYS . 58.6 t -114.16 107.97 24.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.51 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.27 145.65 29.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.845 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.9 mmmt -110.59 158.55 18.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.407 0.623 . . . . 0.0 111.774 -174.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -61.61 134.92 57.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.267 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.49 -9.36 64.63 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.053 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.444 ' HB ' HD22 ' A' ' 21' ' ' LEU . 97.6 m -59.5 124.56 20.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.815 0.308 . . . . 0.0 110.316 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.8 ttm -96.55 124.92 40.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.516 0.674 . . . . 0.0 111.038 -176.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.435 HG12 ' HB ' ' A' ' 56' ' ' THR . 52.0 mt -115.14 94.47 3.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.002 174.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -111.23 147.13 35.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -177.352 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.23 39.03 5.51 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.561 HG21 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -89.99 166.7 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.906 0.384 . . . . 0.0 110.278 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 5.7 ptp85 -140.29 158.07 44.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.936 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD23 ' HB ' ' A' ' 5' ' ' VAL . 39.7 mt -84.12 130.51 34.85 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.9 p -93.43 -171.62 2.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.55 6.96 15.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.497 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -103.64 143.66 32.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.48 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.604 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 17.3 mt-10 -87.58 -25.14 23.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.359 0.6 . . . . 0.0 109.936 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.94 -7.31 33.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.136 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -126.87 147.74 50.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 111.5 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.731 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -131.6 168.45 23.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.339 173.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.25 129.31 53.99 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.561 ' HA3' HG21 ' A' ' 43' ' ' ILE . . . -141.21 -165.86 10.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.074 -175.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 18.3 ptt85 -152.41 141.0 20.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.177 0.513 . . . . 0.0 110.046 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.435 ' HB ' HG12 ' A' ' 40' ' ' ILE . 9.0 t -131.8 -174.79 3.52 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.526 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 3.9 p30 -63.57 -24.54 67.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 111.475 -176.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 27.8 mtmm -98.85 -72.31 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.076 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.8 mm -100.2 127.47 53.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.636 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 11.5 ptmm? -114.78 139.84 49.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.416 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.65 30.66 39.07 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.411 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -101.81 139.9 36.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.32 116.88 36.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.761 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -128.37 144.51 51.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.579 0.704 . . . . 0.0 111.996 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.556 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 13.8 ptt180 -66.16 135.83 55.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.43 173.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.6 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 9.0 t -89.23 30.51 0.97 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.568 0.699 . . . . 0.0 110.561 -176.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.556 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 31.0 mt-10 -80.1 -31.8 39.21 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.944 0.878 . . . . 0.0 109.501 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 48.8 p90 -116.77 16.57 15.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.441 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.58 145.61 36.09 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.163 0.506 . . . . 0.0 109.871 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -119.74 128.47 53.8 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.588 -178.268 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HA ' HG12 ' A' ' 19' ' ' VAL . 58.5 tttp -63.36 127.81 33.0 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.65 165.72 23.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.806 -169.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.96 -27.93 5.52 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.579 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.508 179.158 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.742 0.306 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 m -135.07 -176.31 4.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.572 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.3 pt -128.33 44.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.145 0.497 . . . . 0.0 109.698 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 34.7 mt-10 -59.41 116.07 3.7 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.567 0.698 . . . . 0.0 111.886 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.616 HG13 HG23 ' A' ' 52' ' ' ILE . 4.6 t -96.99 127.61 49.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.077 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.526 ' HG3' HD21 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -128.03 148.68 50.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.553 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.594 ' HA ' ' HG1' ' A' ' 66' ' ' THR . 3.4 p-10 -73.98 -171.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.627 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 22' ' ' ILE . 26.5 p -63.82 -29.12 70.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -25.89 56.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.38 18.93 13.23 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.962 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.23 136.25 36.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.137 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.526 HD21 ' HG3' ' A' ' 6' ' ' ARG . 25.6 mt -67.93 138.3 55.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.759 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -108.13 170.29 8.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.155 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.42 174.16 15.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.455 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 19.9 t70 -67.68 114.16 6.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.845 0.355 . . . . 0.0 110.357 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.49 2.27 29.25 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.65 173.05 11.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -136.12 141.68 44.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 111.411 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 71' ' ' LYS . 31.3 m -134.88 177.03 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.342 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 m -151.07 153.24 34.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.0 111.321 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.517 HD11 HD21 ' A' ' 25' ' ' LEU . 4.2 mm? -64.21 128.52 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.7 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.689 HG13 ' HG2' ' A' ' 23' ' ' LYS . 42.2 pt -90.53 -11.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.773 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.689 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.99 -178.28 7.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.174 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.55 117.18 26.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 21' ' ' LEU . 3.9 mm? -118.42 116.36 26.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.174 0.512 . . . . 0.0 110.631 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 33' ' ' VAL . 1.6 tmmt? -82.82 138.89 33.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.656 176.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 28' ' ' LYS . 9.0 tt -63.86 145.17 56.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.827 -174.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' N ' HD23 ' A' ' 27' ' ' LEU . 84.5 tttt -42.02 121.5 1.84 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.19 0.931 . . . . 0.0 111.722 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.67 -119.87 5.63 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.924 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 p -151.71 109.8 3.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.629 0.252 . . . . 0.0 110.66 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 t -167.31 -77.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.225 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -104.17 130.66 51.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.616 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 26' ' ' LYS . 33.1 t -107.16 103.57 15.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 38' ' ' THR . 6.0 mp -82.36 149.18 27.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.926 0.393 . . . . 0.0 110.543 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 22.4 mmmt -109.86 163.16 13.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.655 -175.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -61.25 137.83 58.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.142 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.03 -14.88 59.77 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.52 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.454 ' HB ' HD22 ' A' ' 21' ' ' LEU . 88.2 m -56.61 119.93 6.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 110.039 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.1 ttt -94.05 122.91 37.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.363 0.601 . . . . 0.0 110.753 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.3 mt -110.54 90.51 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.797 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -104.67 137.6 42.25 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.371 -175.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.02 50.45 2.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.379 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.54 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -97.18 164.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.7 ptp180 -142.83 157.79 44.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.532 HD22 ' HB ' ' A' ' 5' ' ' VAL . 32.9 mt -75.64 155.1 36.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.665 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -121.69 -167.87 1.6 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.79 -20.08 65.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.6 m -85.75 147.74 26.19 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.954 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HA ' HG23 ' A' ' 5' ' ' VAL . 28.1 mt-10 -96.14 -13.8 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.503 0.668 . . . . 0.0 109.517 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -106.85 -5.92 18.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.862 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 2.0 mp0 -127.96 146.56 50.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.335 0.588 . . . . 0.0 111.44 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.616 HG23 HG13 ' A' ' 5' ' ' VAL . 2.7 pp -131.09 166.62 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.304 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -117.92 124.84 49.23 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.54 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.04 -166.16 10.69 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.085 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 15.5 ptp180 -148.0 141.2 25.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -134.2 -171.93 2.87 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.022 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.63 -40.01 93.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.199 0.523 . . . . 0.0 110.751 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -80.58 -65.9 0.95 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.316 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -116.21 130.24 71.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.28 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 12.6 ptmm? -112.26 136.95 51.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.272 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.69 39.8 13.55 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.209 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -110.54 138.64 46.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.907 0.384 . . . . 0.0 109.983 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.23 116.77 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.48 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -128.69 145.6 51.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 111.796 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.608 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -64.11 130.88 45.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.235 173.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.594 ' HG1' ' HA ' ' A' ' 7' ' ' ASP . 9.5 t -86.41 26.47 1.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.647 -175.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 32.5 mt-10 -84.0 -25.51 29.91 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.938 0.875 . . . . 0.0 109.392 -175.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.608 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 32.1 p90 -113.98 16.95 18.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.61 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 66' ' ' THR . 65.1 mt -114.17 145.84 41.14 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.953 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -118.7 125.59 50.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.124 -178.021 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.555 ' HA ' HG11 ' A' ' 19' ' ' VAL . 54.3 tttp -62.65 122.37 15.68 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.392 0.432 . . . . 0.0 110.125 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.7 116.61 27.95 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.67 -25.09 70.74 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.77 178.13 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB3' HD21 ' A' ' 12' ' ' LEU . 32.6 mt-10 . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.374 0.607 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.768 HG11 HG23 ' A' ' 52' ' ' ILE . 19.2 t -85.96 121.26 37.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.602 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 75.6 mtt180 -124.93 153.19 43.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -174.17 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 111.085 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' HG21 ' A' ' 22' ' ' ILE . 13.7 p -56.05 -30.68 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.607 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -83.85 -56.7 3.55 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.29 19.2 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.245 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 71' ' ' LYS . . . -83.05 135.6 34.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.047 0.423 . . . . 0.0 110.039 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 4' ' ' GLU . 15.8 mt -77.29 135.7 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.288 0.566 . . . . 0.0 112.445 -174.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' HB3' HD11 ' A' ' 43' ' ' ILE . 63.9 mt -112.0 166.72 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.711 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.9 179.49 9.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.26 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -64.69 118.37 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.16 8.56 50.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.217 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.84 174.19 8.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.838 -0.213 . . . . 0.0 110.467 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 3.2 p30 -133.7 139.63 46.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.526 0.679 . . . . 0.0 111.585 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.488 HG21 HD13 ' A' ' 69' ' ' LEU . 34.6 m -131.88 174.7 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.213 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 m -151.89 148.88 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.807 0.337 . . . . 0.0 110.781 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.698 HD12 HD23 ' A' ' 25' ' ' LEU . 4.5 mm? -60.74 130.04 44.5 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.236 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.663 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -91.15 -11.33 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.56 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.663 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.55 178.34 10.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.296 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -91.44 121.9 33.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.698 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.5 mmmt . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.529 0.68 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -61.61 138.78 58.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.984 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.04 -13.07 63.75 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.634 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.547 ' HB ' HD23 ' A' ' 21' ' ' LEU . 77.9 m -58.78 119.41 7.09 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 7.4 ttt -87.98 124.65 33.93 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.282 0.563 . . . . 0.0 110.751 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.6 mt -114.53 91.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.664 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -108.61 149.53 28.77 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.708 -176.113 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.58 6.54 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.221 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.568 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.0 pp -91.65 160.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 8.2 ptt180 -141.06 161.01 38.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.748 0.309 . . . . 0.0 110.579 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.522 HD22 ' CG2' ' A' ' 5' ' ' VAL . 25.9 mt -79.86 154.06 28.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.238 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -121.46 -159.33 0.8 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.23 -14.2 62.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.686 0.755 . . . . 0.0 109.261 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 65.6 m -101.03 148.35 25.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.669 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HA ' HG22 ' A' ' 5' ' ' VAL . 23.8 mt-10 -92.5 -16.43 25.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.36 -14.94 23.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.382 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 8.2 mp0 -125.66 148.73 48.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.548 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.768 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -132.45 160.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.253 171.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.0 tt0 -115.58 122.68 46.37 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -133.33 -156.1 7.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.716 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.7 ptp180 . . . . . 0 C--N 1.32 -0.712 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HD2' ' C ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.797 0.332 . . . . 0.0 110.485 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.61 50.57 42.05 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.64 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.23 135.39 54.22 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.083 0.468 . . . . 0.0 110.033 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.3 t -92.66 122.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.746 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.7 mt -134.02 147.0 50.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.37 0.605 . . . . 0.0 112.191 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.584 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.8 ptp180 -66.34 130.51 43.47 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.947 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.495 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.2 t -86.23 26.29 1.06 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.251 0.548 . . . . 0.0 110.856 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.0 mt-10 -84.17 -22.58 30.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.714 0.769 . . . . 0.0 109.652 -175.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.746 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 24.2 p90 -117.32 19.44 14.09 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.749 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 66' ' ' THR . 60.6 mt -116.68 145.48 43.41 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.014 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -114.4 133.27 55.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.247 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.64 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 52.1 tttt -58.43 122.32 13.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -175.155 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.6 t -91.63 129.84 41.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.779 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.573 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -133.98 171.09 14.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.19 -169.72 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' HG21 ' A' ' 22' ' ' ILE . 7.7 p -66.39 -27.77 68.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.295 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -82.46 -51.03 8.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.09 27.1 0.26 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.772 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.65 123.78 40.43 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.573 HD23 ' HG3' ' A' ' 6' ' ' ARG . 27.4 mt -60.35 143.78 52.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.457 0.646 . . . . 0.0 112.642 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' HB3' HD11 ' A' ' 43' ' ' ILE . 95.7 mt -111.36 170.85 7.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.14 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.47 178.17 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.86 122.0 14.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.012 0.434 . . . . 0.0 110.946 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.19 64.33 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.374 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.54 173.06 12.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.697 0.284 . . . . 0.0 110.703 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -124.46 146.35 48.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.255 0.55 . . . . 0.0 110.523 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 43' ' ' ILE . 27.7 m -142.55 170.82 11.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.532 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -153.18 158.66 42.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.76 0.314 . . . . 0.0 110.713 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 25' ' ' LEU . 3.4 mm? -67.66 135.16 52.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.537 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.601 HG13 ' HG2' ' A' ' 23' ' ' LYS . 37.2 pt -96.59 -11.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 110.838 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -155.86 174.79 14.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.134 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.54 107.61 18.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.278 0.561 . . . . 0.0 111.199 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.6 mmmt . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.471 0.653 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.47 139.56 58.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.249 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.71 68.54 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.943 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.568 ' HB ' HD23 ' A' ' 21' ' ' LEU . 85.3 m -58.17 121.39 10.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.783 0.291 . . . . 0.0 110.256 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.24 117.01 29.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.363 0.601 . . . . 0.0 111.516 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.407 ' HB ' HG23 ' A' ' 19' ' ' VAL . 51.5 mt -104.05 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.586 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.33 135.74 47.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.394 -174.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.68 48.85 2.06 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.335 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 pp -94.25 160.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -138.95 159.88 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.106 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.6 mt -85.87 138.26 32.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.4 p -98.33 -156.8 0.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.779 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -90.29 -2.08 57.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 109.668 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 58.1 m -98.29 149.08 22.98 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.606 ' HA ' HG22 ' A' ' 5' ' ' VAL . 27.3 mt-10 -94.85 -14.88 24.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.623 0.725 . . . . 0.0 109.376 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 66' ' ' THR . 1.0 OUTLIER -108.32 -2.94 18.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.538 -176.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -130.01 147.57 51.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.156 0.503 . . . . 0.0 111.044 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.49 ' CG2' HG11 ' A' ' 5' ' ' VAL . 15.7 pt -135.18 175.76 10.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.642 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -130.74 135.31 47.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -139.65 -177.6 15.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.281 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 55' ' ' ARG . 10.1 ptt180 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 121.234 0.54 . . . . 0.0 110.179 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 60' ' ' LYS . 20.0 ptmt . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.28 5.86 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.651 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -110.99 134.57 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' A' ' 53' ' ' GLU . 39.4 t -91.72 125.09 44.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.908 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.546 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 33.4 mt -137.31 145.77 43.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.666 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.667 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -62.99 130.48 44.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.759 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -83.83 23.96 0.94 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.745 0.783 . . . . 0.0 110.204 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -89.58 -15.1 33.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.537 0.684 . . . . 0.0 110.101 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.667 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 53.4 p90 -121.84 17.0 11.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.303 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 66' ' ' THR . 73.6 mt -113.53 147.11 38.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.512 0.672 . . . . 0.0 110.087 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -117.36 124.81 49.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.106 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -59.95 118.83 6.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 0.0 110.042 -177.722 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.505 ' HB3' HD21 ' A' ' 12' ' ' LEU . 46.1 mt-10 . . . . . 0 CA--C 1.517 -0.297 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.5 t -113.24 119.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.959 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.572 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -122.32 175.17 6.56 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.837 -177.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 3.1 p-10 -86.05 -164.29 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.065 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.433 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 25.8 p -63.57 -20.37 65.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.547 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.495 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 6.7 t30 -95.78 -49.36 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.63 10.89 0.77 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.526 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.86 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.572 HD23 ' HG3' ' A' ' 6' ' ' ARG . 25.3 mt -72.51 143.74 48.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.379 0.609 . . . . 0.0 112.28 -173.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.59 166.06 11.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.387 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.79 174.31 15.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.911 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -63.96 121.5 14.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.514 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.49 1.67 53.4 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.006 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -81.73 174.05 11.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 110.404 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.9 p30 -132.69 142.91 49.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.617 0.722 . . . . 0.0 111.652 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 71' ' ' LYS . 29.5 m -137.57 174.88 10.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.927 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.1 m -152.19 150.87 30.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.715 0.293 . . . . 0.0 110.714 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 25' ' ' LEU . 4.3 mm? -62.0 128.26 35.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.679 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.656 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -89.6 -10.03 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.814 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -159.79 174.27 14.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -85.01 118.75 24.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 21' ' ' LEU . 4.2 mm? . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 110.407 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 26.8 mmmt . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.273 0.559 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.76 145.58 44.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.438 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.92 -8.13 78.4 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.608 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.557 ' HB ' HD23 ' A' ' 21' ' ' LEU . 89.6 m -65.16 112.8 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 0.0 110.313 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.0 ttm -81.5 117.49 21.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.421 0.629 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mt -108.9 99.81 9.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.961 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -111.03 156.58 21.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.924 0.392 . . . . 0.0 111.128 -176.203 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.51 28.52 35.65 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.587 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.3 pp -78.94 161.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.678 0.275 . . . . 0.0 110.423 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.6 ptp180 -140.91 166.2 25.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.489 HD22 ' HB ' ' A' ' 5' ' ' VAL . 39.3 mt -88.47 137.96 31.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.973 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -95.16 -159.77 0.74 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -81.94 -4.76 57.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.385 0.612 . . . . 0.0 109.454 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 73.9 m -99.35 146.75 25.94 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.514 ' HA ' HG22 ' A' ' 5' ' ' VAL . 22.3 mt-10 -90.51 -15.26 31.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.381 0.61 . . . . 0.0 109.904 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.4 -5.44 20.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.078 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -126.67 145.18 50.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 111.81 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -131.04 173.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.2 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.623 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 11.7 tm-20 -127.98 131.19 49.27 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.04 -166.32 11.61 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.69 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.498 HH11 ' HB3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 121.361 0.601 . . . . 0.0 111.258 -175.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.3 ptpp? . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.124 0.487 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.623 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 103.98 43.14 1.83 Allowed Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.405 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.39 132.67 56.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.237 0.541 . . . . 0.0 110.032 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 58.7 t -90.89 124.57 43.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.691 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.711 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -134.05 146.3 50.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.294 0.569 . . . . 0.0 112.189 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.61 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.5 ptp180 -64.7 130.82 45.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.814 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 t -86.24 33.09 0.61 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.986 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.61 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -85.96 -29.63 23.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.435 0.636 . . . . 0.0 110.161 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.711 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 38.3 p90 -113.62 18.97 17.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.982 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 19' ' ' VAL . 59.4 mt -113.31 144.71 42.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.972 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HB2' HG22 ' A' ' 22' ' ' ILE . 3.0 tmtt? -114.17 122.38 46.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.641 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.452 ' HA ' HG12 ' A' ' 19' ' ' VAL . 48.7 tttp -57.77 120.59 8.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.109 0.48 . . . . 0.0 110.602 -174.816 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.404 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 32.6 mt-10 . . . . . 0 CA--C 1.516 -0.35 0 CA-C-O 121.587 0.708 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 52' ' ' ILE . 10.3 t -94.8 132.0 40.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.815 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.48 ' HG3' HD23 ' A' ' 12' ' ' LEU . 2.4 mpt_? -132.43 150.06 52.23 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.577 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 3.8 p-10 -77.59 -163.5 0.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.725 0.297 . . . . 0.0 110.634 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.6 t -70.98 -15.6 62.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.309 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.486 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 59.6 t30 -85.83 -54.78 4.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.716 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 10.89 1.91 Allowed Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.609 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.43 133.07 35.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.48 HD23 ' HG3' ' A' ' 6' ' ' ARG . 15.2 mt -72.7 135.07 45.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.168 0.508 . . . . 0.0 111.621 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -102.4 163.72 12.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.401 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -149.23 177.55 9.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.16 118.24 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 29.01 12.46 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.647 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.7 t0 -98.72 175.13 6.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -132.73 141.15 48.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.664 0.745 . . . . 0.0 111.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.524 HG23 ' HB ' ' A' ' 40' ' ' ILE . 30.6 m -136.86 174.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.097 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.8 m -153.08 150.94 29.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.77 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.596 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -64.61 129.42 39.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.739 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.683 HG13 ' HG2' ' A' ' 23' ' ' LYS . 32.1 pt -90.94 -4.61 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 110.639 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.683 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -165.09 -179.15 5.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.886 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.83 116.56 29.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.596 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.173 0.511 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -63.67 140.13 58.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.474 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.27 84.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.838 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.526 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -64.32 114.43 4.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.95 0.375 . . . . 0.0 110.077 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 29.8 ttm -81.24 119.32 23.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.491 0.662 . . . . 0.0 111.121 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.524 ' HB ' HG23 ' A' ' 19' ' ' VAL . 43.0 mt -106.64 90.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.469 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.467 ' C ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -101.07 162.68 12.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.268 -176.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.82 57.72 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.988 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.699 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -92.96 163.91 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.991 0.424 . . . . 0.0 109.953 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -136.09 159.05 42.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.821 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 14' ' ' ALA . 55.2 mt -82.04 130.19 35.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.631 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.4 p -87.98 -158.69 0.48 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.244 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -85.58 -8.37 58.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 75.4 m -96.94 150.54 20.65 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.665 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.9 mt-10 -90.28 -22.89 21.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 109.927 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -101.77 1.06 36.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.521 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.6 OUTLIER -133.18 144.4 49.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.53 0.681 . . . . 0.0 111.305 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -131.37 157.08 43.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.605 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -113.81 125.84 54.53 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.699 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.49 -160.89 8.72 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.751 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 . . . . . 0 C--N 1.317 -0.845 0 CA-C-O 121.362 0.601 . . . . 0.0 109.971 -178.0 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.78 0.324 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.08 47.35 5.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.818 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -111.53 133.19 53.98 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.99 114.89 30.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.819 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 47.6 mt -128.99 135.79 49.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.78 0.8 . . . . 0.0 112.312 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.571 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 1.4 ptp180 -56.92 130.3 45.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.009 167.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.499 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.1 t -88.31 27.79 1.19 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.758 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 14.6 mt-10 -86.17 -16.19 38.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.981 0.896 . . . . 0.0 109.458 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.819 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 34.5 p90 -120.36 19.05 12.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.097 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 66' ' ' THR . 86.2 mt -116.65 148.28 41.15 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.577 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -115.71 126.59 54.28 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.581 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.0 122.31 16.22 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -174.884 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HB3' HD21 ' A' ' 12' ' ' LEU . 48.4 mt-10 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.433 0.635 . . . . 0.0 111.528 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 45' ' ' LEU . 5.1 t -108.88 130.46 61.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.983 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.622 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -131.89 165.14 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.469 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.31 -166.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.668 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.437 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 21.9 p -61.59 -34.36 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.372 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.28 -40.45 26.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.96 0.41 . . . . 0.0 110.767 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 20.09 2.06 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.238 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.06 132.27 36.12 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.622 HD23 ' HG3' ' A' ' 6' ' ' ARG . 24.7 mt -70.55 142.84 51.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.293 0.568 . . . . 0.0 111.894 -172.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HB3' HD11 ' A' ' 43' ' ' ILE . 83.7 mt -108.96 173.77 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.63 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -164.78 175.89 9.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.873 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.7 t70 -62.26 125.43 23.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.493 . . . . 0.0 110.574 175.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.69 59.38 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.935 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -89.91 171.75 9.37 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -123.91 145.83 48.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.674 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 43' ' ' ILE . 27.7 m -145.07 172.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.5 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.9 m -155.09 156.26 35.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.605 0.24 . . . . 0.0 110.73 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.615 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -70.53 128.16 35.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.651 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.656 HG13 ' HG2' ' A' ' 23' ' ' LYS . 40.2 pt -91.45 -10.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.111 0.481 . . . . 0.0 110.823 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -158.04 176.51 12.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.37 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.33 118.94 25.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.615 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.796 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 26.4 mmmt . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 121.589 0.709 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -59.78 136.35 57.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.43 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.97 64.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.893 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.538 ' HB ' HD23 ' A' ' 21' ' ' LEU . 87.6 m -59.83 115.81 3.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 110.365 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ttm -87.23 123.54 32.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.455 0.645 . . . . 0.0 111.306 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.435 ' HB ' HG23 ' A' ' 19' ' ' VAL . 45.5 mt -114.6 95.92 4.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.145 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.64 135.96 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.733 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.09 40.33 3.79 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.641 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.56 HG21 HG22 ' A' ' 19' ' ' VAL . 2.2 pp -85.09 167.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 6.7 ptp85 -143.2 158.97 43.15 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.072 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 5' ' ' VAL . 33.2 mt -84.01 162.74 20.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.635 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -126.92 -167.62 1.76 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.52 -6.45 55.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.277 0.561 . . . . 0.0 109.542 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 55.1 m -96.81 145.89 25.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.422 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 5' ' ' VAL . 23.2 mt-10 -89.47 -23.94 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.189 0.519 . . . . 0.0 110.616 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 66' ' ' THR . 16.4 m-20 -105.98 -3.37 21.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.972 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 14.9 mp0 -122.64 146.15 47.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.224 0.535 . . . . 0.0 110.836 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.42 ' CG2' HG11 ' A' ' 5' ' ' VAL . 24.7 pt -133.78 178.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.801 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.549 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -132.23 127.88 36.71 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -138.67 178.57 19.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.082 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.397 0.617 . . . . 0.0 110.851 179.777 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.065 0.46 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.549 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 92.58 51.14 2.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -115.28 135.03 54.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 46.4 t -90.16 119.65 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.147 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.663 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 22.3 mt -133.12 142.89 48.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.648 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.607 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 15.8 ptt180 -64.3 131.65 47.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.736 171.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.439 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.6 t -88.35 27.97 1.16 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.972 -174.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.3 mt-10 -79.87 -27.57 40.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.845 0.831 . . . . 0.0 109.24 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.663 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 31.8 p90 -113.92 17.88 17.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.765 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 66' ' ' THR . 72.5 mt -112.48 141.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.393 0.616 . . . . 0.0 110.161 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -110.94 122.05 46.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.486 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -59.13 121.35 11.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 121.512 0.672 . . . . 0.0 110.962 -175.913 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 121.316 0.579 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.643 HG11 HG23 ' A' ' 52' ' ' ILE . 3.0 t -95.81 133.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.629 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.569 ' HG3' HD23 ' A' ' 12' ' ' LEU . 2.0 mpt_? -131.02 166.09 21.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.16 -174.8 5.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 110.21 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 p -57.44 -34.47 69.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.659 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -79.23 -43.19 24.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.836 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.79 18.37 1.4 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.563 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.54 128.26 34.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.569 HD23 ' HG3' ' A' ' 6' ' ' ARG . 17.4 mt -65.53 142.49 58.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -110.39 171.8 7.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.623 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.51 178.99 9.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.6 t70 -75.45 111.04 10.33 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.14 22.75 9.63 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 176.61 6.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 4.3 p30 -135.04 140.45 45.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.467 0.651 . . . . 0.0 111.66 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 43' ' ' ILE . 28.9 m -135.67 176.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.213 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -149.71 157.32 43.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.769 0.319 . . . . 0.0 111.015 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.647 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -69.79 127.24 32.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.813 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.966 HG13 ' HG3' ' A' ' 23' ' ' LYS . 39.2 pt -92.27 -9.24 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.225 0.536 . . . . 0.0 110.368 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.966 ' HG3' HG13 ' A' ' 22' ' ' ILE . 24.1 mtpp -143.02 -179.74 6.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.671 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.27 94.89 7.03 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.647 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 26.1 mmmt . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.454 0.645 . . . . 0.0 112.177 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -57.17 134.02 55.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.374 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.18 -9.26 61.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.908 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.522 ' HB ' HD23 ' A' ' 21' ' ' LEU . 97.2 m -60.56 119.78 8.73 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.964 0.382 . . . . 0.0 110.212 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.0 ttm -88.22 122.24 31.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.434 0.635 . . . . 0.0 111.179 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.2 mt -113.22 91.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.906 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -110.96 135.69 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.284 0.564 . . . . 0.0 110.676 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.67 43.76 1.77 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -171.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.619 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.9 pp -98.5 158.05 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 177.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 5' ' ' VAL . 26.9 mt -75.82 149.03 37.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.163 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.3 p -118.8 -167.96 1.47 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.3 -3.49 33.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 0.0 110.065 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 47.3 m -100.64 138.23 37.96 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.826 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -92.53 -15.04 27.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.146 0.498 . . . . 0.0 110.213 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 66' ' ' THR . 17.6 t70 -106.24 -5.23 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.949 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.5 mp0 -125.9 146.56 49.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.002 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.643 HG23 HG11 ' A' ' 5' ' ' VAL . 9.3 pt -131.4 172.4 16.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.528 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 38.1 tt0 -126.09 129.73 49.69 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.619 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.26 -167.07 10.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.966 -1.112 . . . . 0.0 112.623 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 -179.167 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.93 51.44 9.1 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.32 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -113.33 135.46 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 47.0 t -96.3 119.96 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.116 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.751 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 33.3 mt -133.34 138.91 46.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.585 0.707 . . . . 0.0 112.37 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.516 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.2 ptp180 -56.69 134.06 54.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.283 168.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 50' ' ' ASP . 8.9 t -89.29 31.9 0.87 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.622 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 23.4 mt-10 -81.88 -32.93 30.78 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.851 0.834 . . . . 0.0 109.887 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.751 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 30.3 p90 -115.16 20.63 14.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.921 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 19' ' ' VAL . 72.1 mt -116.03 143.75 45.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.049 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -119.98 128.94 54.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.945 -176.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -59.61 126.39 27.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -172.769 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.435 ' HB3' ' HE ' ' A' ' 6' ' ' ARG . 41.9 mt-10 . . . . . 0 CA--C 1.516 -0.354 0 CA-C-O 121.393 0.616 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.4 t -93.01 123.76 45.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.042 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.558 ' HG3' HD23 ' A' ' 12' ' ' LEU . 1.4 mpt_? -126.49 170.24 12.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.575 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 39.4 p-10 -84.17 -162.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.655 ' SG ' HG21 ' A' ' 22' ' ' ILE . 20.2 p -78.52 12.16 2.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 110.591 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 9' ' ' ASN . 2.1 t-20 -118.35 -48.03 2.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.494 0.664 . . . . 0.0 110.254 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.04 5.51 3.44 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.108 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.1 125.83 29.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.558 HD23 ' HG3' ' A' ' 6' ' ' ARG . 17.3 mt -72.32 135.05 45.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.698 -175.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.01 162.42 13.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.48 8.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.977 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.0 t70 -64.62 125.72 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.82 17.07 53.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.264 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.02 175.48 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 13.3 p30 -131.06 139.08 49.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.698 0.761 . . . . 0.0 112.078 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.28 173.39 14.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.806 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -152.91 152.25 31.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.769 0.318 . . . . 0.0 110.619 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.606 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -64.63 128.58 36.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.641 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.007 HG13 ' HG3' ' A' ' 23' ' ' LYS . 35.0 pt -92.69 -9.68 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.174 0.511 . . . . 0.0 110.361 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 1.007 ' HG3' HG13 ' A' ' 22' ' ' ILE . 23.2 mtpp -145.47 -175.94 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.9 109.22 22.01 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.606 HD23 HD12 ' A' ' 21' ' ' LEU . 3.8 mm? . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.955 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 23.4 mmmt . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.24 0.543 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -59.99 131.71 51.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.459 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.13 -3.46 62.03 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.107 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.525 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -65.09 113.42 3.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.201 0.501 . . . . 0.0 110.371 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -82.97 122.44 28.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.556 0.693 . . . . 0.0 111.499 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.49 93.51 2.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.935 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.38 149.65 24.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.93 43.01 5.51 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.564 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -91.29 166.96 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.297 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -147.22 156.92 43.37 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.609 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.4 mt -84.69 158.49 20.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.559 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -118.21 -162.75 0.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.72 -16.65 60.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.748 0.785 . . . . 0.0 109.235 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 19.9 m -87.22 144.86 26.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.874 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.56 ' HA ' HG22 ' A' ' 5' ' ' VAL . 24.5 mt-10 -91.6 -13.55 31.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.551 0.691 . . . . 0.0 109.749 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -110.46 -5.85 15.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.748 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 14.0 mp0 -123.72 145.44 48.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.346 0.593 . . . . 0.0 110.943 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.49 HG23 HG11 ' A' ' 5' ' ' VAL . 11.6 pt -135.69 175.26 11.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.436 174.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.71 137.46 49.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -140.73 -167.88 11.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.772 -1.204 . . . . 0.0 112.67 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 . . . . . 0 C--N 1.323 -0.566 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.203 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.254 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.05 48.98 70.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.933 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -105.32 134.21 48.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.82 120.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.108 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.829 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 26.2 mt -132.57 144.24 50.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.741 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.603 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 1.1 ptp180 -64.78 133.45 52.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.793 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 t -85.34 26.16 0.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.503 0.668 . . . . 0.0 110.773 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -87.79 -20.89 25.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.636 0.731 . . . . 0.0 110.164 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.829 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 53.5 p90 -120.78 21.16 11.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.53 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.8 mt -117.07 148.93 41.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.269 0.556 . . . . 0.0 110.028 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.6 tmtt? -120.38 131.7 54.94 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.778 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -64.58 122.38 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.269 -172.313 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.509 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 44.4 mt-10 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.413 0.625 . . . . 0.0 111.306 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.739 HG11 HG23 ' A' ' 52' ' ' ILE . 8.5 t -88.08 131.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.673 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HG2' HD23 ' A' ' 12' ' ' LEU . 65.8 mtt85 -122.24 167.04 13.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.639 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 36.4 p-10 -90.07 -162.02 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' HG21 ' A' ' 22' ' ' ILE . 20.2 p -76.32 3.62 10.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.287 0.565 . . . . 0.0 110.752 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -106.58 -48.29 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.73 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.07 7.67 4.91 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.951 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.95 136.64 36.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 4' ' ' GLU . 34.5 mt -80.75 135.71 36.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 112.083 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.4 ' HB3' HD11 ' A' ' 43' ' ' ILE . 86.4 mt -101.47 166.9 10.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.36 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.75 174.45 13.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 14.7 t70 -63.53 118.18 7.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.775 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.02 -0.78 38.39 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.068 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.475 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -83.12 175.15 10.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 110.691 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -135.55 137.67 42.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.172 -177.258 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 69' ' ' LEU . 34.5 m -128.82 167.31 24.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.613 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.44 152.5 47.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.613 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.537 HD12 HD23 ' A' ' 25' ' ' LEU . 3.4 mm? -72.7 122.92 22.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.5 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.566 HG13 ' HG2' ' A' ' 23' ' ' LYS . 39.4 pt -88.33 -7.34 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 111.102 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.566 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -160.05 -176.79 5.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.177 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.5 117.57 30.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.032 0.444 . . . . 0.0 110.253 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.141 0.496 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -60.53 135.88 57.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.41 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.41 -0.63 59.98 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.859 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.482 ' HB ' ' HG ' ' A' ' 21' ' ' LEU . 91.8 m -63.48 120.21 11.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.842 0.353 . . . . 0.0 110.049 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.9 tpt -93.52 114.58 26.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.624 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.9 mt -111.21 90.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.472 0.653 . . . . 0.0 109.434 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.45 136.98 45.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.65 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.48 46.24 2.19 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.579 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -93.48 168.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 0.0 110.325 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 4.6 ptp180 -151.71 156.68 40.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.48 HD22 ' CG2' ' A' ' 5' ' ' VAL . 20.2 mt -78.6 127.7 32.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 p -82.81 -68.91 0.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.204 1.002 . . . . 0.0 111.878 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -176.79 -34.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.763 -173.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 38.1 m -75.08 146.49 41.43 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.356 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HA ' HG22 ' A' ' 5' ' ' VAL . 2.1 mp0 -91.46 -19.25 23.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.513 0.673 . . . . 0.0 110.163 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -103.54 -3.59 25.07 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.728 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 2.5 mt-10 -132.65 145.56 51.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.584 0.707 . . . . 0.0 111.347 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.739 HG23 HG11 ' A' ' 5' ' ' VAL . 9.4 pt -132.09 173.8 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.451 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 22.5 tt0 -125.01 137.01 54.25 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -142.54 -161.18 8.67 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.232 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 9.0 ptp180 . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 120.918 0.39 . . . . 0.0 110.633 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 17.7 ptpt . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.82 0.343 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.94 47.98 5.63 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.076 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -112.51 136.63 51.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 40.1 t -94.41 119.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.648 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.8 mt -128.16 146.11 50.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.706 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 14.1 ptt180 -65.36 135.32 55.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.23 172.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 t -89.27 33.01 0.81 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.502 0.668 . . . . 0.0 110.656 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.7 mt-10 -81.69 -30.97 32.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.005 0.907 . . . . 0.0 109.444 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.648 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 39.9 p90 -115.79 19.11 15.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.506 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 19' ' ' VAL . 68.6 mt -113.2 147.65 37.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.224 0.535 . . . . 0.0 110.349 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -117.8 130.89 56.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.752 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.2 tmtt? -67.04 121.14 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.303 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HB3' HD21 ' A' ' 12' ' ' LEU . 82.3 mt-10 . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.122 0.487 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -95.48 121.28 45.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -125.92 153.41 44.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.252 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 8.5 p-10 -79.57 -170.52 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.0 p -63.49 -26.37 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -76.03 -39.37 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.096 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.68 12.27 8.04 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.529 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.71 132.18 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 6' ' ' ARG . 20.0 mt -69.24 131.18 44.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.1 177.33 5.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.803 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.541 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -154.61 178.47 10.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -80.14 111.61 16.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.689 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.78 27.36 8.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.656 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.08 176.5 5.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.366 0.266 . . . . 0.0 110.361 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -129.2 136.09 49.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 111.102 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 69' ' ' LEU . 35.4 m -125.05 179.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.992 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -154.82 151.15 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.692 0.282 . . . . 0.0 111.239 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.75 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -66.25 130.49 43.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.629 HG21 ' SG ' ' A' ' 8' ' ' CYS . 41.4 pt -91.99 -9.15 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 110.856 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.563 ' HG3' HD21 ' A' ' 25' ' ' LEU . 4.9 ptpt -156.88 -178.86 7.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.93 108.18 19.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.75 HD23 HD12 ' A' ' 21' ' ' LEU . 3.3 mm? . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.645 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 21.3 mmmt . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.491 0.662 . . . . 0.0 112.356 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -59.69 136.56 58.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.711 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.69 -3.05 81.09 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.989 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.548 ' HB ' HD23 ' A' ' 21' ' ' LEU . 93.0 m -63.86 112.56 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.7 ttm -83.35 116.29 22.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.321 0.582 . . . . 0.0 111.144 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' HB ' HG23 ' A' ' 19' ' ' VAL . 39.7 mt -99.66 89.97 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.901 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 3.3 ppt_? -100.15 135.72 41.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 46.98 1.8 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.626 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 1.9 pp -97.18 148.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.55 142.6 51.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.246 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 14' ' ' ALA . 61.3 mt -71.93 132.69 44.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -97.43 -169.17 1.8 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.07 7.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.434 0.635 . . . . 0.0 109.564 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -109.89 149.38 29.97 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.671 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -103.39 -14.8 16.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -102.18 -7.74 21.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.897 0.379 . . . . 0.0 110.333 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.1 mp0 -123.31 149.3 45.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.507 0.67 . . . . 0.0 111.125 -176.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.473 HD12 ' HB ' ' A' ' 43' ' ' ILE . 17.9 pt -136.29 172.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.161 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.2 tt0 -125.53 122.01 35.33 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -128.43 -169.47 12.62 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.846 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 . . . . . 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 110.203 179.779 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 60' ' ' LYS . 17.1 ptmt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.775 0.321 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.16 43.71 31.66 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.785 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -107.18 131.31 54.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.9 t -89.73 120.53 38.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.655 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 28.8 mt -134.35 140.93 46.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.574 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 1.5 ptp180 -58.88 130.39 46.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 168.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -87.68 25.64 1.45 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.454 0.645 . . . . 0.0 110.204 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.5 mt-10 -89.31 -10.0 48.41 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.762 0.791 . . . . 0.0 109.769 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 42.8 p90 -125.22 15.59 8.39 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.114 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 19' ' ' VAL . 68.8 mt -112.06 149.06 32.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.832 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -61.15 120.9 11.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.733 -171.395 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HB3' HD21 ' A' ' 12' ' ' LEU . 33.3 mt-10 . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 121.467 0.651 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.727 HG11 HG23 ' A' ' 52' ' ' ILE . 6.7 t -80.84 118.29 28.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.526 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 92.4 mtt180 -124.75 155.07 39.91 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 38.2 p-10 -79.48 -161.93 0.37 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.815 0.34 . . . . 0.0 110.343 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.503 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.8 p -74.62 -1.14 20.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.188 0.518 . . . . 0.0 110.85 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.13 -44.96 4.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.37 11.05 4.31 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.033 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' ARG . . . -82.5 134.52 35.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 4' ' ' GLU . 20.9 mt -78.3 134.34 37.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.338 0.589 . . . . 0.0 112.01 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -100.63 162.73 12.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.229 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.98 176.53 12.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.295 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 22.0 t70 -60.56 123.27 16.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 16.82 46.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.596 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.445 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t70 -93.93 175.64 6.64 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.725 -0.279 . . . . 0.0 110.716 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -130.22 135.98 48.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.199 0.523 . . . . 0.0 110.938 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.587 HG21 HD13 ' A' ' 69' ' ' LEU . 27.6 m -124.05 175.95 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.787 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -150.59 151.79 33.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.858 0.361 . . . . 0.0 111.366 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.675 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -64.68 127.4 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.45 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.879 HG13 ' HG3' ' A' ' 23' ' ' LYS . 38.5 pt -95.53 -8.36 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.762 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.4 mttt -141.87 179.8 6.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.56 100.64 12.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.675 HD23 HD12 ' A' ' 21' ' ' LEU . 3.8 mm? . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mmmt . . . . . 0 CA--C 1.516 -0.339 0 CA-C-O 121.17 0.509 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 36' ' ' ARG . 27.5 ttt180 -62.42 137.55 58.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.488 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.73 8.03 70.57 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.916 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.538 ' HB ' HD23 ' A' ' 21' ' ' LEU . 90.9 m -73.47 116.28 13.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.2 ttm -87.75 111.71 21.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.449 0.642 . . . . 0.0 111.448 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.462 ' HB ' HG23 ' A' ' 19' ' ' VAL . 48.8 mt -95.12 91.51 3.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 135.1 43.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.33 1.43 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.677 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -102.89 162.66 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.366 . . . . 0.0 110.231 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 12.2 ptt180 -143.24 164.66 29.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.345 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 5' ' ' VAL . 43.3 mt -82.16 142.28 32.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.204 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.1 p -104.35 -154.48 0.51 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.176 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.31 -2.95 56.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 33.5 t -108.16 157.92 17.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.014 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.61 ' HA ' HG22 ' A' ' 5' ' ' VAL . 31.9 mt-10 -95.89 -13.43 23.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.909 172.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -108.98 -9.6 15.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.356 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -121.68 146.28 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 111.427 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.727 HG23 HG11 ' A' ' 5' ' ' VAL . 2.4 pp -134.76 166.86 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.505 172.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' HB2' HG22 ' A' ' 63' ' ' VAL . 37.2 tt0 -120.36 130.0 54.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.677 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.01 -175.4 13.99 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.964 -175.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 17.0 ptt180 . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.459 0.647 . . . . 0.0 110.765 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.66 54.09 6.88 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.677 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.6 pt? -115.09 138.34 50.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 53' ' ' GLU . 46.3 t -92.5 116.29 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.554 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -129.48 146.13 51.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.558 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.658 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 2.3 ptp180 -65.25 139.07 58.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.055 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' HD12 ' A' ' 69' ' ' LEU . 8.9 t -93.74 23.82 4.51 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.593 -174.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HG2' HH11 ' A' ' 65' ' ' ARG . 0.6 OUTLIER -92.81 -8.46 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.275 -176.319 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.658 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 54.0 p90 -122.41 19.58 10.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.587 HD13 HG21 ' A' ' 19' ' ' VAL . 65.7 mt -120.46 145.66 47.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.081 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.515 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -113.35 130.68 56.22 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.698 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.4 tmtt? -64.21 123.14 18.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . . . . . . 0 C--N 1.322 -0.597 0 CA-C-O 121.137 0.494 . . . . 0.0 111.319 -174.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.504 ' HB3' HD21 ' A' ' 12' ' ' LEU . 37.7 mt-10 . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 111.457 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 49' ' ' GLU . 14.9 t -90.19 117.83 34.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.079 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -128.19 148.58 50.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.413 ' OD2' ' HA ' ' A' ' 70' ' ' LYS . 5.8 p-10 -80.63 -169.78 2.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.456 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.643 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.9 p -65.05 -22.82 67.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 110.961 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.406 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 35.9 t30 -76.14 -31.76 58.76 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.536 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.89 14.29 27.24 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.53 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.94 31.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 120.799 0.333 . . . . 0.0 110.143 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 4' ' ' GLU . 19.9 mt -71.57 141.0 50.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.872 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.57 176.85 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.602 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.96 10.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.849 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 17.3 t70 -65.3 121.33 14.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.798 0.332 . . . . 0.0 110.164 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.91 11.13 50.89 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.036 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.93 174.81 8.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 1.1 p30 -139.11 136.15 34.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.399 0.619 . . . . 0.0 111.565 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 69' ' ' LEU . 27.3 m -128.63 176.81 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.968 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -150.67 149.24 29.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.733 0.301 . . . . 0.0 111.048 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.665 HD12 HD23 ' A' ' 25' ' ' LEU . 4.5 mm? -61.17 133.36 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.329 0.651 . . . . 0.0 112.259 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.661 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -94.71 -11.56 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.2 0.524 . . . . 0.0 110.559 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.661 ' HG2' HG13 ' A' ' 22' ' ' ILE . 18.4 ptmt -158.43 176.1 12.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.232 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' HD22 ' A' ' 25' ' ' LEU . 8.2 m-20 -83.13 127.63 33.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.665 HD23 HD12 ' A' ' 21' ' ' LEU . 4.1 mm? . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 22.4 mmmt . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 121.297 0.57 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.22 132.74 51.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.82 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.16 -11.39 55.29 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.729 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.539 ' HB ' HD23 ' A' ' 21' ' ' LEU . 60.6 m -59.33 125.7 24.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.981 0.39 . . . . 0.0 110.037 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -90.71 122.58 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.082 0.468 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 90.53 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.11 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -101.51 154.29 18.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.2 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.99 45.94 6.9 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.301 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.557 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.39 160.45 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 19.6 ptt180 -139.46 159.09 42.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.305 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.452 HD22 ' HB ' ' A' ' 5' ' ' VAL . 52.0 mt -78.85 134.58 36.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.141 -176.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -94.44 -157.95 0.6 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.807 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.94 -6.99 59.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.504 0.669 . . . . 0.0 109.205 174.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 66.1 m -102.88 150.47 23.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.913 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -87.76 -26.57 22.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.477 0.656 . . . . 0.0 109.939 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -98.01 -6.67 31.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.695 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 10.8 mp0 -124.42 145.16 49.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 111.499 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.474 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -133.32 167.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.521 173.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -119.93 128.36 53.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.42 -159.32 7.95 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.333 -177.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.5 ptp180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 120.821 0.343 . . . . 0.0 110.243 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.01 52.08 4.78 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.388 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -114.31 137.05 52.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.65 121.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.926 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.667 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.4 mt -135.42 143.58 46.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.226 0.536 . . . . 0.0 111.941 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 9.4 ptp180 -60.71 130.13 44.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.694 171.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -88.48 22.27 2.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.219 0.533 . . . . 0.0 110.739 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 2.4 pt-20 -90.92 -9.74 45.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.318 0.58 . . . . 0.0 110.222 -176.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.667 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 28.7 p90 -117.06 16.99 14.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.329 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 19' ' ' VAL . 68.8 mt -117.29 146.38 43.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.296 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -118.45 125.0 49.01 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.008 -178.381 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HA ' HG12 ' A' ' 19' ' ' VAL . 46.5 tttp -62.06 121.01 11.97 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.313 0.383 . . . . 0.0 110.235 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . . . . . . 0 C--N 1.321 -0.666 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 121.282 0.563 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 49' ' ' GLU . 10.9 t -92.28 122.65 43.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.983 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.533 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -130.26 162.19 29.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.65 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 4.1 p-10 -82.51 -165.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.6 p -64.24 -25.62 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.772 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.41 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 65.9 t30 -74.5 -51.97 13.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.236 177.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.41 12.73 3.34 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.974 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.47 132.72 33.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.533 HD23 ' HG3' ' A' ' 6' ' ' ARG . 21.5 mt -69.15 145.18 53.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.509 0.671 . . . . 0.0 112.223 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.96 169.36 9.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.427 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.32 13.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.038 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 31.3 t70 -68.09 117.6 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.22 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.88 30.77 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.796 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.71 174.22 7.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -133.4 145.03 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.297 0.57 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 71' ' ' LYS . 28.3 m -140.54 175.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.275 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -152.31 156.89 40.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.745 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -69.23 131.51 45.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.721 -178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.681 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -91.94 -11.01 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.405 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.681 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -154.6 -179.09 7.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.96 113.56 25.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.745 HD23 HD12 ' A' ' 21' ' ' LEU . 3.5 mm? . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.522 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 121.295 0.569 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 36' ' ' ARG . 30.2 ttt180 -58.39 129.86 44.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.256 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.43 66.36 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.322 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.539 ' HB ' HD23 ' A' ' 21' ' ' LEU . 98.6 m -63.32 118.49 8.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.497 0.649 . . . . 0.0 110.23 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.435 ' HG2' ' HG3' ' A' ' 41' ' ' ARG . 35.7 ttm -87.62 119.88 28.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.628 0.728 . . . . 0.0 111.445 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -108.34 95.03 3.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.026 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' HG3' ' HG2' ' A' ' 39' ' ' MET . 0.0 OUTLIER -104.95 136.17 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.231 -176.557 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.94 50.69 1.59 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.64 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -99.32 164.0 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.581 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 7.0 ptp85 -141.62 167.49 22.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 ' HB ' ' A' ' 5' ' ' VAL . 36.5 mt -89.27 147.79 23.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.155 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -104.14 -159.77 0.73 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -85.05 2.4 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 m -113.51 156.68 23.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.598 ' HA ' HG22 ' A' ' 5' ' ' VAL . 21.9 mt-10 -93.54 -27.9 16.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.605 0.717 . . . . 0.0 109.65 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 66' ' ' THR . 6.6 m-20 -90.21 -12.01 39.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.321 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.7 mp0 -121.17 148.84 43.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.359 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.493 ' CG2' HG11 ' A' ' 5' ' ' VAL . 26.8 pt -133.91 175.78 10.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.716 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.537 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -130.14 123.78 31.13 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.008 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.64 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -136.38 -177.01 14.68 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.89 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.56 . . . . 0.0 110.401 179.707 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 58.5 46.59 92.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.444 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.5 pt? -103.38 135.01 45.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.225 0.513 . . . . 0.0 109.754 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.5 t -88.68 116.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.002 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.571 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 30.7 mt -129.56 143.45 50.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.452 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.645 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 14.6 ptt180 -62.14 129.95 43.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.444 ' HA ' HD12 ' A' ' 69' ' ' LEU . 11.9 t -88.19 27.06 1.27 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.238 0.542 . . . . 0.0 110.525 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.638 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.5 mt-10 -81.85 -26.27 34.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 109.159 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.645 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 21.4 p90 -114.56 17.91 17.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.998 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 66' ' ' THR . 58.3 mt -113.74 144.84 42.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.3 0.572 . . . . 0.0 110.205 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.65 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtp? -113.82 129.67 56.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.107 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.424 ' HA ' HG12 ' A' ' 19' ' ' VAL . 53.1 tttp -60.44 129.76 43.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.596 0 CA-C-O 121.11 0.481 . . . . 0.0 111.331 -174.471 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.321 0.582 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 49' ' ' GLU . 7.0 t -97.8 121.36 48.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.709 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.567 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.67 157.35 42.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.027 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 7.7 p-10 -83.25 -168.7 2.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 p -68.2 -13.09 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.496 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 50.4 t30 -87.65 -38.23 16.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 9.56 10.49 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.179 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.86 124.25 30.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.567 HD23 ' HG3' ' A' ' 6' ' ' ARG . 23.9 mt -66.76 129.54 40.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.907 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.96 166.71 10.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.579 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.49 178.42 10.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.139 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 13.2 t70 -65.12 129.66 40.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.452 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.61 60.67 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.542 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t0 -88.11 173.81 8.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.594 0.235 . . . . 0.0 110.453 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -132.7 128.84 37.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 -177.091 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 69' ' ' LEU . 26.9 m -125.78 176.94 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.29 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -153.53 149.25 27.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.593 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -65.25 125.18 24.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.743 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.929 HG13 ' HG3' ' A' ' 23' ' ' LYS . 33.5 pt -93.56 -7.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.162 0.506 . . . . 0.0 110.283 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.929 ' HG3' HG13 ' A' ' 22' ' ' ILE . 4.2 mtpm? -144.58 177.91 8.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.856 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.886 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 5.8 m-20 -93.73 102.22 14.36 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.684 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 4.3 mm? . . . . . 0 CA--C 1.511 -0.539 0 CA-C-O 121.632 0.73 . . . . 0.0 111.647 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.886 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 3.3 mmpt? . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 121.248 0.547 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -68.76 144.77 54.25 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.281 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.59 15.3 73.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.722 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.551 ' HB ' HD23 ' A' ' 21' ' ' LEU . 60.2 m -84.84 117.75 24.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 ttm -86.13 123.18 31.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.397 0.617 . . . . 0.0 110.975 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.425 ' HB ' HG23 ' A' ' 19' ' ' VAL . 35.0 mt -112.23 95.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.504 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -108.16 142.45 38.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.067 0.461 . . . . 0.0 111.009 -178.533 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.97 42.14 4.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.649 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.4 pp -92.5 165.72 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 110.234 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.557 ' HD2' ' OE1' ' A' ' 53' ' ' GLU . 3.8 ptp180 -139.76 164.19 30.62 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.321 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.5 162.18 14.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -130.48 -166.56 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -75.86 -8.98 58.2 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.249 0.547 . . . . 0.0 109.644 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 53.7 m -92.33 145.7 24.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.195 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -95.81 -20.6 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.806 -178.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.33 -5.94 22.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.145 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 17.7 mp0 -124.0 147.71 47.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.9 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -137.1 173.12 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.214 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.557 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 41.1 tt0 -125.62 135.02 51.72 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.649 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.92 -177.98 21.04 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.138 -177.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 121.009 0.433 . . . . 0.0 110.127 179.922 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.55 53.41 3.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.514 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.538 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -115.29 138.71 50.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 48.5 t -93.11 116.72 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.001 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.594 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 26.6 mt -129.33 142.93 50.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.663 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.635 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.9 ptp85 -60.68 130.61 47.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.563 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.4 t -88.59 24.24 2.03 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.294 0.569 . . . . 0.0 110.379 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.566 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.7 mt-10 -82.42 -20.3 37.32 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.926 0.87 . . . . 0.0 109.525 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 33.1 p90 -117.27 17.53 14.69 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.61 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 19' ' ' VAL . 63.8 mt -113.42 144.02 43.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.058 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HD3' ' HB2' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -113.93 126.98 55.77 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.358 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.542 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 11.1 tmtt? -59.83 124.87 21.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 71' ' ' LYS . . . . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.247 -170.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 121.302 0.572 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.814 HG11 HG23 ' A' ' 52' ' ' ILE . 2.7 t -87.58 128.91 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.257 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.567 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -132.28 158.93 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -178.164 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -78.51 -171.8 2.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 110.589 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.6 p -58.49 -29.73 66.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 9.3 m120 -84.02 -42.85 15.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.072 0.463 . . . . 0.0 110.516 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.21 16.91 1.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.47 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.02 126.26 30.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.567 HD23 ' HG3' ' A' ' 6' ' ' ARG . 27.1 mt -64.96 131.58 46.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.331 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.61 164.15 12.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.88 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.78 178.52 10.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 16.1 t70 -67.02 115.36 6.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 0.0 110.564 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.36 25.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.479 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -91.7 174.1 7.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -134.27 137.13 44.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.497 0.665 . . . . 0.0 111.49 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.506 HG21 HD13 ' A' ' 69' ' ' LEU . 27.2 m -126.4 176.01 7.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.236 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -153.24 156.69 38.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.72 0.295 . . . . 0.0 110.75 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.609 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -66.96 127.53 32.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.351 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.901 HG13 ' HG3' ' A' ' 23' ' ' LYS . 34.9 pt -92.91 -10.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.901 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.7 mtpt -141.71 -174.01 3.94 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.9 94.31 6.5 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.65 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 3.4 mm? . . . . . 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.586 -175.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.3 mmmt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.284 0.564 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -59.88 129.86 43.94 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.685 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.95 -6.66 54.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.849 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.527 ' HB ' HD23 ' A' ' 21' ' ' LEU . 89.3 m -59.98 112.11 1.75 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.152 0.476 . . . . 0.0 110.241 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.4 ttm -89.29 117.6 28.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.303 0.573 . . . . 0.0 111.254 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -106.27 92.85 2.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.89 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.75 140.27 37.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 -175.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 49.68 2.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.644 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.603 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.71 169.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 21.6 ptt180 -148.56 156.21 42.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.133 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 5' ' ' VAL . 37.6 mt -76.82 135.42 38.91 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 p -87.33 -70.96 0.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.801 0.81 . . . . 0.0 111.164 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.4 t70 179.07 -31.05 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.283 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -73.6 145.51 45.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.833 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.604 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -89.32 -18.23 27.34 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.44 -20.29 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.506 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 65' ' ' ARG . 7.2 mp0 -127.26 154.56 44.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.533 -174.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.814 HG23 HG11 ' A' ' 5' ' ' VAL . 10.7 pt -134.35 176.71 8.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.254 171.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 7.8 tt0 -125.39 140.02 53.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.7 -166.33 11.85 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.053 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 . . . . . 0 C--N 1.316 -0.881 0 CA-C-O 121.195 0.521 . . . . 0.0 110.473 -177.991 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.7 48.25 29.43 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.337 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.6 pt? -114.39 135.99 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 109.831 177.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 32.0 t -92.77 123.84 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.906 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -135.5 143.17 45.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.899 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.748 ' HG3' ' HE1' ' A' ' 68' ' ' PHE . 3.2 ptp85 -60.05 134.29 56.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.482 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.41 HG21 HG12 ' A' ' 5' ' ' VAL . 8.8 t -87.98 26.21 1.41 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.546 0.688 . . . . 0.0 110.456 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 28.8 mt-10 -84.59 -30.98 24.56 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.835 0.826 . . . . 0.0 109.96 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.748 ' HE1' ' HG3' ' A' ' 65' ' ' ARG . 53.7 p90 -114.15 19.72 16.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.106 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 19' ' ' VAL . 74.4 mt -114.22 145.48 41.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.405 0.621 . . . . 0.0 110.62 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 1.5 tmtt? -113.27 126.0 54.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.583 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -64.71 121.94 15.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.053 -174.617 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.515 ' HB2' HD21 ' A' ' 12' ' ' LEU . 5.2 pt-20 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 121.381 0.61 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.695 HG11 HG23 ' A' ' 52' ' ' ILE . 3.0 t -92.45 119.42 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.41 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -123.73 161.32 25.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.868 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.644 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 21.0 p-10 -82.64 -166.23 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.9 p -72.1 -7.62 50.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.994 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -97.94 -37.51 9.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.444 0.64 . . . . 0.0 109.712 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.92 9.37 7.51 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.269 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 128.84 34.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 4' ' ' GLU . 24.7 mt -70.77 139.75 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.744 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -103.64 173.31 6.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.032 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -160.92 -179.73 7.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.307 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.31 122.18 17.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 0.0 110.288 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.03 27.56 20.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.758 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -98.35 173.62 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -135.17 140.57 45.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.707 0.765 . . . . 0.0 111.69 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.547 HG21 HD13 ' A' ' 69' ' ' LEU . 19.4 m -139.44 178.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.245 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -153.38 155.1 35.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 0.0 111.197 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.719 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -68.9 127.53 33.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.704 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 68' ' ' PHE . 27.3 pt -93.09 -7.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.982 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' HD22 ' A' ' 25' ' ' LEU . 18.6 ptpt -160.1 178.55 9.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.4 122.58 30.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.719 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.647 0.261 . . . . 0.0 110.33 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt . . . . . 0 N--CA 1.448 -0.532 0 CA-C-O 121.029 0.443 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -61.87 141.14 58.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.022 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.82 -6.28 54.43 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.433 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.517 ' HB ' HD23 ' A' ' 21' ' ' LEU . 31.6 m -71.77 121.47 18.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.44 129.07 36.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.328 0.585 . . . . 0.0 110.763 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' A' ' 19' ' ' VAL . 33.1 mt -113.7 94.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.189 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.07 142.91 42.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.005 0.431 . . . . 0.0 110.915 -176.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.15 47.34 4.44 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.68 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -94.71 164.29 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.783 0.325 . . . . 0.0 110.192 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -137.72 148.91 46.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.205 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.88 149.76 44.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.912 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.4 p -116.86 -160.9 0.78 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.791 0.329 . . . . 0.0 110.43 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.47 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.42 0.629 . . . . 0.0 109.601 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.615 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.5 m -107.47 142.45 37.31 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.028 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.553 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -87.9 -18.49 29.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.503 177.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -94.98 -13.77 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.138 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 4.0 mt-10 -126.63 146.32 50.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.959 0.885 . . . . 0.0 112.48 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.695 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -135.33 162.75 37.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.303 173.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.91 132.9 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.68 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -148.93 -163.98 11.26 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.83 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 . . . . . 0 C--N 1.317 -0.821 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 -179.176 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.755 0.312 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.98 47.33 89.66 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.58 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -109.93 135.55 50.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.65 120.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.672 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.751 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 38.6 mt -132.01 141.11 49.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.539 0.685 . . . . 0.0 112.785 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.623 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.7 ptm180 -53.61 129.05 31.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.095 164.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.0 t -91.78 21.07 5.04 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.26 0.552 . . . . 0.0 110.843 -173.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.69 -8.49 37.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.192 0.52 . . . . 0.0 110.675 -174.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.751 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 5.1 p90 -114.4 16.07 17.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.435 0.636 . . . . 0.0 109.938 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 19' ' ' VAL . 82.4 mt -112.24 149.1 32.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.386 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.644 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtt? -119.58 124.76 47.16 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.675 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.515 ' HA ' HG12 ' A' ' 19' ' ' VAL . 62.1 tttp -62.39 125.29 23.39 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.977 0.418 . . . . 0.0 111.015 -174.049 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.514 -0.429 0 CA-C-O 121.469 0.652 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.738 HG22 ' HA ' ' A' ' 49' ' ' GLU . 2.6 t -81.95 127.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.091 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.43 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.48 160.52 32.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.881 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -172.84 1.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.509 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 22' ' ' ILE . 11.2 p -54.88 -33.37 61.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.66 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -81.33 -59.64 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.322 0.582 . . . . 0.0 110.647 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.23 25.21 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.722 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 128.23 35.56 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' ' 6' ' ' ARG . 18.6 mt -71.05 137.58 49.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.543 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 43' ' ' ILE . 87.3 mt -107.49 172.26 6.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.736 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.25 175.38 11.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.188 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 21.7 t70 -65.87 117.04 7.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.989 0.423 . . . . 0.0 110.796 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.6 10.15 38.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.983 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.559 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -90.08 174.87 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.58 143.89 47.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.643 0.735 . . . . 0.0 112.215 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.414 HG21 HD13 ' A' ' 69' ' ' LEU . 34.7 m -135.09 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.096 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.491 ' OG ' ' HG3' ' A' ' 39' ' ' MET . 73.9 m -153.2 157.82 40.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.542 HD12 HD23 ' A' ' 25' ' ' LEU . 3.9 mm? -70.15 129.13 38.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.889 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.769 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.2 pt -93.04 -4.76 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.769 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -164.22 179.34 6.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.272 -178.172 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.09 110.1 19.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.191 0.307 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.556 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 4.0 mm? . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 21.9 mmmt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.361 0.601 . . . . 0.0 111.977 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -59.61 132.53 54.25 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.171 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.72 -15.92 40.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.726 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.489 ' HB ' HD23 ' A' ' 21' ' ' LEU . 59.9 m -56.2 121.93 10.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.491 ' HG3' ' OG ' ' A' ' 20' ' ' SER . 11.0 ttt -100.31 120.47 39.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.179 0.514 . . . . 0.0 111.039 -173.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.9 mt -109.84 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.669 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.18 135.81 43.11 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.874 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 51.13 1.3 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.414 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.586 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -100.51 165.29 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.703 0.287 . . . . 0.0 110.322 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.5 ptp180 -142.19 158.47 43.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.394 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.488 HD22 ' CG2' ' A' ' 5' ' ' VAL . 34.8 mt -78.15 138.47 38.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -107.48 -172.4 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.658 -171.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.34 -35.75 78.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.684 0.754 . . . . 0.0 109.217 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 71.3 m -88.02 147.12 25.14 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.208 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.738 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.76 -1.4 26.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.842 0.83 . . . . 0.0 109.593 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 66' ' ' THR . 36.1 t70 -95.94 -5.69 40.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.81 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 7.6 mt-10 -133.3 157.9 44.3 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.559 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.535 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 7.3 pt -139.01 168.12 19.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.625 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -122.67 127.84 49.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.349 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.586 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -138.98 -170.98 11.99 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.274 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 . . . . . 0 C--N 1.317 -0.805 0 CA-C-O 121.173 0.511 . . . . 0.0 109.952 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.26 47.69 69.87 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.016 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -107.53 133.35 52.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.6 t -92.49 117.46 35.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.814 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.614 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 23.7 mt -127.34 143.97 51.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.135 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.599 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.8 ptp180 -59.66 133.35 56.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.377 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 50' ' ' ASP . 13.1 t -89.37 31.83 0.89 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.487 0.661 . . . . 0.0 110.732 -175.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 16.3 mt-10 -85.3 -32.4 22.52 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.58 0.705 . . . . 0.0 109.795 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.614 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 38.2 p90 -112.92 15.95 19.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.366 -172.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 19' ' ' VAL . 61.3 mt -112.64 142.31 45.39 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.337 0.589 . . . . 0.0 110.294 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -115.32 132.82 56.49 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.767 -177.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.559 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.0 tmtt? -66.07 120.54 13.34 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.618 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -167.616 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.509 ' HB3' HD21 ' A' ' 12' ' ' LEU . 41.4 mt-10 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.278 0.561 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 49' ' ' GLU . 5.8 t -105.24 123.92 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.05 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.54 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -131.14 158.79 39.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 30.0 p-10 -80.27 -169.75 2.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' HG21 ' A' ' 22' ' ' ILE . 26.7 p -67.34 -19.24 65.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.665 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -80.29 -48.67 12.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.844 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 17.18 2.85 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.612 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.53 133.22 35.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.54 HD23 ' HG3' ' A' ' 6' ' ' ARG . 19.8 mt -72.7 135.91 45.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.102 0.477 . . . . 0.0 111.354 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.04 168.74 8.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.749 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.48 172.98 14.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.669 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.0 t70 -63.95 120.73 12.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.968 0.414 . . . . 0.0 110.134 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.12 3.79 44.83 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.975 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -84.28 174.85 9.82 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -139.9 132.85 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.328 0.585 . . . . 0.0 111.094 -178.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.575 HG21 HD13 ' A' ' 69' ' ' LEU . 29.7 m -124.77 173.62 10.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.004 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 m -150.49 151.95 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.962 0.411 . . . . 0.0 111.146 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.671 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -65.03 127.12 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.78 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.6 HG21 ' SG ' ' A' ' 8' ' ' CYS . 35.0 pt -90.31 -11.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.26 0.553 . . . . 0.0 110.765 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.584 ' HG3' ' CD2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -154.47 -178.81 7.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.333 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . 1.6 m-20 -96.79 110.22 22.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.671 HD23 HD12 ' A' ' 21' ' ' LEU . 3.6 mm? . . . . . 0 C--N 1.323 -0.545 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HD2' ' HB3' ' A' ' 24' ' ' ASP . 29.0 mmmt . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 36' ' ' ARG . 39.0 ttt-85 -56.43 133.57 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.563 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.79 -10.2 64.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.184 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.418 ' HB ' HD23 ' A' ' 21' ' ' LEU . 87.3 m -57.23 124.0 17.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.142 0.471 . . . . 0.0 110.291 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -93.96 122.4 36.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.255 0.55 . . . . 0.0 111.281 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.426 ' HB ' HG23 ' A' ' 19' ' ' VAL . 41.1 mt -110.8 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.069 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 13.3 ptt180 -108.76 159.28 16.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.719 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.2 39.63 15.44 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.634 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -91.05 161.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.874 0.368 . . . . 0.0 110.368 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 2.9 ptp180 -141.99 158.25 43.99 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.258 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 5' ' ' VAL . 30.9 mt -80.33 154.75 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.808 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 p -127.8 -167.13 1.71 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.232 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.42 -21.95 66.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.201 0.525 . . . . 0.0 110.324 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 70.8 m -85.09 142.87 29.23 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -90.03 -7.6 53.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.8 0.809 . . . . 0.0 108.969 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -116.39 -5.5 11.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.185 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.7 mp0 -125.25 144.4 50.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 0.0 111.217 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.42 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -134.32 156.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.146 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HB2' HG22 ' A' ' 63' ' ' VAL . 37.9 tt0 -115.32 130.56 56.94 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.634 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -148.92 -161.14 9.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.299 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.646 -178.311 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.915 0.388 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.0 47.04 5.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.756 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.09 136.08 53.51 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.184 0.516 . . . . 0.0 110.465 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 53' ' ' GLU . 45.7 t -89.48 119.34 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.791 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.0 mt -129.9 147.36 51.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.917 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.577 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 2.4 ptp85 -65.18 130.25 42.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.954 172.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.525 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.8 t -85.58 30.69 0.62 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 0.0 110.592 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -88.03 -21.32 24.84 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.825 0.822 . . . . 0.0 109.706 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.58 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 33.8 p90 -117.97 18.41 13.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.563 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.575 HD13 HG21 ' A' ' 19' ' ' VAL . 68.0 mt -115.54 148.34 39.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.104 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -125.07 128.64 48.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.75 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.06 119.21 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.325 -172.74 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.52 ' HB3' HD21 ' A' ' 12' ' ' LEU . 30.5 mt-10 . . . . . 0 CA--C 1.516 -0.332 0 CA-C-O 121.178 0.513 . . . . 0.0 111.699 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -104.52 126.12 59.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.55 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.618 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 32.4 p-10 -80.07 -165.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.711 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.3 p -74.86 -8.59 56.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.25 0.548 . . . . 0.0 110.646 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -91.83 -44.66 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.686 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.22 13.25 3.61 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.301 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.7 130.76 38.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.55 HD23 ' HG3' ' A' ' 6' ' ' ARG . 19.8 mt -66.7 143.57 56.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 112.241 -176.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -109.93 169.13 8.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.21 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -160.37 177.93 10.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.2 t70 -66.84 122.84 18.59 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 14.74 41.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.747 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -91.14 165.01 13.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -117.96 147.86 42.76 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.539 HG22 HG21 ' A' ' 43' ' ' ILE . 28.0 m -143.82 171.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.119 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -152.11 157.56 41.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.747 0.308 . . . . 0.0 111.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.653 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -69.6 124.19 23.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.632 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.711 HG21 ' SG ' ' A' ' 8' ' ' CYS . 40.5 pt -91.93 -12.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.269 0.557 . . . . 0.0 110.572 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.635 ' HG2' HG13 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -150.95 173.6 14.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.25 -177.016 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.17 122.76 32.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 120.931 0.396 . . . . 0.0 110.71 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 27.4 mmmt . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 121.49 0.662 . . . . 0.0 111.379 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -60.86 149.29 36.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.719 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.21 -3.04 79.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.898 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.458 ' HB ' HD23 ' A' ' 21' ' ' LEU . 84.5 m -68.08 121.84 16.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.509 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttm -87.86 129.38 35.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.603 . . . . 0.0 111.192 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.488 ' HB ' HG23 ' A' ' 19' ' ' VAL . 52.0 mt -122.14 92.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.973 172.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -106.87 136.26 47.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 111.012 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.82 52.09 1.22 Allowed Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.583 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -104.41 164.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 10.2 ptp85 -143.91 165.4 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.239 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD22 ' HB ' ' A' ' 5' ' ' VAL . 30.7 mt -80.67 150.88 29.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.052 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -111.99 -155.97 0.58 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.62 -8.53 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.094 0.473 . . . . 0.0 109.736 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 44.4 t -94.99 161.81 13.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.702 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' HA ' HG22 ' A' ' 5' ' ' VAL . 33.8 mt-10 -101.02 -5.29 26.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.774 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 66' ' ' THR . 5.1 m-20 -131.5 0.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.297 -176.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 3.6 mp0 -120.43 143.41 48.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.104 0.478 . . . . 0.0 110.185 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.11 165.33 32.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.873 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 4.0 tm-20 -125.04 125.56 44.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -151.94 -166.78 14.38 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.676 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 35.6 ptt180 . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 60' ' ' LYS . 1.6 ptmm? . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.819 0.342 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.456 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 89.6 52.48 2.65 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.703 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -116.13 140.71 49.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.035 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.69 116.57 35.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.082 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.598 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 31.7 mt -130.17 152.66 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.245 0.545 . . . . 0.0 111.988 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.584 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 ptt180 -72.93 131.04 41.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.48 173.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.2 t -85.6 25.86 1.01 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.659 -175.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 1.3 pt-20 -83.33 -19.9 35.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.626 0.727 . . . . 0.0 109.667 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.598 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 26.8 p90 -118.31 17.51 13.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.055 -178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.523 HD13 HG21 ' A' ' 19' ' ' VAL . 76.1 mt -114.21 149.07 36.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.444 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.618 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.6 tmtt? -119.54 129.06 54.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.666 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HZ2' ' CG ' ' A' ' 17' ' ' ASP . 39.9 tttp -62.05 116.49 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.419 . . . . 0.0 111.406 -174.531 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.507 ' HB3' HD21 ' A' ' 12' ' ' LEU . 42.4 mt-10 . . . . . 0 CA--C 1.511 -0.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.754 HG11 HG23 ' A' ' 52' ' ' ILE . 2.7 t -78.58 121.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.226 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -126.29 151.59 47.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.969 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -77.37 -172.05 2.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.637 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.7 p -65.11 -23.64 67.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.602 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.17 -28.62 31.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.563 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.14 15.73 12.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.229 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.7 136.05 33.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 4' ' ' GLU . 17.7 mt -70.51 138.75 51.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.559 . . . . 0.0 111.658 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.428 ' HB3' HD11 ' A' ' 43' ' ' ILE . 94.7 mt -104.63 173.53 6.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.06 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.2 173.36 14.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.128 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 29.2 t70 -64.84 121.34 14.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.344 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.27 31.55 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.024 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.91 173.93 6.83 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.826 -0.22 . . . . 0.0 111.147 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.3 p30 -131.22 139.45 49.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.619 0.723 . . . . 0.0 112.092 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.557 HG12 ' HA ' ' A' ' 71' ' ' LYS . 29.3 m -140.45 172.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.036 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -152.55 157.03 40.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 0.0 111.625 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -66.9 135.73 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.381 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.745 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.3 pt -97.1 -8.32 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.092 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.745 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -159.63 175.71 12.88 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -176.286 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.36 110.3 21.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.601 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.578 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.9 mmmt . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.407 0.623 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -61.61 134.92 57.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.267 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.49 -9.36 64.63 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.053 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.461 ' HB ' HD23 ' A' ' 21' ' ' LEU . 97.6 m -59.5 124.56 20.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.815 0.308 . . . . 0.0 110.316 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.8 ttm -96.55 124.92 40.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.516 0.674 . . . . 0.0 111.038 -176.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.0 mt -115.14 94.47 3.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.002 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -111.23 147.13 35.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -177.352 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.23 39.03 5.51 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.624 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -89.99 166.7 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.906 0.384 . . . . 0.0 110.278 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 5.7 ptp85 -140.29 158.07 44.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.936 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.555 HD22 ' HB ' ' A' ' 5' ' ' VAL . 39.7 mt -84.12 130.51 34.85 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.9 p -93.43 -171.62 2.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.55 6.96 15.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.497 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -103.64 143.66 32.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.48 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 5' ' ' VAL . 17.3 mt-10 -87.58 -25.14 23.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.359 0.6 . . . . 0.0 109.936 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 66' ' ' THR . 9.2 m-20 -96.94 -7.31 33.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.136 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -126.87 147.74 50.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 111.5 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.754 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -131.6 168.45 23.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.339 173.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.25 129.31 53.99 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.624 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -141.21 -165.86 10.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.074 -175.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 18.3 ptt85 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.177 0.513 . . . . 0.0 110.046 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 11.5 ptmm? . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.768 0.318 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.65 30.66 39.07 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.411 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -101.81 139.9 36.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.32 116.88 36.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.761 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -128.37 144.51 51.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.579 0.704 . . . . 0.0 111.996 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.569 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 13.8 ptt180 -66.16 135.83 55.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.43 173.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 50' ' ' ASP . 9.0 t -89.23 30.51 0.97 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.568 0.699 . . . . 0.0 110.561 -176.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 31.0 mt-10 -80.1 -31.8 39.21 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.944 0.878 . . . . 0.0 109.501 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 48.8 p90 -116.77 16.57 15.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.441 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.58 145.61 36.09 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.163 0.506 . . . . 0.0 109.871 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -119.74 128.47 53.8 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.588 -178.268 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.557 ' HA ' HG12 ' A' ' 19' ' ' VAL . 58.5 tttp -63.36 127.81 33.0 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.806 -169.073 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 34.7 mt-10 . . . . . 0 CA--C 1.516 -0.342 0 CA-C-O 121.567 0.698 . . . . 0.0 111.886 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.636 HG11 HG23 ' A' ' 52' ' ' ILE . 4.6 t -96.99 127.61 49.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.077 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -128.03 148.68 50.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.553 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -73.98 -171.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.627 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 22' ' ' ILE . 26.5 p -63.82 -29.12 70.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -25.89 56.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.38 18.93 13.23 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.962 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.23 136.25 36.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.137 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.568 HD23 ' HG3' ' A' ' 6' ' ' ARG . 25.6 mt -67.93 138.3 55.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.759 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -108.13 170.29 8.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.155 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.42 174.16 15.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.455 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 19.9 t70 -67.68 114.16 6.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.845 0.355 . . . . 0.0 110.357 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.49 2.27 29.25 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.65 173.05 11.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -136.12 141.68 44.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 111.411 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 71' ' ' LYS . 31.3 m -134.88 177.03 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.342 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 m -151.07 153.24 34.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.0 111.321 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -64.21 128.52 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.7 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.721 HG13 ' HG2' ' A' ' 23' ' ' LYS . 42.2 pt -90.53 -11.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.773 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.721 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.99 -178.28 7.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.174 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.55 117.18 26.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.601 HD23 HD12 ' A' ' 21' ' ' LEU . 3.9 mm? . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.174 0.512 . . . . 0.0 110.631 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 22.4 mmmt . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 121.321 0.582 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -61.25 137.83 58.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.142 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.03 -14.88 59.77 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.52 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.476 ' HB ' HD23 ' A' ' 21' ' ' LEU . 88.2 m -56.61 119.93 6.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 110.039 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.1 ttt -94.05 122.91 37.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.363 0.601 . . . . 0.0 110.753 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.3 mt -110.54 90.51 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.797 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.506 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -104.67 137.6 42.25 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.371 -175.823 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.02 50.45 2.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.379 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.567 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -97.18 164.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.7 ptp180 -142.83 157.79 44.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.543 HD22 ' HB ' ' A' ' 5' ' ' VAL . 32.9 mt -75.64 155.1 36.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.665 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -121.69 -167.87 1.6 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.79 -20.08 65.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.6 m -85.75 147.74 26.19 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.954 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.499 ' HA ' HG22 ' A' ' 5' ' ' VAL . 28.1 mt-10 -96.14 -13.8 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.503 0.668 . . . . 0.0 109.517 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -106.85 -5.92 18.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.862 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 2.0 mp0 -127.96 146.56 50.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.335 0.588 . . . . 0.0 111.44 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.636 HG23 HG11 ' A' ' 5' ' ' VAL . 2.7 pp -131.09 166.62 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.304 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 31.2 tt0 -117.92 124.84 49.23 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.04 -166.16 10.69 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.085 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 15.5 ptp180 . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 12.6 ptmm? . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.69 39.8 13.55 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.209 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -110.54 138.64 46.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.907 0.384 . . . . 0.0 109.983 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 43.4 t -93.23 116.77 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.518 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -128.69 145.6 51.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 111.796 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.619 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -64.11 130.88 45.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.235 173.176 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.5 t -86.41 26.47 1.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.647 -175.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 32.5 mt-10 -84.0 -25.51 29.91 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.938 0.875 . . . . 0.0 109.392 -175.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.619 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 32.1 p90 -113.98 16.95 18.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.61 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 66' ' ' THR . 65.1 mt -114.17 145.84 41.14 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.953 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -118.7 125.59 50.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.124 -178.021 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.569 ' HA ' HG12 ' A' ' 19' ' ' VAL . 54.3 tttp -62.65 122.37 15.68 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.392 0.432 . . . . 0.0 110.125 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.653 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -177.234 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.849 0.357 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 m -136.8 93.59 2.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.624 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -113.85 53.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.484 0.659 . . . . 0.0 109.467 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB3' HD21 ' A' ' 12' ' ' LEU . 32.6 mt-10 -63.55 100.09 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.559 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.768 HG11 HG23 ' A' ' 52' ' ' ILE . 19.2 t -85.96 121.26 37.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.602 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 75.6 mtt180 -124.93 153.19 43.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -174.17 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 111.085 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' HG21 ' A' ' 22' ' ' ILE . 13.7 p -56.05 -30.68 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.607 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -83.85 -56.7 3.55 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.29 19.2 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.245 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 71' ' ' LYS . . . -83.05 135.6 34.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.047 0.423 . . . . 0.0 110.039 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 4' ' ' GLU . 15.8 mt -77.29 135.7 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.288 0.566 . . . . 0.0 112.445 -174.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' HB3' HD11 ' A' ' 43' ' ' ILE . 63.9 mt -112.0 166.72 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.711 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.9 179.49 9.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.26 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -64.69 118.37 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.16 8.56 50.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.217 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.84 174.19 8.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.838 -0.213 . . . . 0.0 110.467 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 3.2 p30 -133.7 139.63 46.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.526 0.679 . . . . 0.0 111.585 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.488 HG21 HD13 ' A' ' 69' ' ' LEU . 34.6 m -131.88 174.7 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.213 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 m -151.89 148.88 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.807 0.337 . . . . 0.0 110.781 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.698 HD12 HD23 ' A' ' 25' ' ' LEU . 4.5 mm? -60.74 130.04 44.5 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.236 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.663 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -91.15 -11.33 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.56 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.663 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.55 178.34 10.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.296 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -91.44 121.9 33.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.698 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? -117.33 125.23 50.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.759 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.6 tmmt? -101.04 138.01 38.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.576 0.703 . . . . 0.0 111.167 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.429 HD23 HD13 ' A' ' 34' ' ' LEU . 4.4 mm? -109.31 149.64 29.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.543 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 49.5 mtpt -72.48 -33.7 67.16 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.796 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.25 105.81 0.54 Allowed Glycine 0 C--N 1.329 0.172 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.976 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 m 59.42 20.78 9.13 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 122.837 0.455 . . . . 0.0 111.315 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 t 55.89 73.53 0.43 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.261 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.1 m -101.51 103.14 14.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.828 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG22 ' HG3' ' A' ' 26' ' ' LYS . 30.0 t -96.88 101.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.013 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.429 HD13 HD23 ' A' ' 27' ' ' LEU . 6.1 mp -77.86 147.53 35.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.5 mmmt -109.96 160.85 16.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.529 0.68 . . . . 0.0 111.668 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -61.61 138.78 58.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.984 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.04 -13.07 63.75 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.634 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.547 ' HB ' HD23 ' A' ' 21' ' ' LEU . 77.9 m -58.78 119.41 7.09 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 7.4 ttt -87.98 124.65 33.93 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.282 0.563 . . . . 0.0 110.751 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.753 HG12 HG22 ' A' ' 56' ' ' THR . 43.6 mt -114.53 91.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.664 173.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -108.61 149.53 28.77 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.708 -176.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.58 6.54 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.221 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.568 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.0 pp -91.65 160.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 8.2 ptt180 -141.06 161.01 38.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.748 0.309 . . . . 0.0 110.579 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.522 HD22 ' CG2' ' A' ' 5' ' ' VAL . 25.9 mt -79.86 154.06 28.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.238 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -121.46 -159.33 0.8 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.23 -14.2 62.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.686 0.755 . . . . 0.0 109.261 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 65.6 m -101.03 148.35 25.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.669 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HA ' HG22 ' A' ' 5' ' ' VAL . 23.8 mt-10 -92.5 -16.43 25.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.36 -14.94 23.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.382 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 8.2 mp0 -125.66 148.73 48.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.548 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.768 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -132.45 160.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.253 171.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.0 tt0 -115.58 122.68 46.37 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -133.33 -156.1 7.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.716 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.7 ptp180 -149.45 148.17 29.11 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.753 HG22 HG12 ' A' ' 40' ' ' ILE . 68.4 p -122.41 -176.06 3.28 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.58 -38.03 89.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.963 0.411 . . . . 0.0 110.677 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -101.98 -39.9 7.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mm -114.63 104.2 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HD2' ' C ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -100.16 149.16 23.82 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.485 176.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.61 50.57 42.05 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.64 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.23 135.39 54.22 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.083 0.468 . . . . 0.0 110.033 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.3 t -92.66 122.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.746 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.7 mt -134.02 147.0 50.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.37 0.605 . . . . 0.0 112.191 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.584 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.8 ptp180 -66.34 130.51 43.47 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.947 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.495 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.2 t -86.23 26.29 1.06 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.251 0.548 . . . . 0.0 110.856 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.0 mt-10 -84.17 -22.58 30.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.714 0.769 . . . . 0.0 109.652 -175.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.746 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 24.2 p90 -117.32 19.44 14.09 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.749 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 66' ' ' THR . 60.6 mt -116.68 145.48 43.41 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.014 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -114.4 133.27 55.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.247 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.64 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 52.1 tttt -58.43 122.32 13.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.64 173.1 8.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.35 -89.37 1.3 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.585 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.57 -0.728 . . . . 0.0 109.955 178.804 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -129.1 110.16 11.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.248 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 23.7 pt -138.91 68.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.567 0.698 . . . . 0.0 110.181 172.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.83 102.91 7.45 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.6 t -91.63 129.84 41.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.779 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.573 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -133.98 171.09 14.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.19 -169.72 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' HG21 ' A' ' 22' ' ' ILE . 7.7 p -66.39 -27.77 68.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.295 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -82.46 -51.03 8.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.09 27.1 0.26 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.772 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.65 123.78 40.43 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.573 HD23 ' HG3' ' A' ' 6' ' ' ARG . 27.4 mt -60.35 143.78 52.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.457 0.646 . . . . 0.0 112.642 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' HB3' HD11 ' A' ' 43' ' ' ILE . 95.7 mt -111.36 170.85 7.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.14 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.47 178.17 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.86 122.0 14.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.012 0.434 . . . . 0.0 110.946 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.19 64.33 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.374 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.54 173.06 12.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.697 0.284 . . . . 0.0 110.703 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -124.46 146.35 48.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.255 0.55 . . . . 0.0 110.523 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 43' ' ' ILE . 27.7 m -142.55 170.82 11.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.532 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -153.18 158.66 42.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.76 0.314 . . . . 0.0 110.713 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 25' ' ' LEU . 3.4 mm? -67.66 135.16 52.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.537 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.601 HG13 ' HG2' ' A' ' 23' ' ' LYS . 37.2 pt -96.59 -11.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 110.838 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -155.86 174.79 14.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.134 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.54 107.61 18.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? -101.1 115.66 31.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.278 0.561 . . . . 0.0 111.199 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.734 ' HG3' HG22 ' A' ' 33' ' ' VAL . 4.3 tmmt? -98.88 132.68 44.03 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.448 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.6 mt -104.36 157.34 17.21 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.078 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.36 148.32 35.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.655 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.15 -119.91 2.48 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 p -86.54 23.25 1.68 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.722 0.296 . . . . 0.0 110.548 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.6 m 63.91 79.52 0.26 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.574 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 m -101.07 104.03 15.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.942 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.734 HG22 ' HG3' ' A' ' 26' ' ' LYS . 31.4 t -99.57 116.69 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.464 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.46 146.82 26.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.6 mmmt -106.76 161.38 14.72 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.471 0.653 . . . . 0.0 111.812 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.47 139.56 58.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.249 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.71 68.54 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.943 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.568 ' HB ' HD23 ' A' ' 21' ' ' LEU . 85.3 m -58.17 121.39 10.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.783 0.291 . . . . 0.0 110.256 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.24 117.01 29.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.363 0.601 . . . . 0.0 111.516 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.407 ' HB ' HG23 ' A' ' 19' ' ' VAL . 51.5 mt -104.05 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.586 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.33 135.74 47.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.394 -174.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.68 48.85 2.06 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.335 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 pp -94.25 160.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -138.95 159.88 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.106 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.6 mt -85.87 138.26 32.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.4 p -98.33 -156.8 0.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.779 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -90.29 -2.08 57.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 109.668 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 58.1 m -98.29 149.08 22.98 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.606 ' HA ' HG22 ' A' ' 5' ' ' VAL . 27.3 mt-10 -94.85 -14.88 24.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.623 0.725 . . . . 0.0 109.376 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 66' ' ' THR . 1.0 OUTLIER -108.32 -2.94 18.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.538 -176.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -130.01 147.57 51.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.156 0.503 . . . . 0.0 111.044 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.49 ' CG2' HG11 ' A' ' 5' ' ' VAL . 15.7 pt -135.18 175.76 10.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.642 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -130.74 135.31 47.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -139.65 -177.6 15.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.281 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 55' ' ' ARG . 10.1 ptt180 -130.0 137.07 50.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.234 0.54 . . . . 0.0 110.179 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.6 p -104.55 -171.52 1.94 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.244 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.01 -23.64 62.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.994 0.426 . . . . 0.0 110.265 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -108.48 -73.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.166 0.507 . . . . 0.0 110.556 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.8 mm -82.25 117.22 27.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.415 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 60' ' ' LYS . 20.0 ptmt -107.17 135.03 49.39 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.28 5.86 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.651 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -110.99 134.57 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' A' ' 53' ' ' GLU . 39.4 t -91.72 125.09 44.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.908 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.546 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 33.4 mt -137.31 145.77 43.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.666 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.667 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -62.99 130.48 44.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.759 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -83.83 23.96 0.94 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.745 0.783 . . . . 0.0 110.204 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -89.58 -15.1 33.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.537 0.684 . . . . 0.0 110.101 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.667 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 53.4 p90 -121.84 17.0 11.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.303 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 66' ' ' THR . 73.6 mt -113.53 147.11 38.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.512 0.672 . . . . 0.0 110.087 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -117.36 124.81 49.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.106 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -59.95 118.83 6.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.61 -46.59 78.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 0.0 110.042 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.41 -129.63 3.29 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.267 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.175 178.085 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.835 0.35 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -135.93 97.98 3.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.808 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.436 ' HB ' ' HG2' ' A' ' 49' ' ' GLU . 20.9 pt -115.12 53.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.505 ' HB3' HD21 ' A' ' 12' ' ' LEU . 46.1 mt-10 -54.69 123.97 14.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.496 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.5 t -113.24 119.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.959 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.572 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -122.32 175.17 6.56 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.837 -177.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 3.1 p-10 -86.05 -164.29 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.065 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.433 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 25.8 p -63.57 -20.37 65.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.547 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.495 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 6.7 t30 -95.78 -49.36 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.63 10.89 0.77 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.526 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.86 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.572 HD23 ' HG3' ' A' ' 6' ' ' ARG . 25.3 mt -72.51 143.74 48.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.379 0.609 . . . . 0.0 112.28 -173.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.59 166.06 11.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.387 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.79 174.31 15.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.911 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -63.96 121.5 14.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.514 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.49 1.67 53.4 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.006 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -81.73 174.05 11.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 110.404 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.9 p30 -132.69 142.91 49.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.617 0.722 . . . . 0.0 111.652 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 71' ' ' LYS . 29.5 m -137.57 174.88 10.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.927 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.1 m -152.19 150.87 30.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.715 0.293 . . . . 0.0 110.714 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 25' ' ' LEU . 4.3 mm? -62.0 128.26 35.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.679 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.656 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -89.6 -10.03 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.814 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -159.79 174.27 14.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -85.01 118.75 24.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 21' ' ' LEU . 4.2 mm? -112.18 108.71 18.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 110.407 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 33' ' ' VAL . 5.2 tmmm? -95.07 130.63 41.68 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 32' ' ' THR . 56.2 mt -78.08 151.08 33.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.491 -173.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -86.77 -47.65 8.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.086 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.78 11.52 10.42 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.266 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 58.0 m -159.76 -174.24 4.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.5 m -103.93 20.82 17.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.801 0.81 . . . . 0.0 109.124 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.428 ' HB ' HD12 ' A' ' 27' ' ' LEU . 27.7 m -71.44 104.53 3.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG22 ' HG3' ' A' ' 26' ' ' LYS . 6.5 t -100.92 102.75 13.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.06 141.1 32.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 26.8 mmmt -111.79 157.84 20.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.273 0.559 . . . . 0.0 111.579 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.76 145.58 44.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.438 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.92 -8.13 78.4 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.608 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.557 ' HB ' HD23 ' A' ' 21' ' ' LEU . 89.6 m -65.16 112.8 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 0.0 110.313 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.0 ttm -81.5 117.49 21.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.421 0.629 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 56' ' ' THR . 48.1 mt -108.9 99.81 9.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.961 174.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -111.03 156.58 21.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.924 0.392 . . . . 0.0 111.128 -176.203 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.51 28.52 35.65 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.587 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.3 pp -78.94 161.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.678 0.275 . . . . 0.0 110.423 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.6 ptp180 -140.91 166.2 25.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.489 HD22 ' HB ' ' A' ' 5' ' ' VAL . 39.3 mt -88.47 137.96 31.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.973 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -95.16 -159.77 0.74 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -81.94 -4.76 57.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.385 0.612 . . . . 0.0 109.454 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 73.9 m -99.35 146.75 25.94 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' HA ' HG22 ' A' ' 5' ' ' VAL . 22.3 mt-10 -90.51 -15.26 31.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.381 0.61 . . . . 0.0 109.904 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.4 -5.44 20.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.078 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -126.67 145.18 50.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 111.81 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -131.04 173.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.2 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.623 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 11.7 tm-20 -127.98 131.19 49.27 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.04 -166.32 11.61 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.69 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.498 HH11 ' HB3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -151.16 147.87 27.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.361 0.601 . . . . 0.0 111.258 -175.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.58 HG22 HG12 ' A' ' 40' ' ' ILE . 44.2 p -122.17 -170.97 2.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.142 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -59.53 -47.08 86.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.887 0.375 . . . . 0.0 110.304 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -96.92 -70.37 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.215 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mm -75.02 102.27 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.775 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.3 ptpp? -119.18 118.37 31.16 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.124 0.487 . . . . 0.0 109.835 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.623 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 103.98 43.14 1.83 Allowed Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.405 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.39 132.67 56.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.237 0.541 . . . . 0.0 110.032 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 58.7 t -90.89 124.57 43.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.691 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.711 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -134.05 146.3 50.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.294 0.569 . . . . 0.0 112.189 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.61 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.5 ptp180 -64.7 130.82 45.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.814 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 t -86.24 33.09 0.61 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.986 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.61 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -85.96 -29.63 23.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.435 0.636 . . . . 0.0 110.161 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.711 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 38.3 p90 -113.62 18.97 17.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.982 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 19' ' ' VAL . 59.4 mt -113.31 144.71 42.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.972 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HB2' HG22 ' A' ' 22' ' ' ILE . 3.0 tmtt? -114.17 122.38 46.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.641 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.452 ' HA ' HG12 ' A' ' 19' ' ' VAL . 48.7 tttp -57.77 120.59 8.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.3 99.15 6.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.109 0.48 . . . . 0.0 110.602 -174.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.93 24.52 3.62 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.836 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.567 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.628 0.251 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -108.85 151.54 26.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.635 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 45.6 pt -119.93 42.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.889 0.376 . . . . 0.0 110.553 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.404 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 32.6 mt-10 -61.71 111.74 1.98 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.587 0.708 . . . . 0.0 110.535 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 52' ' ' ILE . 10.3 t -94.8 132.0 40.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.815 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' HG3' HD23 ' A' ' 12' ' ' LEU . 2.4 mpt_? -132.43 150.06 52.23 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.577 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 3.8 p-10 -77.59 -163.5 0.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.725 0.297 . . . . 0.0 110.634 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.6 t -70.98 -15.6 62.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.309 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.486 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 59.6 t30 -85.83 -54.78 4.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.716 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 10.89 1.91 Allowed Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.609 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.43 133.07 35.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.48 HD23 ' HG3' ' A' ' 6' ' ' ARG . 15.2 mt -72.7 135.07 45.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.168 0.508 . . . . 0.0 111.621 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -102.4 163.72 12.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.401 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -149.23 177.55 9.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.16 118.24 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 29.01 12.46 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.647 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.7 t0 -98.72 175.13 6.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -132.73 141.15 48.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.664 0.745 . . . . 0.0 111.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.524 HG23 ' HB ' ' A' ' 40' ' ' ILE . 30.6 m -136.86 174.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.097 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.8 m -153.08 150.94 29.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.77 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.596 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -64.61 129.42 39.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.739 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.683 HG13 ' HG2' ' A' ' 23' ' ' LYS . 32.1 pt -90.94 -4.61 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 110.639 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.683 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -165.09 -179.15 5.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.886 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.83 116.56 29.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.596 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? -110.18 117.43 33.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.702 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.6 tmmt? -99.44 130.38 45.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 66.3 mt -103.3 153.9 19.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.776 -171.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -82.8 144.39 30.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.684 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.01 -61.83 0.53 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.8 m -128.26 -76.67 0.56 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -176.18 43.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.3 m -75.19 103.76 5.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.699 -174.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.702 HG22 ' HG3' ' A' ' 26' ' ' LYS . 20.1 t -105.2 100.47 10.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp -80.61 147.7 30.61 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -111.42 159.2 18.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.173 0.511 . . . . 0.0 111.764 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -63.67 140.13 58.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.474 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.27 84.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.838 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.526 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -64.32 114.43 4.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.95 0.375 . . . . 0.0 110.077 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 29.8 ttm -81.24 119.32 23.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.491 0.662 . . . . 0.0 111.121 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.648 HG12 HG22 ' A' ' 56' ' ' THR . 43.0 mt -106.64 90.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.469 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.467 ' C ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -101.07 162.68 12.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.268 -176.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.82 57.72 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.988 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.699 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -92.96 163.91 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.991 0.424 . . . . 0.0 109.953 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -136.09 159.05 42.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.821 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 14' ' ' ALA . 55.2 mt -82.04 130.19 35.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.631 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.4 p -87.98 -158.69 0.48 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.244 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -85.58 -8.37 58.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 75.4 m -96.94 150.54 20.65 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.665 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 2.9 mt-10 -90.28 -22.89 21.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 109.927 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -101.77 1.06 36.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.521 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.6 OUTLIER -133.18 144.4 49.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.53 0.681 . . . . 0.0 111.305 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -131.37 157.08 43.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.605 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -113.81 125.84 54.53 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.699 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.49 -160.89 8.72 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.751 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -148.96 144.7 26.97 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.362 0.601 . . . . 0.0 109.971 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.648 HG22 HG12 ' A' ' 40' ' ' ILE . 80.9 p -111.32 -170.09 1.58 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.003 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.5 11.42 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.534 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -147.39 -56.14 0.24 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.409 176.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.64 104.11 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.611 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.76 129.45 45.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.597 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.08 47.35 5.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.818 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -111.53 133.19 53.98 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.99 114.89 30.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.819 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 47.6 mt -128.99 135.79 49.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.78 0.8 . . . . 0.0 112.312 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.571 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 1.4 ptp180 -56.92 130.3 45.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.009 167.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.499 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.1 t -88.31 27.79 1.19 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.758 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 14.6 mt-10 -86.17 -16.19 38.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.981 0.896 . . . . 0.0 109.458 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.819 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 34.5 p90 -120.36 19.05 12.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.097 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 66' ' ' THR . 86.2 mt -116.65 148.28 41.15 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.577 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -115.71 126.59 54.28 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.581 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.0 122.31 16.22 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.99 121.13 21.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.82 -37.93 3.11 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.147 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.132 -178.755 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 tpp . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.987 0.422 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 m -130.79 84.04 2.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.406 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -107.26 50.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.46 0.648 . . . . 0.0 109.821 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HB3' HD21 ' A' ' 12' ' ' LEU . 48.4 mt-10 -54.89 127.19 27.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.528 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 45' ' ' LEU . 5.1 t -108.88 130.46 61.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.983 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.622 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -131.89 165.14 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.469 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.31 -166.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.668 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.437 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 21.9 p -61.59 -34.36 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.372 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.28 -40.45 26.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.96 0.41 . . . . 0.0 110.767 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 20.09 2.06 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.238 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.06 132.27 36.12 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.622 HD23 ' HG3' ' A' ' 6' ' ' ARG . 24.7 mt -70.55 142.84 51.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.293 0.568 . . . . 0.0 111.894 -172.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HB3' HD11 ' A' ' 43' ' ' ILE . 83.7 mt -108.96 173.77 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.63 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -164.78 175.89 9.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.873 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.7 t70 -62.26 125.43 23.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.493 . . . . 0.0 110.574 175.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.69 59.38 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.935 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -89.91 171.75 9.37 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -123.91 145.83 48.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.674 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 43' ' ' ILE . 27.7 m -145.07 172.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.5 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.9 m -155.09 156.26 35.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.605 0.24 . . . . 0.0 110.73 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.615 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -70.53 128.16 35.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.651 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.656 HG13 ' HG2' ' A' ' 23' ' ' LYS . 40.2 pt -91.45 -10.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.111 0.481 . . . . 0.0 110.823 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -158.04 176.51 12.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.37 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.33 118.94 25.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.615 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? -114.39 109.72 18.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.796 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.766 ' HG3' HG22 ' A' ' 33' ' ' VAL . 4.4 tmmm? -90.9 144.71 25.41 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.036 0.446 . . . . 0.0 110.212 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.7 mt -97.94 141.77 30.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.514 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.88 161.38 23.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.799 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.44 -49.44 1.12 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.942 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.1 p -136.6 178.78 6.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 p -83.93 40.96 0.78 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.8 m -90.0 104.86 17.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.006 0.432 . . . . 0.0 110.586 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.766 HG22 ' HG3' ' A' ' 26' ' ' LYS . 17.3 t -112.91 104.15 16.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.108 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 5.7 mp -76.8 141.79 40.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 26.4 mmmt -111.39 159.78 17.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.589 0.709 . . . . 0.0 112.127 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -59.78 136.35 57.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.43 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.97 64.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.893 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.538 ' HB ' HD23 ' A' ' 21' ' ' LEU . 87.6 m -59.83 115.81 3.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 110.365 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ttm -87.23 123.54 32.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.455 0.645 . . . . 0.0 111.306 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.523 HG12 HG22 ' A' ' 56' ' ' THR . 45.5 mt -114.6 95.92 4.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.145 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.64 135.96 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.733 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.09 40.33 3.79 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.641 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.56 HG21 HG22 ' A' ' 19' ' ' VAL . 2.2 pp -85.09 167.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 6.7 ptp85 -143.2 158.97 43.15 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.072 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 5' ' ' VAL . 33.2 mt -84.01 162.74 20.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.635 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -126.92 -167.62 1.76 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.52 -6.45 55.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.277 0.561 . . . . 0.0 109.542 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 55.1 m -96.81 145.89 25.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.422 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 5' ' ' VAL . 23.2 mt-10 -89.47 -23.94 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.189 0.519 . . . . 0.0 110.616 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 66' ' ' THR . 16.4 m-20 -105.98 -3.37 21.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.972 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 14.9 mp0 -122.64 146.15 47.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.224 0.535 . . . . 0.0 110.836 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.42 ' CG2' HG11 ' A' ' 5' ' ' VAL . 24.7 pt -133.78 178.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.801 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.549 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -132.23 127.88 36.71 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -138.67 178.57 19.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.082 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -136.5 141.09 43.44 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.397 0.617 . . . . 0.0 110.851 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.523 HG22 HG12 ' A' ' 40' ' ' ILE . 30.1 p -107.6 -170.19 1.65 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.618 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.89 -16.7 60.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.162 0.506 . . . . 0.0 109.992 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -114.6 -74.13 0.63 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.733 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -78.81 108.9 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -112.85 122.29 47.21 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.496 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.549 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 92.58 51.14 2.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -115.28 135.03 54.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 46.4 t -90.16 119.65 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.147 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.663 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 22.3 mt -133.12 142.89 48.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.648 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.607 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 15.8 ptt180 -64.3 131.65 47.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.736 171.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.439 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.6 t -88.35 27.97 1.16 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.972 -174.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.3 mt-10 -79.87 -27.57 40.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.845 0.831 . . . . 0.0 109.24 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.663 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 31.8 p90 -113.92 17.88 17.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.765 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 66' ' ' THR . 72.5 mt -112.48 141.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.393 0.616 . . . . 0.0 110.161 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -110.94 122.05 46.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.486 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -59.13 121.35 11.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.69 67.71 3.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.512 0.672 . . . . 0.0 110.962 -175.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.3 126.73 2.15 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.093 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.266 -178.564 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.677 0.275 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -149.6 96.48 2.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.162 0.506 . . . . 0.0 110.182 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.3 pt -135.91 28.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.222 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -49.23 112.63 0.66 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.316 0.579 . . . . 0.0 111.447 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG11 HG23 ' A' ' 52' ' ' ILE . 3.0 t -95.81 133.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.629 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.569 ' HG3' HD23 ' A' ' 12' ' ' LEU . 2.0 mpt_? -131.02 166.09 21.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.16 -174.8 5.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 110.21 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 p -57.44 -34.47 69.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.659 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -79.23 -43.19 24.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.836 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.79 18.37 1.4 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.563 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.54 128.26 34.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.569 HD23 ' HG3' ' A' ' 6' ' ' ARG . 17.4 mt -65.53 142.49 58.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -110.39 171.8 7.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.623 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.51 178.99 9.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.6 t70 -75.45 111.04 10.33 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.14 22.75 9.63 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 176.61 6.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 4.3 p30 -135.04 140.45 45.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.467 0.651 . . . . 0.0 111.66 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 43' ' ' ILE . 28.9 m -135.67 176.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.213 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -149.71 157.32 43.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.769 0.319 . . . . 0.0 111.015 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.647 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -69.79 127.24 32.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.813 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.966 HG13 ' HG3' ' A' ' 23' ' ' LYS . 39.2 pt -92.27 -9.24 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.225 0.536 . . . . 0.0 110.368 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.966 ' HG3' HG13 ' A' ' 22' ' ' ILE . 24.1 mtpp -143.02 -179.74 6.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.671 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.27 94.89 7.03 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.647 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? -96.28 108.65 21.18 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -89.89 128.53 36.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.029 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 30' ' ' SER . 6.4 tt -63.6 136.33 57.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.602 -175.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' N ' HD23 ' A' ' 27' ' ' LEU . 21.9 pttp -82.98 114.23 21.11 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.794 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.26 7.13 55.0 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.135 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.607 ' HB2' HD22 ' A' ' 27' ' ' LEU . 61.1 m -150.59 154.52 37.68 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.4 p -83.44 16.77 2.41 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 m -80.71 104.44 11.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.077 0.465 . . . . 0.0 110.32 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.586 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 4.9 t -94.1 104.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 8.7 mt -80.44 90.69 5.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.55 0.69 . . . . 0.0 109.464 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 26.1 mmmt -71.18 160.86 32.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.177 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -57.17 134.02 55.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.374 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.18 -9.26 61.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.908 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.522 ' HB ' HD23 ' A' ' 21' ' ' LEU . 97.2 m -60.56 119.78 8.73 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.964 0.382 . . . . 0.0 110.212 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.0 ttm -88.22 122.24 31.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.434 0.635 . . . . 0.0 111.179 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.647 HG12 HG22 ' A' ' 56' ' ' THR . 50.2 mt -113.22 91.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.906 173.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -110.96 135.69 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.284 0.564 . . . . 0.0 110.676 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.67 43.76 1.77 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -171.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.619 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.9 pp -98.5 158.05 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 177.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 5' ' ' VAL . 26.9 mt -75.82 149.03 37.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.163 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.3 p -118.8 -167.96 1.47 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.3 -3.49 33.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 0.0 110.065 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 47.3 m -100.64 138.23 37.96 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.826 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -92.53 -15.04 27.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.146 0.498 . . . . 0.0 110.213 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 66' ' ' THR . 17.6 t70 -106.24 -5.23 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.949 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.5 mp0 -125.9 146.56 49.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.002 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.643 HG23 HG11 ' A' ' 5' ' ' VAL . 9.3 pt -131.4 172.4 16.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.528 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 38.1 tt0 -126.09 129.73 49.69 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.619 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.26 -167.07 10.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.966 -1.112 . . . . 0.0 112.623 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -148.19 144.5 27.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.647 HG22 HG12 ' A' ' 40' ' ' ILE . 50.5 p -115.88 -171.35 1.96 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.691 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.34 -25.92 68.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.233 0.54 . . . . 0.0 110.282 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -119.99 -71.18 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.892 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 mm -74.26 109.05 6.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.171 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -108.8 138.88 44.43 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.93 51.44 9.1 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.32 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -113.33 135.46 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 47.0 t -96.3 119.96 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.116 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.751 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 33.3 mt -133.34 138.91 46.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.585 0.707 . . . . 0.0 112.37 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.516 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.2 ptp180 -56.69 134.06 54.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.283 168.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 50' ' ' ASP . 8.9 t -89.29 31.9 0.87 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.622 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 23.4 mt-10 -81.88 -32.93 30.78 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.851 0.834 . . . . 0.0 109.887 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.751 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 30.3 p90 -115.16 20.63 14.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.921 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 19' ' ' VAL . 72.1 mt -116.03 143.75 45.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.049 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -119.98 128.94 54.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.945 -176.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -59.61 126.39 27.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.64 -146.41 0.35 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -172.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.68 145.19 14.37 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.252 1.213 0 C-N-CA 123.877 0.871 . . . . 0.0 112.797 177.583 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.689 0.281 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.2 m -78.61 86.71 4.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.068 0.461 . . . . 0.0 110.61 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.0 pt -129.63 44.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.062 173.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.435 ' HB3' ' HE ' ' A' ' 6' ' ' ARG . 41.9 mt-10 -61.02 106.83 0.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.451 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.4 t -93.01 123.76 45.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.042 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.558 ' HG3' HD23 ' A' ' 12' ' ' LEU . 1.4 mpt_? -126.49 170.24 12.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.575 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 39.4 p-10 -84.17 -162.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.655 ' SG ' HG21 ' A' ' 22' ' ' ILE . 20.2 p -78.52 12.16 2.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 110.591 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 9' ' ' ASN . 2.1 t-20 -118.35 -48.03 2.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.494 0.664 . . . . 0.0 110.254 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.04 5.51 3.44 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.108 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.1 125.83 29.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.558 HD23 ' HG3' ' A' ' 6' ' ' ARG . 17.3 mt -72.32 135.05 45.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.698 -175.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.01 162.42 13.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.48 8.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.977 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.0 t70 -64.62 125.72 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.82 17.07 53.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.264 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.02 175.48 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 13.3 p30 -131.06 139.08 49.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.698 0.761 . . . . 0.0 112.078 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.28 173.39 14.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.806 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -152.91 152.25 31.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.769 0.318 . . . . 0.0 110.619 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.606 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -64.63 128.58 36.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.641 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.007 HG13 ' HG3' ' A' ' 23' ' ' LYS . 35.0 pt -92.69 -9.68 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.174 0.511 . . . . 0.0 110.361 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 1.007 ' HG3' HG13 ' A' ' 22' ' ' ILE . 23.2 mtpp -145.47 -175.94 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.9 109.22 22.01 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.606 HD23 HD12 ' A' ' 21' ' ' LEU . 3.8 mm? -109.91 111.83 23.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.955 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.659 ' HG3' HG22 ' A' ' 33' ' ' VAL . 5.6 tmmm? -94.51 143.24 26.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.326 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.79 138.46 31.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.403 0.62 . . . . 0.0 110.57 -175.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -87.11 128.7 35.11 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.267 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.3 13.62 47.88 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.935 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 t -164.02 173.25 12.78 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.9 p -94.08 8.33 41.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.833 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -69.04 104.63 2.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.765 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.659 HG22 ' HG3' ' A' ' 26' ' ' LYS . 17.5 t -111.31 100.31 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp -76.32 140.31 41.41 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 23.4 mmmt -110.37 160.15 16.82 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.24 0.543 . . . . 0.0 111.269 -175.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -59.99 131.71 51.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.459 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.13 -3.46 62.03 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.107 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.525 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -65.09 113.42 3.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.201 0.501 . . . . 0.0 110.371 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -82.97 122.44 28.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.556 0.693 . . . . 0.0 111.499 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 56' ' ' THR . 56.2 mt -112.49 93.51 2.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.935 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.38 149.65 24.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.93 43.01 5.51 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.564 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -91.29 166.96 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.297 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -147.22 156.92 43.37 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.609 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.4 mt -84.69 158.49 20.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.559 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -118.21 -162.75 0.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.72 -16.65 60.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.748 0.785 . . . . 0.0 109.235 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 19.9 m -87.22 144.86 26.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.874 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.56 ' HA ' HG22 ' A' ' 5' ' ' VAL . 24.5 mt-10 -91.6 -13.55 31.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.551 0.691 . . . . 0.0 109.749 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -110.46 -5.85 15.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.748 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 14.0 mp0 -123.72 145.44 48.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.346 0.593 . . . . 0.0 110.943 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.49 HG23 HG11 ' A' ' 5' ' ' VAL . 11.6 pt -135.69 175.26 11.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.436 174.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.71 137.46 49.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -140.73 -167.88 11.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.772 -1.204 . . . . 0.0 112.67 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -144.72 141.74 29.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.518 HG22 HG12 ' A' ' 40' ' ' ILE . 40.9 p -114.81 -170.39 1.73 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.718 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -56.66 -32.85 65.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.045 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -123.22 -65.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.482 -175.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.3 mp -68.98 107.43 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.313 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -107.18 144.42 33.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.869 0.366 . . . . 0.0 110.254 176.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.05 48.98 70.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.933 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -105.32 134.21 48.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.82 120.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.108 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.829 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 26.2 mt -132.57 144.24 50.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.741 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.603 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 1.1 ptp180 -64.78 133.45 52.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.793 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 t -85.34 26.16 0.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.503 0.668 . . . . 0.0 110.773 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -87.79 -20.89 25.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.636 0.731 . . . . 0.0 110.164 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.829 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 53.5 p90 -120.78 21.16 11.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.53 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.8 mt -117.07 148.93 41.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.269 0.556 . . . . 0.0 110.028 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.6 tmtt? -120.38 131.7 54.94 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.778 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -64.58 122.38 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.67 -59.96 2.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.269 -172.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.63 133.09 2.42 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.923 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.247 0.962 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.101 178.806 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mmt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 111.036 0.013 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.9 m 56.84 43.14 25.45 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.169 0.509 . . . . 0.0 110.328 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -91.46 54.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.684 0.754 . . . . 0.0 109.967 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.509 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 44.4 mt-10 -64.84 95.84 0.17 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.306 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.739 HG11 HG23 ' A' ' 52' ' ' ILE . 8.5 t -88.08 131.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.673 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HG2' HD23 ' A' ' 12' ' ' LEU . 65.8 mtt85 -122.24 167.04 13.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.639 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 36.4 p-10 -90.07 -162.02 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' HG21 ' A' ' 22' ' ' ILE . 20.2 p -76.32 3.62 10.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.287 0.565 . . . . 0.0 110.752 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -106.58 -48.29 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.73 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.07 7.67 4.91 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.951 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.95 136.64 36.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 4' ' ' GLU . 34.5 mt -80.75 135.71 36.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 112.083 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.4 ' HB3' HD11 ' A' ' 43' ' ' ILE . 86.4 mt -101.47 166.9 10.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.36 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.75 174.45 13.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 14.7 t70 -63.53 118.18 7.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.775 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.02 -0.78 38.39 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.068 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.475 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -83.12 175.15 10.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 110.691 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -135.55 137.67 42.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.172 -177.258 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 69' ' ' LEU . 34.5 m -128.82 167.31 24.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.613 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.44 152.5 47.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.613 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.537 HD12 HD23 ' A' ' 25' ' ' LEU . 3.4 mm? -72.7 122.92 22.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.5 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.566 HG13 ' HG2' ' A' ' 23' ' ' LYS . 39.4 pt -88.33 -7.34 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 111.102 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.566 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -160.05 -176.79 5.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.177 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.5 117.57 30.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? -114.11 118.27 33.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.032 0.444 . . . . 0.0 110.253 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HB2' HG13 ' A' ' 33' ' ' VAL . 5.3 tmmm? -96.82 144.29 26.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.314 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.56 157.94 25.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.729 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 31' ' ' SER . 53.5 mtpt 72.03 -62.03 0.47 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.706 0.802 . . . . 0.0 111.654 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.66 -57.74 0.39 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.776 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 p -144.25 55.48 1.29 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.275 0.559 . . . . 0.0 110.661 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.609 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 26.2 m -143.5 -74.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.858 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -99.55 104.47 16.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 110.842 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG13 ' HB2' ' A' ' 26' ' ' LYS . 16.3 t -108.58 109.86 29.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.47 HD23 HG21 ' A' ' 38' ' ' THR . 5.9 mp -87.52 146.44 25.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.916 0.389 . . . . 0.0 109.998 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -111.1 163.18 14.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.512 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -60.53 135.88 57.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.41 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.41 -0.63 59.98 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.859 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.482 ' HB ' ' HG ' ' A' ' 21' ' ' LEU . 91.8 m -63.48 120.21 11.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.842 0.353 . . . . 0.0 110.049 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.9 tpt -93.52 114.58 26.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.624 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 56' ' ' THR . 51.9 mt -111.21 90.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.472 0.653 . . . . 0.0 109.434 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.45 136.98 45.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.65 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.48 46.24 2.19 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.579 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -93.48 168.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 0.0 110.325 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 4.6 ptp180 -151.71 156.68 40.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.48 HD22 ' CG2' ' A' ' 5' ' ' VAL . 20.2 mt -78.6 127.7 32.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 p -82.81 -68.91 0.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.204 1.002 . . . . 0.0 111.878 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -176.79 -34.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.763 -173.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 38.1 m -75.08 146.49 41.43 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.356 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HA ' HG22 ' A' ' 5' ' ' VAL . 2.1 mp0 -91.46 -19.25 23.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.513 0.673 . . . . 0.0 110.163 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -103.54 -3.59 25.07 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.728 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 2.5 mt-10 -132.65 145.56 51.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.584 0.707 . . . . 0.0 111.347 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.739 HG23 HG11 ' A' ' 5' ' ' VAL . 9.4 pt -132.09 173.8 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.451 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 22.5 tt0 -125.01 137.01 54.25 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -142.54 -161.18 8.67 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.232 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 9.0 ptp180 -150.16 148.87 29.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.918 0.39 . . . . 0.0 110.633 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.505 HG22 HG12 ' A' ' 40' ' ' ILE . 39.2 p -122.44 -171.95 2.37 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.96 -30.99 69.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.165 0.507 . . . . 0.0 110.881 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.04 -69.95 0.83 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.068 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 59' ' ' ILE . 1.2 mp -74.57 103.73 2.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.033 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 17.7 ptpt -111.18 131.31 55.21 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.82 0.343 . . . . 0.0 110.159 176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.94 47.98 5.63 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.076 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -112.51 136.63 51.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 40.1 t -94.41 119.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.648 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.8 mt -128.16 146.11 50.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.706 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 14.1 ptt180 -65.36 135.32 55.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.23 172.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 t -89.27 33.01 0.81 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.502 0.668 . . . . 0.0 110.656 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.7 mt-10 -81.69 -30.97 32.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.005 0.907 . . . . 0.0 109.444 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.648 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 39.9 p90 -115.79 19.11 15.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.506 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 19' ' ' VAL . 68.6 mt -113.2 147.65 37.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.224 0.535 . . . . 0.0 110.349 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -117.8 130.89 56.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.752 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.587 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 13.2 tmtt? -67.04 121.14 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . -83.43 135.25 34.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.303 -172.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.26 19.6 56.78 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.035 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.587 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . 46.6 m . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.549 -0.738 . . . . 0.0 110.239 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.602 0.239 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -74.86 84.08 2.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.628 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.7 pt -127.21 43.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.219 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HB3' HD21 ' A' ' 12' ' ' LEU . 82.3 mt-10 -54.4 116.96 2.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.067 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -95.48 121.28 45.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -125.92 153.41 44.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 8.5 p-10 -79.57 -170.52 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.0 p -63.49 -26.37 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -76.03 -39.37 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.096 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.68 12.27 8.04 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.529 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.71 132.18 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 6' ' ' ARG . 20.0 mt -69.24 131.18 44.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.1 177.33 5.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.803 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.541 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -154.61 178.47 10.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -80.14 111.61 16.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.689 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.78 27.36 8.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.656 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.08 176.5 5.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.366 0.266 . . . . 0.0 110.361 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -129.2 136.09 49.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 111.102 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 69' ' ' LEU . 35.4 m -125.05 179.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.992 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -154.82 151.15 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.692 0.282 . . . . 0.0 111.239 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.75 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -66.25 130.49 43.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.629 HG21 ' SG ' ' A' ' 8' ' ' CYS . 41.4 pt -91.99 -9.15 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 110.856 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.563 ' HG3' HD21 ' A' ' 25' ' ' LEU . 4.9 ptpt -156.88 -178.86 7.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.93 108.18 19.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.75 HD23 HD12 ' A' ' 21' ' ' LEU . 3.3 mm? -113.13 110.72 20.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.645 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 19.8 ttmm -68.29 142.13 55.64 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 167.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.586 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 8.9 tt -45.97 -72.48 0.05 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.661 0.601 . . . . 0.0 110.92 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 86.7 mttt -163.21 -96.38 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.97 57.8 0.9 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 25.8 t -138.97 156.82 46.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.563 -0.318 . . . . 0.0 110.403 -171.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.9 m -86.41 12.1 10.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.067 0.46 . . . . 0.0 110.632 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.6 m -96.67 106.36 18.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.594 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 25.6 t -102.07 110.64 29.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mt -85.91 98.91 11.06 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.48 0.657 . . . . 0.0 110.297 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 21.3 mmmt -67.73 161.89 25.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.356 -174.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -59.69 136.56 58.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.711 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.69 -3.05 81.09 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.989 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.548 ' HB ' HD23 ' A' ' 21' ' ' LEU . 93.0 m -63.86 112.56 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.7 ttm -83.35 116.29 22.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.321 0.582 . . . . 0.0 111.144 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 56' ' ' THR . 39.7 mt -99.66 89.97 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.901 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 3.3 ppt_? -100.15 135.72 41.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 46.98 1.8 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.626 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 1.9 pp -97.18 148.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.55 142.6 51.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.246 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 14' ' ' ALA . 61.3 mt -71.93 132.69 44.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -97.43 -169.17 1.8 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.07 7.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.434 0.635 . . . . 0.0 109.564 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -109.89 149.38 29.97 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.671 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -103.39 -14.8 16.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -102.18 -7.74 21.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.897 0.379 . . . . 0.0 110.333 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.1 mp0 -123.31 149.3 45.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.507 0.67 . . . . 0.0 111.125 -176.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.473 HD12 ' HB ' ' A' ' 43' ' ' ILE . 17.9 pt -136.29 172.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.161 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.2 tt0 -125.53 122.01 35.33 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -128.43 -169.47 12.62 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.846 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -147.29 145.19 29.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 110.203 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.564 HG22 HG12 ' A' ' 40' ' ' ILE . 69.4 p -119.34 -171.13 2.06 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.611 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.59 -27.08 68.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.179 0.514 . . . . 0.0 110.338 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.24 -64.05 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.951 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 mm -85.41 108.36 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.477 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 60' ' ' LYS . 17.1 ptmt -105.64 140.47 38.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.775 0.321 . . . . 0.0 110.144 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.16 43.71 31.66 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.785 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -107.18 131.31 54.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.9 t -89.73 120.53 38.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.655 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 28.8 mt -134.35 140.93 46.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.574 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 1.5 ptp180 -58.88 130.39 46.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 168.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -87.68 25.64 1.45 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.454 0.645 . . . . 0.0 110.204 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.5 mt-10 -89.31 -10.0 48.41 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.762 0.791 . . . . 0.0 109.769 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 42.8 p90 -125.22 15.59 8.39 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.114 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 19' ' ' VAL . 68.8 mt -112.06 149.06 32.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.832 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -61.15 120.9 11.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.3 -176.07 4.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.733 -171.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.13 -84.71 1.48 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.202 176.275 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.857 0.36 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -86.89 -163.88 0.98 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.67 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 18.9 pt -127.04 64.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.997 0.903 . . . . 0.0 109.92 174.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HB3' HD21 ' A' ' 12' ' ' LEU . 33.3 mt-10 -75.86 87.25 2.84 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.939 -178.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.727 HG11 HG23 ' A' ' 52' ' ' ILE . 6.7 t -80.84 118.29 28.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.526 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 92.4 mtt180 -124.75 155.07 39.91 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 38.2 p-10 -79.48 -161.93 0.37 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.815 0.34 . . . . 0.0 110.343 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.503 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.8 p -74.62 -1.14 20.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.188 0.518 . . . . 0.0 110.85 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.13 -44.96 4.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.37 11.05 4.31 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.033 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' ARG . . . -82.5 134.52 35.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 4' ' ' GLU . 20.9 mt -78.3 134.34 37.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.338 0.589 . . . . 0.0 112.01 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -100.63 162.73 12.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.229 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.98 176.53 12.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.295 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 22.0 t70 -60.56 123.27 16.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 16.82 46.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.596 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.445 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t70 -93.93 175.64 6.64 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.725 -0.279 . . . . 0.0 110.716 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -130.22 135.98 48.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.199 0.523 . . . . 0.0 110.938 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.587 HG21 HD13 ' A' ' 69' ' ' LEU . 27.6 m -124.05 175.95 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.787 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -150.59 151.79 33.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.858 0.361 . . . . 0.0 111.366 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.675 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -64.68 127.4 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.45 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.879 HG13 ' HG3' ' A' ' 23' ' ' LYS . 38.5 pt -95.53 -8.36 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.762 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.4 mttt -141.87 179.8 6.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.56 100.64 12.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.675 HD23 HD12 ' A' ' 21' ' ' LEU . 3.8 mm? -102.99 115.19 30.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.486 ' CG ' HG22 ' A' ' 33' ' ' VAL . 1.4 tmmt? -91.0 133.26 35.43 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 34.4 mt -71.97 165.09 24.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.716 0.769 . . . . 0.0 112.8 -171.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -82.67 123.41 29.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.039 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.56 -59.64 4.59 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.439 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.9 m -79.57 150.81 30.96 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.0 t -84.33 33.65 0.51 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.629 0.728 . . . . 0.0 110.129 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.5 m -83.6 104.7 13.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.254 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.486 HG22 ' CG ' ' A' ' 26' ' ' LYS . 3.6 t -99.82 111.83 30.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.1 mp -90.73 145.31 24.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mmmt -110.55 161.41 15.73 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.17 0.509 . . . . 0.0 111.211 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 36' ' ' ARG . 27.5 ttt180 -62.42 137.55 58.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.488 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.73 8.03 70.57 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.916 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.538 ' HB ' HD23 ' A' ' 21' ' ' LEU . 90.9 m -73.47 116.28 13.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.2 ttm -87.75 111.71 21.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.449 0.642 . . . . 0.0 111.448 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.633 HG12 HG22 ' A' ' 56' ' ' THR . 48.8 mt -95.12 91.51 3.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 135.1 43.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.33 1.43 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.677 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -102.89 162.66 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.366 . . . . 0.0 110.231 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 12.2 ptt180 -143.24 164.66 29.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.345 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 5' ' ' VAL . 43.3 mt -82.16 142.28 32.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.204 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.1 p -104.35 -154.48 0.51 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.176 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.31 -2.95 56.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 33.5 t -108.16 157.92 17.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.014 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.67 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 31.9 mt-10 -95.89 -13.43 23.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.909 172.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -108.98 -9.6 15.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.356 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -121.68 146.28 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 111.427 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.727 HG23 HG11 ' A' ' 5' ' ' VAL . 2.4 pp -134.76 166.86 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.505 172.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' HB2' HG22 ' A' ' 63' ' ' VAL . 37.2 tt0 -120.36 130.0 54.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.677 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.01 -175.4 13.99 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.964 -175.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 17.0 ptt180 -134.91 139.71 45.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.459 0.647 . . . . 0.0 110.765 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.633 HG22 HG12 ' A' ' 40' ' ' ILE . 31.1 p -106.54 -170.47 1.73 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.514 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.33 -16.51 59.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.106 0.479 . . . . 0.0 110.094 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -113.23 -73.4 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.371 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 59' ' ' ILE . 1.3 mp -77.56 115.93 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.855 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -109.69 134.05 52.43 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.66 54.09 6.88 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.677 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.6 pt? -115.09 138.34 50.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 53' ' ' GLU . 46.3 t -92.5 116.29 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.554 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -129.48 146.13 51.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.558 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.658 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 2.3 ptp180 -65.25 139.07 58.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.055 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' HD12 ' A' ' 69' ' ' LEU . 8.9 t -93.74 23.82 4.51 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.593 -174.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HG2' HH11 ' A' ' 65' ' ' ARG . 0.6 OUTLIER -92.81 -8.46 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.275 -176.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.658 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 54.0 p90 -122.41 19.58 10.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.587 HD13 HG21 ' A' ' 19' ' ' VAL . 65.7 mt -120.46 145.66 47.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.081 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.515 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -113.35 130.68 56.22 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.698 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.4 tmtt? -64.21 123.14 18.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . -83.38 136.14 34.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.137 0.494 . . . . 0.0 111.319 -174.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.83 -169.83 55.01 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.94 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.0 p . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.24 179.66 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m -93.54 120.06 33.35 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.391 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 pt -128.11 64.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.826 0.822 . . . . 0.0 109.706 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.504 ' HB3' HD21 ' A' ' 12' ' ' LEU . 37.7 mt-10 -67.67 107.64 2.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.457 -178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 49' ' ' GLU . 14.9 t -90.19 117.83 34.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.079 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -128.19 148.58 50.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.413 ' OD2' ' HA ' ' A' ' 70' ' ' LYS . 5.8 p-10 -80.63 -169.78 2.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.456 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.643 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.9 p -65.05 -22.82 67.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 110.961 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.406 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 35.9 t30 -76.14 -31.76 58.76 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.536 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.89 14.29 27.24 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.53 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.94 31.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 120.799 0.333 . . . . 0.0 110.143 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 4' ' ' GLU . 19.9 mt -71.57 141.0 50.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.872 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.57 176.85 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.602 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.96 10.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.849 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 17.3 t70 -65.3 121.33 14.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.798 0.332 . . . . 0.0 110.164 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.91 11.13 50.89 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.036 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.93 174.81 8.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 1.1 p30 -139.11 136.15 34.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.399 0.619 . . . . 0.0 111.565 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 69' ' ' LEU . 27.3 m -128.63 176.81 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.968 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -150.67 149.24 29.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.733 0.301 . . . . 0.0 111.048 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.665 HD12 HD23 ' A' ' 25' ' ' LEU . 4.5 mm? -61.17 133.36 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.329 0.651 . . . . 0.0 112.259 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.661 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -94.71 -11.56 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.2 0.524 . . . . 0.0 110.559 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.661 ' HG2' HG13 ' A' ' 22' ' ' ILE . 18.4 ptmt -158.43 176.1 12.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.232 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' HD22 ' A' ' 25' ' ' LEU . 8.2 m-20 -83.13 127.63 33.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.665 HD23 HD12 ' A' ' 21' ' ' LEU . 4.1 mm? -123.78 150.99 43.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.518 ' HG3' HG13 ' A' ' 33' ' ' VAL . 6.7 mptt -121.39 150.53 41.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.439 0.638 . . . . 0.0 111.673 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.601 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 4.3 mm? -119.22 149.38 41.85 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.832 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 91.2 mttt 66.67 2.7 2.65 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.669 0.605 . . . . 0.0 111.475 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.67 -80.91 0.3 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 p -140.58 10.7 2.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.849 0.357 . . . . 0.0 110.8 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 23.4 m -72.37 -70.37 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.562 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 27.3 m -90.45 104.37 16.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG13 ' HG3' ' A' ' 26' ' ' LYS . 51.3 t -105.26 120.66 56.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.162 0.506 . . . . 0.0 110.738 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.567 HD23 HG21 ' A' ' 38' ' ' THR . 6.3 mp -102.47 145.56 29.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.779 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 22.4 mmmt -109.63 160.27 16.41 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.816 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.22 132.74 51.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.82 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.16 -11.39 55.29 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.729 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.567 HG21 HD23 ' A' ' 34' ' ' LEU . 60.6 m -59.33 125.7 24.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.981 0.39 . . . . 0.0 110.037 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -90.71 122.58 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.082 0.468 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 90.53 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.11 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -101.51 154.29 18.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.2 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.99 45.94 6.9 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.301 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.557 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.39 160.45 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 19.6 ptt180 -139.46 159.09 42.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.305 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.452 HD22 ' HB ' ' A' ' 5' ' ' VAL . 52.0 mt -78.85 134.58 36.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.141 -176.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -94.44 -157.95 0.6 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.807 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.94 -6.99 59.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.504 0.669 . . . . 0.0 109.205 174.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 66.1 m -102.88 150.47 23.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.913 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -87.76 -26.57 22.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.477 0.656 . . . . 0.0 109.939 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -98.01 -6.67 31.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.695 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 10.8 mp0 -124.42 145.16 49.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 111.499 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.474 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -133.32 167.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.521 173.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -119.93 128.36 53.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.42 -159.32 7.95 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.333 -177.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.5 ptp180 -142.7 149.91 39.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.821 0.343 . . . . 0.0 110.243 -176.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.8 p -115.31 -171.41 1.95 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -70.87 -24.59 62.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.953 0.406 . . . . 0.0 110.408 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -112.52 -68.05 0.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.1 mp -77.3 107.34 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.94 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -107.06 134.47 50.14 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.01 52.08 4.78 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.388 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -114.31 137.05 52.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.65 121.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.926 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.667 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.4 mt -135.42 143.58 46.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.226 0.536 . . . . 0.0 111.941 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 9.4 ptp180 -60.71 130.13 44.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.694 171.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -88.48 22.27 2.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.219 0.533 . . . . 0.0 110.739 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 2.4 pt-20 -90.92 -9.74 45.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.318 0.58 . . . . 0.0 110.222 -176.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.667 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 28.7 p90 -117.06 16.99 14.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.329 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 19' ' ' VAL . 68.8 mt -117.29 146.38 43.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.296 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -118.45 125.0 49.01 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.008 -178.381 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HA ' HG12 ' A' ' 19' ' ' VAL . 46.5 tttp -62.06 121.01 11.97 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.313 0.383 . . . . 0.0 110.235 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . -78.27 139.04 38.9 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.02 32.51 4.04 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.377 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.045 179.071 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.972 0.415 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 m -83.6 93.76 7.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.197 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.593 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 14.0 pt -146.05 75.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.724 0.773 . . . . 0.0 110.064 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -81.51 99.05 8.57 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.307 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 49' ' ' GLU . 10.9 t -92.28 122.65 43.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.983 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.533 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -130.26 162.19 29.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.65 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 4.1 p-10 -82.51 -165.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.6 p -64.24 -25.62 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.772 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.41 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 65.9 t30 -74.5 -51.97 13.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.236 177.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.41 12.73 3.34 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.974 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.47 132.72 33.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.533 HD23 ' HG3' ' A' ' 6' ' ' ARG . 21.5 mt -69.15 145.18 53.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.509 0.671 . . . . 0.0 112.223 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.96 169.36 9.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.427 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.32 13.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.038 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 31.3 t70 -68.09 117.6 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.22 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.88 30.77 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.796 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.71 174.22 7.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -133.4 145.03 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.297 0.57 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 71' ' ' LYS . 28.3 m -140.54 175.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.275 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -152.31 156.89 40.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.745 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -69.23 131.51 45.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.721 -178.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.681 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -91.94 -11.01 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.405 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.681 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -154.6 -179.09 7.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.96 113.56 25.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.745 HD23 HD12 ' A' ' 21' ' ' LEU . 3.5 mm? -117.57 123.41 46.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.522 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.699 ' HG3' HG22 ' A' ' 33' ' ' VAL . 4.0 tmmm? -92.28 140.5 29.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 43.4 mt -73.07 151.04 41.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.644 -176.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -76.85 3.22 12.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.875 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.59 117.83 3.04 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.1 t 67.17 -171.37 0.19 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.013 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 t -100.0 36.32 1.86 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.159 0.504 . . . . 0.0 110.086 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 m -76.22 105.21 7.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.361 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.699 HG22 ' HG3' ' A' ' 26' ' ' LYS . 3.0 t -104.92 112.01 36.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.371 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mp -81.55 147.47 29.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -111.65 161.72 15.94 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.295 0.569 . . . . 0.0 111.423 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 36' ' ' ARG . 30.2 ttt180 -58.39 129.86 44.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.256 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.43 66.36 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.322 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.539 ' HB ' HD23 ' A' ' 21' ' ' LEU . 98.6 m -63.32 118.49 8.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.497 0.649 . . . . 0.0 110.23 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.435 ' HG2' ' HG3' ' A' ' 41' ' ' ARG . 35.7 ttm -87.62 119.88 28.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.628 0.728 . . . . 0.0 111.445 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -108.34 95.03 3.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.026 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' HG3' ' HG2' ' A' ' 39' ' ' MET . 0.0 OUTLIER -104.95 136.17 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.231 -176.557 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.94 50.69 1.59 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.64 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -99.32 164.0 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.581 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 7.0 ptp85 -141.62 167.49 22.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 ' HB ' ' A' ' 5' ' ' VAL . 36.5 mt -89.27 147.79 23.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.155 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -104.14 -159.77 0.73 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -85.05 2.4 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 m -113.51 156.68 23.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.598 ' HA ' HG22 ' A' ' 5' ' ' VAL . 21.9 mt-10 -93.54 -27.9 16.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.605 0.717 . . . . 0.0 109.65 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 66' ' ' THR . 6.6 m-20 -90.21 -12.01 39.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.321 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.7 mp0 -121.17 148.84 43.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.359 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.493 ' CG2' HG11 ' A' ' 5' ' ' VAL . 26.8 pt -133.91 175.78 10.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.716 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.537 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -130.14 123.78 31.13 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.64 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -136.38 -177.01 14.68 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.89 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -139.51 143.47 37.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.56 . . . . 0.0 110.401 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 58' ' ' LYS . 9.8 t -128.09 -171.5 2.46 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.545 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.22 5.08 3.79 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -174.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.449 ' H ' HG23 ' A' ' 56' ' ' THR . 68.8 mttm -134.79 -69.8 0.51 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.097 0.475 . . . . 0.0 110.111 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.9 mm -92.43 123.66 44.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.053 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -103.33 148.31 26.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 58.5 46.59 92.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.444 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.5 pt? -103.38 135.01 45.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.225 0.513 . . . . 0.0 109.754 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.5 t -88.68 116.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.002 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.571 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 30.7 mt -129.56 143.45 50.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.452 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.645 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 14.6 ptt180 -62.14 129.95 43.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.444 ' HA ' HD12 ' A' ' 69' ' ' LEU . 11.9 t -88.19 27.06 1.27 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.238 0.542 . . . . 0.0 110.525 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.638 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.5 mt-10 -81.85 -26.27 34.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 109.159 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.645 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 21.4 p90 -114.56 17.91 17.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.998 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 66' ' ' THR . 58.3 mt -113.74 144.84 42.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.3 0.572 . . . . 0.0 110.205 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.65 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtp? -113.82 129.67 56.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.107 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.424 ' HA ' HG12 ' A' ' 19' ' ' VAL . 53.1 tttp -60.44 129.76 43.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.07 -157.94 0.47 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.11 0.481 . . . . 0.0 111.331 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.5 -31.78 6.01 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.263 177.267 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.917 0.389 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -107.25 84.83 2.03 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.669 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.598 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 38.8 pt -137.35 60.75 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.432 0.634 . . . . 0.0 110.692 175.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.21 111.45 9.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.321 0.582 . . . . 0.0 110.334 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 49' ' ' GLU . 7.0 t -97.8 121.36 48.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.709 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.567 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.67 157.35 42.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.027 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 7.7 p-10 -83.25 -168.7 2.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 p -68.2 -13.09 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.496 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 50.4 t30 -87.65 -38.23 16.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 9.56 10.49 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.179 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.86 124.25 30.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.567 HD23 ' HG3' ' A' ' 6' ' ' ARG . 23.9 mt -66.76 129.54 40.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.907 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.96 166.71 10.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.579 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.49 178.42 10.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.139 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 13.2 t70 -65.12 129.66 40.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.452 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.61 60.67 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.542 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t0 -88.11 173.81 8.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.594 0.235 . . . . 0.0 110.453 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -132.7 128.84 37.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 -177.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 69' ' ' LEU . 26.9 m -125.78 176.94 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.29 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -153.53 149.25 27.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.593 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -65.25 125.18 24.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.743 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.929 HG13 ' HG3' ' A' ' 23' ' ' LYS . 33.5 pt -93.56 -7.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.162 0.506 . . . . 0.0 110.283 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.929 ' HG3' HG13 ' A' ' 22' ' ' ILE . 4.2 mtpm? -144.58 177.91 8.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.856 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.886 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 5.8 m-20 -93.73 102.22 14.36 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.684 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 4.3 mm? -102.62 108.95 20.41 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.632 0.73 . . . . 0.0 111.647 -171.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 33' ' ' VAL . 1.6 tmmt? -90.58 137.76 32.1 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.895 173.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -78.23 -74.85 0.25 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.716 -172.03 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -143.54 142.9 31.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.952 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 26' ' ' LYS . . . 55.08 -117.26 7.95 Favored Glycine 0 N--CA 1.45 -0.411 0 O-C-N 123.642 0.589 . . . . 0.0 112.065 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.5 m -138.06 18.09 2.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.0 m -75.37 -64.0 1.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.357 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -104.14 108.42 19.79 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.391 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 26' ' ' LYS . 31.3 t -117.89 110.73 31.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp -92.36 150.41 20.85 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.886 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 3.3 mmpt? -110.61 162.74 14.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.248 0.547 . . . . 0.0 111.523 -176.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -68.76 144.77 54.25 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.281 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.59 15.3 73.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.722 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.551 ' HB ' HD23 ' A' ' 21' ' ' LEU . 60.2 m -84.84 117.75 24.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 ttm -86.13 123.18 31.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.397 0.617 . . . . 0.0 110.975 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.725 HG12 HG22 ' A' ' 56' ' ' THR . 35.0 mt -112.23 95.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.504 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -108.16 142.45 38.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.067 0.461 . . . . 0.0 111.009 -178.533 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.97 42.14 4.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.649 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.4 pp -92.5 165.72 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 110.234 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.557 ' HD2' ' OE1' ' A' ' 53' ' ' GLU . 3.8 ptp180 -139.76 164.19 30.62 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.321 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.5 162.18 14.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -130.48 -166.56 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -75.86 -8.98 58.2 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.249 0.547 . . . . 0.0 109.644 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 53.7 m -92.33 145.7 24.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.195 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 16.3 mt-10 -95.81 -20.6 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.806 -178.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.33 -5.94 22.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.145 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 17.7 mp0 -124.0 147.71 47.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.9 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -137.1 173.12 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.214 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.557 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 41.1 tt0 -125.62 135.02 51.72 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.649 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.92 -177.98 21.04 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.138 -177.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -132.1 142.47 49.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.009 0.433 . . . . 0.0 110.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.725 HG22 HG12 ' A' ' 40' ' ' ILE . 27.3 p -122.56 -171.84 2.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.565 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.17 -15.55 59.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.808 0.337 . . . . 0.0 110.658 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -114.2 -59.23 2.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.413 0.625 . . . . 0.0 110.597 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -100.69 112.88 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.205 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -105.06 121.24 43.38 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.928 0.394 . . . . 0.0 110.848 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.55 53.41 3.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.514 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.538 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -115.29 138.71 50.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 48.5 t -93.11 116.72 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.001 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.594 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 26.6 mt -129.33 142.93 50.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.663 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.635 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.9 ptp85 -60.68 130.61 47.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.563 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.4 t -88.59 24.24 2.03 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.294 0.569 . . . . 0.0 110.379 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.566 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.7 mt-10 -82.42 -20.3 37.32 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.926 0.87 . . . . 0.0 109.525 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 33.1 p90 -117.27 17.53 14.69 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.61 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 19' ' ' VAL . 63.8 mt -113.42 144.02 43.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.058 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HD3' ' HB2' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -113.93 126.98 55.77 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.358 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.542 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 11.1 tmtt? -59.83 124.87 21.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 71' ' ' LYS . . . -69.99 125.24 26.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.247 -170.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.11 -122.5 25.79 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.558 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.425 177.701 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 p -81.81 117.81 22.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.167 -172.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.583 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 33.8 pt -138.72 68.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 122.345 1.069 . . . . 0.0 108.901 171.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -81.05 92.7 6.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.27 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.814 HG11 HG23 ' A' ' 52' ' ' ILE . 2.7 t -87.58 128.91 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.257 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.567 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -132.28 158.93 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -178.164 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -78.51 -171.8 2.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 110.589 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.6 p -58.49 -29.73 66.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 9.3 m120 -84.02 -42.85 15.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.072 0.463 . . . . 0.0 110.516 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.21 16.91 1.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.47 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.02 126.26 30.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.567 HD23 ' HG3' ' A' ' 6' ' ' ARG . 27.1 mt -64.96 131.58 46.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.331 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.61 164.15 12.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.88 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.78 178.52 10.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 16.1 t70 -67.02 115.36 6.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 0.0 110.564 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.36 25.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.479 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -91.7 174.1 7.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -134.27 137.13 44.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.497 0.665 . . . . 0.0 111.49 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.506 HG21 HD13 ' A' ' 69' ' ' LEU . 27.2 m -126.4 176.01 7.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.236 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -153.24 156.69 38.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.72 0.295 . . . . 0.0 110.75 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.609 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -66.96 127.53 32.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.351 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.901 HG13 ' HG3' ' A' ' 23' ' ' LYS . 34.9 pt -92.91 -10.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.901 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.7 mtpt -141.71 -174.01 3.94 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.9 94.31 6.5 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.65 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 3.4 mm? -103.02 111.12 23.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.586 -175.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.1 tmmt? -88.01 134.9 33.63 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.559 0.695 . . . . 0.0 110.535 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 67.3 mt -103.71 143.06 33.29 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.378 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -72.89 -32.98 65.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.943 0.401 . . . . 0.0 110.158 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.11 114.08 6.26 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.016 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.6 t 65.81 13.92 9.26 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.788 0.435 . . . . 0.0 110.927 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.5 m 54.85 35.86 25.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.217 0.532 . . . . 0.0 110.486 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 50.0 m -71.04 103.53 2.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.193 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 16.7 t -91.61 102.78 13.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 28.6 mt -85.06 91.99 8.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.438 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.3 mmmt -64.73 158.96 23.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.533 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -59.88 129.86 43.94 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.685 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.95 -6.66 54.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.849 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.527 ' HB ' HD23 ' A' ' 21' ' ' LEU . 89.3 m -59.98 112.11 1.75 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.152 0.476 . . . . 0.0 110.241 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.4 ttm -89.29 117.6 28.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.303 0.573 . . . . 0.0 111.254 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.442 HG12 ' HB ' ' A' ' 56' ' ' THR . 65.1 mt -106.27 92.85 2.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.89 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.75 140.27 37.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 -175.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 49.68 2.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.644 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.603 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.71 169.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 21.6 ptt180 -148.56 156.21 42.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.133 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 5' ' ' VAL . 37.6 mt -76.82 135.42 38.91 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 p -87.33 -70.96 0.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.801 0.81 . . . . 0.0 111.164 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.4 t70 179.07 -31.05 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.283 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -73.6 145.51 45.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.833 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.604 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -89.32 -18.23 27.34 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.44 -20.29 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.506 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 65' ' ' ARG . 7.2 mp0 -127.26 154.56 44.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.533 -174.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.814 HG23 HG11 ' A' ' 5' ' ' VAL . 10.7 pt -134.35 176.71 8.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.254 171.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 7.8 tt0 -125.39 140.02 53.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.7 -166.33 11.85 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.053 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -147.25 139.11 24.25 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.195 0.521 . . . . 0.0 110.473 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.442 ' HB ' HG12 ' A' ' 40' ' ' ILE . 12.1 t -131.17 -176.15 3.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.214 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -67.41 -33.98 76.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 -173.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HG2' HG13 ' A' ' 59' ' ' ILE . 86.0 tttt -83.54 -50.37 8.32 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.001 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.435 ' H ' HG23 ' A' ' 56' ' ' THR . 5.3 mt -130.02 129.11 65.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.047 -171.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -109.68 146.28 35.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.7 48.25 29.43 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.337 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.6 pt? -114.39 135.99 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 109.831 177.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 32.0 t -92.77 123.84 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.906 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -135.5 143.17 45.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.899 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.748 ' HG3' ' HE1' ' A' ' 68' ' ' PHE . 3.2 ptp85 -60.05 134.29 56.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.482 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.41 HG21 HG12 ' A' ' 5' ' ' VAL . 8.8 t -87.98 26.21 1.41 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.546 0.688 . . . . 0.0 110.456 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 28.8 mt-10 -84.59 -30.98 24.56 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.835 0.826 . . . . 0.0 109.96 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.748 ' HE1' ' HG3' ' A' ' 65' ' ' ARG . 53.7 p90 -114.15 19.72 16.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.106 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 19' ' ' VAL . 74.4 mt -114.22 145.48 41.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.405 0.621 . . . . 0.0 110.62 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 1.5 tmtt? -113.27 126.0 54.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.583 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -64.71 121.94 15.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.82 139.12 31.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.053 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.34 -176.32 35.44 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.046 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.087 -179.945 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.567 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 60.2 m -162.79 121.35 2.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.021 -176.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.553 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 37.4 pt -116.37 25.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 169.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.567 ' HG2' ' HB3' ' A' ' 2' ' ' SER . 5.2 pt-20 -51.39 107.71 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.908 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.695 HG11 HG23 ' A' ' 52' ' ' ILE . 3.0 t -92.45 119.42 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.41 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -123.73 161.32 25.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.868 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.644 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 21.0 p-10 -82.64 -166.23 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.9 p -72.1 -7.62 50.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.994 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -97.94 -37.51 9.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.444 0.64 . . . . 0.0 109.712 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.92 9.37 7.51 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.269 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 128.84 34.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 4' ' ' GLU . 24.7 mt -70.77 139.75 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.744 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -103.64 173.31 6.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.032 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -160.92 -179.73 7.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.307 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.31 122.18 17.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 0.0 110.288 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.03 27.56 20.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.758 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -98.35 173.62 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -135.17 140.57 45.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.707 0.765 . . . . 0.0 111.69 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.547 HG21 HD13 ' A' ' 69' ' ' LEU . 19.4 m -139.44 178.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.245 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -153.38 155.1 35.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 0.0 111.197 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.719 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -68.9 127.53 33.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.704 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 68' ' ' PHE . 27.3 pt -93.09 -7.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.982 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' HD22 ' A' ' 25' ' ' LEU . 18.6 ptpt -160.1 178.55 9.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.4 122.58 30.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.719 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? -117.99 123.42 45.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.647 0.261 . . . . 0.0 110.33 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.777 ' HG3' HG22 ' A' ' 33' ' ' VAL . 3.2 tmmt? -100.49 139.5 36.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.17 0.51 . . . . 0.0 110.315 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.0 155.48 19.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.77 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 29' ' ' GLY . 25.9 tptt 65.16 -165.36 0.24 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.828 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' H ' ' HG3' ' A' ' 28' ' ' LYS . . . -68.94 -58.58 6.66 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.998 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 m -157.13 84.95 0.93 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.2 t -144.51 -79.9 0.18 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.111 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 m -91.4 104.34 16.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.974 0.416 . . . . 0.0 110.784 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.777 HG22 ' HG3' ' A' ' 26' ' ' LYS . 24.7 t -101.92 105.89 18.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.18 146.11 27.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.895 0.378 . . . . 0.0 110.119 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -111.39 160.76 16.77 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.018 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -61.87 141.14 58.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.022 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.82 -6.28 54.43 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.433 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.517 ' HB ' HD23 ' A' ' 21' ' ' LEU . 31.6 m -71.77 121.47 18.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.44 129.07 36.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.328 0.585 . . . . 0.0 110.763 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.852 HG12 HG22 ' A' ' 56' ' ' THR . 33.1 mt -113.7 94.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.189 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.07 142.91 42.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.005 0.431 . . . . 0.0 110.915 -176.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.15 47.34 4.44 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.68 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -94.71 164.29 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.783 0.325 . . . . 0.0 110.192 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -137.72 148.91 46.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.205 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.88 149.76 44.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.912 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.4 p -116.86 -160.9 0.78 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.791 0.329 . . . . 0.0 110.43 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.47 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.42 0.629 . . . . 0.0 109.601 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.615 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.5 m -107.47 142.45 37.31 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.028 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.553 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 0.8 OUTLIER -87.9 -18.49 29.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.503 177.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -94.98 -13.77 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.138 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 4.0 mt-10 -126.63 146.32 50.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.959 0.885 . . . . 0.0 112.48 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.695 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -135.33 162.75 37.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.303 173.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.91 132.9 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.68 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -148.93 -163.98 11.26 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.83 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -141.68 146.37 36.03 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.852 HG22 HG12 ' A' ' 40' ' ' ILE . 24.5 p -114.04 -170.61 1.75 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.215 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.31 -27.24 66.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.909 0.385 . . . . 0.0 110.42 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -113.64 -70.86 0.78 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.193 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.3 mp -71.05 143.78 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -133.05 144.76 50.24 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.397 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.98 47.33 89.66 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.58 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -109.93 135.55 50.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.65 120.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.672 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.751 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 38.6 mt -132.01 141.11 49.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.539 0.685 . . . . 0.0 112.785 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.623 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.7 ptm180 -53.61 129.05 31.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.095 164.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.0 t -91.78 21.07 5.04 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.26 0.552 . . . . 0.0 110.843 -173.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.69 -8.49 37.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.192 0.52 . . . . 0.0 110.675 -174.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.751 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 5.1 p90 -114.4 16.07 17.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.435 0.636 . . . . 0.0 109.938 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 19' ' ' VAL . 82.4 mt -112.24 149.1 32.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.386 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.644 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtt? -119.58 124.76 47.16 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.675 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.515 ' HA ' HG12 ' A' ' 19' ' ' VAL . 62.1 tttp -62.39 125.29 23.39 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.41 152.06 34.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.977 0.418 . . . . 0.0 111.015 -174.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.48 -40.52 2.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.774 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.335 178.803 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 m -142.66 147.58 35.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.971 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.643 ' HB ' ' HB3' ' A' ' 49' ' ' GLU . 48.6 pt -107.99 50.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.497 0.665 . . . . 0.0 110.103 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.68 99.43 0.79 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.119 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.738 HG22 ' HA ' ' A' ' 49' ' ' GLU . 2.6 t -81.95 127.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.091 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.43 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.48 160.52 32.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.881 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -172.84 1.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.509 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 22' ' ' ILE . 11.2 p -54.88 -33.37 61.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.66 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -81.33 -59.64 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.322 0.582 . . . . 0.0 110.647 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.23 25.21 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.722 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 128.23 35.56 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' ' 6' ' ' ARG . 18.6 mt -71.05 137.58 49.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.543 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 43' ' ' ILE . 87.3 mt -107.49 172.26 6.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.736 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.25 175.38 11.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.188 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 21.7 t70 -65.87 117.04 7.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.989 0.423 . . . . 0.0 110.796 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.6 10.15 38.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.983 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.559 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -90.08 174.87 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.58 143.89 47.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.643 0.735 . . . . 0.0 112.215 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.414 HG21 HD13 ' A' ' 69' ' ' LEU . 34.7 m -135.09 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.096 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.491 ' OG ' ' HG3' ' A' ' 39' ' ' MET . 73.9 m -153.2 157.82 40.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.542 HD12 HD23 ' A' ' 25' ' ' LEU . 3.9 mm? -70.15 129.13 38.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.889 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.769 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.2 pt -93.04 -4.76 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.769 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -164.22 179.34 6.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.272 -178.172 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.09 110.1 19.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.191 0.307 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.556 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 4.0 mm? -109.74 118.83 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.681 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.9 tmmm? -99.96 136.86 39.23 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.59 145.18 34.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.105 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -84.88 -51.06 7.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -170.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.46 -49.83 50.3 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.465 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.6 m -131.49 145.23 51.66 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 p -70.04 74.52 0.47 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.367 0.603 . . . . 0.0 112.159 -174.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.1 m -105.62 106.97 17.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.538 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.681 HG22 ' HG3' ' A' ' 26' ' ' LYS . 4.2 t -91.65 106.96 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.896 0.379 . . . . 0.0 110.705 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.13 98.56 11.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.206 0.526 . . . . 0.0 109.934 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 21.9 mmmt -68.65 162.85 25.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.977 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -59.61 132.53 54.25 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.171 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.72 -15.92 40.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.726 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.489 ' HB ' HD23 ' A' ' 21' ' ' LEU . 59.9 m -56.2 121.93 10.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.491 ' HG3' ' OG ' ' A' ' 20' ' ' SER . 11.0 ttt -100.31 120.47 39.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.179 0.514 . . . . 0.0 111.039 -173.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.63 HG12 HG22 ' A' ' 56' ' ' THR . 47.9 mt -109.84 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.669 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.18 135.81 43.11 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.874 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 51.13 1.3 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.414 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.586 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -100.51 165.29 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.703 0.287 . . . . 0.0 110.322 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.5 ptp180 -142.19 158.47 43.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.394 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.488 HD22 ' CG2' ' A' ' 5' ' ' VAL . 34.8 mt -78.15 138.47 38.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -107.48 -172.4 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.658 -171.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.34 -35.75 78.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.684 0.754 . . . . 0.0 109.217 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 71.3 m -88.02 147.12 25.14 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.208 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.738 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.76 -1.4 26.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.842 0.83 . . . . 0.0 109.593 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 66' ' ' THR . 36.1 t70 -95.94 -5.69 40.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.81 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 7.6 mt-10 -133.3 157.9 44.3 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.559 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.535 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 7.3 pt -139.01 168.12 19.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.625 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -122.67 127.84 49.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.586 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -138.98 -170.98 11.99 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.274 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -135.86 143.01 44.84 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.173 0.511 . . . . 0.0 109.952 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.63 HG22 HG12 ' A' ' 40' ' ' ILE . 71.2 p -111.95 -171.17 1.79 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.454 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.74 -25.29 67.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.955 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -117.19 -63.04 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 111.019 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mm -85.23 113.58 23.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.46 -174.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -101.41 146.69 27.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.26 47.69 69.87 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.016 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -107.53 133.35 52.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.6 t -92.49 117.46 35.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.814 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.614 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 23.7 mt -127.34 143.97 51.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.135 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.599 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.8 ptp180 -59.66 133.35 56.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.377 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 50' ' ' ASP . 13.1 t -89.37 31.83 0.89 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.487 0.661 . . . . 0.0 110.732 -175.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 16.3 mt-10 -85.3 -32.4 22.52 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.58 0.705 . . . . 0.0 109.795 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.614 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 38.2 p90 -112.92 15.95 19.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.366 -172.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 19' ' ' VAL . 61.3 mt -112.64 142.31 45.39 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.337 0.589 . . . . 0.0 110.294 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -115.32 132.82 56.49 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.767 -177.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.559 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.0 tmtt? -66.07 120.54 13.34 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.83 -72.99 0.2 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -167.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.64 -123.21 1.03 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.97 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.858 -0.592 . . . . 0.0 110.632 -179.289 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.922 0.392 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.3 m -99.78 126.66 45.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.113 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -110.83 56.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.402 0.62 . . . . 0.0 110.891 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.509 ' HB3' HD21 ' A' ' 12' ' ' LEU . 41.4 mt-10 -54.67 121.85 9.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.423 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 49' ' ' GLU . 5.8 t -105.24 123.92 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.05 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.54 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -131.14 158.79 39.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 30.0 p-10 -80.27 -169.75 2.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' HG21 ' A' ' 22' ' ' ILE . 26.7 p -67.34 -19.24 65.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.665 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -80.29 -48.67 12.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.844 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 17.18 2.85 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.612 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.53 133.22 35.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.54 HD23 ' HG3' ' A' ' 6' ' ' ARG . 19.8 mt -72.7 135.91 45.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.102 0.477 . . . . 0.0 111.354 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.04 168.74 8.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.749 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.48 172.98 14.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.669 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.0 t70 -63.95 120.73 12.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.968 0.414 . . . . 0.0 110.134 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.12 3.79 44.83 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.975 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -84.28 174.85 9.82 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -139.9 132.85 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.328 0.585 . . . . 0.0 111.094 -178.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.575 HG21 HD13 ' A' ' 69' ' ' LEU . 29.7 m -124.77 173.62 10.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.004 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 m -150.49 151.95 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.962 0.411 . . . . 0.0 111.146 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.671 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -65.03 127.12 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.78 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.6 HG21 ' SG ' ' A' ' 8' ' ' CYS . 35.0 pt -90.31 -11.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.26 0.553 . . . . 0.0 110.765 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.584 ' HG3' ' CD2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -154.47 -178.81 7.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.333 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . 1.6 m-20 -96.79 110.22 22.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.671 HD23 HD12 ' A' ' 21' ' ' LEU . 3.6 mm? -103.8 146.63 28.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' HG2' HG13 ' A' ' 33' ' ' VAL . 55.5 mtmt -126.76 123.27 37.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.207 0.527 . . . . 0.0 110.446 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 3.3 mm? -110.71 173.52 6.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.174 -169.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -85.06 -173.09 4.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.321 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.08 -108.42 3.58 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -95.05 26.36 3.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.7 m 58.17 73.61 0.46 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.871 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 19.7 m -83.3 103.12 12.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.184 -175.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.512 HG13 ' HG2' ' A' ' 26' ' ' LYS . 51.6 t -93.59 108.47 20.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.237 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 38' ' ' THR . 30.6 mt -100.16 91.76 4.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.308 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HD2' ' HB3' ' A' ' 24' ' ' ASP . 29.0 mmmt -70.51 164.61 24.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.363 -175.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 36' ' ' ARG . 39.0 ttt-85 -56.43 133.57 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.563 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.79 -10.2 64.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.184 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.418 ' HB ' HD23 ' A' ' 21' ' ' LEU . 87.3 m -57.23 124.0 17.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.142 0.471 . . . . 0.0 110.291 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -93.96 122.4 36.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.255 0.55 . . . . 0.0 111.281 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.841 HG12 HG22 ' A' ' 56' ' ' THR . 41.1 mt -110.8 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.069 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 13.3 ptt180 -108.76 159.28 16.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.719 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.2 39.63 15.44 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.634 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -91.05 161.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.874 0.368 . . . . 0.0 110.368 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 2.9 ptp180 -141.99 158.25 43.99 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.258 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 5' ' ' VAL . 30.9 mt -80.33 154.75 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.808 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 p -127.8 -167.13 1.71 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.232 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.42 -21.95 66.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.201 0.525 . . . . 0.0 110.324 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 70.8 m -85.09 142.87 29.23 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -90.03 -7.6 53.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.8 0.809 . . . . 0.0 108.969 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -116.39 -5.5 11.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.185 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.7 mp0 -125.25 144.4 50.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 0.0 111.217 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.42 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -134.32 156.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.146 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HB2' HG22 ' A' ' 63' ' ' VAL . 37.9 tt0 -115.32 130.56 56.94 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.634 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -148.92 -161.14 9.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.299 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -137.36 142.64 41.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.646 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.841 HG22 HG12 ' A' ' 40' ' ' ILE . 21.1 p -114.51 -172.21 2.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -73.74 -26.1 60.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.18 0.514 . . . . 0.0 109.768 174.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.48 -75.87 0.53 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.301 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mm -89.08 125.17 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.502 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -113.66 130.52 56.39 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.915 0.388 . . . . 0.0 110.289 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.0 47.04 5.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.756 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.09 136.08 53.51 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.184 0.516 . . . . 0.0 110.465 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 53' ' ' GLU . 45.7 t -89.48 119.34 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.791 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.0 mt -129.9 147.36 51.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.917 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.577 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 2.4 ptp85 -65.18 130.25 42.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.954 172.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.525 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.8 t -85.58 30.69 0.62 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 0.0 110.592 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -88.03 -21.32 24.84 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.825 0.822 . . . . 0.0 109.706 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.58 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 33.8 p90 -117.97 18.41 13.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.563 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.575 HD13 HG21 ' A' ' 19' ' ' VAL . 68.0 mt -115.54 148.34 39.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.104 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -125.07 128.64 48.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.75 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.06 119.21 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.06 -64.8 0.84 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.325 -172.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.8 75.19 0.59 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.841 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.433 178.217 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mtp . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -64.79 112.38 3.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.189 0.518 . . . . 0.0 110.506 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -118.63 63.43 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.748 0.785 . . . . 0.0 109.227 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.52 ' HB3' HD21 ' A' ' 12' ' ' LEU . 30.5 mt-10 -56.13 112.52 1.23 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.699 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -104.52 126.12 59.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.55 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.618 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 32.4 p-10 -80.07 -165.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.711 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.3 p -74.86 -8.59 56.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.25 0.548 . . . . 0.0 110.646 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -91.83 -44.66 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.686 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.22 13.25 3.61 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.301 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.7 130.76 38.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.55 HD23 ' HG3' ' A' ' 6' ' ' ARG . 19.8 mt -66.7 143.57 56.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 112.241 -176.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -109.93 169.13 8.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.21 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -160.37 177.93 10.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.2 t70 -66.84 122.84 18.59 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 14.74 41.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.747 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -91.14 165.01 13.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -117.96 147.86 42.76 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.539 HG22 HG21 ' A' ' 43' ' ' ILE . 28.0 m -143.82 171.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.119 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -152.11 157.56 41.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.747 0.308 . . . . 0.0 111.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.653 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -69.6 124.19 23.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.632 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.711 HG21 ' SG ' ' A' ' 8' ' ' CYS . 40.5 pt -91.93 -12.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.269 0.557 . . . . 0.0 110.572 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.635 ' HG2' HG13 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -150.95 173.6 14.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.25 -177.016 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.17 122.76 32.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? -117.48 116.1 26.47 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.931 0.396 . . . . 0.0 110.71 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.73 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.4 tmmt? -97.18 129.4 44.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.281 0.562 . . . . 0.0 109.497 176.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 34' ' ' LEU . 4.0 mm? -99.94 155.39 17.71 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.529 -173.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -76.23 176.56 7.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.797 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.33 -87.19 0.81 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.567 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -80.16 -0.91 38.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.434 0.159 . . . . 0.0 111.394 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m 60.17 32.96 21.08 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.316 0.579 . . . . 0.0 110.122 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.0 m -66.67 108.99 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.391 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 26' ' ' LYS . 21.0 t -95.9 99.33 9.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.498 HD13 HD23 ' A' ' 27' ' ' LEU . 5.8 mp -85.87 145.68 27.07 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 27.4 mmmt -110.5 163.62 13.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.49 0.662 . . . . 0.0 111.379 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -60.86 149.29 36.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.719 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.21 -3.04 79.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.898 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.458 ' HB ' HD23 ' A' ' 21' ' ' LEU . 84.5 m -68.08 121.84 16.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.509 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttm -87.86 129.38 35.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.603 . . . . 0.0 111.192 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.67 HG12 ' HB ' ' A' ' 56' ' ' THR . 52.0 mt -122.14 92.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.973 172.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -106.87 136.26 47.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 111.012 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.82 52.09 1.22 Allowed Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.583 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -104.41 164.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 10.2 ptp85 -143.91 165.4 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.239 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD22 ' HB ' ' A' ' 5' ' ' VAL . 30.7 mt -80.67 150.88 29.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.052 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -111.99 -155.97 0.58 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.62 -8.53 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.094 0.473 . . . . 0.0 109.736 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 44.4 t -94.99 161.81 13.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.702 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' HA ' HG22 ' A' ' 5' ' ' VAL . 33.8 mt-10 -101.02 -5.29 26.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.774 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 66' ' ' THR . 5.1 m-20 -131.5 0.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.297 -176.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 3.6 mp0 -120.43 143.41 48.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.104 0.478 . . . . 0.0 110.185 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.11 165.33 32.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.873 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 4.0 tm-20 -125.04 125.56 44.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -151.94 -166.78 14.38 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.676 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 35.6 ptt180 -134.16 145.08 48.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.67 ' HB ' HG12 ' A' ' 40' ' ' ILE . 9.3 t -122.73 -177.95 3.79 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -65.06 -18.73 65.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.724 0.297 . . . . 0.0 111.458 -177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.437 ' H ' HG23 ' A' ' 56' ' ' THR . 62.0 mttm -100.69 -73.38 0.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.134 175.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mp -94.85 122.63 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.988 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 60' ' ' LYS . 1.6 ptmm? -104.26 121.41 43.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.819 0.342 . . . . 0.0 110.518 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.456 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 89.6 52.48 2.65 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.703 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -116.13 140.71 49.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.035 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.69 116.57 35.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.082 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.598 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 31.7 mt -130.17 152.66 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.245 0.545 . . . . 0.0 111.988 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.584 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 ptt180 -72.93 131.04 41.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.48 173.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.2 t -85.6 25.86 1.01 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.659 -175.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 1.3 pt-20 -83.33 -19.9 35.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.626 0.727 . . . . 0.0 109.667 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.598 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 26.8 p90 -118.31 17.51 13.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.055 -178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.523 HD13 HG21 ' A' ' 19' ' ' VAL . 76.1 mt -114.21 149.07 36.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.444 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.618 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.6 tmtt? -119.54 129.06 54.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.666 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HZ2' ' CG ' ' A' ' 17' ' ' ASP . 39.9 tttp -62.05 116.49 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.73 31.93 0.75 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.419 . . . . 0.0 111.406 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.15 -15.45 74.52 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.601 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.595 177.652 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.256 0.074 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m 69.76 136.75 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.724 0.64 . . . . 0.0 111.644 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.619 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 21.0 pt 38.83 54.24 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.621 1.168 . . . . 0.0 113.421 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.507 ' HB3' HD21 ' A' ' 12' ' ' LEU . 42.4 mt-10 -78.82 85.38 4.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.388 170.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.754 HG11 HG23 ' A' ' 52' ' ' ILE . 2.7 t -78.58 121.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.226 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -126.29 151.59 47.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.969 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -77.37 -172.05 2.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.637 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.7 p -65.11 -23.64 67.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.602 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.17 -28.62 31.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.563 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.14 15.73 12.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.229 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.7 136.05 33.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 4' ' ' GLU . 17.7 mt -70.51 138.75 51.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.559 . . . . 0.0 111.658 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.428 ' HB3' HD11 ' A' ' 43' ' ' ILE . 94.7 mt -104.63 173.53 6.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.06 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.2 173.36 14.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.128 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 29.2 t70 -64.84 121.34 14.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.344 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.27 31.55 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.024 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.91 173.93 6.83 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.826 -0.22 . . . . 0.0 111.147 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.3 p30 -131.22 139.45 49.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.619 0.723 . . . . 0.0 112.092 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.557 HG12 ' HA ' ' A' ' 71' ' ' LYS . 29.3 m -140.45 172.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.036 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -152.55 157.03 40.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 0.0 111.625 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -66.9 135.73 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.381 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.745 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.3 pt -97.1 -8.32 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.092 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.745 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -159.63 175.71 12.88 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -176.286 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.36 110.3 21.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.601 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? -100.18 125.65 46.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.578 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' HG3' HG13 ' A' ' 33' ' ' VAL . 10.7 mptt -93.84 148.01 22.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.233 0.54 . . . . 0.0 110.514 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -126.81 154.53 44.17 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.954 -174.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -99.27 147.07 25.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.801 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.9 -74.38 0.44 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.8 m -111.04 17.09 20.77 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.5 m 58.64 38.97 25.05 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.379 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 m -75.57 121.44 22.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.808 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 26' ' ' LYS . 58.6 t -114.16 107.97 24.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.51 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.27 145.65 29.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.845 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.9 mmmt -110.59 158.55 18.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.407 0.623 . . . . 0.0 111.774 -174.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -61.61 134.92 57.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.267 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.49 -9.36 64.63 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.053 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.461 ' HB ' HD23 ' A' ' 21' ' ' LEU . 97.6 m -59.5 124.56 20.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.815 0.308 . . . . 0.0 110.316 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.8 ttm -96.55 124.92 40.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.516 0.674 . . . . 0.0 111.038 -176.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.451 HG12 ' HB ' ' A' ' 56' ' ' THR . 52.0 mt -115.14 94.47 3.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.002 174.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -111.23 147.13 35.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -177.352 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.23 39.03 5.51 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.624 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -89.99 166.7 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.906 0.384 . . . . 0.0 110.278 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 5.7 ptp85 -140.29 158.07 44.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.936 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.555 HD22 ' HB ' ' A' ' 5' ' ' VAL . 39.7 mt -84.12 130.51 34.85 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.9 p -93.43 -171.62 2.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.55 6.96 15.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.497 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -103.64 143.66 32.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.48 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 17.3 mt-10 -87.58 -25.14 23.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.359 0.6 . . . . 0.0 109.936 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 66' ' ' THR . 9.2 m-20 -96.94 -7.31 33.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.136 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -126.87 147.74 50.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 111.5 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.754 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -131.6 168.45 23.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.339 173.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.25 129.31 53.99 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.624 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -141.21 -165.86 10.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.074 -175.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 18.3 ptt85 -152.41 141.0 20.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.177 0.513 . . . . 0.0 110.046 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.451 ' HB ' HG12 ' A' ' 40' ' ' ILE . 9.0 t -131.8 -174.79 3.52 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.526 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 3.9 p30 -63.57 -24.54 67.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 111.475 -176.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 27.8 mtmm -98.85 -72.31 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.076 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.8 mm -100.2 127.47 53.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.636 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 11.5 ptmm? -114.78 139.84 49.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.416 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.65 30.66 39.07 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.411 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -101.81 139.9 36.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.32 116.88 36.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.761 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -128.37 144.51 51.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.579 0.704 . . . . 0.0 111.996 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.569 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 13.8 ptt180 -66.16 135.83 55.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.43 173.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 50' ' ' ASP . 9.0 t -89.23 30.51 0.97 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.568 0.699 . . . . 0.0 110.561 -176.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 31.0 mt-10 -80.1 -31.8 39.21 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.944 0.878 . . . . 0.0 109.501 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 48.8 p90 -116.77 16.57 15.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.441 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.58 145.61 36.09 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.163 0.506 . . . . 0.0 109.871 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -119.74 128.47 53.8 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.588 -178.268 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.557 ' HA ' HG12 ' A' ' 19' ' ' VAL . 58.5 tttp -63.36 127.81 33.0 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.65 165.72 23.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.806 -169.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.96 -27.93 5.52 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.579 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.508 179.158 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.742 0.306 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 m -135.07 -176.31 4.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.572 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.3 pt -128.33 44.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.145 0.497 . . . . 0.0 109.698 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 34.7 mt-10 -59.41 116.07 3.7 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.567 0.698 . . . . 0.0 111.886 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.636 HG11 HG23 ' A' ' 52' ' ' ILE . 4.6 t -96.99 127.61 49.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.077 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -128.03 148.68 50.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.553 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -73.98 -171.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.627 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 22' ' ' ILE . 26.5 p -63.82 -29.12 70.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -25.89 56.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.38 18.93 13.23 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.962 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.23 136.25 36.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.137 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.568 HD23 ' HG3' ' A' ' 6' ' ' ARG . 25.6 mt -67.93 138.3 55.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.759 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -108.13 170.29 8.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.155 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.42 174.16 15.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.455 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 19.9 t70 -67.68 114.16 6.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.845 0.355 . . . . 0.0 110.357 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.49 2.27 29.25 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.65 173.05 11.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -136.12 141.68 44.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 111.411 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 71' ' ' LYS . 31.3 m -134.88 177.03 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.342 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 m -151.07 153.24 34.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.0 111.321 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -64.21 128.52 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.7 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.721 HG13 ' HG2' ' A' ' 23' ' ' LYS . 42.2 pt -90.53 -11.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.773 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.721 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.99 -178.28 7.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.174 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.55 117.18 26.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.601 HD23 HD12 ' A' ' 21' ' ' LEU . 3.9 mm? -118.42 116.36 26.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.174 0.512 . . . . 0.0 110.631 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 33' ' ' VAL . 1.6 tmmt? -82.82 138.89 33.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.656 176.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 28' ' ' LYS . 9.0 tt -63.86 145.17 56.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.827 -174.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.472 ' N ' HD23 ' A' ' 27' ' ' LEU . 84.5 tttt -42.02 121.5 1.84 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.19 0.931 . . . . 0.0 111.722 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.67 -119.87 5.63 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.924 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 p -151.71 109.8 3.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.629 0.252 . . . . 0.0 110.66 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 t -167.31 -77.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.225 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -104.17 130.66 51.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.616 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 26' ' ' LYS . 33.1 t -107.16 103.57 15.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD23 HG21 ' A' ' 38' ' ' THR . 6.0 mp -82.36 149.18 27.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.926 0.393 . . . . 0.0 110.543 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 22.4 mmmt -109.86 163.16 13.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.655 -175.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -61.25 137.83 58.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.142 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.03 -14.88 59.77 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.52 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.476 ' HB ' HD23 ' A' ' 21' ' ' LEU . 88.2 m -56.61 119.93 6.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 110.039 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.1 ttt -94.05 122.91 37.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.363 0.601 . . . . 0.0 110.753 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.412 HG12 ' HB ' ' A' ' 56' ' ' THR . 46.3 mt -110.54 90.51 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.797 175.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.506 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -104.67 137.6 42.25 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.371 -175.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.02 50.45 2.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.379 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.567 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -97.18 164.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.7 ptp180 -142.83 157.79 44.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.543 HD22 ' HB ' ' A' ' 5' ' ' VAL . 32.9 mt -75.64 155.1 36.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.665 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -121.69 -167.87 1.6 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.79 -20.08 65.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.6 m -85.75 147.74 26.19 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.954 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' HA ' HG22 ' A' ' 5' ' ' VAL . 28.1 mt-10 -96.14 -13.8 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.503 0.668 . . . . 0.0 109.517 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -106.85 -5.92 18.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.862 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 2.0 mp0 -127.96 146.56 50.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.335 0.588 . . . . 0.0 111.44 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.636 HG23 HG11 ' A' ' 5' ' ' VAL . 2.7 pp -131.09 166.62 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.304 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 31.2 tt0 -117.92 124.84 49.23 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.04 -166.16 10.69 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.085 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 15.5 ptp180 -148.0 141.2 25.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.412 ' HB ' HG12 ' A' ' 40' ' ' ILE . 8.9 t -134.2 -171.93 2.87 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.022 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.63 -40.01 93.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.199 0.523 . . . . 0.0 110.751 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -80.58 -65.9 0.95 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.316 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -116.21 130.24 71.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.28 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 12.6 ptmm? -112.26 136.95 51.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.272 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.69 39.8 13.55 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.209 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -110.54 138.64 46.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.907 0.384 . . . . 0.0 109.983 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 43.4 t -93.23 116.77 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.518 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -128.69 145.6 51.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 111.796 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.619 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -64.11 130.88 45.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.235 173.176 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.5 t -86.41 26.47 1.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.647 -175.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 32.5 mt-10 -84.0 -25.51 29.91 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.938 0.875 . . . . 0.0 109.392 -175.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.619 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 32.1 p90 -113.98 16.95 18.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.61 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 66' ' ' THR . 65.1 mt -114.17 145.84 41.14 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.953 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -118.7 125.59 50.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.124 -178.021 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.569 ' HA ' HG12 ' A' ' 19' ' ' VAL . 54.3 tttp -62.65 122.37 15.68 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.392 0.432 . . . . 0.0 110.125 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.7 116.61 27.95 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.67 -25.09 70.74 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.77 178.13 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB3' HD21 ' A' ' 12' ' ' LEU . 32.6 mt-10 . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.374 0.607 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.768 HG11 HG23 ' A' ' 52' ' ' ILE . 19.2 t -85.96 121.26 37.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.602 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 75.6 mtt180 -124.93 153.19 43.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -174.17 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 111.085 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' HG21 ' A' ' 22' ' ' ILE . 13.7 p -56.05 -30.68 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.607 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -83.85 -56.7 3.55 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.29 19.2 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.245 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 71' ' ' LYS . . . -83.05 135.6 34.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.047 0.423 . . . . 0.0 110.039 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 4' ' ' GLU . 15.8 mt -77.29 135.7 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.288 0.566 . . . . 0.0 112.445 -174.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' HB3' HD11 ' A' ' 43' ' ' ILE . 63.9 mt -112.0 166.72 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.711 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.9 179.49 9.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.26 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -64.69 118.37 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.16 8.56 50.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.217 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.84 174.19 8.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.838 -0.213 . . . . 0.0 110.467 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 3.2 p30 -133.7 139.63 46.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.526 0.679 . . . . 0.0 111.585 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.488 HG21 HD13 ' A' ' 69' ' ' LEU . 34.6 m -131.88 174.7 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.213 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 m -151.89 148.88 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.807 0.337 . . . . 0.0 110.781 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.698 HD12 HD23 ' A' ' 25' ' ' LEU . 4.5 mm? -60.74 130.04 44.5 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.236 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.663 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -91.15 -11.33 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.56 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.663 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.55 178.34 10.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.296 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -91.44 121.9 33.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.698 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.5 mmmt . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.529 0.68 . . . . 0.0 111.668 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -61.61 138.78 58.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.984 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.04 -13.07 63.75 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.634 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.547 ' HB ' HD23 ' A' ' 21' ' ' LEU . 77.9 m -58.78 119.41 7.09 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 7.4 ttt -87.98 124.65 33.93 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.282 0.563 . . . . 0.0 110.751 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.6 mt -114.53 91.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.664 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -108.61 149.53 28.77 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.708 -176.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.58 6.54 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.221 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.568 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.0 pp -91.65 160.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 8.2 ptt180 -141.06 161.01 38.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.748 0.309 . . . . 0.0 110.579 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.522 HD22 ' CG2' ' A' ' 5' ' ' VAL . 25.9 mt -79.86 154.06 28.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.238 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -121.46 -159.33 0.8 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.23 -14.2 62.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.686 0.755 . . . . 0.0 109.261 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 65.6 m -101.03 148.35 25.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.669 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HA ' HG22 ' A' ' 5' ' ' VAL . 23.8 mt-10 -92.5 -16.43 25.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.36 -14.94 23.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.382 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 8.2 mp0 -125.66 148.73 48.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.548 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.768 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -132.45 160.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.253 171.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.0 tt0 -115.58 122.68 46.37 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -133.33 -156.1 7.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.716 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.7 ptp180 . . . . . 0 C--N 1.32 -0.712 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HD2' ' C ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.797 0.332 . . . . 0.0 110.485 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.61 50.57 42.05 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.64 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.23 135.39 54.22 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.083 0.468 . . . . 0.0 110.033 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.3 t -92.66 122.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.746 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.7 mt -134.02 147.0 50.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.37 0.605 . . . . 0.0 112.191 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.584 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.8 ptp180 -66.34 130.51 43.47 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.947 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.495 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.2 t -86.23 26.29 1.06 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.251 0.548 . . . . 0.0 110.856 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.0 mt-10 -84.17 -22.58 30.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.714 0.769 . . . . 0.0 109.652 -175.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.746 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 24.2 p90 -117.32 19.44 14.09 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.749 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 66' ' ' THR . 60.6 mt -116.68 145.48 43.41 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.014 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -114.4 133.27 55.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.247 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.64 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 52.1 tttt -58.43 122.32 13.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -175.155 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.6 t -91.63 129.84 41.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.779 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.573 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -133.98 171.09 14.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.19 -169.72 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' HG21 ' A' ' 22' ' ' ILE . 7.7 p -66.39 -27.77 68.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.295 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -82.46 -51.03 8.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.09 27.1 0.26 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.772 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.65 123.78 40.43 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.573 HD23 ' HG3' ' A' ' 6' ' ' ARG . 27.4 mt -60.35 143.78 52.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.457 0.646 . . . . 0.0 112.642 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' HB3' HD11 ' A' ' 43' ' ' ILE . 95.7 mt -111.36 170.85 7.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.14 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.47 178.17 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.86 122.0 14.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.012 0.434 . . . . 0.0 110.946 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.19 64.33 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.374 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.615 ' C ' HD22 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -78.54 173.06 12.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.697 0.284 . . . . 0.0 110.703 -175.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.615 HD22 ' C ' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -124.46 146.35 48.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.255 0.55 . . . . 0.0 110.523 -177.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 43' ' ' ILE . 27.7 m -142.55 170.82 11.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.532 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -153.18 158.66 42.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.76 0.314 . . . . 0.0 110.713 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 25' ' ' LEU . 3.4 mm? -67.66 135.16 52.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.537 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.601 HG13 ' HG2' ' A' ' 23' ' ' LYS . 37.2 pt -96.59 -11.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 110.838 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -155.86 174.79 14.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.134 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.54 107.61 18.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 121.278 0.561 . . . . 0.0 111.199 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.6 mmmt . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.471 0.653 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.47 139.56 58.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.249 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.71 68.54 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.943 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.568 ' HB ' HD23 ' A' ' 21' ' ' LEU . 85.3 m -58.17 121.39 10.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.783 0.291 . . . . 0.0 110.256 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.24 117.01 29.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.363 0.601 . . . . 0.0 111.516 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.407 ' HB ' HG23 ' A' ' 19' ' ' VAL . 51.5 mt -104.05 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.586 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.33 135.74 47.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.394 -174.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.68 48.85 2.06 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.335 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 pp -94.25 160.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -138.95 159.88 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.106 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.6 mt -85.87 138.26 32.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.4 p -98.33 -156.8 0.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.779 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -90.29 -2.08 57.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 109.668 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 58.1 m -98.29 149.08 22.98 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.606 ' HA ' HG22 ' A' ' 5' ' ' VAL . 27.3 mt-10 -94.85 -14.88 24.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.623 0.725 . . . . 0.0 109.376 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 66' ' ' THR . 1.0 OUTLIER -108.32 -2.94 18.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.538 -176.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -130.01 147.57 51.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.156 0.503 . . . . 0.0 111.044 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.49 ' CG2' HG11 ' A' ' 5' ' ' VAL . 15.7 pt -135.18 175.76 10.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.642 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -130.74 135.31 47.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -139.65 -177.6 15.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.281 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 55' ' ' ARG . 10.1 ptt180 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 121.234 0.54 . . . . 0.0 110.179 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 60' ' ' LYS . 20.0 ptmt . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.28 5.86 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.651 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -110.99 134.57 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' A' ' 53' ' ' GLU . 39.4 t -91.72 125.09 44.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.908 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.546 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 33.4 mt -137.31 145.77 43.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.666 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.667 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -62.99 130.48 44.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.759 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -83.83 23.96 0.94 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.745 0.783 . . . . 0.0 110.204 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -89.58 -15.1 33.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.537 0.684 . . . . 0.0 110.101 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.667 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 53.4 p90 -121.84 17.0 11.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.303 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 66' ' ' THR . 73.6 mt -113.53 147.11 38.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.512 0.672 . . . . 0.0 110.087 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -117.36 124.81 49.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.106 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -59.95 118.83 6.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 0.0 110.042 -177.722 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.505 ' HB3' HD21 ' A' ' 12' ' ' LEU . 46.1 mt-10 . . . . . 0 CA--C 1.517 -0.297 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.5 t -113.24 119.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.959 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.572 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -122.32 175.17 6.56 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.837 -177.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 3.1 p-10 -86.05 -164.29 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.065 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.433 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 25.8 p -63.57 -20.37 65.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.547 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.495 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -95.78 -49.36 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.63 10.89 0.77 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.526 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.86 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.572 HD23 ' HG3' ' A' ' 6' ' ' ARG . 25.3 mt -72.51 143.74 48.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.379 0.609 . . . . 0.0 112.28 -173.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.59 166.06 11.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.387 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.79 174.31 15.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.911 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -63.96 121.5 14.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.514 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.49 1.67 53.4 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.006 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -81.73 174.05 11.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 110.404 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.9 p30 -132.69 142.91 49.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.617 0.722 . . . . 0.0 111.652 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 71' ' ' LYS . 29.5 m -137.57 174.88 10.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.927 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.1 m -152.19 150.87 30.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.715 0.293 . . . . 0.0 110.714 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 25' ' ' LEU . 4.3 mm? -62.0 128.26 35.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.679 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.656 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -89.6 -10.03 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.814 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -159.79 174.27 14.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -85.01 118.75 24.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 21' ' ' LEU . 4.2 mm? . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 110.407 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 26.8 mmmt . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.273 0.559 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.76 145.58 44.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.438 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.92 -8.13 78.4 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.608 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.557 ' HB ' HD23 ' A' ' 21' ' ' LEU . 89.6 m -65.16 112.8 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 0.0 110.313 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.0 ttm -81.5 117.49 21.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.421 0.629 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mt -108.9 99.81 9.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.961 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -111.03 156.58 21.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.924 0.392 . . . . 0.0 111.128 -176.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.51 28.52 35.65 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.587 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.3 pp -78.94 161.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.678 0.275 . . . . 0.0 110.423 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.6 ptp180 -140.91 166.2 25.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.489 HD22 ' HB ' ' A' ' 5' ' ' VAL . 39.3 mt -88.47 137.96 31.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.973 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -95.16 -159.77 0.74 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -81.94 -4.76 57.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.385 0.612 . . . . 0.0 109.454 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 73.9 m -99.35 146.75 25.94 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.514 ' HA ' HG22 ' A' ' 5' ' ' VAL . 22.3 mt-10 -90.51 -15.26 31.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.381 0.61 . . . . 0.0 109.904 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.4 -5.44 20.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.078 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -126.67 145.18 50.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 111.81 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -131.04 173.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.2 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.623 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 11.7 tm-20 -127.98 131.19 49.27 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.04 -166.32 11.61 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.69 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.498 HH11 ' HB3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 121.361 0.601 . . . . 0.0 111.258 -175.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.3 ptpp? . . . . . 0 N--CA 1.442 -0.832 0 CA-C-O 121.124 0.487 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.623 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 103.98 43.14 1.83 Allowed Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.405 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.39 132.67 56.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.237 0.541 . . . . 0.0 110.032 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 58.7 t -90.89 124.57 43.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.691 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.711 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -134.05 146.3 50.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.294 0.569 . . . . 0.0 112.189 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.61 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.5 ptp180 -64.7 130.82 45.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.814 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 t -86.24 33.09 0.61 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.986 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.61 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -85.96 -29.63 23.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.435 0.636 . . . . 0.0 110.161 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.711 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 38.3 p90 -113.62 18.97 17.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.982 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 19' ' ' VAL . 59.4 mt -113.31 144.71 42.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.972 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HB2' HG22 ' A' ' 22' ' ' ILE . 3.0 tmtt? -114.17 122.38 46.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.641 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.452 ' HA ' HG12 ' A' ' 19' ' ' VAL . 48.7 tttp -57.77 120.59 8.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.109 0.48 . . . . 0.0 110.602 -174.816 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.404 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 32.6 mt-10 . . . . . 0 CA--C 1.516 -0.35 0 CA-C-O 121.587 0.708 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 52' ' ' ILE . 10.3 t -94.8 132.0 40.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.815 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.48 ' HG3' HD23 ' A' ' 12' ' ' LEU . 2.4 mpt_? -132.43 150.06 52.23 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.577 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 3.8 p-10 -77.59 -163.5 0.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.725 0.297 . . . . 0.0 110.634 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.6 t -70.98 -15.6 62.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.309 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.486 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 2.3 t-20 -85.83 -54.78 4.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.716 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 10.89 1.91 Allowed Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.609 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.43 133.07 35.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.48 HD23 ' HG3' ' A' ' 6' ' ' ARG . 15.2 mt -72.7 135.07 45.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.168 0.508 . . . . 0.0 111.621 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -102.4 163.72 12.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.401 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -149.23 177.55 9.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.16 118.24 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 29.01 12.46 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.647 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.7 t0 -98.72 175.13 6.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -132.73 141.15 48.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.664 0.745 . . . . 0.0 111.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.524 HG23 ' HB ' ' A' ' 40' ' ' ILE . 30.6 m -136.86 174.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.097 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.8 m -153.08 150.94 29.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.77 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.596 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -64.61 129.42 39.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.739 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.683 HG13 ' HG2' ' A' ' 23' ' ' LYS . 32.1 pt -90.94 -4.61 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 110.639 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.683 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -165.09 -179.15 5.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.886 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.83 116.56 29.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.596 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.173 0.511 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -63.67 140.13 58.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.474 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.27 84.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.838 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.526 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -64.32 114.43 4.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.95 0.375 . . . . 0.0 110.077 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 29.8 ttm -81.24 119.32 23.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.491 0.662 . . . . 0.0 111.121 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.524 ' HB ' HG23 ' A' ' 19' ' ' VAL . 43.0 mt -106.64 90.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.469 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.467 ' C ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -101.07 162.68 12.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.268 -176.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.82 57.72 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.988 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.699 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -92.96 163.91 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.991 0.424 . . . . 0.0 109.953 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -136.09 159.05 42.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.821 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 14' ' ' ALA . 55.2 mt -82.04 130.19 35.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.631 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.4 p -87.98 -158.69 0.48 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.244 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -85.58 -8.37 58.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 75.4 m -96.94 150.54 20.65 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.665 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.9 mt-10 -90.28 -22.89 21.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 109.927 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -101.77 1.06 36.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.521 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.6 OUTLIER -133.18 144.4 49.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.53 0.681 . . . . 0.0 111.305 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -131.37 157.08 43.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.605 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -113.81 125.84 54.53 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.699 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.49 -160.89 8.72 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.751 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 . . . . . 0 C--N 1.317 -0.845 0 CA-C-O 121.362 0.601 . . . . 0.0 109.971 -178.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.78 0.324 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.08 47.35 5.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.818 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -111.53 133.19 53.98 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.99 114.89 30.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.819 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 47.6 mt -128.99 135.79 49.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.78 0.8 . . . . 0.0 112.312 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.571 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 1.4 ptp180 -56.92 130.3 45.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.009 167.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.499 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.1 t -88.31 27.79 1.19 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.758 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 14.6 mt-10 -86.17 -16.19 38.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.981 0.896 . . . . 0.0 109.458 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.819 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 34.5 p90 -120.36 19.05 12.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.097 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 66' ' ' THR . 86.2 mt -116.65 148.28 41.15 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.577 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -115.71 126.59 54.28 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.581 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.0 122.31 16.22 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -174.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HB3' HD21 ' A' ' 12' ' ' LEU . 48.4 mt-10 . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.433 0.635 . . . . 0.0 111.528 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 45' ' ' LEU . 5.1 t -108.88 130.46 61.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.983 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.622 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -131.89 165.14 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.469 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.31 -166.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.668 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.437 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 21.9 p -61.59 -34.36 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.372 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.28 -40.45 26.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.96 0.41 . . . . 0.0 110.767 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 20.09 2.06 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.238 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.06 132.27 36.12 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.622 HD23 ' HG3' ' A' ' 6' ' ' ARG . 24.7 mt -70.55 142.84 51.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.293 0.568 . . . . 0.0 111.894 -172.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HB3' HD11 ' A' ' 43' ' ' ILE . 83.7 mt -108.96 173.77 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.63 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -164.78 175.89 9.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.873 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.7 t70 -62.26 125.43 23.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.493 . . . . 0.0 110.574 175.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.69 59.38 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.935 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.592 ' C ' HD22 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -89.91 171.75 9.37 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.592 HD22 ' C ' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -123.91 145.83 48.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.674 -176.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 43' ' ' ILE . 27.7 m -145.07 172.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.5 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.9 m -155.09 156.26 35.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.605 0.24 . . . . 0.0 110.73 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.615 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -70.53 128.16 35.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.651 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.656 HG13 ' HG2' ' A' ' 23' ' ' LYS . 40.2 pt -91.45 -10.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.111 0.481 . . . . 0.0 110.823 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -158.04 176.51 12.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.37 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.33 118.94 25.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.615 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.796 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 26.4 mmmt . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 121.589 0.709 . . . . 0.0 112.127 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -59.78 136.35 57.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.43 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.97 64.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.893 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.538 ' HB ' HD23 ' A' ' 21' ' ' LEU . 87.6 m -59.83 115.81 3.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 110.365 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ttm -87.23 123.54 32.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.455 0.645 . . . . 0.0 111.306 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.435 ' HB ' HG23 ' A' ' 19' ' ' VAL . 45.5 mt -114.6 95.92 4.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.145 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.64 135.96 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.733 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.09 40.33 3.79 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.641 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.56 HG21 HG22 ' A' ' 19' ' ' VAL . 2.2 pp -85.09 167.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 6.7 ptp85 -143.2 158.97 43.15 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.072 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 5' ' ' VAL . 33.2 mt -84.01 162.74 20.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.635 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -126.92 -167.62 1.76 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.52 -6.45 55.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.277 0.561 . . . . 0.0 109.542 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 55.1 m -96.81 145.89 25.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.422 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 5' ' ' VAL . 23.2 mt-10 -89.47 -23.94 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.189 0.519 . . . . 0.0 110.616 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 66' ' ' THR . 16.4 m-20 -105.98 -3.37 21.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.972 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 14.9 mp0 -122.64 146.15 47.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.224 0.535 . . . . 0.0 110.836 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.42 ' CG2' HG11 ' A' ' 5' ' ' VAL . 24.7 pt -133.78 178.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.801 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.549 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -132.23 127.88 36.71 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -138.67 178.57 19.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.082 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.397 0.617 . . . . 0.0 110.851 179.777 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.065 0.46 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.549 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 92.58 51.14 2.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -115.28 135.03 54.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 46.4 t -90.16 119.65 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.147 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.663 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 22.3 mt -133.12 142.89 48.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.648 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.607 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 15.8 ptt180 -64.3 131.65 47.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.736 171.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.439 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.6 t -88.35 27.97 1.16 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.972 -174.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.3 mt-10 -79.87 -27.57 40.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.845 0.831 . . . . 0.0 109.24 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.663 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 31.8 p90 -113.92 17.88 17.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.765 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 66' ' ' THR . 72.5 mt -112.48 141.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.393 0.616 . . . . 0.0 110.161 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -110.94 122.05 46.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.486 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -59.13 121.35 11.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 121.512 0.672 . . . . 0.0 110.962 -175.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 121.316 0.579 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.643 HG11 HG23 ' A' ' 52' ' ' ILE . 3.0 t -95.81 133.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.629 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.569 ' HG3' HD23 ' A' ' 12' ' ' LEU . 2.0 mpt_? -131.02 166.09 21.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.16 -174.8 5.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 110.21 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 p -57.44 -34.47 69.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.659 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -79.23 -43.19 24.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.836 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.79 18.37 1.4 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.563 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.54 128.26 34.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.569 HD23 ' HG3' ' A' ' 6' ' ' ARG . 17.4 mt -65.53 142.49 58.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -110.39 171.8 7.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.623 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.51 178.99 9.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.6 t70 -75.45 111.04 10.33 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.14 22.75 9.63 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 176.61 6.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 4.3 p30 -135.04 140.45 45.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.467 0.651 . . . . 0.0 111.66 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 43' ' ' ILE . 28.9 m -135.67 176.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.213 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -149.71 157.32 43.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.769 0.319 . . . . 0.0 111.015 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.647 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -69.79 127.24 32.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.813 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.966 HG13 ' HG3' ' A' ' 23' ' ' LYS . 39.2 pt -92.27 -9.24 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.225 0.536 . . . . 0.0 110.368 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.966 ' HG3' HG13 ' A' ' 22' ' ' ILE . 24.1 mtpp -143.02 -179.74 6.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.671 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.27 94.89 7.03 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.647 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 26.1 mmmt . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.454 0.645 . . . . 0.0 112.177 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -57.17 134.02 55.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.374 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.18 -9.26 61.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.908 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.522 ' HB ' HD23 ' A' ' 21' ' ' LEU . 97.2 m -60.56 119.78 8.73 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.964 0.382 . . . . 0.0 110.212 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.0 ttm -88.22 122.24 31.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.434 0.635 . . . . 0.0 111.179 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.2 mt -113.22 91.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.906 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -110.96 135.69 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.284 0.564 . . . . 0.0 110.676 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.67 43.76 1.77 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -171.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.619 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.9 pp -98.5 158.05 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 177.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 5' ' ' VAL . 26.9 mt -75.82 149.03 37.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.163 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.3 p -118.8 -167.96 1.47 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.3 -3.49 33.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 0.0 110.065 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 47.3 m -100.64 138.23 37.96 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.826 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -92.53 -15.04 27.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.146 0.498 . . . . 0.0 110.213 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 66' ' ' THR . 17.6 t70 -106.24 -5.23 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.949 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.5 mp0 -125.9 146.56 49.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.002 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.643 HG23 HG11 ' A' ' 5' ' ' VAL . 9.3 pt -131.4 172.4 16.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.528 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 38.1 tt0 -126.09 129.73 49.69 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.619 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.26 -167.07 10.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.966 -1.112 . . . . 0.0 112.623 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 -179.167 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.93 51.44 9.1 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.32 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -113.33 135.46 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 47.0 t -96.3 119.96 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.116 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.751 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 33.3 mt -133.34 138.91 46.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.585 0.707 . . . . 0.0 112.37 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.516 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.2 ptp180 -56.69 134.06 54.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.283 168.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 50' ' ' ASP . 8.9 t -89.29 31.9 0.87 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.622 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 23.4 mt-10 -81.88 -32.93 30.78 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.851 0.834 . . . . 0.0 109.887 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.751 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 30.3 p90 -115.16 20.63 14.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.921 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 19' ' ' VAL . 72.1 mt -116.03 143.75 45.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.049 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -119.98 128.94 54.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.945 -176.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -59.61 126.39 27.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -172.769 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.435 ' HB3' ' HE ' ' A' ' 6' ' ' ARG . 41.9 mt-10 . . . . . 0 CA--C 1.516 -0.354 0 CA-C-O 121.393 0.616 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.4 t -93.01 123.76 45.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.042 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.558 ' HG3' HD23 ' A' ' 12' ' ' LEU . 1.4 mpt_? -126.49 170.24 12.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.575 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 39.4 p-10 -84.17 -162.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.655 ' SG ' HG21 ' A' ' 22' ' ' ILE . 20.2 p -78.52 12.16 2.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 110.591 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 9' ' ' ASN . 2.1 t-20 -118.35 -48.03 2.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.494 0.664 . . . . 0.0 110.254 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.04 5.51 3.44 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.108 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.1 125.83 29.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.558 HD23 ' HG3' ' A' ' 6' ' ' ARG . 17.3 mt -72.32 135.05 45.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.698 -175.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.01 162.42 13.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.48 8.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.977 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.0 t70 -64.62 125.72 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.82 17.07 53.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.264 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.02 175.48 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 13.3 p30 -131.06 139.08 49.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.698 0.761 . . . . 0.0 112.078 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.28 173.39 14.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.806 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -152.91 152.25 31.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.769 0.318 . . . . 0.0 110.619 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.606 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -64.63 128.58 36.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.641 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.007 HG13 ' HG3' ' A' ' 23' ' ' LYS . 35.0 pt -92.69 -9.68 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.174 0.511 . . . . 0.0 110.361 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 1.007 ' HG3' HG13 ' A' ' 22' ' ' ILE . 23.2 mtpp -145.47 -175.94 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.9 109.22 22.01 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.606 HD23 HD12 ' A' ' 21' ' ' LEU . 3.8 mm? . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.955 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 23.4 mmmt . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.24 0.543 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -59.99 131.71 51.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.459 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.13 -3.46 62.03 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.107 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.525 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -65.09 113.42 3.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.201 0.501 . . . . 0.0 110.371 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -82.97 122.44 28.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.556 0.693 . . . . 0.0 111.499 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.49 93.51 2.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.935 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.38 149.65 24.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.93 43.01 5.51 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.564 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -91.29 166.96 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.297 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -147.22 156.92 43.37 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.609 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.4 mt -84.69 158.49 20.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.559 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -118.21 -162.75 0.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.72 -16.65 60.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.748 0.785 . . . . 0.0 109.235 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 19.9 m -87.22 144.86 26.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.874 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.56 ' HA ' HG22 ' A' ' 5' ' ' VAL . 24.5 mt-10 -91.6 -13.55 31.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.551 0.691 . . . . 0.0 109.749 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -110.46 -5.85 15.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.748 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 14.0 mp0 -123.72 145.44 48.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.346 0.593 . . . . 0.0 110.943 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.49 HG23 HG11 ' A' ' 5' ' ' VAL . 11.6 pt -135.69 175.26 11.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.436 174.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.71 137.46 49.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -140.73 -167.88 11.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.772 -1.204 . . . . 0.0 112.67 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 . . . . . 0 C--N 1.323 -0.566 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.203 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.254 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.05 48.98 70.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.933 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -105.32 134.21 48.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.82 120.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.108 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.829 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 26.2 mt -132.57 144.24 50.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.741 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.603 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 1.1 ptp180 -64.78 133.45 52.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.793 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 t -85.34 26.16 0.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.503 0.668 . . . . 0.0 110.773 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -87.79 -20.89 25.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.636 0.731 . . . . 0.0 110.164 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.829 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 53.5 p90 -120.78 21.16 11.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.53 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.8 mt -117.07 148.93 41.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.269 0.556 . . . . 0.0 110.028 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.6 tmtt? -120.38 131.7 54.94 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.778 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -64.58 122.38 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.269 -172.313 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.509 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 44.4 mt-10 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.413 0.625 . . . . 0.0 111.306 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.739 HG11 HG23 ' A' ' 52' ' ' ILE . 8.5 t -88.08 131.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.673 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HG2' HD23 ' A' ' 12' ' ' LEU . 65.8 mtt85 -122.24 167.04 13.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.639 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 36.4 p-10 -90.07 -162.02 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' HG21 ' A' ' 22' ' ' ILE . 20.2 p -76.32 3.62 10.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.287 0.565 . . . . 0.0 110.752 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.58 -48.29 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.73 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.07 7.67 4.91 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.951 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.95 136.64 36.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 4' ' ' GLU . 34.5 mt -80.75 135.71 36.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 112.083 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.4 ' HB3' HD11 ' A' ' 43' ' ' ILE . 86.4 mt -101.47 166.9 10.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.36 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.75 174.45 13.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 14.7 t70 -63.53 118.18 7.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.775 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.02 -0.78 38.39 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.068 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.475 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -83.12 175.15 10.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 110.691 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -135.55 137.67 42.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.172 -177.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 69' ' ' LEU . 34.5 m -128.82 167.31 24.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.613 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.44 152.5 47.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.613 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.537 HD12 HD23 ' A' ' 25' ' ' LEU . 3.4 mm? -72.7 122.92 22.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.5 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.566 HG13 ' HG2' ' A' ' 23' ' ' LYS . 39.4 pt -88.33 -7.34 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 111.102 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.566 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -160.05 -176.79 5.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.177 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.5 117.57 30.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.032 0.444 . . . . 0.0 110.253 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.141 0.496 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -60.53 135.88 57.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.41 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.41 -0.63 59.98 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.859 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.482 ' HB ' ' HG ' ' A' ' 21' ' ' LEU . 91.8 m -63.48 120.21 11.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.842 0.353 . . . . 0.0 110.049 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.9 tpt -93.52 114.58 26.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.624 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.9 mt -111.21 90.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.472 0.653 . . . . 0.0 109.434 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.45 136.98 45.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.65 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.48 46.24 2.19 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.579 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -93.48 168.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 0.0 110.325 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 4.6 ptp180 -151.71 156.68 40.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.48 HD22 ' CG2' ' A' ' 5' ' ' VAL . 20.2 mt -78.6 127.7 32.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 p -82.81 -68.91 0.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.204 1.002 . . . . 0.0 111.878 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -176.79 -34.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.763 -173.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 38.1 m -75.08 146.49 41.43 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.356 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HA ' HG22 ' A' ' 5' ' ' VAL . 2.1 mp0 -91.46 -19.25 23.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.513 0.673 . . . . 0.0 110.163 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -103.54 -3.59 25.07 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.728 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 2.5 mt-10 -132.65 145.56 51.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.584 0.707 . . . . 0.0 111.347 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.739 HG23 HG11 ' A' ' 5' ' ' VAL . 9.4 pt -132.09 173.8 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.451 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 22.5 tt0 -125.01 137.01 54.25 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -142.54 -161.18 8.67 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.232 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 9.0 ptp180 . . . . . 0 C--N 1.318 -0.769 0 CA-C-O 120.918 0.39 . . . . 0.0 110.633 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 17.7 ptpt . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.82 0.343 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.94 47.98 5.63 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.076 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -112.51 136.63 51.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 40.1 t -94.41 119.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.648 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.8 mt -128.16 146.11 50.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.706 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 14.1 ptt180 -65.36 135.32 55.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.23 172.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 t -89.27 33.01 0.81 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.502 0.668 . . . . 0.0 110.656 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.7 mt-10 -81.69 -30.97 32.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.005 0.907 . . . . 0.0 109.444 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.648 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 39.9 p90 -115.79 19.11 15.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.506 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 19' ' ' VAL . 68.6 mt -113.2 147.65 37.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.224 0.535 . . . . 0.0 110.349 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -117.8 130.89 56.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.752 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.2 tmtt? -67.04 121.14 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.303 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HB3' HD21 ' A' ' 12' ' ' LEU . 82.3 mt-10 . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 121.122 0.487 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -95.48 121.28 45.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -125.92 153.41 44.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 8.5 p-10 -79.57 -170.52 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.0 p -63.49 -26.37 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -76.03 -39.37 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.096 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.68 12.27 8.04 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.529 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.71 132.18 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 6' ' ' ARG . 20.0 mt -69.24 131.18 44.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.1 177.33 5.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.803 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.541 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -154.61 178.47 10.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -80.14 111.61 16.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.689 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.78 27.36 8.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.656 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.08 176.5 5.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.366 0.266 . . . . 0.0 110.361 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -129.2 136.09 49.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 111.102 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 69' ' ' LEU . 35.4 m -125.05 179.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.992 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -154.82 151.15 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.692 0.282 . . . . 0.0 111.239 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.75 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -66.25 130.49 43.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.629 HG21 ' SG ' ' A' ' 8' ' ' CYS . 41.4 pt -91.99 -9.15 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 110.856 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.563 ' HG3' HD21 ' A' ' 25' ' ' LEU . 4.9 ptpt -156.88 -178.86 7.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.93 108.18 19.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.75 HD23 HD12 ' A' ' 21' ' ' LEU . 3.3 mm? . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.645 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 21.3 mmmt . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.491 0.662 . . . . 0.0 112.356 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -59.69 136.56 58.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.711 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.69 -3.05 81.09 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.989 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.548 ' HB ' HD23 ' A' ' 21' ' ' LEU . 93.0 m -63.86 112.56 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.7 ttm -83.35 116.29 22.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.321 0.582 . . . . 0.0 111.144 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' HB ' HG23 ' A' ' 19' ' ' VAL . 39.7 mt -99.66 89.97 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.901 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 3.3 ppt_? -100.15 135.72 41.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 46.98 1.8 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.626 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 1.9 pp -97.18 148.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.55 142.6 51.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.246 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 14' ' ' ALA . 61.3 mt -71.93 132.69 44.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -97.43 -169.17 1.8 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.07 7.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.434 0.635 . . . . 0.0 109.564 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -109.89 149.38 29.97 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.671 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -103.39 -14.8 16.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -102.18 -7.74 21.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.897 0.379 . . . . 0.0 110.333 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.1 mp0 -123.31 149.3 45.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.507 0.67 . . . . 0.0 111.125 -176.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.473 HD12 ' HB ' ' A' ' 43' ' ' ILE . 17.9 pt -136.29 172.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.161 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.2 tt0 -125.53 122.01 35.33 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -128.43 -169.47 12.62 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.846 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 . . . . . 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 110.203 179.779 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 60' ' ' LYS . 17.1 ptmt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.775 0.321 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.16 43.71 31.66 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.785 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -107.18 131.31 54.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.9 t -89.73 120.53 38.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.655 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 28.8 mt -134.35 140.93 46.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.574 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 1.5 ptp180 -58.88 130.39 46.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 168.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -87.68 25.64 1.45 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.454 0.645 . . . . 0.0 110.204 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.5 mt-10 -89.31 -10.0 48.41 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.762 0.791 . . . . 0.0 109.769 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 42.8 p90 -125.22 15.59 8.39 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.114 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 19' ' ' VAL . 68.8 mt -112.06 149.06 32.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.832 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -61.15 120.9 11.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.733 -171.395 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HB3' HD21 ' A' ' 12' ' ' LEU . 33.3 mt-10 . . . . . 0 N--CA 1.448 -0.552 0 CA-C-O 121.467 0.651 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.727 HG11 HG23 ' A' ' 52' ' ' ILE . 6.7 t -80.84 118.29 28.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.526 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 92.4 mtt180 -124.75 155.07 39.91 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 38.2 p-10 -79.48 -161.93 0.37 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.815 0.34 . . . . 0.0 110.343 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.503 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.8 p -74.62 -1.14 20.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.188 0.518 . . . . 0.0 110.85 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.13 -44.96 4.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.37 11.05 4.31 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.033 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' ARG . . . -82.5 134.52 35.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 4' ' ' GLU . 20.9 mt -78.3 134.34 37.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.338 0.589 . . . . 0.0 112.01 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -100.63 162.73 12.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.229 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.98 176.53 12.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.295 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 22.0 t70 -60.56 123.27 16.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 16.82 46.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.596 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.445 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t70 -93.93 175.64 6.64 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.725 -0.279 . . . . 0.0 110.716 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -130.22 135.98 48.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.199 0.523 . . . . 0.0 110.938 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.587 HG21 HD13 ' A' ' 69' ' ' LEU . 27.6 m -124.05 175.95 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.787 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -150.59 151.79 33.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.858 0.361 . . . . 0.0 111.366 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.675 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -64.68 127.4 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.45 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.879 HG13 ' HG3' ' A' ' 23' ' ' LYS . 38.5 pt -95.53 -8.36 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.762 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.4 mttt -141.87 179.8 6.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.56 100.64 12.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.675 HD23 HD12 ' A' ' 21' ' ' LEU . 3.8 mm? . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mmmt . . . . . 0 CA--C 1.516 -0.339 0 CA-C-O 121.17 0.509 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 36' ' ' ARG . 27.5 ttt180 -62.42 137.55 58.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.488 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.73 8.03 70.57 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.916 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.538 ' HB ' HD23 ' A' ' 21' ' ' LEU . 90.9 m -73.47 116.28 13.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.2 ttm -87.75 111.71 21.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.449 0.642 . . . . 0.0 111.448 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.462 ' HB ' HG23 ' A' ' 19' ' ' VAL . 48.8 mt -95.12 91.51 3.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 135.1 43.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.33 1.43 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.677 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -102.89 162.66 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.366 . . . . 0.0 110.231 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 12.2 ptt180 -143.24 164.66 29.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.345 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 5' ' ' VAL . 43.3 mt -82.16 142.28 32.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.204 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.1 p -104.35 -154.48 0.51 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.176 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.31 -2.95 56.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 33.5 t -108.16 157.92 17.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.014 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.61 ' HA ' HG22 ' A' ' 5' ' ' VAL . 31.9 mt-10 -95.89 -13.43 23.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.909 172.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -108.98 -9.6 15.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.356 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -121.68 146.28 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 111.427 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.727 HG23 HG11 ' A' ' 5' ' ' VAL . 2.4 pp -134.76 166.86 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.505 172.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' HB2' HG22 ' A' ' 63' ' ' VAL . 37.2 tt0 -120.36 130.0 54.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.677 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.01 -175.4 13.99 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.964 -175.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 17.0 ptt180 . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.459 0.647 . . . . 0.0 110.765 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.66 54.09 6.88 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.677 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.6 pt? -115.09 138.34 50.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 53' ' ' GLU . 46.3 t -92.5 116.29 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.554 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -129.48 146.13 51.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.558 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.658 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 2.3 ptp180 -65.25 139.07 58.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.055 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' HD12 ' A' ' 69' ' ' LEU . 8.9 t -93.74 23.82 4.51 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.593 -174.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HG2' HH11 ' A' ' 65' ' ' ARG . 0.6 OUTLIER -92.81 -8.46 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.275 -176.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.658 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 54.0 p90 -122.41 19.58 10.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.587 HD13 HG21 ' A' ' 19' ' ' VAL . 65.7 mt -120.46 145.66 47.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.081 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.515 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -113.35 130.68 56.22 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.698 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.4 tmtt? -64.21 123.14 18.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . . . . . . 0 C--N 1.322 -0.597 0 CA-C-O 121.137 0.494 . . . . 0.0 111.319 -174.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.504 ' HB3' HD21 ' A' ' 12' ' ' LEU . 37.7 mt-10 . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 111.457 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 49' ' ' GLU . 14.9 t -90.19 117.83 34.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.079 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -128.19 148.58 50.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.413 ' OD2' ' HA ' ' A' ' 70' ' ' LYS . 5.8 p-10 -80.63 -169.78 2.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.456 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.643 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.9 p -65.05 -22.82 67.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 110.961 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.406 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 35.9 t30 -76.14 -31.76 58.76 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.536 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.89 14.29 27.24 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.53 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.94 31.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 120.799 0.333 . . . . 0.0 110.143 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 4' ' ' GLU . 19.9 mt -71.57 141.0 50.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.872 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.57 176.85 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.602 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.96 10.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.849 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 17.3 t70 -65.3 121.33 14.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.798 0.332 . . . . 0.0 110.164 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.91 11.13 50.89 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.036 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.93 174.81 8.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 1.1 p30 -139.11 136.15 34.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.399 0.619 . . . . 0.0 111.565 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 69' ' ' LEU . 27.3 m -128.63 176.81 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.968 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -150.67 149.24 29.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.733 0.301 . . . . 0.0 111.048 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.665 HD12 HD23 ' A' ' 25' ' ' LEU . 4.5 mm? -61.17 133.36 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.329 0.651 . . . . 0.0 112.259 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.661 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -94.71 -11.56 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.2 0.524 . . . . 0.0 110.559 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.661 ' HG2' HG13 ' A' ' 22' ' ' ILE . 18.4 ptmt -158.43 176.1 12.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.232 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' HD22 ' A' ' 25' ' ' LEU . 8.2 m-20 -83.13 127.63 33.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.665 HD23 HD12 ' A' ' 21' ' ' LEU . 4.1 mm? . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 22.4 mmmt . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 121.297 0.57 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.22 132.74 51.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.82 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.16 -11.39 55.29 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.729 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.539 ' HB ' HD23 ' A' ' 21' ' ' LEU . 60.6 m -59.33 125.7 24.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.981 0.39 . . . . 0.0 110.037 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -90.71 122.58 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.082 0.468 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 90.53 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.11 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -101.51 154.29 18.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.2 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.99 45.94 6.9 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.301 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.557 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.39 160.45 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 19.6 ptt180 -139.46 159.09 42.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.305 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.452 HD22 ' HB ' ' A' ' 5' ' ' VAL . 52.0 mt -78.85 134.58 36.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.141 -176.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -94.44 -157.95 0.6 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.807 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.94 -6.99 59.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.504 0.669 . . . . 0.0 109.205 174.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 66.1 m -102.88 150.47 23.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.913 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -87.76 -26.57 22.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.477 0.656 . . . . 0.0 109.939 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -98.01 -6.67 31.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.695 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 10.8 mp0 -124.42 145.16 49.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 111.499 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.474 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -133.32 167.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.521 173.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -119.93 128.36 53.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.42 -159.32 7.95 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.333 -177.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.5 ptp180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 120.821 0.343 . . . . 0.0 110.243 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.01 52.08 4.78 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.388 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -114.31 137.05 52.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.65 121.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.926 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.667 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.4 mt -135.42 143.58 46.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.226 0.536 . . . . 0.0 111.941 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 9.4 ptp180 -60.71 130.13 44.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.694 171.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -88.48 22.27 2.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.219 0.533 . . . . 0.0 110.739 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 2.4 pt-20 -90.92 -9.74 45.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.318 0.58 . . . . 0.0 110.222 -176.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.667 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 28.7 p90 -117.06 16.99 14.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.329 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 19' ' ' VAL . 68.8 mt -117.29 146.38 43.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.296 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -118.45 125.0 49.01 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.008 -178.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HA ' HG12 ' A' ' 19' ' ' VAL . 46.5 tttp -62.06 121.01 11.97 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.313 0.383 . . . . 0.0 110.235 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . . . . . . 0 C--N 1.321 -0.666 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 121.282 0.563 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 49' ' ' GLU . 10.9 t -92.28 122.65 43.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.983 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.533 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -130.26 162.19 29.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.65 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 4.1 p-10 -82.51 -165.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.6 p -64.24 -25.62 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.772 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.41 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 65.9 t30 -74.5 -51.97 13.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.236 177.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.41 12.73 3.34 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.974 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.47 132.72 33.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.533 HD23 ' HG3' ' A' ' 6' ' ' ARG . 21.5 mt -69.15 145.18 53.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.509 0.671 . . . . 0.0 112.223 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.96 169.36 9.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.427 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.32 13.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.038 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 31.3 t70 -68.09 117.6 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.22 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.88 30.77 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.796 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.71 174.22 7.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -133.4 145.03 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.297 0.57 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 71' ' ' LYS . 28.3 m -140.54 175.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.275 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -152.31 156.89 40.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.745 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -69.23 131.51 45.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.721 -178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.681 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -91.94 -11.01 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.405 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.681 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -154.6 -179.09 7.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.96 113.56 25.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.745 HD23 HD12 ' A' ' 21' ' ' LEU . 3.5 mm? . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.522 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 121.295 0.569 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 36' ' ' ARG . 30.2 ttt180 -58.39 129.86 44.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.256 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.43 66.36 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.322 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.539 ' HB ' HD23 ' A' ' 21' ' ' LEU . 98.6 m -63.32 118.49 8.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.497 0.649 . . . . 0.0 110.23 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.435 ' HG2' ' HG3' ' A' ' 41' ' ' ARG . 35.7 ttm -87.62 119.88 28.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.628 0.728 . . . . 0.0 111.445 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -108.34 95.03 3.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.026 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' HG3' ' HG2' ' A' ' 39' ' ' MET . 0.0 OUTLIER -104.95 136.17 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.231 -176.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.94 50.69 1.59 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.64 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -99.32 164.0 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.581 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 7.0 ptp85 -141.62 167.49 22.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 ' HB ' ' A' ' 5' ' ' VAL . 36.5 mt -89.27 147.79 23.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.155 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -104.14 -159.77 0.73 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -85.05 2.4 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 m -113.51 156.68 23.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.598 ' HA ' HG22 ' A' ' 5' ' ' VAL . 21.9 mt-10 -93.54 -27.9 16.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.605 0.717 . . . . 0.0 109.65 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 66' ' ' THR . 6.6 m-20 -90.21 -12.01 39.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.321 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.7 mp0 -121.17 148.84 43.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.359 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.493 ' CG2' HG11 ' A' ' 5' ' ' VAL . 26.8 pt -133.91 175.78 10.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.716 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.537 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -130.14 123.78 31.13 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.64 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -136.38 -177.01 14.68 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.89 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.56 . . . . 0.0 110.401 179.707 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 58.5 46.59 92.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.444 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.5 pt? -103.38 135.01 45.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.225 0.513 . . . . 0.0 109.754 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.5 t -88.68 116.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.002 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.571 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 30.7 mt -129.56 143.45 50.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.452 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.645 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 14.6 ptt180 -62.14 129.95 43.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.444 ' HA ' HD12 ' A' ' 69' ' ' LEU . 11.9 t -88.19 27.06 1.27 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.238 0.542 . . . . 0.0 110.525 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.638 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.5 mt-10 -81.85 -26.27 34.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 109.159 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.645 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 21.4 p90 -114.56 17.91 17.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.998 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 66' ' ' THR . 58.3 mt -113.74 144.84 42.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.3 0.572 . . . . 0.0 110.205 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.65 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtp? -113.82 129.67 56.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.107 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.424 ' HA ' HG12 ' A' ' 19' ' ' VAL . 53.1 tttp -60.44 129.76 43.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.596 0 CA-C-O 121.11 0.481 . . . . 0.0 111.331 -174.471 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.321 0.582 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 49' ' ' GLU . 7.0 t -97.8 121.36 48.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.709 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.567 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.67 157.35 42.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.027 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 7.7 p-10 -83.25 -168.7 2.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 p -68.2 -13.09 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.496 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 50.4 t30 -87.65 -38.23 16.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 9.56 10.49 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.179 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.86 124.25 30.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.567 HD23 ' HG3' ' A' ' 6' ' ' ARG . 23.9 mt -66.76 129.54 40.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.907 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.96 166.71 10.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.579 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.49 178.42 10.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.139 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 13.2 t70 -65.12 129.66 40.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.452 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.61 60.67 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.542 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t0 -88.11 173.81 8.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.594 0.235 . . . . 0.0 110.453 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -132.7 128.84 37.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 -177.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 69' ' ' LEU . 26.9 m -125.78 176.94 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.29 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -153.53 149.25 27.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.593 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -65.25 125.18 24.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.743 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.929 HG13 ' HG3' ' A' ' 23' ' ' LYS . 33.5 pt -93.56 -7.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.162 0.506 . . . . 0.0 110.283 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.929 ' HG3' HG13 ' A' ' 22' ' ' ILE . 4.2 mtpm? -144.58 177.91 8.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.856 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.886 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 5.8 m-20 -93.73 102.22 14.36 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.684 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 4.3 mm? . . . . . 0 CA--C 1.511 -0.539 0 CA-C-O 121.632 0.73 . . . . 0.0 111.647 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.886 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 3.3 mmpt? . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 121.248 0.547 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -68.76 144.77 54.25 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.281 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.59 15.3 73.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.722 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.551 ' HB ' HD23 ' A' ' 21' ' ' LEU . 60.2 m -84.84 117.75 24.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 ttm -86.13 123.18 31.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.397 0.617 . . . . 0.0 110.975 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.425 ' HB ' HG23 ' A' ' 19' ' ' VAL . 35.0 mt -112.23 95.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.504 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -108.16 142.45 38.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.067 0.461 . . . . 0.0 111.009 -178.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.97 42.14 4.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.649 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.4 pp -92.5 165.72 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 110.234 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.557 ' HD2' ' OE1' ' A' ' 53' ' ' GLU . 3.8 ptp180 -139.76 164.19 30.62 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.321 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.5 162.18 14.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -130.48 -166.56 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -75.86 -8.98 58.2 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.249 0.547 . . . . 0.0 109.644 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 53.7 m -92.33 145.7 24.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.195 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -95.81 -20.6 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.806 -178.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.33 -5.94 22.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.145 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 17.7 mp0 -124.0 147.71 47.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.9 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -137.1 173.12 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.214 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.557 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 41.1 tt0 -125.62 135.02 51.72 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.649 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.92 -177.98 21.04 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.138 -177.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 121.009 0.433 . . . . 0.0 110.127 179.922 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.928 0.394 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.55 53.41 3.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.514 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.538 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -115.29 138.71 50.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 48.5 t -93.11 116.72 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.001 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.594 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 26.6 mt -129.33 142.93 50.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.663 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.635 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.9 ptp85 -60.68 130.61 47.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.563 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.4 t -88.59 24.24 2.03 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.294 0.569 . . . . 0.0 110.379 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.566 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.7 mt-10 -82.42 -20.3 37.32 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.926 0.87 . . . . 0.0 109.525 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 33.1 p90 -117.27 17.53 14.69 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.61 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 19' ' ' VAL . 63.8 mt -113.42 144.02 43.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.058 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HD3' ' HB2' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -113.93 126.98 55.77 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.358 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.542 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 11.1 tmtt? -59.83 124.87 21.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 71' ' ' LYS . . . . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.247 -170.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 121.302 0.572 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.814 HG11 HG23 ' A' ' 52' ' ' ILE . 2.7 t -87.58 128.91 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.257 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.567 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -132.28 158.93 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -178.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -78.51 -171.8 2.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 110.589 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.6 p -58.49 -29.73 66.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 9.3 m120 -84.02 -42.85 15.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.072 0.463 . . . . 0.0 110.516 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.21 16.91 1.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.47 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.02 126.26 30.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.567 HD23 ' HG3' ' A' ' 6' ' ' ARG . 27.1 mt -64.96 131.58 46.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.331 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.61 164.15 12.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.88 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.78 178.52 10.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 16.1 t70 -67.02 115.36 6.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 0.0 110.564 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.36 25.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.479 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -91.7 174.1 7.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -134.27 137.13 44.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.497 0.665 . . . . 0.0 111.49 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.506 HG21 HD13 ' A' ' 69' ' ' LEU . 27.2 m -126.4 176.01 7.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.236 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -153.24 156.69 38.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.72 0.295 . . . . 0.0 110.75 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.609 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -66.96 127.53 32.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.351 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.901 HG13 ' HG3' ' A' ' 23' ' ' LYS . 34.9 pt -92.91 -10.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.901 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.7 mtpt -141.71 -174.01 3.94 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.9 94.31 6.5 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.65 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 3.4 mm? . . . . . 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.586 -175.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.3 mmmt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.284 0.564 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -59.88 129.86 43.94 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.685 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.95 -6.66 54.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.849 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.527 ' HB ' HD23 ' A' ' 21' ' ' LEU . 89.3 m -59.98 112.11 1.75 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.152 0.476 . . . . 0.0 110.241 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.4 ttm -89.29 117.6 28.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.303 0.573 . . . . 0.0 111.254 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.1 mt -106.27 92.85 2.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.89 175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.75 140.27 37.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 -175.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 49.68 2.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.644 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.603 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.71 169.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 21.6 ptt180 -148.56 156.21 42.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.133 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 5' ' ' VAL . 37.6 mt -76.82 135.42 38.91 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 p -87.33 -70.96 0.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.801 0.81 . . . . 0.0 111.164 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.4 t70 179.07 -31.05 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.283 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -73.6 145.51 45.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.833 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.604 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -89.32 -18.23 27.34 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.44 -20.29 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.506 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 65' ' ' ARG . 7.2 mp0 -127.26 154.56 44.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.533 -174.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.814 HG23 HG11 ' A' ' 5' ' ' VAL . 10.7 pt -134.35 176.71 8.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.254 171.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 7.8 tt0 -125.39 140.02 53.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.7 -166.33 11.85 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.053 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 . . . . . 0 C--N 1.316 -0.881 0 CA-C-O 121.195 0.521 . . . . 0.0 110.473 -177.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.7 48.25 29.43 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.337 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.6 pt? -114.39 135.99 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 109.831 177.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 32.0 t -92.77 123.84 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.906 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -135.5 143.17 45.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.899 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.748 ' HG3' ' HE1' ' A' ' 68' ' ' PHE . 3.2 ptp85 -60.05 134.29 56.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.482 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.41 HG21 HG12 ' A' ' 5' ' ' VAL . 8.8 t -87.98 26.21 1.41 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.546 0.688 . . . . 0.0 110.456 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 28.8 mt-10 -84.59 -30.98 24.56 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.835 0.826 . . . . 0.0 109.96 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.748 ' HE1' ' HG3' ' A' ' 65' ' ' ARG . 53.7 p90 -114.15 19.72 16.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.106 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 19' ' ' VAL . 74.4 mt -114.22 145.48 41.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.405 0.621 . . . . 0.0 110.62 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 1.5 tmtt? -113.27 126.0 54.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.583 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -64.71 121.94 15.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.053 -174.617 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.515 ' HB2' HD21 ' A' ' 12' ' ' LEU . 5.2 pt-20 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 121.381 0.61 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.695 HG11 HG23 ' A' ' 52' ' ' ILE . 3.0 t -92.45 119.42 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.41 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -123.73 161.32 25.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.868 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.644 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 21.0 p-10 -82.64 -166.23 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.9 p -72.1 -7.62 50.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.994 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -97.94 -37.51 9.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.444 0.64 . . . . 0.0 109.712 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.92 9.37 7.51 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.269 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 128.84 34.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 4' ' ' GLU . 24.7 mt -70.77 139.75 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.744 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -103.64 173.31 6.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.032 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -160.92 -179.73 7.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.307 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.31 122.18 17.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 0.0 110.288 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.03 27.56 20.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.758 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -98.35 173.62 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -135.17 140.57 45.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.707 0.765 . . . . 0.0 111.69 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.547 HG21 HD13 ' A' ' 69' ' ' LEU . 19.4 m -139.44 178.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.245 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -153.38 155.1 35.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 0.0 111.197 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.719 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -68.9 127.53 33.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.704 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 68' ' ' PHE . 27.3 pt -93.09 -7.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.982 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' HD22 ' A' ' 25' ' ' LEU . 18.6 ptpt -160.1 178.55 9.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.4 122.58 30.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.719 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.647 0.261 . . . . 0.0 110.33 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt . . . . . 0 N--CA 1.448 -0.532 0 CA-C-O 121.029 0.443 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -61.87 141.14 58.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.022 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.82 -6.28 54.43 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.433 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.517 ' HB ' HD23 ' A' ' 21' ' ' LEU . 31.6 m -71.77 121.47 18.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.44 129.07 36.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.328 0.585 . . . . 0.0 110.763 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' A' ' 19' ' ' VAL . 33.1 mt -113.7 94.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.189 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.07 142.91 42.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.005 0.431 . . . . 0.0 110.915 -176.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.15 47.34 4.44 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.68 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -94.71 164.29 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.783 0.325 . . . . 0.0 110.192 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -137.72 148.91 46.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.205 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.88 149.76 44.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.912 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.4 p -116.86 -160.9 0.78 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.791 0.329 . . . . 0.0 110.43 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.47 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.42 0.629 . . . . 0.0 109.601 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.615 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.5 m -107.47 142.45 37.31 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.028 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.553 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -87.9 -18.49 29.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.503 177.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -94.98 -13.77 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.138 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 4.0 mt-10 -126.63 146.32 50.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.959 0.885 . . . . 0.0 112.48 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.695 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -135.33 162.75 37.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.303 173.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.91 132.9 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.68 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -148.93 -163.98 11.26 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.83 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 . . . . . 0 C--N 1.317 -0.821 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 -179.176 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.755 0.312 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.98 47.33 89.66 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.58 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -109.93 135.55 50.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.65 120.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.672 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.751 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 38.6 mt -132.01 141.11 49.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.539 0.685 . . . . 0.0 112.785 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.623 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.7 ptm180 -53.61 129.05 31.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.095 164.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.0 t -91.78 21.07 5.04 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.26 0.552 . . . . 0.0 110.843 -173.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.69 -8.49 37.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.192 0.52 . . . . 0.0 110.675 -174.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.751 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 5.1 p90 -114.4 16.07 17.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.435 0.636 . . . . 0.0 109.938 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 19' ' ' VAL . 82.4 mt -112.24 149.1 32.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.386 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.644 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtt? -119.58 124.76 47.16 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.675 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.515 ' HA ' HG12 ' A' ' 19' ' ' VAL . 62.1 tttp -62.39 125.29 23.39 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.977 0.418 . . . . 0.0 111.015 -174.049 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.514 -0.429 0 CA-C-O 121.469 0.652 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.738 HG22 ' HA ' ' A' ' 49' ' ' GLU . 2.6 t -81.95 127.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.091 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.43 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.48 160.52 32.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.881 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -172.84 1.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.509 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 22' ' ' ILE . 11.2 p -54.88 -33.37 61.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.66 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -81.33 -59.64 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.322 0.582 . . . . 0.0 110.647 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.23 25.21 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.722 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 128.23 35.56 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' ' 6' ' ' ARG . 18.6 mt -71.05 137.58 49.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.543 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 43' ' ' ILE . 87.3 mt -107.49 172.26 6.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.736 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.25 175.38 11.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.188 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 21.7 t70 -65.87 117.04 7.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.989 0.423 . . . . 0.0 110.796 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.6 10.15 38.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.983 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.559 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -90.08 174.87 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.58 143.89 47.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.643 0.735 . . . . 0.0 112.215 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.414 HG21 HD13 ' A' ' 69' ' ' LEU . 34.7 m -135.09 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.096 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.491 ' OG ' ' HG3' ' A' ' 39' ' ' MET . 73.9 m -153.2 157.82 40.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.542 HD12 HD23 ' A' ' 25' ' ' LEU . 3.9 mm? -70.15 129.13 38.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.889 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.769 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.2 pt -93.04 -4.76 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.769 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -164.22 179.34 6.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.272 -178.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.09 110.1 19.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.191 0.307 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.556 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 4.0 mm? . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 21.9 mmmt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 121.361 0.601 . . . . 0.0 111.977 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -59.61 132.53 54.25 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.171 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.72 -15.92 40.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.726 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.489 ' HB ' HD23 ' A' ' 21' ' ' LEU . 59.9 m -56.2 121.93 10.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.491 ' HG3' ' OG ' ' A' ' 20' ' ' SER . 11.0 ttt -100.31 120.47 39.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.179 0.514 . . . . 0.0 111.039 -173.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.9 mt -109.84 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.669 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.18 135.81 43.11 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.874 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 51.13 1.3 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.414 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.586 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -100.51 165.29 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.703 0.287 . . . . 0.0 110.322 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.5 ptp180 -142.19 158.47 43.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.394 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.488 HD22 ' CG2' ' A' ' 5' ' ' VAL . 34.8 mt -78.15 138.47 38.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -107.48 -172.4 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.658 -171.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.34 -35.75 78.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.684 0.754 . . . . 0.0 109.217 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 71.3 m -88.02 147.12 25.14 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.208 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.738 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.76 -1.4 26.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.842 0.83 . . . . 0.0 109.593 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 66' ' ' THR . 36.1 t70 -95.94 -5.69 40.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.81 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 7.6 mt-10 -133.3 157.9 44.3 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.559 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.535 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 7.3 pt -139.01 168.12 19.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.625 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -122.67 127.84 49.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.586 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -138.98 -170.98 11.99 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.274 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 . . . . . 0 C--N 1.317 -0.805 0 CA-C-O 121.173 0.511 . . . . 0.0 109.952 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.26 47.69 69.87 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.016 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -107.53 133.35 52.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.6 t -92.49 117.46 35.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.814 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.614 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 23.7 mt -127.34 143.97 51.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.135 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.599 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.8 ptp180 -59.66 133.35 56.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.377 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 50' ' ' ASP . 13.1 t -89.37 31.83 0.89 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.487 0.661 . . . . 0.0 110.732 -175.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 16.3 mt-10 -85.3 -32.4 22.52 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.58 0.705 . . . . 0.0 109.795 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.614 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 38.2 p90 -112.92 15.95 19.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.366 -172.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 19' ' ' VAL . 61.3 mt -112.64 142.31 45.39 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.337 0.589 . . . . 0.0 110.294 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -115.32 132.82 56.49 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.767 -177.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.559 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.0 tmtt? -66.07 120.54 13.34 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.618 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -167.616 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.509 ' HB3' HD21 ' A' ' 12' ' ' LEU . 41.4 mt-10 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.278 0.561 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 49' ' ' GLU . 5.8 t -105.24 123.92 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.05 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.54 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -131.14 158.79 39.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 30.0 p-10 -80.27 -169.75 2.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' HG21 ' A' ' 22' ' ' ILE . 26.7 p -67.34 -19.24 65.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.665 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -80.29 -48.67 12.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.844 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 17.18 2.85 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.612 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.53 133.22 35.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.54 HD23 ' HG3' ' A' ' 6' ' ' ARG . 19.8 mt -72.7 135.91 45.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.102 0.477 . . . . 0.0 111.354 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.04 168.74 8.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.749 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.48 172.98 14.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.669 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.0 t70 -63.95 120.73 12.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.968 0.414 . . . . 0.0 110.134 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.12 3.79 44.83 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.975 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -84.28 174.85 9.82 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -139.9 132.85 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.328 0.585 . . . . 0.0 111.094 -178.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.575 HG21 HD13 ' A' ' 69' ' ' LEU . 29.7 m -124.77 173.62 10.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.004 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 m -150.49 151.95 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.962 0.411 . . . . 0.0 111.146 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.671 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -65.03 127.12 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.78 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.6 HG21 ' SG ' ' A' ' 8' ' ' CYS . 35.0 pt -90.31 -11.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.26 0.553 . . . . 0.0 110.765 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.584 ' HG3' ' CD2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -154.47 -178.81 7.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . 1.6 m-20 -96.79 110.22 22.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.671 HD23 HD12 ' A' ' 21' ' ' LEU . 3.6 mm? . . . . . 0 C--N 1.323 -0.545 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HD2' ' HB3' ' A' ' 24' ' ' ASP . 29.0 mmmt . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 36' ' ' ARG . 39.0 ttt-85 -56.43 133.57 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.563 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.79 -10.2 64.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.184 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.418 ' HB ' HD23 ' A' ' 21' ' ' LEU . 87.3 m -57.23 124.0 17.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.142 0.471 . . . . 0.0 110.291 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -93.96 122.4 36.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.255 0.55 . . . . 0.0 111.281 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.426 ' HB ' HG23 ' A' ' 19' ' ' VAL . 41.1 mt -110.8 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.069 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 13.3 ptt180 -108.76 159.28 16.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.719 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.2 39.63 15.44 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.634 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -91.05 161.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.874 0.368 . . . . 0.0 110.368 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 2.9 ptp180 -141.99 158.25 43.99 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.258 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 5' ' ' VAL . 30.9 mt -80.33 154.75 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.808 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 p -127.8 -167.13 1.71 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.232 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.42 -21.95 66.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.201 0.525 . . . . 0.0 110.324 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 70.8 m -85.09 142.87 29.23 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -90.03 -7.6 53.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.8 0.809 . . . . 0.0 108.969 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -116.39 -5.5 11.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.185 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.7 mp0 -125.25 144.4 50.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 0.0 111.217 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.42 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -134.32 156.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.146 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HB2' HG22 ' A' ' 63' ' ' VAL . 37.9 tt0 -115.32 130.56 56.94 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.634 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -148.92 -161.14 9.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.299 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.646 -178.311 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.915 0.388 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.0 47.04 5.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.756 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.09 136.08 53.51 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.184 0.516 . . . . 0.0 110.465 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 53' ' ' GLU . 45.7 t -89.48 119.34 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.791 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.0 mt -129.9 147.36 51.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.917 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.577 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 2.4 ptp85 -65.18 130.25 42.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.954 172.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.525 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.8 t -85.58 30.69 0.62 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 0.0 110.592 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -88.03 -21.32 24.84 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.825 0.822 . . . . 0.0 109.706 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.58 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 33.8 p90 -117.97 18.41 13.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.563 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.575 HD13 HG21 ' A' ' 19' ' ' VAL . 68.0 mt -115.54 148.34 39.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.104 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -125.07 128.64 48.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.75 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.06 119.21 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.325 -172.74 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.52 ' HB3' HD21 ' A' ' 12' ' ' LEU . 30.5 mt-10 . . . . . 0 CA--C 1.516 -0.332 0 CA-C-O 121.178 0.513 . . . . 0.0 111.699 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -104.52 126.12 59.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.55 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.618 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 32.4 p-10 -80.07 -165.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.711 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.3 p -74.86 -8.59 56.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.25 0.548 . . . . 0.0 110.646 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -91.83 -44.66 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.686 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.22 13.25 3.61 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.301 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.7 130.76 38.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.55 HD23 ' HG3' ' A' ' 6' ' ' ARG . 19.8 mt -66.7 143.57 56.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 112.241 -176.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -109.93 169.13 8.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.21 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -160.37 177.93 10.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.2 t70 -66.84 122.84 18.59 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 14.74 41.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.747 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.482 ' C ' HD22 ' A' ' 18' ' ' ASN . 0.7 OUTLIER -91.14 165.01 13.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -117.96 147.86 42.76 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.539 HG22 HG21 ' A' ' 43' ' ' ILE . 28.0 m -143.82 171.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.119 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -152.11 157.56 41.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.747 0.308 . . . . 0.0 111.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.653 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -69.6 124.19 23.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.632 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.711 HG21 ' SG ' ' A' ' 8' ' ' CYS . 40.5 pt -91.93 -12.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.269 0.557 . . . . 0.0 110.572 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.635 ' HG2' HG13 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -150.95 173.6 14.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.25 -177.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.17 122.76 32.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 120.931 0.396 . . . . 0.0 110.71 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 27.4 mmmt . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 121.49 0.662 . . . . 0.0 111.379 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -60.86 149.29 36.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.719 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.21 -3.04 79.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.898 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.458 ' HB ' HD23 ' A' ' 21' ' ' LEU . 84.5 m -68.08 121.84 16.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.509 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttm -87.86 129.38 35.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.603 . . . . 0.0 111.192 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.488 ' HB ' HG23 ' A' ' 19' ' ' VAL . 52.0 mt -122.14 92.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.973 172.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -106.87 136.26 47.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 111.012 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.82 52.09 1.22 Allowed Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.583 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -104.41 164.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 10.2 ptp85 -143.91 165.4 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.239 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD22 ' HB ' ' A' ' 5' ' ' VAL . 30.7 mt -80.67 150.88 29.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.052 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -111.99 -155.97 0.58 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.62 -8.53 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.094 0.473 . . . . 0.0 109.736 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 44.4 t -94.99 161.81 13.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.702 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' HA ' HG22 ' A' ' 5' ' ' VAL . 33.8 mt-10 -101.02 -5.29 26.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.774 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 66' ' ' THR . 5.1 m-20 -131.5 0.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.297 -176.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 3.6 mp0 -120.43 143.41 48.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.104 0.478 . . . . 0.0 110.185 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.11 165.33 32.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.873 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 4.0 tm-20 -125.04 125.56 44.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -151.94 -166.78 14.38 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.676 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 35.6 ptt180 . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 60' ' ' LYS . 1.6 ptmm? . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.819 0.342 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.456 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 89.6 52.48 2.65 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.703 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -116.13 140.71 49.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.035 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.69 116.57 35.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.082 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.598 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 31.7 mt -130.17 152.66 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.245 0.545 . . . . 0.0 111.988 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.584 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 ptt180 -72.93 131.04 41.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.48 173.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.2 t -85.6 25.86 1.01 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.659 -175.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 1.3 pt-20 -83.33 -19.9 35.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.626 0.727 . . . . 0.0 109.667 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.598 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 26.8 p90 -118.31 17.51 13.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.055 -178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.523 HD13 HG21 ' A' ' 19' ' ' VAL . 76.1 mt -114.21 149.07 36.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.444 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.618 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.6 tmtt? -119.54 129.06 54.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.666 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HZ2' ' CG ' ' A' ' 17' ' ' ASP . 39.9 tttp -62.05 116.49 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.419 . . . . 0.0 111.406 -174.531 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.507 ' HB3' HD21 ' A' ' 12' ' ' LEU . 42.4 mt-10 . . . . . 0 CA--C 1.511 -0.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.754 HG11 HG23 ' A' ' 52' ' ' ILE . 2.7 t -78.58 121.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.226 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -126.29 151.59 47.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.969 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -77.37 -172.05 2.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.637 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.7 p -65.11 -23.64 67.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.602 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.17 -28.62 31.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.563 177.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.14 15.73 12.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.229 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.7 136.05 33.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 4' ' ' GLU . 17.7 mt -70.51 138.75 51.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.559 . . . . 0.0 111.658 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.428 ' HB3' HD11 ' A' ' 43' ' ' ILE . 94.7 mt -104.63 173.53 6.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.06 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.2 173.36 14.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.128 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 29.2 t70 -64.84 121.34 14.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.344 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.27 31.55 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.024 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.91 173.93 6.83 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.826 -0.22 . . . . 0.0 111.147 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.3 p30 -131.22 139.45 49.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.619 0.723 . . . . 0.0 112.092 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.557 HG12 ' HA ' ' A' ' 71' ' ' LYS . 29.3 m -140.45 172.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.036 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -152.55 157.03 40.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 0.0 111.625 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -66.9 135.73 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.381 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.745 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.3 pt -97.1 -8.32 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.092 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.745 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -159.63 175.71 12.88 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -176.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.36 110.3 21.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.601 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.578 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.9 mmmt . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.407 0.623 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -61.61 134.92 57.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.267 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.49 -9.36 64.63 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.053 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.461 ' HB ' HD23 ' A' ' 21' ' ' LEU . 97.6 m -59.5 124.56 20.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.815 0.308 . . . . 0.0 110.316 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.8 ttm -96.55 124.92 40.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.516 0.674 . . . . 0.0 111.038 -176.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.0 mt -115.14 94.47 3.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.002 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -111.23 147.13 35.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -177.352 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.23 39.03 5.51 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.624 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -89.99 166.7 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.906 0.384 . . . . 0.0 110.278 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 5.7 ptp85 -140.29 158.07 44.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.936 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.555 HD22 ' HB ' ' A' ' 5' ' ' VAL . 39.7 mt -84.12 130.51 34.85 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.9 p -93.43 -171.62 2.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.55 6.96 15.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.497 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -103.64 143.66 32.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.48 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 5' ' ' VAL . 17.3 mt-10 -87.58 -25.14 23.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.359 0.6 . . . . 0.0 109.936 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 66' ' ' THR . 9.2 m-20 -96.94 -7.31 33.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.136 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -126.87 147.74 50.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 111.5 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.754 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -131.6 168.45 23.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.339 173.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.25 129.31 53.99 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.624 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -141.21 -165.86 10.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.074 -175.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 18.3 ptt85 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.177 0.513 . . . . 0.0 110.046 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 11.5 ptmm? . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.768 0.318 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.65 30.66 39.07 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.411 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -101.81 139.9 36.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.32 116.88 36.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.761 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -128.37 144.51 51.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.579 0.704 . . . . 0.0 111.996 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.569 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 13.8 ptt180 -66.16 135.83 55.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.43 173.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 50' ' ' ASP . 9.0 t -89.23 30.51 0.97 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.568 0.699 . . . . 0.0 110.561 -176.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 31.0 mt-10 -80.1 -31.8 39.21 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.944 0.878 . . . . 0.0 109.501 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 48.8 p90 -116.77 16.57 15.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.441 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.58 145.61 36.09 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.163 0.506 . . . . 0.0 109.871 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -119.74 128.47 53.8 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.588 -178.268 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.557 ' HA ' HG12 ' A' ' 19' ' ' VAL . 58.5 tttp -63.36 127.81 33.0 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.806 -169.073 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 34.7 mt-10 . . . . . 0 CA--C 1.516 -0.342 0 CA-C-O 121.567 0.698 . . . . 0.0 111.886 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.636 HG11 HG23 ' A' ' 52' ' ' ILE . 4.6 t -96.99 127.61 49.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.077 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -128.03 148.68 50.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -73.98 -171.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.627 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 22' ' ' ILE . 26.5 p -63.82 -29.12 70.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -25.89 56.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.38 18.93 13.23 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.962 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.23 136.25 36.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.137 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.568 HD23 ' HG3' ' A' ' 6' ' ' ARG . 25.6 mt -67.93 138.3 55.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.759 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -108.13 170.29 8.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.155 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.42 174.16 15.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.455 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 19.9 t70 -67.68 114.16 6.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.845 0.355 . . . . 0.0 110.357 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.49 2.27 29.25 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.65 173.05 11.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -136.12 141.68 44.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 111.411 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 71' ' ' LYS . 31.3 m -134.88 177.03 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.342 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 m -151.07 153.24 34.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.0 111.321 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -64.21 128.52 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.7 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.721 HG13 ' HG2' ' A' ' 23' ' ' LYS . 42.2 pt -90.53 -11.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.773 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.721 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.99 -178.28 7.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.174 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.55 117.18 26.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.601 HD23 HD12 ' A' ' 21' ' ' LEU . 3.9 mm? . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.174 0.512 . . . . 0.0 110.631 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 22.4 mmmt . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 121.321 0.582 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -61.25 137.83 58.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.142 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.03 -14.88 59.77 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.52 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.476 ' HB ' HD23 ' A' ' 21' ' ' LEU . 88.2 m -56.61 119.93 6.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 110.039 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.1 ttt -94.05 122.91 37.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.363 0.601 . . . . 0.0 110.753 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.3 mt -110.54 90.51 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.797 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.506 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -104.67 137.6 42.25 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.371 -175.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.02 50.45 2.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.379 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.567 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -97.18 164.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.7 ptp180 -142.83 157.79 44.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.543 HD22 ' HB ' ' A' ' 5' ' ' VAL . 32.9 mt -75.64 155.1 36.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.665 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -121.69 -167.87 1.6 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.79 -20.08 65.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.6 m -85.75 147.74 26.19 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.954 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.499 ' HA ' HG22 ' A' ' 5' ' ' VAL . 28.1 mt-10 -96.14 -13.8 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.503 0.668 . . . . 0.0 109.517 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -106.85 -5.92 18.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.862 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 2.0 mp0 -127.96 146.56 50.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.335 0.588 . . . . 0.0 111.44 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.636 HG23 HG11 ' A' ' 5' ' ' VAL . 2.7 pp -131.09 166.62 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.304 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 31.2 tt0 -117.92 124.84 49.23 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.04 -166.16 10.69 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.085 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 15.5 ptp180 . . . . . 0 C--N 1.322 -0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 12.6 ptmm? . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.69 39.8 13.55 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.209 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -110.54 138.64 46.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.907 0.384 . . . . 0.0 109.983 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 43.4 t -93.23 116.77 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.518 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -128.69 145.6 51.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 111.796 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.619 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -64.11 130.88 45.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.235 173.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.5 t -86.41 26.47 1.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.647 -175.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 32.5 mt-10 -84.0 -25.51 29.91 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.938 0.875 . . . . 0.0 109.392 -175.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.619 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 32.1 p90 -113.98 16.95 18.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.61 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 66' ' ' THR . 65.1 mt -114.17 145.84 41.14 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.953 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -118.7 125.59 50.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.124 -178.021 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.569 ' HA ' HG12 ' A' ' 19' ' ' VAL . 54.3 tttp -62.65 122.37 15.68 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.392 0.432 . . . . 0.0 110.125 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.653 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -177.234 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.849 0.357 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 m -136.8 93.59 2.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.624 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -113.85 53.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.484 0.659 . . . . 0.0 109.467 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' HB3' HD21 ' A' ' 12' ' ' LEU . 32.6 mt-10 -63.55 100.09 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.559 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.768 HG11 HG23 ' A' ' 52' ' ' ILE . 19.2 t -85.96 121.26 37.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.602 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 75.6 mtt180 -124.93 153.19 43.08 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -174.17 0.88 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 111.085 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' HG21 ' A' ' 22' ' ' ILE . 13.7 p -56.05 -30.68 62.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.607 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -83.85 -56.7 3.55 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.974 0.416 . . . . 0.0 110.352 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.29 19.2 0.13 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.245 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 71' ' ' LYS . . . -83.05 135.6 34.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.047 0.423 . . . . 0.0 110.039 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 4' ' ' GLU . 15.8 mt -77.29 135.7 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.288 0.566 . . . . 0.0 112.445 -174.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' HB3' HD11 ' A' ' 43' ' ' ILE . 63.9 mt -112.0 166.72 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.711 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.9 179.49 9.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.26 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -64.69 118.37 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.16 8.56 50.24 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.217 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.84 174.19 8.11 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.838 -0.213 . . . . 0.0 110.467 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 3.2 p30 -133.7 139.63 46.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.526 0.679 . . . . 0.0 111.585 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.488 HG21 HD13 ' A' ' 69' ' ' LEU . 34.6 m -131.88 174.7 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.213 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 m -151.89 148.88 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.807 0.337 . . . . 0.0 110.781 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.698 HD12 HD23 ' A' ' 25' ' ' LEU . 4.5 mm? -60.74 130.04 44.5 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.236 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.663 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -91.15 -11.33 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.56 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.663 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.55 178.34 10.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.296 -178.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -91.44 121.9 33.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.698 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? -117.33 125.23 50.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.759 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.6 tmmt? -101.04 138.01 38.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.576 0.703 . . . . 0.0 111.167 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.429 HD23 HD13 ' A' ' 34' ' ' LEU . 4.4 mm? -109.31 149.64 29.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.543 176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 49.5 mtpt -72.48 -33.7 67.16 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.796 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.25 105.81 0.54 Allowed Glycine 0 C--N 1.329 0.172 0 C-N-CA 121.276 -0.488 . . . . 0.0 112.976 -176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 m 59.42 20.78 9.13 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 122.837 0.455 . . . . 0.0 111.315 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 t 55.89 73.53 0.43 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.261 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.1 m -101.51 103.14 14.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.828 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG22 ' HG3' ' A' ' 26' ' ' LYS . 30.0 t -96.88 101.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.013 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.429 HD13 HD23 ' A' ' 27' ' ' LEU . 6.1 mp -77.86 147.53 35.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.5 mmmt -109.96 160.85 16.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.529 0.68 . . . . 0.0 111.668 -174.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -61.61 138.78 58.32 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.984 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.04 -13.07 63.75 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.634 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.547 ' HB ' HD23 ' A' ' 21' ' ' LEU . 77.9 m -58.78 119.41 7.09 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 7.4 ttt -87.98 124.65 33.93 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.282 0.563 . . . . 0.0 110.751 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.753 HG12 HG22 ' A' ' 56' ' ' THR . 43.6 mt -114.53 91.02 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.664 173.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -108.61 149.53 28.77 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.708 -176.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.58 6.54 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.221 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.568 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.0 pp -91.65 160.18 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 8.2 ptt180 -141.06 161.01 38.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.748 0.309 . . . . 0.0 110.579 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.522 HD22 ' CG2' ' A' ' 5' ' ' VAL . 25.9 mt -79.86 154.06 28.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.238 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -121.46 -159.33 0.8 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.23 -14.2 62.16 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.686 0.755 . . . . 0.0 109.261 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 65.6 m -101.03 148.35 25.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.669 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HA ' HG22 ' A' ' 5' ' ' VAL . 23.8 mt-10 -92.5 -16.43 25.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.36 -14.94 23.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.382 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 8.2 mp0 -125.66 148.73 48.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.548 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.768 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -132.45 160.92 42.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.253 171.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.0 tt0 -115.58 122.68 46.37 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -133.33 -156.1 7.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.716 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.7 ptp180 -149.45 148.17 29.11 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.753 HG22 HG12 ' A' ' 40' ' ' ILE . 68.4 p -122.41 -176.06 3.28 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -64.58 -38.03 89.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.963 0.411 . . . . 0.0 110.677 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -101.98 -39.9 7.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mm -114.63 104.2 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HD2' ' C ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -100.16 149.16 23.82 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.485 176.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.61 50.57 42.05 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.64 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.23 135.39 54.22 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.083 0.468 . . . . 0.0 110.033 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.3 t -92.66 122.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.746 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.7 mt -134.02 147.0 50.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.37 0.605 . . . . 0.0 112.191 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.584 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.8 ptp180 -66.34 130.51 43.47 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.947 170.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.495 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.2 t -86.23 26.29 1.06 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.251 0.548 . . . . 0.0 110.856 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.0 mt-10 -84.17 -22.58 30.93 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.714 0.769 . . . . 0.0 109.652 -175.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.746 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 24.2 p90 -117.32 19.44 14.09 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.749 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 66' ' ' THR . 60.6 mt -116.68 145.48 43.41 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.014 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -114.4 133.27 55.84 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.247 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.64 ' HD2' ' HB1' ' A' ' 11' ' ' ALA . 52.1 tttt -58.43 122.32 13.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.64 173.1 8.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.785 0.326 . . . . 0.0 110.929 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.35 -89.37 1.3 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.585 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.57 -0.728 . . . . 0.0 109.955 178.804 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -129.1 110.16 11.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.248 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 23.7 pt -138.91 68.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.567 0.698 . . . . 0.0 110.181 172.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.83 102.91 7.45 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.6 t -91.63 129.84 41.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.779 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.573 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -133.98 171.09 14.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.19 -169.72 2.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' HG21 ' A' ' 22' ' ' ILE . 7.7 p -66.39 -27.77 68.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.295 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -82.46 -51.03 8.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.642 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.09 27.1 0.26 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.772 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.65 123.78 40.43 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.573 HD23 ' HG3' ' A' ' 6' ' ' ARG . 27.4 mt -60.35 143.78 52.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.457 0.646 . . . . 0.0 112.642 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' HB3' HD11 ' A' ' 43' ' ' ILE . 95.7 mt -111.36 170.85 7.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.14 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.47 178.17 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.613 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.86 122.0 14.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.012 0.434 . . . . 0.0 110.946 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.19 64.33 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.374 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.615 ' C ' HD22 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -78.54 173.06 12.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.697 0.284 . . . . 0.0 110.703 -175.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.615 HD22 ' C ' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -124.46 146.35 48.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.255 0.55 . . . . 0.0 110.523 -177.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 43' ' ' ILE . 27.7 m -142.55 170.82 11.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.532 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -153.18 158.66 42.11 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.76 0.314 . . . . 0.0 110.713 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.586 HD12 HD23 ' A' ' 25' ' ' LEU . 3.4 mm? -67.66 135.16 52.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.537 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.601 HG13 ' HG2' ' A' ' 23' ' ' LYS . 37.2 pt -96.59 -11.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 110.838 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -155.86 174.79 14.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.134 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.54 107.61 18.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.586 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? -101.1 115.66 31.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.278 0.561 . . . . 0.0 111.199 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.734 ' HG3' HG22 ' A' ' 33' ' ' VAL . 4.3 tmmt? -98.88 132.68 44.03 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.448 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.6 mt -104.36 157.34 17.21 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.078 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.36 148.32 35.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.655 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.15 -119.91 2.48 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 p -86.54 23.25 1.68 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.722 0.296 . . . . 0.0 110.548 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.6 m 63.91 79.52 0.26 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.574 -174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.3 m -101.07 104.03 15.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.942 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.734 HG22 ' HG3' ' A' ' 26' ' ' LYS . 31.4 t -99.57 116.69 43.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.464 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.46 146.82 26.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 23.6 mmmt -106.76 161.38 14.72 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.471 0.653 . . . . 0.0 111.812 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.47 139.56 58.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.249 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.71 68.54 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.943 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.568 ' HB ' HD23 ' A' ' 21' ' ' LEU . 85.3 m -58.17 121.39 10.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.783 0.291 . . . . 0.0 110.256 177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.2 ttm -92.24 117.01 29.45 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.363 0.601 . . . . 0.0 111.516 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.407 ' HB ' HG23 ' A' ' 19' ' ' VAL . 51.5 mt -104.05 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.586 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.33 135.74 47.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.394 -174.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.68 48.85 2.06 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.335 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 2.1 pp -94.25 160.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -138.95 159.88 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.106 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.6 mt -85.87 138.26 32.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 79.4 p -98.33 -156.8 0.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.779 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -90.29 -2.08 57.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 109.668 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 58.1 m -98.29 149.08 22.98 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.27 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.606 ' HA ' HG22 ' A' ' 5' ' ' VAL . 27.3 mt-10 -94.85 -14.88 24.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.623 0.725 . . . . 0.0 109.376 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 66' ' ' THR . 1.0 OUTLIER -108.32 -2.94 18.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.538 -176.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -130.01 147.57 51.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.156 0.503 . . . . 0.0 111.044 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.49 ' CG2' HG11 ' A' ' 5' ' ' VAL . 15.7 pt -135.18 175.76 10.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.642 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -130.74 135.31 47.67 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 172.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -139.65 -177.6 15.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.864 -1.16 . . . . 0.0 112.281 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 55' ' ' ARG . 10.1 ptt180 -130.0 137.07 50.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.234 0.54 . . . . 0.0 110.179 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.6 p -104.55 -171.52 1.94 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.244 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.01 -23.64 62.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.994 0.426 . . . . 0.0 110.265 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -108.48 -73.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.166 0.507 . . . . 0.0 110.556 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.8 mm -82.25 117.22 27.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.415 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 60' ' ' LYS . 20.0 ptmt -107.17 135.03 49.39 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.55 49.28 5.86 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.651 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -110.99 134.57 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' A' ' 53' ' ' GLU . 39.4 t -91.72 125.09 44.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.908 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.546 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 33.4 mt -137.31 145.77 43.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.666 -177.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.667 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -62.99 130.48 44.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.759 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -83.83 23.96 0.94 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.745 0.783 . . . . 0.0 110.204 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -89.58 -15.1 33.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.537 0.684 . . . . 0.0 110.101 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.667 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 53.4 p90 -121.84 17.0 11.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.303 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 66' ' ' THR . 73.6 mt -113.53 147.11 38.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.512 0.672 . . . . 0.0 110.087 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -117.36 124.81 49.82 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.106 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -59.95 118.83 6.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.61 -46.59 78.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.112 0.482 . . . . 0.0 110.042 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 147.41 -129.63 3.29 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.267 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.175 178.085 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.835 0.35 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -135.93 97.98 3.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.808 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.436 ' HB ' ' HG2' ' A' ' 49' ' ' GLU . 20.9 pt -115.12 53.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.505 ' HB3' HD21 ' A' ' 12' ' ' LEU . 46.1 mt-10 -54.69 123.97 14.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.496 -174.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.5 t -113.24 119.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.959 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.572 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -122.32 175.17 6.56 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.837 -177.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 3.1 p-10 -86.05 -164.29 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.065 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.433 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 25.8 p -63.57 -20.37 65.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.547 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.495 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -95.78 -49.36 5.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 0.0 111.005 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.63 10.89 0.77 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.526 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.86 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.572 HD23 ' HG3' ' A' ' 6' ' ' ARG . 25.3 mt -72.51 143.74 48.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.379 0.609 . . . . 0.0 112.28 -173.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.59 166.06 11.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.387 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.79 174.31 15.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.911 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.6 t70 -63.96 121.5 14.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.514 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.49 1.67 53.4 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.006 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -81.73 174.05 11.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.652 0.263 . . . . 0.0 110.404 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 6.9 p30 -132.69 142.91 49.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.617 0.722 . . . . 0.0 111.652 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 71' ' ' LYS . 29.5 m -137.57 174.88 10.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.927 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.1 m -152.19 150.87 30.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.715 0.293 . . . . 0.0 110.714 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 25' ' ' LEU . 4.3 mm? -62.0 128.26 35.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.679 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.656 HG13 ' HG2' ' A' ' 23' ' ' LYS . 36.1 pt -89.6 -10.03 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.814 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -159.79 174.27 14.75 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -85.01 118.75 24.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 21' ' ' LEU . 4.2 mm? -112.18 108.71 18.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 110.407 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 33' ' ' VAL . 5.2 tmmm? -95.07 130.63 41.68 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 32' ' ' THR . 56.2 mt -78.08 151.08 33.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.491 -173.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -86.77 -47.65 8.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.086 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.78 11.52 10.42 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.266 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 58.0 m -159.76 -174.24 4.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.5 m -103.93 20.82 17.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.801 0.81 . . . . 0.0 109.124 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.428 ' HB ' HD12 ' A' ' 27' ' ' LEU . 27.7 m -71.44 104.53 3.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG22 ' HG3' ' A' ' 26' ' ' LYS . 6.5 t -100.92 102.75 13.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.06 141.1 32.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 26.8 mmmt -111.79 157.84 20.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.273 0.559 . . . . 0.0 111.579 -176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -59.76 145.58 44.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.438 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.92 -8.13 78.4 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.608 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.557 ' HB ' HD23 ' A' ' 21' ' ' LEU . 89.6 m -65.16 112.8 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 0.0 110.313 177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.0 ttm -81.5 117.49 21.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.421 0.629 . . . . 0.0 110.979 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 56' ' ' THR . 48.1 mt -108.9 99.81 9.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.961 174.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -111.03 156.58 21.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.924 0.392 . . . . 0.0 111.128 -176.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.51 28.52 35.65 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.587 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.3 pp -78.94 161.77 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.678 0.275 . . . . 0.0 110.423 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.6 ptp180 -140.91 166.2 25.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.922 0.391 . . . . 0.0 110.943 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.489 HD22 ' HB ' ' A' ' 5' ' ' VAL . 39.3 mt -88.47 137.96 31.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.973 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -95.16 -159.77 0.74 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -81.94 -4.76 57.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.385 0.612 . . . . 0.0 109.454 172.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 73.9 m -99.35 146.75 25.94 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' HA ' HG22 ' A' ' 5' ' ' VAL . 22.3 mt-10 -90.51 -15.26 31.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.381 0.61 . . . . 0.0 109.904 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.4 -5.44 20.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.078 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -126.67 145.18 50.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 111.81 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -131.04 173.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.2 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.623 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 11.7 tm-20 -127.98 131.19 49.27 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.04 -166.32 11.61 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.69 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.498 HH11 ' HB3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -151.16 147.87 27.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.361 0.601 . . . . 0.0 111.258 -175.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.58 HG22 HG12 ' A' ' 40' ' ' ILE . 44.2 p -122.17 -170.97 2.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.142 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -59.53 -47.08 86.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.887 0.375 . . . . 0.0 110.304 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -96.92 -70.37 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.215 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mm -75.02 102.27 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.775 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 7.3 ptpp? -119.18 118.37 31.16 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.124 0.487 . . . . 0.0 109.835 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.623 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 103.98 43.14 1.83 Allowed Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.405 -174.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.39 132.67 56.55 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.237 0.541 . . . . 0.0 110.032 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 58.7 t -90.89 124.57 43.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.691 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.711 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -134.05 146.3 50.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.294 0.569 . . . . 0.0 112.189 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.61 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.5 ptp180 -64.7 130.82 45.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.814 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 t -86.24 33.09 0.61 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.986 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.61 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -85.96 -29.63 23.4 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.435 0.636 . . . . 0.0 110.161 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.711 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 38.3 p90 -113.62 18.97 17.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.982 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 19' ' ' VAL . 59.4 mt -113.31 144.71 42.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.972 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HB2' HG22 ' A' ' 22' ' ' ILE . 3.0 tmtt? -114.17 122.38 46.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.641 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.452 ' HA ' HG12 ' A' ' 19' ' ' VAL . 48.7 tttp -57.77 120.59 8.69 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.3 99.15 6.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.109 0.48 . . . . 0.0 110.602 -174.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.93 24.52 3.62 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.836 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.567 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.628 0.251 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -108.85 151.54 26.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.635 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 45.6 pt -119.93 42.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.889 0.376 . . . . 0.0 110.553 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.404 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 32.6 mt-10 -61.71 111.74 1.98 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.587 0.708 . . . . 0.0 110.535 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 52' ' ' ILE . 10.3 t -94.8 132.0 40.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.815 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' HG3' HD23 ' A' ' 12' ' ' LEU . 2.4 mpt_? -132.43 150.06 52.23 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.577 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 3.8 p-10 -77.59 -163.5 0.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.725 0.297 . . . . 0.0 110.634 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.6 t -70.98 -15.6 62.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.309 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.486 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 2.3 t-20 -85.83 -54.78 4.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.716 176.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 10.89 1.91 Allowed Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.609 -174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.43 133.07 35.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.48 HD23 ' HG3' ' A' ' 6' ' ' ARG . 15.2 mt -72.7 135.07 45.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.168 0.508 . . . . 0.0 111.621 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.4 mt -102.4 163.72 12.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.401 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -149.23 177.55 9.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.16 118.24 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.517 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 29.01 12.46 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.647 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.7 t0 -98.72 175.13 6.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -132.73 141.15 48.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.664 0.745 . . . . 0.0 111.818 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.524 HG23 ' HB ' ' A' ' 40' ' ' ILE . 30.6 m -136.86 174.47 11.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.097 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.8 m -153.08 150.94 29.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.77 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.596 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -64.61 129.42 39.78 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.739 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.683 HG13 ' HG2' ' A' ' 23' ' ' LYS . 32.1 pt -90.94 -4.61 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 110.639 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.683 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -165.09 -179.15 5.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.886 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.83 116.56 29.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.596 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? -110.18 117.43 33.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.702 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.6 tmmt? -99.44 130.38 45.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 66.3 mt -103.3 153.9 19.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.776 -171.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -82.8 144.39 30.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.684 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.01 -61.83 0.53 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.8 m -128.26 -76.67 0.56 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -176.18 43.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.3 m -75.19 103.76 5.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.699 -174.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.702 HG22 ' HG3' ' A' ' 26' ' ' LYS . 20.1 t -105.2 100.47 10.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp -80.61 147.7 30.61 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -111.42 159.2 18.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.173 0.511 . . . . 0.0 111.764 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -63.67 140.13 58.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.474 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.89 -5.27 84.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.838 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.526 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -64.32 114.43 4.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.95 0.375 . . . . 0.0 110.077 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 29.8 ttm -81.24 119.32 23.48 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.491 0.662 . . . . 0.0 111.121 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.648 HG12 HG22 ' A' ' 56' ' ' THR . 43.0 mt -106.64 90.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.469 172.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.467 ' C ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -101.07 162.68 12.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.268 -176.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.09 48.82 57.72 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.988 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.699 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -92.96 163.91 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.991 0.424 . . . . 0.0 109.953 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -136.09 159.05 42.91 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.821 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 14' ' ' ALA . 55.2 mt -82.04 130.19 35.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.631 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.4 p -87.98 -158.69 0.48 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.244 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -85.58 -8.37 58.32 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 75.4 m -96.94 150.54 20.65 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.665 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 2.9 mt-10 -90.28 -22.89 21.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 109.927 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -101.77 1.06 36.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.521 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.6 OUTLIER -133.18 144.4 49.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.53 0.681 . . . . 0.0 111.305 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -131.37 157.08 43.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.605 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -113.81 125.84 54.53 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.699 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.49 -160.89 8.72 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.751 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -148.96 144.7 26.97 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.362 0.601 . . . . 0.0 109.971 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.648 HG22 HG12 ' A' ' 40' ' ' ILE . 80.9 p -111.32 -170.09 1.58 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.003 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.5 11.42 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.534 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -147.39 -56.14 0.24 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.409 176.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.64 104.11 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.611 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.76 129.45 45.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.597 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.08 47.35 5.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.818 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -111.53 133.19 53.98 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.99 114.89 30.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.819 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 47.6 mt -128.99 135.79 49.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.78 0.8 . . . . 0.0 112.312 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.571 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 1.4 ptp180 -56.92 130.3 45.31 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.009 167.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.499 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.1 t -88.31 27.79 1.19 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.758 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 14.6 mt-10 -86.17 -16.19 38.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.981 0.896 . . . . 0.0 109.458 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.819 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 34.5 p90 -120.36 19.05 12.15 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.097 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 66' ' ' THR . 86.2 mt -116.65 148.28 41.15 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.131 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.577 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -115.71 126.59 54.28 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.581 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -64.0 122.31 16.22 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.99 121.13 21.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.82 -37.93 3.11 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.147 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.132 -178.755 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 tpp . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.987 0.422 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 m -130.79 84.04 2.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.406 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -107.26 50.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.46 0.648 . . . . 0.0 109.821 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HB3' HD21 ' A' ' 12' ' ' LEU . 48.4 mt-10 -54.89 127.19 27.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.528 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 45' ' ' LEU . 5.1 t -108.88 130.46 61.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.983 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.622 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -131.89 165.14 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.469 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.31 -166.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.668 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.437 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 21.9 p -61.59 -34.36 75.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.372 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -80.28 -40.45 26.88 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.96 0.41 . . . . 0.0 110.767 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 20.09 2.06 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.238 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.06 132.27 36.12 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.622 HD23 ' HG3' ' A' ' 6' ' ' ARG . 24.7 mt -70.55 142.84 51.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.293 0.568 . . . . 0.0 111.894 -172.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HB3' HD11 ' A' ' 43' ' ' ILE . 83.7 mt -108.96 173.77 6.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.63 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -164.78 175.89 9.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.873 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.7 t70 -62.26 125.43 23.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.493 . . . . 0.0 110.574 175.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.73 15.69 59.38 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.935 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.592 ' C ' HD22 ' A' ' 18' ' ' ASN . 0.8 OUTLIER -89.91 171.75 9.37 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.592 HD22 ' C ' ' A' ' 17' ' ' ASP . 0.8 OUTLIER -123.91 145.83 48.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.242 0.544 . . . . 0.0 110.674 -176.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 43' ' ' ILE . 27.7 m -145.07 172.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.5 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.9 m -155.09 156.26 35.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.605 0.24 . . . . 0.0 110.73 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.615 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -70.53 128.16 35.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.651 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.656 HG13 ' HG2' ' A' ' 23' ' ' LYS . 40.2 pt -91.45 -10.0 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.111 0.481 . . . . 0.0 110.823 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -158.04 176.51 12.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.37 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.33 118.94 25.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.615 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? -114.39 109.72 18.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.796 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.766 ' HG3' HG22 ' A' ' 33' ' ' VAL . 4.4 tmmm? -90.9 144.71 25.41 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.036 0.446 . . . . 0.0 110.212 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.7 mt -97.94 141.77 30.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.514 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.88 161.38 23.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.799 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.44 -49.44 1.12 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.942 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.1 p -136.6 178.78 6.8 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 p -83.93 40.96 0.78 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.8 m -90.0 104.86 17.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.006 0.432 . . . . 0.0 110.586 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.766 HG22 ' HG3' ' A' ' 26' ' ' LYS . 17.3 t -112.91 104.15 16.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.108 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 5.7 mp -76.8 141.79 40.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 175.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 26.4 mmmt -111.39 159.78 17.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.589 0.709 . . . . 0.0 112.127 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -59.78 136.35 57.97 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.43 174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.78 -9.97 64.23 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.893 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.538 ' HB ' HD23 ' A' ' 21' ' ' LEU . 87.6 m -59.83 115.81 3.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 110.365 177.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 ttm -87.23 123.54 32.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.455 0.645 . . . . 0.0 111.306 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.523 HG12 HG22 ' A' ' 56' ' ' THR . 45.5 mt -114.6 95.92 4.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.145 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.64 135.96 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.733 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.09 40.33 3.79 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.641 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.56 HG21 HG22 ' A' ' 19' ' ' VAL . 2.2 pp -85.09 167.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 53' ' ' GLU . 6.7 ptp85 -143.2 158.97 43.15 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.072 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 5' ' ' VAL . 33.2 mt -84.01 162.74 20.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.635 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -126.92 -167.62 1.76 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.52 -6.45 55.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.277 0.561 . . . . 0.0 109.542 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 55.1 m -96.81 145.89 25.42 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.422 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 5' ' ' VAL . 23.2 mt-10 -89.47 -23.94 21.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.189 0.519 . . . . 0.0 110.616 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 66' ' ' THR . 16.4 m-20 -105.98 -3.37 21.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.972 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 14.9 mp0 -122.64 146.15 47.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.224 0.535 . . . . 0.0 110.836 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.42 ' CG2' HG11 ' A' ' 5' ' ' VAL . 24.7 pt -133.78 178.21 5.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.801 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.549 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -132.23 127.88 36.71 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -138.67 178.57 19.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.688 -1.244 . . . . 0.0 113.082 -174.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -136.5 141.09 43.44 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.397 0.617 . . . . 0.0 110.851 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.523 HG22 HG12 ' A' ' 40' ' ' ILE . 30.1 p -107.6 -170.19 1.65 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.618 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.89 -16.7 60.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.162 0.506 . . . . 0.0 109.992 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -114.6 -74.13 0.63 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.733 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -78.81 108.9 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -112.85 122.29 47.21 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.496 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.549 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 92.58 51.14 2.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.4 pt? -115.28 135.03 54.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 46.4 t -90.16 119.65 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.147 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.663 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 22.3 mt -133.12 142.89 48.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.648 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.607 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 15.8 ptt180 -64.3 131.65 47.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.736 171.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.439 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.6 t -88.35 27.97 1.16 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.972 -174.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.3 mt-10 -79.87 -27.57 40.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.845 0.831 . . . . 0.0 109.24 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.663 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 31.8 p90 -113.92 17.88 17.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.765 -176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 66' ' ' THR . 72.5 mt -112.48 141.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.393 0.616 . . . . 0.0 110.161 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -110.94 122.05 46.89 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.486 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -59.13 121.35 11.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.69 67.71 3.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.512 0.672 . . . . 0.0 110.962 -175.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.3 126.73 2.15 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.093 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.266 -178.564 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.677 0.275 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -149.6 96.48 2.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.162 0.506 . . . . 0.0 110.182 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.3 pt -135.91 28.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.222 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -49.23 112.63 0.66 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.316 0.579 . . . . 0.0 111.447 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG11 HG23 ' A' ' 52' ' ' ILE . 3.0 t -95.81 133.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.629 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.569 ' HG3' HD23 ' A' ' 12' ' ' LEU . 2.0 mpt_? -131.02 166.09 21.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.16 -174.8 5.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 110.21 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 p -57.44 -34.47 69.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.659 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -79.23 -43.19 24.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.836 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.79 18.37 1.4 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.563 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.54 128.26 34.96 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.569 HD23 ' HG3' ' A' ' 6' ' ' ARG . 17.4 mt -65.53 142.49 58.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.893 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.5 mt -110.39 171.8 7.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.623 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.51 178.99 9.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.6 t70 -75.45 111.04 10.33 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.14 22.75 9.63 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 176.61 6.0 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 4.3 p30 -135.04 140.45 45.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.467 0.651 . . . . 0.0 111.66 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 43' ' ' ILE . 28.9 m -135.67 176.1 9.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.213 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -149.71 157.32 43.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.769 0.319 . . . . 0.0 111.015 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.647 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -69.79 127.24 32.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.813 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.966 HG13 ' HG3' ' A' ' 23' ' ' LYS . 39.2 pt -92.27 -9.24 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.225 0.536 . . . . 0.0 110.368 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.966 ' HG3' HG13 ' A' ' 22' ' ' ILE . 24.1 mtpp -143.02 -179.74 6.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.671 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.27 94.89 7.03 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 172.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.647 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? -96.28 108.65 21.18 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -89.89 128.53 36.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 30' ' ' SER . 6.4 tt -63.6 136.33 57.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.602 -175.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' N ' HD23 ' A' ' 27' ' ' LEU . 21.9 pttp -82.98 114.23 21.11 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.794 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.26 7.13 55.0 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.135 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.607 ' HB2' HD22 ' A' ' 27' ' ' LEU . 61.1 m -150.59 154.52 37.68 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.4 p -83.44 16.77 2.41 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.8 m -80.71 104.44 11.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.077 0.465 . . . . 0.0 110.32 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.586 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 4.9 t -94.1 104.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 8.7 mt -80.44 90.69 5.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.55 0.69 . . . . 0.0 109.464 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 26.1 mmmt -71.18 160.86 32.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.177 -172.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -57.17 134.02 55.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.374 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.18 -9.26 61.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.908 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.522 ' HB ' HD23 ' A' ' 21' ' ' LEU . 97.2 m -60.56 119.78 8.73 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.964 0.382 . . . . 0.0 110.212 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.0 ttm -88.22 122.24 31.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.434 0.635 . . . . 0.0 111.179 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.647 HG12 HG22 ' A' ' 56' ' ' THR . 50.2 mt -113.22 91.86 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.906 173.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -110.96 135.69 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.284 0.564 . . . . 0.0 110.676 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.67 43.76 1.77 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -171.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.619 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.9 pp -98.5 158.05 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -135.26 156.14 49.46 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.9 0.381 . . . . 0.0 111.176 177.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.553 HD22 ' HB ' ' A' ' 5' ' ' VAL . 26.9 mt -75.82 149.03 37.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.163 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.3 p -118.8 -167.96 1.47 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.3 -3.49 33.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 0.0 110.065 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 47.3 m -100.64 138.23 37.96 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.826 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -92.53 -15.04 27.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.146 0.498 . . . . 0.0 110.213 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' O ' HG22 ' A' ' 66' ' ' THR . 17.6 t70 -106.24 -5.23 19.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.949 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.5 mp0 -125.9 146.56 49.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.002 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.643 HG23 HG11 ' A' ' 5' ' ' VAL . 9.3 pt -131.4 172.4 16.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.528 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 38.1 tt0 -126.09 129.73 49.69 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.619 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.26 -167.07 10.98 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 119.966 -1.112 . . . . 0.0 112.623 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -148.19 144.5 27.77 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.647 HG22 HG12 ' A' ' 40' ' ' ILE . 50.5 p -115.88 -171.35 1.96 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.691 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.34 -25.92 68.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.233 0.54 . . . . 0.0 110.282 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -119.99 -71.18 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.892 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 mm -74.26 109.05 6.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.171 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -108.8 138.88 44.43 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.93 51.44 9.1 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.32 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -113.33 135.46 53.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 47.0 t -96.3 119.96 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.116 -176.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.751 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 33.3 mt -133.34 138.91 46.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.585 0.707 . . . . 0.0 112.37 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.516 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 7.2 ptp180 -56.69 134.06 54.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.283 168.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 50' ' ' ASP . 8.9 t -89.29 31.9 0.87 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.622 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 23.4 mt-10 -81.88 -32.93 30.78 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.851 0.834 . . . . 0.0 109.887 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.751 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 30.3 p90 -115.16 20.63 14.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.921 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 19' ' ' VAL . 72.1 mt -116.03 143.75 45.04 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.049 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -119.98 128.94 54.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.945 -176.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -59.61 126.39 27.4 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.64 -146.41 0.35 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.805 0.336 . . . . 0.0 111.132 -172.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.68 145.19 14.37 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.252 1.213 0 C-N-CA 123.877 0.871 . . . . 0.0 112.797 177.583 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.689 0.281 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.2 m -78.61 86.71 4.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.068 0.461 . . . . 0.0 110.61 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.0 pt -129.63 44.62 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.062 173.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.435 ' HB3' ' HE ' ' A' ' 6' ' ' ARG . 41.9 mt-10 -61.02 106.83 0.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.451 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 49' ' ' GLU . 3.4 t -93.01 123.76 45.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.042 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.558 ' HG3' HD23 ' A' ' 12' ' ' LEU . 1.4 mpt_? -126.49 170.24 12.2 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.575 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 39.4 p-10 -84.17 -162.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.655 ' SG ' HG21 ' A' ' 22' ' ' ILE . 20.2 p -78.52 12.16 2.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.255 0.55 . . . . 0.0 110.591 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 9' ' ' ASN . 2.1 t-20 -118.35 -48.03 2.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.494 0.664 . . . . 0.0 110.254 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.04 5.51 3.44 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.108 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.1 125.83 29.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.558 HD23 ' HG3' ' A' ' 6' ' ' ARG . 17.3 mt -72.32 135.05 45.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.698 -175.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.01 162.42 13.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.48 8.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.977 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 12.0 t70 -64.62 125.72 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.82 17.07 53.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.264 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.02 175.48 6.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 13.3 p30 -131.06 139.08 49.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.698 0.761 . . . . 0.0 112.078 -178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.28 173.39 14.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.806 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -152.91 152.25 31.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.769 0.318 . . . . 0.0 110.619 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.606 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -64.63 128.58 36.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.641 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.007 HG13 ' HG3' ' A' ' 23' ' ' LYS . 35.0 pt -92.69 -9.68 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.174 0.511 . . . . 0.0 110.361 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 1.007 ' HG3' HG13 ' A' ' 22' ' ' ILE . 23.2 mtpp -145.47 -175.94 4.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -98.9 109.22 22.01 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.606 HD23 HD12 ' A' ' 21' ' ' LEU . 3.8 mm? -109.91 111.83 23.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.955 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.659 ' HG3' HG22 ' A' ' 33' ' ' VAL . 5.6 tmmm? -94.51 143.24 26.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.326 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.79 138.46 31.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.403 0.62 . . . . 0.0 110.57 -175.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -87.11 128.7 35.11 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.267 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.3 13.62 47.88 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.935 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 t -164.02 173.25 12.78 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.9 p -94.08 8.33 41.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.833 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 m -69.04 104.63 2.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.765 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.659 HG22 ' HG3' ' A' ' 26' ' ' LYS . 17.5 t -111.31 100.31 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp -76.32 140.31 41.41 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 23.4 mmmt -110.37 160.15 16.82 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.24 0.543 . . . . 0.0 111.269 -175.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -59.99 131.71 51.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.459 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.13 -3.46 62.03 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.107 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.525 ' HB ' HD23 ' A' ' 21' ' ' LEU . 86.4 m -65.09 113.42 3.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.201 0.501 . . . . 0.0 110.371 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -82.97 122.44 28.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.556 0.693 . . . . 0.0 111.499 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 56' ' ' THR . 56.2 mt -112.49 93.51 2.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.935 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.38 149.65 24.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.93 43.01 5.51 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.564 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -91.29 166.96 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.382 . . . . 0.0 110.297 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -147.22 156.92 43.37 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.609 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.4 mt -84.69 158.49 20.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.559 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -118.21 -162.75 0.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.72 -16.65 60.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.748 0.785 . . . . 0.0 109.235 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 19.9 m -87.22 144.86 26.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.874 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.56 ' HA ' HG22 ' A' ' 5' ' ' VAL . 24.5 mt-10 -91.6 -13.55 31.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.551 0.691 . . . . 0.0 109.749 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -110.46 -5.85 15.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.748 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 14.0 mp0 -123.72 145.44 48.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.346 0.593 . . . . 0.0 110.943 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.49 HG23 HG11 ' A' ' 5' ' ' VAL . 11.6 pt -135.69 175.26 11.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.436 174.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.71 137.46 49.53 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -140.73 -167.88 11.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 119.772 -1.204 . . . . 0.0 112.67 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -144.72 141.74 29.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.518 HG22 HG12 ' A' ' 40' ' ' ILE . 40.9 p -114.81 -170.39 1.73 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.718 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -56.66 -32.85 65.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.045 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -123.22 -65.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.482 -175.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.3 mp -68.98 107.43 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.313 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -107.18 144.42 33.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.869 0.366 . . . . 0.0 110.254 176.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.05 48.98 70.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.933 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -105.32 134.21 48.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.82 120.79 44.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.108 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.829 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 26.2 mt -132.57 144.24 50.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.741 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.603 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 1.1 ptp180 -64.78 133.45 52.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.793 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 t -85.34 26.16 0.94 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.503 0.668 . . . . 0.0 110.773 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 13.4 mt-10 -87.79 -20.89 25.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.636 0.731 . . . . 0.0 110.164 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.829 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 53.5 p90 -120.78 21.16 11.54 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.53 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.8 mt -117.07 148.93 41.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.269 0.556 . . . . 0.0 110.028 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.6 tmtt? -120.38 131.7 54.94 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.778 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -64.58 122.38 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.67 -59.96 2.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.269 -172.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 146.63 133.09 2.42 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.923 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.247 0.962 0 CA-C-O 119.109 -0.472 . . . . 0.0 110.101 178.806 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mmt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 111.036 0.013 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.9 m 56.84 43.14 25.45 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.169 0.509 . . . . 0.0 110.328 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -91.46 54.59 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.684 0.754 . . . . 0.0 109.967 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.509 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 44.4 mt-10 -64.84 95.84 0.17 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.306 176.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.739 HG11 HG23 ' A' ' 52' ' ' ILE . 8.5 t -88.08 131.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.673 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HG2' HD23 ' A' ' 12' ' ' LEU . 65.8 mtt85 -122.24 167.04 13.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.639 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 36.4 p-10 -90.07 -162.02 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.71 0.29 . . . . 0.0 110.441 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' HG21 ' A' ' 22' ' ' ILE . 20.2 p -76.32 3.62 10.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.287 0.565 . . . . 0.0 110.752 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.58 -48.29 3.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.73 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.07 7.67 4.91 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.951 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.95 136.64 36.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 4' ' ' GLU . 34.5 mt -80.75 135.71 36.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.234 0.54 . . . . 0.0 112.083 -173.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.4 ' HB3' HD11 ' A' ' 43' ' ' ILE . 86.4 mt -101.47 166.9 10.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.36 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.75 174.45 13.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 14.7 t70 -63.53 118.18 7.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.775 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.02 -0.78 38.39 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.068 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.475 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -83.12 175.15 10.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.967 0.413 . . . . 0.0 110.691 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -135.55 137.67 42.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.172 -177.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 69' ' ' LEU . 34.5 m -128.82 167.31 24.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.613 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.44 152.5 47.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.613 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.537 HD12 HD23 ' A' ' 25' ' ' LEU . 3.4 mm? -72.7 122.92 22.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.5 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.566 HG13 ' HG2' ' A' ' 23' ' ' LYS . 39.4 pt -88.33 -7.34 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.077 0.465 . . . . 0.0 111.102 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.566 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -160.05 -176.79 5.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.177 178.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.5 117.57 30.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.537 HD23 HD12 ' A' ' 21' ' ' LEU . 4.0 mm? -114.11 118.27 33.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.032 0.444 . . . . 0.0 110.253 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HB2' HG13 ' A' ' 33' ' ' VAL . 5.3 tmmm? -96.82 144.29 26.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.314 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.56 157.94 25.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.729 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 31' ' ' SER . 53.5 mtpt 72.03 -62.03 0.47 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.706 0.802 . . . . 0.0 111.654 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.66 -57.74 0.39 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.776 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 p -144.25 55.48 1.29 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.275 0.559 . . . . 0.0 110.661 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.609 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 26.2 m -143.5 -74.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.858 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 m -99.55 104.47 16.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 110.842 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG13 ' HB2' ' A' ' 26' ' ' LYS . 16.3 t -108.58 109.86 29.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.47 HD23 HG21 ' A' ' 38' ' ' THR . 5.9 mp -87.52 146.44 25.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.916 0.389 . . . . 0.0 109.998 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -111.1 163.18 14.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.512 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -60.53 135.88 57.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.41 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.41 -0.63 59.98 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.859 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.482 ' HB ' ' HG ' ' A' ' 21' ' ' LEU . 91.8 m -63.48 120.21 11.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.842 0.353 . . . . 0.0 110.049 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.9 tpt -93.52 114.58 26.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.624 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.505 HG12 HG22 ' A' ' 56' ' ' THR . 51.9 mt -111.21 90.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.472 0.653 . . . . 0.0 109.434 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.45 136.98 45.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.65 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.48 46.24 2.19 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.579 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -93.48 168.22 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 0.0 110.325 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 4.6 ptp180 -151.71 156.68 40.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.48 HD22 ' CG2' ' A' ' 5' ' ' VAL . 20.2 mt -78.6 127.7 32.49 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 p -82.81 -68.91 0.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.204 1.002 . . . . 0.0 111.878 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -176.79 -34.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.06 -1.882 . . . . 0.0 106.763 -173.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 38.1 m -75.08 146.49 41.43 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.356 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HA ' HG22 ' A' ' 5' ' ' VAL . 2.1 mp0 -91.46 -19.25 23.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.513 0.673 . . . . 0.0 110.163 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -103.54 -3.59 25.07 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.728 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 2.5 mt-10 -132.65 145.56 51.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.584 0.707 . . . . 0.0 111.347 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.739 HG23 HG11 ' A' ' 5' ' ' VAL . 9.4 pt -132.09 173.8 14.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.451 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 22.5 tt0 -125.01 137.01 54.25 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -142.54 -161.18 8.67 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.232 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 9.0 ptp180 -150.16 148.87 29.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.918 0.39 . . . . 0.0 110.633 -176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.505 HG22 HG12 ' A' ' 40' ' ' ILE . 39.2 p -122.44 -171.95 2.37 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.96 -30.99 69.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.165 0.507 . . . . 0.0 110.881 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -115.04 -69.95 0.83 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.068 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 59' ' ' ILE . 1.2 mp -74.57 103.73 2.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.033 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 17.7 ptpt -111.18 131.31 55.21 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.82 0.343 . . . . 0.0 110.159 176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.94 47.98 5.63 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.076 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -112.51 136.63 51.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 40.1 t -94.41 119.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.648 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.8 mt -128.16 146.11 50.81 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.706 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 14.1 ptt180 -65.36 135.32 55.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.23 172.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 t -89.27 33.01 0.81 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.502 0.668 . . . . 0.0 110.656 -174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 19.7 mt-10 -81.69 -30.97 32.4 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.005 0.907 . . . . 0.0 109.444 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.648 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 39.9 p90 -115.79 19.11 15.4 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.264 -1.335 . . . . 0.0 111.506 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 19' ' ' VAL . 68.6 mt -113.2 147.65 37.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.224 0.535 . . . . 0.0 110.349 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -117.8 130.89 56.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.752 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.587 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 13.2 tmtt? -67.04 121.14 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . -83.43 135.25 34.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.303 -172.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.26 19.6 56.78 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.035 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.587 ' HB2' ' HD2' ' A' ' 71' ' ' LYS . 46.6 m . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.549 -0.738 . . . . 0.0 110.239 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.602 0.239 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -74.86 84.08 2.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.628 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.7 pt -127.21 43.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.219 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HB3' HD21 ' A' ' 12' ' ' LEU . 82.3 mt-10 -54.4 116.96 2.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.067 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -95.48 121.28 45.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.571 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -125.92 153.41 44.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 8.5 p-10 -79.57 -170.52 2.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.0 p -63.49 -26.37 68.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -76.03 -39.37 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.096 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.68 12.27 8.04 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.529 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.71 132.18 33.94 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 6' ' ' ARG . 20.0 mt -69.24 131.18 44.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.417 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.1 177.33 5.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.803 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.541 ' HA ' HD11 ' A' ' 45' ' ' LEU . . . -154.61 178.47 10.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -80.14 111.61 16.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.689 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.78 27.36 8.45 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.656 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.08 176.5 5.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.366 0.266 . . . . 0.0 110.361 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.9 OUTLIER -129.2 136.09 49.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.454 0.645 . . . . 0.0 111.102 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 69' ' ' LEU . 35.4 m -125.05 179.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.992 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -154.82 151.15 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.692 0.282 . . . . 0.0 111.239 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.75 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -66.25 130.49 43.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.629 HG21 ' SG ' ' A' ' 8' ' ' CYS . 41.4 pt -91.99 -9.15 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 0.0 110.856 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.563 ' HG3' HD21 ' A' ' 25' ' ' LEU . 4.9 ptpt -156.88 -178.86 7.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.93 108.18 19.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.75 HD23 HD12 ' A' ' 21' ' ' LEU . 3.3 mm? -113.13 110.72 20.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.645 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 19.8 ttmm -68.29 142.13 55.64 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 167.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.586 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 8.9 tt -45.97 -72.48 0.05 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.661 0.601 . . . . 0.0 110.92 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 27' ' ' LEU . 86.7 mttt -163.21 -96.38 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.97 57.8 0.9 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . 25.8 t -138.97 156.82 46.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.563 -0.318 . . . . 0.0 110.403 -171.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.9 m -86.41 12.1 10.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.067 0.46 . . . . 0.0 110.632 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.6 m -96.67 106.36 18.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.594 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 25.6 t -102.07 110.64 29.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mt -85.91 98.91 11.06 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.48 0.657 . . . . 0.0 110.297 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 21.3 mmmt -67.73 161.89 25.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.356 -174.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -59.69 136.56 58.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.711 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.69 -3.05 81.09 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.989 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.548 ' HB ' HD23 ' A' ' 21' ' ' LEU . 93.0 m -63.86 112.56 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 39.7 ttm -83.35 116.29 22.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.321 0.582 . . . . 0.0 111.144 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.564 HG12 HG22 ' A' ' 56' ' ' THR . 39.7 mt -99.66 89.97 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.901 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 3.3 ppt_? -100.15 135.72 41.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.09 46.98 1.8 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.626 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . 1.9 pp -97.18 148.4 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.55 142.6 51.42 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.246 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 14' ' ' ALA . 61.3 mt -71.93 132.69 44.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.462 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -97.43 -169.17 1.8 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -83.07 7.51 15.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.434 0.635 . . . . 0.0 109.564 173.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -109.89 149.38 29.97 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.671 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.609 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -103.39 -14.8 16.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -175.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -102.18 -7.74 21.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.897 0.379 . . . . 0.0 110.333 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.1 mp0 -123.31 149.3 45.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.507 0.67 . . . . 0.0 111.125 -176.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.473 HD12 ' HB ' ' A' ' 43' ' ' ILE . 17.9 pt -136.29 172.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.161 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 12.2 tt0 -125.53 122.01 35.33 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 43' ' ' ILE . . . -128.43 -169.47 12.62 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.742 -1.218 . . . . 0.0 112.846 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -147.29 145.19 29.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.194 0.521 . . . . 0.0 110.203 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.564 HG22 HG12 ' A' ' 40' ' ' ILE . 69.4 p -119.34 -171.13 2.06 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.611 -177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.59 -27.08 68.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.179 0.514 . . . . 0.0 110.338 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.24 -64.05 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.951 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 mm -85.41 108.36 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.477 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 60' ' ' LYS . 17.1 ptmt -105.64 140.47 38.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.775 0.321 . . . . 0.0 110.144 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.16 43.71 31.66 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.785 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -107.18 131.31 54.29 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.9 t -89.73 120.53 38.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.844 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.655 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 28.8 mt -134.35 140.93 46.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.574 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 1.5 ptp180 -58.88 130.39 46.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.699 168.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -87.68 25.64 1.45 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.454 0.645 . . . . 0.0 110.204 -176.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 15.5 mt-10 -89.31 -10.0 48.41 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.762 0.791 . . . . 0.0 109.769 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 42.8 p90 -125.22 15.59 8.39 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.114 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 19' ' ' VAL . 68.8 mt -112.06 149.06 32.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.789 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -120.07 129.98 54.46 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.832 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -61.15 120.9 11.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.3 -176.07 4.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.733 -171.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.13 -84.71 1.48 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.202 176.275 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.857 0.36 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -86.89 -163.88 0.98 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.67 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 18.9 pt -127.04 64.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.997 0.903 . . . . 0.0 109.92 174.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' HB3' HD21 ' A' ' 12' ' ' LEU . 33.3 mt-10 -75.86 87.25 2.84 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.939 -178.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.727 HG11 HG23 ' A' ' 52' ' ' ILE . 6.7 t -80.84 118.29 28.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.526 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 92.4 mtt180 -124.75 155.07 39.91 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 38.2 p-10 -79.48 -161.93 0.37 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.815 0.34 . . . . 0.0 110.343 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.503 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.8 p -74.62 -1.14 20.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.188 0.518 . . . . 0.0 110.85 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -104.13 -44.96 4.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.593 0.711 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.37 11.05 4.31 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.033 -174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' ARG . . . -82.5 134.52 35.21 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 4' ' ' GLU . 20.9 mt -78.3 134.34 37.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.338 0.589 . . . . 0.0 112.01 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.6 mt -100.63 162.73 12.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.229 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.98 176.53 12.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.295 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 22.0 t70 -60.56 123.27 16.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.92 16.82 46.45 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.596 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.445 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t70 -93.93 175.64 6.64 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.725 -0.279 . . . . 0.0 110.716 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.423 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -130.22 135.98 48.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.199 0.523 . . . . 0.0 110.938 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.587 HG21 HD13 ' A' ' 69' ' ' LEU . 27.6 m -124.05 175.95 6.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.787 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.3 m -150.59 151.79 33.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.858 0.361 . . . . 0.0 111.366 176.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.675 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -64.68 127.4 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.45 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.879 HG13 ' HG3' ' A' ' 23' ' ' LYS . 38.5 pt -95.53 -8.36 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.762 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.4 mttt -141.87 179.8 6.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.56 100.64 12.06 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.675 HD23 HD12 ' A' ' 21' ' ' LEU . 3.8 mm? -102.99 115.19 30.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.486 ' CG ' HG22 ' A' ' 33' ' ' VAL . 1.4 tmmt? -91.0 133.26 35.43 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 34.4 mt -71.97 165.09 24.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.716 0.769 . . . . 0.0 112.8 -171.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -82.67 123.41 29.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.039 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.56 -59.64 4.59 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.439 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.9 m -79.57 150.81 30.96 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.0 t -84.33 33.65 0.51 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.629 0.728 . . . . 0.0 110.129 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.5 m -83.6 104.7 13.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.254 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.486 HG22 ' CG ' ' A' ' 26' ' ' LYS . 3.6 t -99.82 111.83 30.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.1 mp -90.73 145.31 24.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.5 mmmt -110.55 161.41 15.73 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.17 0.509 . . . . 0.0 111.211 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 36' ' ' ARG . 27.5 ttt180 -62.42 137.55 58.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.488 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.73 8.03 70.57 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.916 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.538 ' HB ' HD23 ' A' ' 21' ' ' LEU . 90.9 m -73.47 116.28 13.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 41.2 ttm -87.75 111.71 21.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.449 0.642 . . . . 0.0 111.448 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.633 HG12 HG22 ' A' ' 56' ' ' THR . 48.8 mt -95.12 91.51 3.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.11 135.1 43.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.117 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.33 1.43 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.677 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -102.89 162.66 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.87 0.366 . . . . 0.0 110.231 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 12.2 ptt180 -143.24 164.66 29.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.345 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 5' ' ' VAL . 43.3 mt -82.16 142.28 32.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.204 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.1 p -104.35 -154.48 0.51 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.176 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.31 -2.95 56.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 33.5 t -108.16 157.92 17.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.014 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.67 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 31.9 mt-10 -95.89 -13.43 23.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.909 172.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -108.98 -9.6 15.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.356 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -121.68 146.28 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.314 0.578 . . . . 0.0 111.427 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.727 HG23 HG11 ' A' ' 5' ' ' VAL . 2.4 pp -134.76 166.86 27.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.505 172.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' HB2' HG22 ' A' ' 63' ' ' VAL . 37.2 tt0 -120.36 130.0 54.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.677 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.01 -175.4 13.99 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.964 -175.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 17.0 ptt180 -134.91 139.71 45.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.459 0.647 . . . . 0.0 110.765 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.633 HG22 HG12 ' A' ' 40' ' ' ILE . 31.1 p -106.54 -170.47 1.73 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.514 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.33 -16.51 59.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.106 0.479 . . . . 0.0 110.094 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -113.23 -73.4 0.66 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.371 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 59' ' ' ILE . 1.3 mp -77.56 115.93 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.855 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -109.69 134.05 52.43 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.66 54.09 6.88 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.677 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.6 pt? -115.09 138.34 50.99 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 53' ' ' GLU . 46.3 t -92.5 116.29 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.554 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.8 mt -129.48 146.13 51.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.558 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.658 ' HG3' ' HE2' ' A' ' 68' ' ' PHE . 2.3 ptp180 -65.25 139.07 58.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.055 173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' HD12 ' A' ' 69' ' ' LEU . 8.9 t -93.74 23.82 4.51 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.593 -174.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HG2' HH11 ' A' ' 65' ' ' ARG . 0.6 OUTLIER -92.81 -8.46 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 110.275 -176.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.658 ' HE2' ' HG3' ' A' ' 65' ' ' ARG . 54.0 p90 -122.41 19.58 10.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.677 174.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.587 HD13 HG21 ' A' ' 19' ' ' VAL . 65.7 mt -120.46 145.66 47.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.081 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.515 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 3.1 tmtt? -113.35 130.68 56.22 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.698 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.445 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.4 tmtt? -64.21 123.14 18.32 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.423 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . -83.38 136.14 34.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.137 0.494 . . . . 0.0 111.319 -174.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.83 -169.83 55.01 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.94 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.0 p . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.24 179.66 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m -93.54 120.06 33.35 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.391 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 pt -128.11 64.4 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.826 0.822 . . . . 0.0 109.706 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.504 ' HB3' HD21 ' A' ' 12' ' ' LEU . 37.7 mt-10 -67.67 107.64 2.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.457 -178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 49' ' ' GLU . 14.9 t -90.19 117.83 34.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.079 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -128.19 148.58 50.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.413 ' OD2' ' HA ' ' A' ' 70' ' ' LYS . 5.8 p-10 -80.63 -169.78 2.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.456 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.643 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.9 p -65.05 -22.82 67.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.006 0.431 . . . . 0.0 110.961 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.406 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 35.9 t30 -76.14 -31.76 58.76 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.536 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.89 14.29 27.24 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.53 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.25 137.94 31.97 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 120.799 0.333 . . . . 0.0 110.143 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 4' ' ' GLU . 19.9 mt -71.57 141.0 50.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.375 0.607 . . . . 0.0 111.872 -176.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.57 176.85 4.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.602 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.96 10.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.849 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 17.3 t70 -65.3 121.33 14.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.798 0.332 . . . . 0.0 110.164 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.91 11.13 50.89 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.036 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.93 174.81 8.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 72' ' ' ALA . 1.1 p30 -139.11 136.15 34.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.399 0.619 . . . . 0.0 111.565 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 69' ' ' LEU . 27.3 m -128.63 176.81 7.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.968 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -150.67 149.24 29.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.733 0.301 . . . . 0.0 111.048 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.665 HD12 HD23 ' A' ' 25' ' ' LEU . 4.5 mm? -61.17 133.36 55.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.329 0.651 . . . . 0.0 112.259 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.661 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -94.71 -11.56 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.2 0.524 . . . . 0.0 110.559 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.661 ' HG2' HG13 ' A' ' 22' ' ' ILE . 18.4 ptmt -158.43 176.1 12.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.232 -177.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' C ' HD22 ' A' ' 25' ' ' LEU . 8.2 m-20 -83.13 127.63 33.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.665 HD23 HD12 ' A' ' 21' ' ' LEU . 4.1 mm? -123.78 150.99 43.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.518 ' HG3' HG13 ' A' ' 33' ' ' VAL . 6.7 mptt -121.39 150.53 41.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.439 0.638 . . . . 0.0 111.673 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.601 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 4.3 mm? -119.22 149.38 41.85 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.832 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 31' ' ' SER . 91.2 mttt 66.67 2.7 2.65 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.669 0.605 . . . . 0.0 111.475 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.67 -80.91 0.3 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 p -140.58 10.7 2.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.849 0.357 . . . . 0.0 110.8 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 23.4 m -72.37 -70.37 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.562 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 27.3 m -90.45 104.37 16.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG13 ' HG3' ' A' ' 26' ' ' LYS . 51.3 t -105.26 120.66 56.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.162 0.506 . . . . 0.0 110.738 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.567 HD23 HG21 ' A' ' 38' ' ' THR . 6.3 mp -102.47 145.56 29.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.779 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 22.4 mmmt -109.63 160.27 16.41 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.816 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -56.22 132.74 51.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.82 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.16 -11.39 55.29 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.729 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.567 HG21 HD23 ' A' ' 34' ' ' LEU . 60.6 m -59.33 125.7 24.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.981 0.39 . . . . 0.0 110.037 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -90.71 122.58 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.082 0.468 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 53.0 mt -111.6 90.53 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.11 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -101.51 154.29 18.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.2 -179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.99 45.94 6.9 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.301 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.557 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.39 160.45 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 19.6 ptt180 -139.46 159.09 42.97 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.305 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.452 HD22 ' HB ' ' A' ' 5' ' ' VAL . 52.0 mt -78.85 134.58 36.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.141 -176.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.0 p -94.44 -157.95 0.6 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.807 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -83.94 -6.99 59.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.504 0.669 . . . . 0.0 109.205 174.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.61 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 66.1 m -102.88 150.47 23.48 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.913 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -87.76 -26.57 22.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.477 0.656 . . . . 0.0 109.939 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -98.01 -6.67 31.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.695 -175.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 10.8 mp0 -124.42 145.16 49.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 111.499 -175.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.474 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -133.32 167.41 26.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.521 173.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -119.93 128.36 53.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -139.42 -159.32 7.95 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.333 -177.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 17.5 ptp180 -142.7 149.91 39.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.821 0.343 . . . . 0.0 110.243 -176.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.8 p -115.31 -171.41 1.95 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -70.87 -24.59 62.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.953 0.406 . . . . 0.0 110.408 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -112.52 -68.05 0.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.1 mp -77.3 107.34 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.94 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -107.06 134.47 50.14 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.01 52.08 4.78 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.388 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -114.31 137.05 52.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.65 121.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.926 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.667 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 27.4 mt -135.42 143.58 46.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.226 0.536 . . . . 0.0 111.941 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.651 ' HB2' ' HG2' ' A' ' 67' ' ' GLU . 9.4 ptp180 -60.71 130.13 44.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.694 171.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.9 t -88.48 22.27 2.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.219 0.533 . . . . 0.0 110.739 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 2.4 pt-20 -90.92 -9.74 45.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.318 0.58 . . . . 0.0 110.222 -176.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.667 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 28.7 p90 -117.06 16.99 14.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.329 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 19' ' ' VAL . 68.8 mt -117.29 146.38 43.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.296 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -118.45 125.0 49.01 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.008 -178.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HA ' HG12 ' A' ' 19' ' ' VAL . 46.5 tttp -62.06 121.01 11.97 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.313 0.383 . . . . 0.0 110.235 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . . . -78.27 139.04 38.9 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.02 32.51 4.04 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.377 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.045 179.071 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.972 0.415 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 m -83.6 93.76 7.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.197 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.593 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 14.0 pt -146.05 75.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.724 0.773 . . . . 0.0 110.064 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -81.51 99.05 8.57 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.307 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 49' ' ' GLU . 10.9 t -92.28 122.65 43.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.983 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.533 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -130.26 162.19 29.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.65 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 4.1 p-10 -82.51 -165.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -178.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' HG21 ' A' ' 22' ' ' ILE . 28.6 p -64.24 -25.62 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.772 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.41 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 65.9 t30 -74.5 -51.97 13.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.236 177.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.41 12.73 3.34 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.974 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.47 132.72 33.86 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.533 HD23 ' HG3' ' A' ' 6' ' ' ARG . 21.5 mt -69.15 145.18 53.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.509 0.671 . . . . 0.0 112.223 -174.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.3 mt -114.96 169.36 9.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.427 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -159.17 175.32 13.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.038 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 31.3 t70 -68.09 117.6 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 110.22 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.88 30.77 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.796 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.71 174.22 7.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -133.4 145.03 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.297 0.57 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 71' ' ' LYS . 28.3 m -140.54 175.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.275 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -152.31 156.89 40.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.679 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.745 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -69.23 131.51 45.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.721 -178.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.681 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.6 pt -91.94 -11.01 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.405 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.681 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -154.6 -179.09 7.65 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.96 113.56 25.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.745 HD23 HD12 ' A' ' 21' ' ' LEU . 3.5 mm? -117.57 123.41 46.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.522 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.699 ' HG3' HG22 ' A' ' 33' ' ' VAL . 4.0 tmmm? -92.28 140.5 29.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 43.4 mt -73.07 151.04 41.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.644 -176.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -76.85 3.22 12.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.875 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.59 117.83 3.04 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.1 t 67.17 -171.37 0.19 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.013 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 t -100.0 36.32 1.86 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.159 0.504 . . . . 0.0 110.086 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 m -76.22 105.21 7.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.361 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.699 HG22 ' HG3' ' A' ' 26' ' ' LYS . 3.0 t -104.92 112.01 36.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.371 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mp -81.55 147.47 29.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -111.65 161.72 15.94 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.295 0.569 . . . . 0.0 111.423 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 36' ' ' ARG . 30.2 ttt180 -58.39 129.86 44.04 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.256 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.9 -5.43 66.36 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.322 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.539 ' HB ' HD23 ' A' ' 21' ' ' LEU . 98.6 m -63.32 118.49 8.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.497 0.649 . . . . 0.0 110.23 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.435 ' HG2' ' HG3' ' A' ' 41' ' ' ARG . 35.7 ttm -87.62 119.88 28.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.628 0.728 . . . . 0.0 111.445 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -108.34 95.03 3.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.026 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' HG3' ' HG2' ' A' ' 39' ' ' MET . 0.0 OUTLIER -104.95 136.17 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.231 -176.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.94 50.69 1.59 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.64 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -99.32 164.0 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.581 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 7.0 ptp85 -141.62 167.49 22.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 ' HB ' ' A' ' 5' ' ' VAL . 36.5 mt -89.27 147.79 23.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.155 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.6 p -104.14 -159.77 0.73 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -85.05 2.4 43.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 m -113.51 156.68 23.14 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.598 ' HA ' HG22 ' A' ' 5' ' ' VAL . 21.9 mt-10 -93.54 -27.9 16.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.605 0.717 . . . . 0.0 109.65 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 66' ' ' THR . 6.6 m-20 -90.21 -12.01 39.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.321 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 3.7 mp0 -121.17 148.84 43.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.294 0.569 . . . . 0.0 111.359 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.493 ' CG2' HG11 ' A' ' 5' ' ' VAL . 26.8 pt -133.91 175.78 10.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.716 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.537 ' OE1' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -130.14 123.78 31.13 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 175.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.64 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -136.38 -177.01 14.68 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.89 -174.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -139.51 143.47 37.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.277 0.56 . . . . 0.0 110.401 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 58' ' ' LYS . 9.8 t -128.09 -171.5 2.46 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.545 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.22 5.08 3.79 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -174.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.449 ' H ' HG23 ' A' ' 56' ' ' THR . 68.8 mttm -134.79 -69.8 0.51 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.097 0.475 . . . . 0.0 110.111 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.9 mm -92.43 123.66 44.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.053 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -103.33 148.31 26.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' HA2' ' OE1' ' A' ' 53' ' ' GLU . . . 58.5 46.59 92.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.444 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 54' ' ' GLY . 2.5 pt? -103.38 135.01 45.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.225 0.513 . . . . 0.0 109.754 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 42.5 t -88.68 116.32 30.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.002 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.571 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 30.7 mt -129.56 143.45 50.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.452 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.645 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 14.6 ptt180 -62.14 129.95 43.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.444 ' HA ' HD12 ' A' ' 69' ' ' LEU . 11.9 t -88.19 27.06 1.27 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.238 0.542 . . . . 0.0 110.525 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.638 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.5 mt-10 -81.85 -26.27 34.39 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.797 0.808 . . . . 0.0 109.159 -176.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.645 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 21.4 p90 -114.56 17.91 17.03 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.998 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 66' ' ' THR . 58.3 mt -113.74 144.84 42.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.3 0.572 . . . . 0.0 110.205 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.65 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtp? -113.82 129.67 56.56 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.107 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.424 ' HA ' HG12 ' A' ' 19' ' ' VAL . 53.1 tttp -60.44 129.76 43.22 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.07 -157.94 0.47 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.11 0.481 . . . . 0.0 111.331 -174.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.5 -31.78 6.01 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.263 177.267 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.917 0.389 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -107.25 84.83 2.03 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.669 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.598 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 38.8 pt -137.35 60.75 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.432 0.634 . . . . 0.0 110.692 175.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.21 111.45 9.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.321 0.582 . . . . 0.0 110.334 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 49' ' ' GLU . 7.0 t -97.8 121.36 48.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.709 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.567 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.67 157.35 42.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.027 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 7.7 p-10 -83.25 -168.7 2.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.9 p -68.2 -13.09 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.496 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 50.4 t30 -87.65 -38.23 16.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 9.56 10.49 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.179 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.86 124.25 30.15 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.567 HD23 ' HG3' ' A' ' 6' ' ' ARG . 23.9 mt -66.76 129.54 40.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.907 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.96 166.71 10.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.579 -176.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -157.49 178.42 10.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.139 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 13.2 t70 -65.12 129.66 40.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.452 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.82 13.61 60.67 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.542 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t0 -88.11 173.81 8.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.594 0.235 . . . . 0.0 110.453 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -132.7 128.84 37.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 -177.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 69' ' ' LEU . 26.9 m -125.78 176.94 5.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.29 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -153.53 149.25 27.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 111.067 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.593 HD12 HD23 ' A' ' 25' ' ' LEU . 4.4 mm? -65.25 125.18 24.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.743 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.929 HG13 ' HG3' ' A' ' 23' ' ' LYS . 33.5 pt -93.56 -7.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.162 0.506 . . . . 0.0 110.283 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.929 ' HG3' HG13 ' A' ' 22' ' ' ILE . 4.2 mtpm? -144.58 177.91 8.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.856 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.886 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . 5.8 m-20 -93.73 102.22 14.36 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 170.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.684 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 4.3 mm? -102.62 108.95 20.41 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.632 0.73 . . . . 0.0 111.647 -171.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 33' ' ' VAL . 1.6 tmmt? -90.58 137.76 32.1 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.895 173.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -78.23 -74.85 0.25 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.716 -172.03 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -143.54 142.9 31.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.952 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 26' ' ' LYS . . . 55.08 -117.26 7.95 Favored Glycine 0 N--CA 1.45 -0.411 0 O-C-N 123.642 0.589 . . . . 0.0 112.065 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.5 m -138.06 18.09 2.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.135 0.493 . . . . 0.0 109.992 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.0 m -75.37 -64.0 1.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.357 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -104.14 108.42 19.79 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.391 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 26' ' ' LYS . 31.3 t -117.89 110.73 31.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp -92.36 150.41 20.85 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.886 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 3.3 mmpt? -110.61 162.74 14.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.248 0.547 . . . . 0.0 111.523 -176.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -68.76 144.77 54.25 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.281 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.59 15.3 73.84 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.722 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.551 ' HB ' HD23 ' A' ' 21' ' ' LEU . 60.2 m -84.84 117.75 24.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 ttm -86.13 123.18 31.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.397 0.617 . . . . 0.0 110.975 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.725 HG12 HG22 ' A' ' 56' ' ' THR . 35.0 mt -112.23 95.56 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.504 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -108.16 142.45 38.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.067 0.461 . . . . 0.0 111.009 -178.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.97 42.14 4.17 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.649 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.4 pp -92.5 165.72 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 110.234 -179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.557 ' HD2' ' OE1' ' A' ' 53' ' ' GLU . 3.8 ptp180 -139.76 164.19 30.62 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.321 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.5 162.18 14.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.6 p -130.48 -166.56 1.7 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -75.86 -8.98 58.2 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.249 0.547 . . . . 0.0 109.644 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 53.7 m -92.33 145.7 24.27 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.195 176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 16.3 mt-10 -95.81 -20.6 18.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.806 -178.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.33 -5.94 22.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.145 -175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 17.7 mp0 -124.0 147.71 47.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.9 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -137.1 173.12 13.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.214 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.557 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 41.1 tt0 -125.62 135.02 51.72 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 174.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.649 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.92 -177.98 21.04 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.138 -177.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -132.1 142.47 49.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.009 0.433 . . . . 0.0 110.127 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.725 HG22 HG12 ' A' ' 40' ' ' ILE . 27.3 p -122.56 -171.84 2.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.565 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.17 -15.55 59.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.808 0.337 . . . . 0.0 110.658 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -114.2 -59.23 2.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.413 0.625 . . . . 0.0 110.597 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -100.69 112.88 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.205 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -105.06 121.24 43.38 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.928 0.394 . . . . 0.0 110.848 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.55 53.41 3.24 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.514 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.538 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -115.29 138.71 50.67 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 48.5 t -93.11 116.72 34.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.001 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.594 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 26.6 mt -129.33 142.93 50.69 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.663 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.635 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 2.9 ptp85 -60.68 130.61 47.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.563 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.4 t -88.59 24.24 2.03 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.294 0.569 . . . . 0.0 110.379 -175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.566 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 21.7 mt-10 -82.42 -20.3 37.32 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.926 0.87 . . . . 0.0 109.525 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 33.1 p90 -117.27 17.53 14.69 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.61 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 19' ' ' VAL . 63.8 mt -113.42 144.02 43.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.058 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.496 ' HD3' ' HB2' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -113.93 126.98 55.77 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.358 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.542 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 11.1 tmtt? -59.83 124.87 21.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 71' ' ' LYS . . . -69.99 125.24 26.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.247 -170.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.11 -122.5 25.79 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.558 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.425 177.701 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 p -81.81 117.81 22.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.167 -172.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.583 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 33.8 pt -138.72 68.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 122.345 1.069 . . . . 0.0 108.901 171.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -81.05 92.7 6.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.27 -174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.814 HG11 HG23 ' A' ' 52' ' ' ILE . 2.7 t -87.58 128.91 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.257 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.567 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -132.28 158.93 40.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -178.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -78.51 -171.8 2.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.708 0.29 . . . . 0.0 110.589 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.6 p -58.49 -29.73 66.47 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.743 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 9.3 m120 -84.02 -42.85 15.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.072 0.463 . . . . 0.0 110.516 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.21 16.91 1.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.47 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.02 126.26 30.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.567 HD23 ' HG3' ' A' ' 6' ' ' ARG . 27.1 mt -64.96 131.58 46.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.331 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.61 164.15 12.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.88 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -155.78 178.52 10.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.394 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 16.1 t70 -67.02 115.36 6.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 0.0 110.564 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.69 14.36 25.5 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.479 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -91.7 174.1 7.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -134.27 137.13 44.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.497 0.665 . . . . 0.0 111.49 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.506 HG21 HD13 ' A' ' 69' ' ' LEU . 27.2 m -126.4 176.01 7.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.236 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.2 m -153.24 156.69 38.96 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.72 0.295 . . . . 0.0 110.75 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.609 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -66.96 127.53 32.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.351 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.901 HG13 ' HG3' ' A' ' 23' ' ' LYS . 34.9 pt -92.91 -10.02 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.901 ' HG3' HG13 ' A' ' 22' ' ' ILE . 38.7 mtpt -141.71 -174.01 3.94 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.9 94.31 6.5 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 172.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.65 ' CD2' ' HB2' ' A' ' 23' ' ' LYS . 3.4 mm? -103.02 111.12 23.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.245 0.545 . . . . 0.0 110.586 -175.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.1 tmmt? -88.01 134.9 33.63 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.559 0.695 . . . . 0.0 110.535 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 67.3 mt -103.71 143.06 33.29 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.378 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -72.89 -32.98 65.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.943 0.401 . . . . 0.0 110.158 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.11 114.08 6.26 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.016 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.6 t 65.81 13.92 9.26 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.788 0.435 . . . . 0.0 110.927 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.5 m 54.85 35.86 25.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.217 0.532 . . . . 0.0 110.486 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 50.0 m -71.04 103.53 2.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.193 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 16.7 t -91.61 102.78 13.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 28.6 mt -85.06 91.99 8.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.438 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.3 mmmt -64.73 158.96 23.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.533 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -59.88 129.86 43.94 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.685 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.95 -6.66 54.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.849 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.527 ' HB ' HD23 ' A' ' 21' ' ' LEU . 89.3 m -59.98 112.11 1.75 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.152 0.476 . . . . 0.0 110.241 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.4 ttm -89.29 117.6 28.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.303 0.573 . . . . 0.0 111.254 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.442 HG12 ' HB ' ' A' ' 56' ' ' THR . 65.1 mt -106.27 92.85 2.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.89 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.75 140.27 37.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 0.0 111.256 -175.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.29 49.68 2.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.644 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.603 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -94.71 169.84 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 21.6 ptt180 -148.56 156.21 42.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.133 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 5' ' ' VAL . 37.6 mt -76.82 135.42 38.91 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 p -87.33 -70.96 0.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.801 0.81 . . . . 0.0 111.164 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.4 t70 179.07 -31.05 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.283 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -73.6 145.51 45.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.996 -1.457 . . . . 0.0 109.833 171.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.604 ' HA ' HG22 ' A' ' 5' ' ' VAL . 16.3 mt-10 -89.32 -18.23 27.34 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.44 -20.29 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.506 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 65' ' ' ARG . 7.2 mp0 -127.26 154.56 44.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.533 -174.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.814 HG23 HG11 ' A' ' 5' ' ' VAL . 10.7 pt -134.35 176.71 8.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.254 171.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 7.8 tt0 -125.39 140.02 53.16 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -145.7 -166.33 11.85 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.056 -1.069 . . . . 0.0 112.053 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -147.25 139.11 24.25 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.195 0.521 . . . . 0.0 110.473 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.442 ' HB ' HG12 ' A' ' 40' ' ' ILE . 12.1 t -131.17 -176.15 3.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.214 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -67.41 -33.98 76.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 -173.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' HG2' HG13 ' A' ' 59' ' ' ILE . 86.0 tttt -83.54 -50.37 8.32 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.001 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.435 ' H ' HG23 ' A' ' 56' ' ' THR . 5.3 mt -130.02 129.11 65.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.047 -171.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -109.68 146.28 35.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.7 48.25 29.43 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.337 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.6 pt? -114.39 135.99 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.17 0.51 . . . . 0.0 109.831 177.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 32.0 t -92.77 123.84 45.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.906 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -135.5 143.17 45.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.899 -176.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.748 ' HG3' ' HE1' ' A' ' 68' ' ' PHE . 3.2 ptp85 -60.05 134.29 56.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.482 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.41 HG21 HG12 ' A' ' 5' ' ' VAL . 8.8 t -87.98 26.21 1.41 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.546 0.688 . . . . 0.0 110.456 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 28.8 mt-10 -84.59 -30.98 24.56 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.835 0.826 . . . . 0.0 109.96 -176.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.748 ' HE1' ' HG3' ' A' ' 65' ' ' ARG . 53.7 p90 -114.15 19.72 16.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.106 -175.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 19' ' ' VAL . 74.4 mt -114.22 145.48 41.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.405 0.621 . . . . 0.0 110.62 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 1.5 tmtt? -113.27 126.0 54.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.583 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -64.71 121.94 15.7 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.82 139.12 31.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.053 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.34 -176.32 35.44 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.046 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.087 -179.945 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.567 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 60.2 m -162.79 121.35 2.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.021 -176.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.553 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 37.4 pt -116.37 25.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 169.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.567 ' HG2' ' HB3' ' A' ' 2' ' ' SER . 5.2 pt-20 -51.39 107.71 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.908 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.695 HG11 HG23 ' A' ' 52' ' ' ILE . 3.0 t -92.45 119.42 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.41 177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -123.73 161.32 25.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.868 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.644 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 21.0 p-10 -82.64 -166.23 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.9 p -72.1 -7.62 50.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.994 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -97.94 -37.51 9.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.444 0.64 . . . . 0.0 109.712 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.92 9.37 7.51 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.269 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 128.84 34.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.515 HD21 ' HB2' ' A' ' 4' ' ' GLU . 24.7 mt -70.77 139.75 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.744 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -103.64 173.31 6.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.032 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -160.92 -179.73 7.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.307 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.31 122.18 17.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.829 0.347 . . . . 0.0 110.288 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.03 27.56 20.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.758 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -98.35 173.62 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -135.17 140.57 45.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.707 0.765 . . . . 0.0 111.69 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.547 HG21 HD13 ' A' ' 69' ' ' LEU . 19.4 m -139.44 178.47 3.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.245 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -153.38 155.1 35.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.301 . . . . 0.0 111.197 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.719 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -68.9 127.53 33.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.704 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 68' ' ' PHE . 27.3 pt -93.09 -7.3 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.982 178.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HG3' HD22 ' A' ' 25' ' ' LEU . 18.6 ptpt -160.1 178.55 9.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.4 122.58 30.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.719 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? -117.99 123.42 45.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.647 0.261 . . . . 0.0 110.33 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.777 ' HG3' HG22 ' A' ' 33' ' ' VAL . 3.2 tmmt? -100.49 139.5 36.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.17 0.51 . . . . 0.0 110.315 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.0 155.48 19.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.77 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 29' ' ' GLY . 25.9 tptt 65.16 -165.36 0.24 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.828 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' H ' ' HG3' ' A' ' 28' ' ' LYS . . . -68.94 -58.58 6.66 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.998 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 m -157.13 84.95 0.93 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.2 t -144.51 -79.9 0.18 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.111 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 m -91.4 104.34 16.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.974 0.416 . . . . 0.0 110.784 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.777 HG22 ' HG3' ' A' ' 26' ' ' LYS . 24.7 t -101.92 105.89 18.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.18 146.11 27.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.895 0.378 . . . . 0.0 110.119 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -111.39 160.76 16.77 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.018 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -61.87 141.14 58.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.022 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.82 -6.28 54.43 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.433 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.517 ' HB ' HD23 ' A' ' 21' ' ' LEU . 31.6 m -71.77 121.47 18.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.44 129.07 36.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.328 0.585 . . . . 0.0 110.763 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.852 HG12 HG22 ' A' ' 56' ' ' THR . 33.1 mt -113.7 94.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.189 174.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -111.07 142.91 42.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.005 0.431 . . . . 0.0 110.915 -176.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.15 47.34 4.44 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.68 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -94.71 164.29 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 120.783 0.325 . . . . 0.0 110.192 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -137.72 148.91 46.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.205 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.88 149.76 44.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.912 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.4 p -116.86 -160.9 0.78 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.791 0.329 . . . . 0.0 110.43 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.47 -8.36 57.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.42 0.629 . . . . 0.0 109.601 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.615 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.5 m -107.47 142.45 37.31 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.028 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.553 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 0.8 OUTLIER -87.9 -18.49 29.08 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.503 177.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -94.98 -13.77 24.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.138 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 4.0 mt-10 -126.63 146.32 50.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.959 0.885 . . . . 0.0 112.48 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.695 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -135.33 162.75 37.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.303 173.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.91 132.9 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.68 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -148.93 -163.98 11.26 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.83 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -141.68 146.37 36.03 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.144 0.497 . . . . 0.0 109.91 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.852 HG22 HG12 ' A' ' 40' ' ' ILE . 24.5 p -114.04 -170.61 1.75 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.215 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -67.31 -27.24 66.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.909 0.385 . . . . 0.0 110.42 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -113.64 -70.86 0.78 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.193 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 59' ' ' ILE . 2.3 mp -71.05 143.78 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -133.05 144.76 50.24 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.397 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.98 47.33 89.66 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.58 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -109.93 135.55 50.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.65 120.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.672 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.751 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 38.6 mt -132.01 141.11 49.15 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.539 0.685 . . . . 0.0 112.785 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.623 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.7 ptm180 -53.61 129.05 31.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.095 164.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.0 t -91.78 21.07 5.04 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.26 0.552 . . . . 0.0 110.843 -173.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.69 -8.49 37.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.192 0.52 . . . . 0.0 110.675 -174.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.751 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 5.1 p90 -114.4 16.07 17.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.435 0.636 . . . . 0.0 109.938 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.547 HD13 HG21 ' A' ' 19' ' ' VAL . 82.4 mt -112.24 149.1 32.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.386 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.644 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.2 tmtt? -119.58 124.76 47.16 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.675 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.515 ' HA ' HG12 ' A' ' 19' ' ' VAL . 62.1 tttp -62.39 125.29 23.39 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.41 152.06 34.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.977 0.418 . . . . 0.0 111.015 -174.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.48 -40.52 2.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.774 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.335 178.803 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 m -142.66 147.58 35.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.971 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.643 ' HB ' ' HB3' ' A' ' 49' ' ' GLU . 48.6 pt -107.99 50.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.497 0.665 . . . . 0.0 110.103 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.68 99.43 0.79 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.119 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.738 HG22 ' HA ' ' A' ' 49' ' ' GLU . 2.6 t -81.95 127.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.091 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.43 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -129.48 160.52 32.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.881 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -172.84 1.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.779 0.323 . . . . 0.0 110.509 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 22' ' ' ILE . 11.2 p -54.88 -33.37 61.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.66 178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -81.33 -59.64 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.322 0.582 . . . . 0.0 110.647 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.23 25.21 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.722 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 128.23 35.56 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' ' 6' ' ' ARG . 18.6 mt -71.05 137.58 49.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.543 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 43' ' ' ILE . 87.3 mt -107.49 172.26 6.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.736 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.25 175.38 11.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.188 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 21.7 t70 -65.87 117.04 7.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.989 0.423 . . . . 0.0 110.796 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.6 10.15 38.89 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.983 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.559 ' OD1' ' HE2' ' A' ' 71' ' ' LYS . 1.4 t0 -90.08 174.87 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.58 143.89 47.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.643 0.735 . . . . 0.0 112.215 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.414 HG21 HD13 ' A' ' 69' ' ' LEU . 34.7 m -135.09 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.096 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.491 ' OG ' ' HG3' ' A' ' 39' ' ' MET . 73.9 m -153.2 157.82 40.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.542 HD12 HD23 ' A' ' 25' ' ' LEU . 3.9 mm? -70.15 129.13 38.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.889 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.769 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.2 pt -93.04 -4.76 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.769 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -164.22 179.34 6.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.272 -178.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.09 110.1 19.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.191 0.307 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.556 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 4.0 mm? -109.74 118.83 37.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.681 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.9 tmmm? -99.96 136.86 39.23 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.5 tt -78.59 145.18 34.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.105 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -84.88 -51.06 7.0 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -170.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.46 -49.83 50.3 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.465 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.6 m -131.49 145.23 51.66 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.4 p -70.04 74.52 0.47 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.367 0.603 . . . . 0.0 112.159 -174.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.1 m -105.62 106.97 17.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.538 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.681 HG22 ' HG3' ' A' ' 26' ' ' LYS . 4.2 t -91.65 106.96 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.896 0.379 . . . . 0.0 110.705 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.13 98.56 11.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.206 0.526 . . . . 0.0 109.934 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 21.9 mmmt -68.65 162.85 25.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.977 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -59.61 132.53 54.25 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.171 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.72 -15.92 40.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.726 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.489 ' HB ' HD23 ' A' ' 21' ' ' LEU . 59.9 m -56.2 121.93 10.58 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.491 ' HG3' ' OG ' ' A' ' 20' ' ' SER . 11.0 ttt -100.31 120.47 39.98 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.179 0.514 . . . . 0.0 111.039 -173.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.63 HG12 HG22 ' A' ' 56' ' ' THR . 47.9 mt -109.84 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.669 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -102.18 135.81 43.11 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.874 -179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.88 51.13 1.3 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.414 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.586 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -100.51 165.29 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.703 0.287 . . . . 0.0 110.322 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.5 ptp180 -142.19 158.47 43.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.394 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.488 HD22 ' CG2' ' A' ' 5' ' ' VAL . 34.8 mt -78.15 138.47 38.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -107.48 -172.4 2.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.658 -171.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.34 -35.75 78.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.684 0.754 . . . . 0.0 109.217 171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.578 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 71.3 m -88.02 147.12 25.14 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.208 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.738 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.76 -1.4 26.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.842 0.83 . . . . 0.0 109.593 174.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 66' ' ' THR . 36.1 t70 -95.94 -5.69 40.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.81 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 7.6 mt-10 -133.3 157.9 44.3 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.559 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.535 ' HA ' ' OG1' ' A' ' 46' ' ' THR . 7.3 pt -139.01 168.12 19.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.625 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' OE1' ' HD2' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -122.67 127.84 49.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.586 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -138.98 -170.98 11.99 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.274 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -135.86 143.01 44.84 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.173 0.511 . . . . 0.0 109.952 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.63 HG22 HG12 ' A' ' 40' ' ' ILE . 71.2 p -111.95 -171.17 1.79 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.454 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.74 -25.29 67.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.955 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -117.19 -63.04 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 111.019 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 mm -85.23 113.58 23.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.46 -174.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -101.41 146.69 27.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.26 47.69 69.87 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.016 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -107.53 133.35 52.13 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.6 t -92.49 117.46 35.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.814 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.614 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 23.7 mt -127.34 143.97 51.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.135 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.599 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.8 ptp180 -59.66 133.35 56.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.377 172.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 50' ' ' ASP . 13.1 t -89.37 31.83 0.89 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.487 0.661 . . . . 0.0 110.732 -175.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 16.3 mt-10 -85.3 -32.4 22.52 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.58 0.705 . . . . 0.0 109.795 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.614 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 38.2 p90 -112.92 15.95 19.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.366 -172.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 19' ' ' VAL . 61.3 mt -112.64 142.31 45.39 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.337 0.589 . . . . 0.0 110.294 -178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -115.32 132.82 56.49 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.767 -177.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.559 ' HE2' ' OD1' ' A' ' 17' ' ' ASP . 13.0 tmtt? -66.07 120.54 13.34 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.83 -72.99 0.2 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -167.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.64 -123.21 1.03 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.97 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.858 -0.592 . . . . 0.0 110.632 -179.289 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.922 0.392 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.3 m -99.78 126.66 45.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.113 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 pt -110.83 56.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.402 0.62 . . . . 0.0 110.891 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.509 ' HB3' HD21 ' A' ' 12' ' ' LEU . 41.4 mt-10 -54.67 121.85 9.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.423 177.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 49' ' ' GLU . 5.8 t -105.24 123.92 59.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.05 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.54 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -131.14 158.79 39.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 30.0 p-10 -80.27 -169.75 2.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' HG21 ' A' ' 22' ' ' ILE . 26.7 p -67.34 -19.24 65.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.192 0.52 . . . . 0.0 110.665 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -80.29 -48.67 12.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.844 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 17.18 2.85 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.612 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.53 133.22 35.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.54 HD23 ' HG3' ' A' ' 6' ' ' ARG . 19.8 mt -72.7 135.91 45.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.102 0.477 . . . . 0.0 111.354 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -104.04 168.74 8.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.749 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.48 172.98 14.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.669 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.0 t70 -63.95 120.73 12.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.968 0.414 . . . . 0.0 110.134 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.12 3.79 44.83 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.975 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -84.28 174.85 9.82 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -139.9 132.85 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.328 0.585 . . . . 0.0 111.094 -178.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.575 HG21 HD13 ' A' ' 69' ' ' LEU . 29.7 m -124.77 173.62 10.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.004 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 m -150.49 151.95 33.48 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.962 0.411 . . . . 0.0 111.146 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.671 HD12 HD23 ' A' ' 25' ' ' LEU . 4.1 mm? -65.03 127.12 30.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.78 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.6 HG21 ' SG ' ' A' ' 8' ' ' CYS . 35.0 pt -90.31 -11.97 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.26 0.553 . . . . 0.0 110.765 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.584 ' HG3' ' CD2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -154.47 -178.81 7.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 35' ' ' LYS . 1.6 m-20 -96.79 110.22 22.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.671 HD23 HD12 ' A' ' 21' ' ' LEU . 3.6 mm? -103.8 146.63 28.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' HG2' HG13 ' A' ' 33' ' ' VAL . 55.5 mtmt -126.76 123.27 37.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.207 0.527 . . . . 0.0 110.446 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.581 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 3.3 mm? -110.71 173.52 6.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.174 -169.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -85.06 -173.09 4.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.321 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.08 -108.42 3.58 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -95.05 26.36 3.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.7 m 58.17 73.61 0.46 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.871 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 19.7 m -83.3 103.12 12.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.184 -175.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.512 HG13 ' HG2' ' A' ' 26' ' ' LYS . 51.6 t -93.59 108.47 20.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.237 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 38' ' ' THR . 30.6 mt -100.16 91.76 4.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.308 177.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HD2' ' HB3' ' A' ' 24' ' ' ASP . 29.0 mmmt -70.51 164.61 24.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.363 -175.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 36' ' ' ARG . 39.0 ttt-85 -56.43 133.57 53.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.563 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.79 -10.2 64.29 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.184 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.418 ' HB ' HD23 ' A' ' 21' ' ' LEU . 87.3 m -57.23 124.0 17.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.142 0.471 . . . . 0.0 110.291 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 ttt -93.96 122.4 36.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.255 0.55 . . . . 0.0 111.281 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.841 HG12 HG22 ' A' ' 56' ' ' THR . 41.1 mt -110.8 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.069 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 13.3 ptt180 -108.76 159.28 16.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.719 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.2 39.63 15.44 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.634 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -91.05 161.85 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.874 0.368 . . . . 0.0 110.368 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 2.9 ptp180 -141.99 158.25 43.99 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.258 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 5' ' ' VAL . 30.9 mt -80.33 154.75 27.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.808 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.5 p -127.8 -167.13 1.71 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.232 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.42 -21.95 66.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.201 0.525 . . . . 0.0 110.324 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 70.8 m -85.09 142.87 29.23 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.91 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -90.03 -7.6 53.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.8 0.809 . . . . 0.0 108.969 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -116.39 -5.5 11.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.185 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 3.7 mp0 -125.25 144.4 50.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.372 0.606 . . . . 0.0 111.217 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.42 HG23 HG11 ' A' ' 5' ' ' VAL . 2.6 pp -134.32 156.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.146 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HB2' HG22 ' A' ' 63' ' ' VAL . 37.9 tt0 -115.32 130.56 56.94 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.634 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -148.92 -161.14 9.5 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.299 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -137.36 142.64 41.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.646 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.841 HG22 HG12 ' A' ' 40' ' ' ILE . 21.1 p -114.51 -172.21 2.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -73.74 -26.1 60.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.18 0.514 . . . . 0.0 109.768 174.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.48 -75.87 0.53 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.301 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mm -89.08 125.17 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.502 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -113.66 130.52 56.39 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.915 0.388 . . . . 0.0 110.289 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.0 47.04 5.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.756 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.3 pt? -115.09 136.08 53.51 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.184 0.516 . . . . 0.0 110.465 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 53' ' ' GLU . 45.7 t -89.48 119.34 36.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.791 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.0 mt -129.9 147.36 51.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.917 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.577 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 2.4 ptp85 -65.18 130.25 42.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.954 172.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.525 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.8 t -85.58 30.69 0.62 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.44 0.638 . . . . 0.0 110.592 -176.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.577 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 17.9 mt-10 -88.03 -21.32 24.84 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.825 0.822 . . . . 0.0 109.706 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.58 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 33.8 p90 -117.97 18.41 13.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.563 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.575 HD13 HG21 ' A' ' 19' ' ' VAL . 68.0 mt -115.54 148.34 39.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.104 -178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -125.07 128.64 48.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.75 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.06 119.21 11.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.06 -64.8 0.84 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.325 -172.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.8 75.19 0.59 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.841 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.433 178.217 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mtp . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -64.79 112.38 3.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.189 0.518 . . . . 0.0 110.506 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -118.63 63.43 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.748 0.785 . . . . 0.0 109.227 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.52 ' HB3' HD21 ' A' ' 12' ' ' LEU . 30.5 mt-10 -56.13 112.52 1.23 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.699 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 49' ' ' GLU . 4.1 t -104.52 126.12 59.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.285 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.55 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -129.66 163.38 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.618 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 32.4 p-10 -80.07 -165.01 0.75 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.783 0.325 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.711 ' SG ' HG21 ' A' ' 22' ' ' ILE . 24.3 p -74.86 -8.59 56.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.25 0.548 . . . . 0.0 110.646 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -91.83 -44.66 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.686 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.22 13.25 3.61 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.301 -176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.7 130.76 38.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.55 HD23 ' HG3' ' A' ' 6' ' ' ARG . 19.8 mt -66.7 143.57 56.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 112.241 -176.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -109.93 169.13 8.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.21 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' ASP . . . -160.37 177.93 10.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.87 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 11.2 t70 -66.84 122.84 18.59 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 14.74 41.19 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.747 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.482 ' C ' HD22 ' A' ' 18' ' ' ASN . 0.7 OUTLIER -91.14 165.01 13.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -117.96 147.86 42.76 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.539 HG22 HG21 ' A' ' 43' ' ' ILE . 28.0 m -143.82 171.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.119 175.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -152.11 157.56 41.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.747 0.308 . . . . 0.0 111.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.653 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -69.6 124.19 23.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.632 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.711 HG21 ' SG ' ' A' ' 8' ' ' CYS . 40.5 pt -91.93 -12.77 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.269 0.557 . . . . 0.0 110.572 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.635 ' HG2' HG13 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -150.95 173.6 14.11 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.25 -177.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.17 122.76 32.77 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 21' ' ' LEU . 3.7 mm? -117.48 116.1 26.47 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.931 0.396 . . . . 0.0 110.71 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.73 ' HG3' HG22 ' A' ' 33' ' ' VAL . 2.4 tmmt? -97.18 129.4 44.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.281 0.562 . . . . 0.0 109.497 176.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 34' ' ' LEU . 4.0 mm? -99.94 155.39 17.71 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.529 -173.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -76.23 176.56 7.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.797 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.33 -87.19 0.81 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.567 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -80.16 -0.91 38.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.434 0.159 . . . . 0.0 111.394 -176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m 60.17 32.96 21.08 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.316 0.579 . . . . 0.0 110.122 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 27' ' ' LEU . 5.0 m -66.67 108.99 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.391 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 26' ' ' LYS . 21.0 t -95.9 99.33 9.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.498 HD13 HD23 ' A' ' 27' ' ' LEU . 5.8 mp -85.87 145.68 27.07 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 175.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 27.4 mmmt -110.5 163.62 13.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.49 0.662 . . . . 0.0 111.379 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -60.86 149.29 36.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.719 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.21 -3.04 79.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.898 176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.458 ' HB ' HD23 ' A' ' 21' ' ' LEU . 84.5 m -68.08 121.84 16.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.746 0.308 . . . . 0.0 110.509 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.1 ttm -87.86 129.38 35.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.365 0.603 . . . . 0.0 111.192 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.67 HG12 ' HB ' ' A' ' 56' ' ' THR . 52.0 mt -122.14 92.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.973 172.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -106.87 136.26 47.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.031 0.443 . . . . 0.0 111.012 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.82 52.09 1.22 Allowed Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.583 HG22 ' HA3' ' A' ' 54' ' ' GLY . 1.8 pp -104.41 164.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 10.2 ptp85 -143.91 165.4 27.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.239 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD22 ' HB ' ' A' ' 5' ' ' VAL . 30.7 mt -80.67 150.88 29.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.052 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.9 p -111.99 -155.97 0.58 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -79.62 -8.53 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.094 0.473 . . . . 0.0 109.736 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 44.4 t -94.99 161.81 13.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.702 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' HA ' HG22 ' A' ' 5' ' ' VAL . 33.8 mt-10 -101.02 -5.29 26.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.774 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 66' ' ' THR . 5.1 m-20 -131.5 0.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.297 -176.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 3.6 mp0 -120.43 143.41 48.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.104 0.478 . . . . 0.0 110.185 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.11 165.33 32.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.873 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' OE2' ' HA2' ' A' ' 61' ' ' GLY . 4.0 tm-20 -125.04 125.56 44.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -151.94 -166.78 14.38 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.676 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 35.6 ptt180 -134.16 145.08 48.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.67 ' HB ' HG12 ' A' ' 40' ' ' ILE . 9.3 t -122.73 -177.95 3.79 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -65.06 -18.73 65.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.724 0.297 . . . . 0.0 111.458 -177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.437 ' H ' HG23 ' A' ' 56' ' ' THR . 62.0 mttm -100.69 -73.38 0.64 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.134 175.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mp -94.85 122.63 46.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.988 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 60' ' ' LYS . 1.6 ptmm? -104.26 121.41 43.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.819 0.342 . . . . 0.0 110.518 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.456 ' HA2' ' OE2' ' A' ' 53' ' ' GLU . . . 89.6 52.48 2.65 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.703 177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.5 pt? -116.13 140.71 49.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.035 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.1 t -93.69 116.57 35.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.082 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.598 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 31.7 mt -130.17 152.66 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.245 0.545 . . . . 0.0 111.988 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.584 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 ptt180 -72.93 131.04 41.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.48 173.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' HD12 ' A' ' 69' ' ' LEU . 10.2 t -85.6 25.86 1.01 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.659 -175.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 65' ' ' ARG . 1.3 pt-20 -83.33 -19.9 35.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.626 0.727 . . . . 0.0 109.667 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.598 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 26.8 p90 -118.31 17.51 13.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.055 -178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.523 HD13 HG21 ' A' ' 19' ' ' VAL . 76.1 mt -114.21 149.07 36.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.444 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.618 ' HD3' ' OD2' ' A' ' 7' ' ' ASP . 2.6 tmtt? -119.54 129.06 54.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.666 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HZ2' ' CG ' ' A' ' 17' ' ' ASP . 39.9 tttp -62.05 116.49 4.97 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.73 31.93 0.75 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.981 0.419 . . . . 0.0 111.406 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.15 -15.45 74.52 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.601 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.595 177.652 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.256 0.074 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m 69.76 136.75 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.724 0.64 . . . . 0.0 111.644 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.619 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 21.0 pt 38.83 54.24 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.621 1.168 . . . . 0.0 113.421 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.507 ' HB3' HD21 ' A' ' 12' ' ' LEU . 42.4 mt-10 -78.82 85.38 4.81 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.388 170.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.754 HG11 HG23 ' A' ' 52' ' ' ILE . 2.7 t -78.58 121.67 32.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.226 -175.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -126.29 151.59 47.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.969 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -77.37 -172.05 2.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.637 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HG2' ' A' ' 70' ' ' LYS . 26.7 p -65.11 -23.64 67.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.602 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.17 -28.62 31.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.563 177.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.14 15.73 12.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.229 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.7 136.05 33.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 4' ' ' GLU . 17.7 mt -70.51 138.75 51.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.559 . . . . 0.0 111.658 -177.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.428 ' HB3' HD11 ' A' ' 43' ' ' ILE . 94.7 mt -104.63 173.53 6.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.06 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.2 173.36 14.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.128 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 29.2 t70 -64.84 121.34 14.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.344 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.27 31.55 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.024 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.91 173.93 6.83 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 122.826 -0.22 . . . . 0.0 111.147 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 11.3 p30 -131.22 139.45 49.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.619 0.723 . . . . 0.0 112.092 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.557 HG12 ' HA ' ' A' ' 71' ' ' LYS . 29.3 m -140.45 172.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.036 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.5 m -152.55 157.03 40.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 0.0 111.625 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 25' ' ' LEU . 4.0 mm? -66.9 135.73 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.381 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.745 HG13 ' HG2' ' A' ' 23' ' ' LYS . 38.3 pt -97.1 -8.32 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 111.092 176.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.745 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -159.63 175.71 12.88 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -176.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.36 110.3 21.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.601 HD23 HD12 ' A' ' 21' ' ' LEU . 4.3 mm? -100.18 125.65 46.36 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.578 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' HG3' HG13 ' A' ' 33' ' ' VAL . 10.7 mptt -93.84 148.01 22.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.233 0.54 . . . . 0.0 110.514 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -126.81 154.53 44.17 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.954 -174.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -99.27 147.07 25.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.801 176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.9 -74.38 0.44 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.8 m -111.04 17.09 20.77 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.5 m 58.64 38.97 25.05 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.379 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 m -75.57 121.44 22.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.808 -176.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 26' ' ' LYS . 58.6 t -114.16 107.97 24.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.51 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.27 145.65 29.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.845 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 24.9 mmmt -110.59 158.55 18.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.407 0.623 . . . . 0.0 111.774 -174.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -61.61 134.92 57.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.267 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.49 -9.36 64.63 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.053 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.461 ' HB ' HD23 ' A' ' 21' ' ' LEU . 97.6 m -59.5 124.56 20.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.815 0.308 . . . . 0.0 110.316 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.8 ttm -96.55 124.92 40.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.516 0.674 . . . . 0.0 111.038 -176.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.451 HG12 ' HB ' ' A' ' 56' ' ' THR . 52.0 mt -115.14 94.47 3.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.002 174.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 18' ' ' ASN . 0.4 OUTLIER -111.23 147.13 35.68 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -177.352 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.23 39.03 5.51 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.624 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.1 pp -89.99 166.7 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 120.906 0.384 . . . . 0.0 110.278 -177.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 5.7 ptp85 -140.29 158.07 44.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.936 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.555 HD22 ' HB ' ' A' ' 5' ' ' VAL . 39.7 mt -84.12 130.51 34.85 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.9 p -93.43 -171.62 2.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -82.55 6.96 15.83 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.572 0.701 . . . . 0.0 109.497 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.2 m -103.64 143.66 32.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.48 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 3' ' ' ILE . 17.3 mt-10 -87.58 -25.14 23.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.359 0.6 . . . . 0.0 109.936 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 66' ' ' THR . 9.2 m-20 -96.94 -7.31 33.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.136 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 9.6 mp0 -126.87 147.74 50.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.545 0.688 . . . . 0.0 111.5 -176.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.754 HG23 HG11 ' A' ' 5' ' ' VAL . 2.5 pp -131.6 168.45 23.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.339 173.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.25 129.31 53.99 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.624 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -141.21 -165.86 10.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.074 -175.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 18.3 ptt85 -152.41 141.0 20.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.177 0.513 . . . . 0.0 110.046 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.451 ' HB ' HG12 ' A' ' 40' ' ' ILE . 9.0 t -131.8 -174.79 3.52 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.526 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' OD1' ' HG3' ' A' ' 58' ' ' LYS . 3.9 p30 -63.57 -24.54 67.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 111.475 -176.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 27.8 mtmm -98.85 -72.31 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.076 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.8 mm -100.2 127.47 53.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.636 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 11.5 ptmm? -114.78 139.84 49.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.416 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.65 30.66 39.07 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.411 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -101.81 139.9 36.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.32 116.88 36.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.761 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -128.37 144.51 51.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.579 0.704 . . . . 0.0 111.996 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.569 ' HB2' ' HG3' ' A' ' 67' ' ' GLU . 13.8 ptt180 -66.16 135.83 55.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.43 173.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 50' ' ' ASP . 9.0 t -89.23 30.51 0.97 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.568 0.699 . . . . 0.0 110.561 -176.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 31.0 mt-10 -80.1 -31.8 39.21 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.944 0.878 . . . . 0.0 109.501 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 48.8 p90 -116.77 16.57 15.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.441 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.58 145.61 36.09 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.163 0.506 . . . . 0.0 109.871 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -119.74 128.47 53.8 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.588 -178.268 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.557 ' HA ' HG12 ' A' ' 19' ' ' VAL . 58.5 tttp -63.36 127.81 33.0 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.65 165.72 23.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.806 -169.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.96 -27.93 5.52 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.579 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.373 -0.822 . . . . 0.0 109.508 179.158 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.742 0.306 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 m -135.07 -176.31 4.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.572 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.3 pt -128.33 44.46 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.145 0.497 . . . . 0.0 109.698 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 12' ' ' LEU . 34.7 mt-10 -59.41 116.07 3.7 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.567 0.698 . . . . 0.0 111.886 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.636 HG11 HG23 ' A' ' 52' ' ' ILE . 4.6 t -96.99 127.61 49.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.077 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HG3' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -128.03 148.68 50.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 177.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -73.98 -171.13 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.627 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 22' ' ' ILE . 26.5 p -63.82 -29.12 70.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.125 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.97 -25.89 56.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.917 0.389 . . . . 0.0 110.852 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.38 18.93 13.23 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.962 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.23 136.25 36.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.782 0.325 . . . . 0.0 110.137 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.568 HD23 ' HG3' ' A' ' 6' ' ' ARG . 25.6 mt -67.93 138.3 55.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.759 -177.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.2 mt -108.13 170.29 8.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.155 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.42 174.16 15.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.455 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 19.9 t70 -67.68 114.16 6.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.845 0.355 . . . . 0.0 110.357 175.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.49 2.27 29.25 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.65 173.05 11.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -136.12 141.68 44.19 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 111.411 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 71' ' ' LYS . 31.3 m -134.88 177.03 7.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.342 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.2 m -151.07 153.24 34.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.83 0.348 . . . . 0.0 111.321 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.601 HD12 HD23 ' A' ' 25' ' ' LEU . 4.2 mm? -64.21 128.52 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.7 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.721 HG13 ' HG2' ' A' ' 23' ' ' LYS . 42.2 pt -90.53 -11.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 110.773 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.721 ' HG2' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -156.99 -178.28 7.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.174 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.55 117.18 26.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.601 HD23 HD12 ' A' ' 21' ' ' LEU . 3.9 mm? -118.42 116.36 26.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.174 0.512 . . . . 0.0 110.631 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 33' ' ' VAL . 1.6 tmmt? -82.82 138.89 33.79 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.656 176.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 28' ' ' LYS . 9.0 tt -63.86 145.17 56.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.827 -174.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.472 ' N ' HD23 ' A' ' 27' ' ' LEU . 84.5 tttt -42.02 121.5 1.84 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.19 0.931 . . . . 0.0 111.722 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.67 -119.87 5.63 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.924 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 p -151.71 109.8 3.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.629 0.252 . . . . 0.0 110.66 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 t -167.31 -77.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.225 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -104.17 130.66 51.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.616 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 26' ' ' LYS . 33.1 t -107.16 103.57 15.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD23 HG21 ' A' ' 38' ' ' THR . 6.0 mp -82.36 149.18 27.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.926 0.393 . . . . 0.0 110.543 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 22.4 mmmt -109.86 163.16 13.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.655 -175.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttt-85 -61.25 137.83 58.23 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.142 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.03 -14.88 59.77 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.52 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.476 ' HB ' HD23 ' A' ' 21' ' ' LEU . 88.2 m -56.61 119.93 6.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 110.039 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.1 ttt -94.05 122.91 37.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.363 0.601 . . . . 0.0 110.753 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.412 HG12 ' HB ' ' A' ' 56' ' ' THR . 46.3 mt -110.54 90.51 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.797 175.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.506 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -104.67 137.6 42.25 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.371 -175.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.02 50.45 2.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.379 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.567 HG22 ' HA3' ' A' ' 54' ' ' GLY . 2.2 pp -97.18 164.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 3.7 ptp180 -142.83 157.79 44.27 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.655 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.543 HD22 ' HB ' ' A' ' 5' ' ' VAL . 32.9 mt -75.64 155.1 36.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.665 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -121.69 -167.87 1.6 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.79 -20.08 65.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 173.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 67.6 m -85.75 147.74 26.19 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.954 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' HA ' HG22 ' A' ' 5' ' ' VAL . 28.1 mt-10 -96.14 -13.8 23.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.503 0.668 . . . . 0.0 109.517 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -106.85 -5.92 18.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.862 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 2.0 mp0 -127.96 146.56 50.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.335 0.588 . . . . 0.0 111.44 -176.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.636 HG23 HG11 ' A' ' 5' ' ' VAL . 2.7 pp -131.09 166.62 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.304 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 31.2 tt0 -117.92 124.84 49.23 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 43' ' ' ILE . . . -137.04 -166.16 10.69 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.059 -1.067 . . . . 0.0 113.085 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 15.5 ptp180 -148.0 141.2 25.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.119 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.412 ' HB ' HG12 ' A' ' 40' ' ' ILE . 8.9 t -134.2 -171.93 2.87 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.022 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.63 -40.01 93.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.199 0.523 . . . . 0.0 110.751 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -80.58 -65.9 0.95 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.316 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mt -116.21 130.24 71.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.28 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . 12.6 ptmm? -112.26 136.95 51.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.272 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.69 39.8 13.55 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.209 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' H ' HD23 ' A' ' 62' ' ' LEU . 2.4 pt? -110.54 138.64 46.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.907 0.384 . . . . 0.0 109.983 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 43.4 t -93.23 116.77 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.518 HD22 ' HZ ' ' A' ' 68' ' ' PHE . 25.9 mt -128.69 145.6 51.12 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.391 0.615 . . . . 0.0 111.796 -177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.619 ' HG3' ' CE2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -64.11 130.88 45.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.235 173.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' HD12 ' A' ' 69' ' ' LEU . 9.5 t -86.41 26.47 1.06 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.647 -175.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 65' ' ' ARG . 32.5 mt-10 -84.0 -25.51 29.91 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.938 0.875 . . . . 0.0 109.392 -175.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.619 ' CE2' ' HG3' ' A' ' 65' ' ' ARG . 32.1 p90 -113.98 16.95 18.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.61 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 66' ' ' THR . 65.1 mt -114.17 145.84 41.14 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.953 -179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -118.7 125.59 50.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.124 -178.021 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.569 ' HA ' HG12 ' A' ' 19' ' ' VAL . 54.3 tttp -62.65 122.37 15.68 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.392 0.432 . . . . 0.0 110.125 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.7 116.61 27.95 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.67 -25.09 70.74 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.1 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.77 178.13 . . . . . . . . 0 0 . 1 stop_ save_